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Abstract 
Aim: 
The overall aim of the study was to investigate the performance of the EQ-5D-Y, a self-reported Health 
Related Quality of Life (HRQoL) outcome measure, in children between eight and twelve years of age. The 
study objectives were to examine the measure’s psychometric properties of criterion validity, 
discriminant and concurrent validity, when used on children with different health statuses, and to 
determine its ability to detect change within the different groups over a period of time. The study also set 
out to determine whether a life event had an impact on HRQoL, and whether children and their therapists 
or parents shared the same perceptions of HRQoL. The feasibility of using the EQ-5D-Y as a routine, 
additional, physiotherapy assessment tool was monitored. The study also assessed the usefulness of the 
collected data to the therapists administering the measure to children under their management. 
Method: 
A longitudinal, analytical descriptive study design was used. Typically developing children attending a 
Main Stream (MS) school (105), children with lifelong physical disabilities at a Special School (SS) (35), 
chronically ill children at an institution (CI) (32) and acutely ill children in hospital (AI) (52) were recruited.  
The EQ-5D-Y was the primary outcome measure, and was administered at baseline and again at three 
monthly intervals, or, in the case of AI children, at admission and discharge. The PedsQL as a parallel 
HRQoL measure, the WeeFim as a functional measure and the Faces Pain Scale (FPS) to monitor pain 
were used. A self-designed questionnaire was completed by the therapists treating the children to assess 
feasibility and usefulness of the EQ-5D-Y.   
Data analysis: 
Descriptive statistics were used to describe the sample and the health conditions of the participants. 
Reliability of the measures was determined at different time intervals by Cohen’s kappa coefficient for 
dimension scores. Spearman’s rho and Intraclass Correlation (ICC) were used to determine reliability of 
Visual Analogue Scale (VAS) scores and also total scores of the measures over time. The same analysis 
was used to compare self-reports and proxy reports. Kruskal-Wallis ANOVA by ranks, median scores and 
mean rankings were used to examine discriminant validity between known groups, using the same 
outcome measure and convergent validity between similar dimensions on different outcome measures. 
Responsiveness was described by examining the effect size of the Wilcoxon Signed-rank test. The VAS 
score was compared against the ranking of different levels of the dimensions, across groups, using Kruskal 
Wallis H statistic. A discrepancy between changes in VAS and changes in Worried, Sad or Unhappy (WSU) 
dimension were examined after three months to determine whether these were related to life events 
and/or changes in management of health condition. The clinical feasibility of using the EQ-5D-Y and its 
usefulness as an additional evaluation tool in providing a holistic assessment of the child’s condition was 
established by analysing the frequency of positive responses on the questionnaire.   
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Results: 
A total of 224 children were recruited. The level of problems on the dimensions was associated with 
institution and in all cases, apart from Mobility, the AI children reported more problems. The EQ-5D-Y 
only demonstrated discriminant validity between the MS children and AI children. The MS group scored 
significantly lower ranked scores on all dimensions and a significantly higher VAS (better overall HRQoL) 
compared to the AI group with more problems on each dimension and lower VAS. When comparing VAS 
across the mean ranking on each dimension, it was found to be significantly correlated at the AI only.    
Convergent validity between EQ-5D-Y and PedsQL was evident only at the AI for all similar dimensions. 
The other groups demonstrated convergent validity with some, but not all of the dimensions. Convergent 
validity was evident between the EQ-5D-Y VAS and total scores of PedsQL and WeeFIM (p<.05 in all cases) 
across institutions.  
The treatment effect over time was largest in the AI.  
For all groups, there was limited agreement between proxy and self-report at a dimension level, except 
for Mobility with moderate to good agreement. Even though the proxy and self-report VAS scores 
demonstrated good (.58) ICC overall, at an institutional level, this was only significant in the MS children. 
The EQ-5D-Y only took five minutes to complete. Six of the nine therapists who took part in the study, 
found the measure easy to apply, used the information in the management of the child and would 
continue to use it in future. 
Conclusion: 
The performance of the EQ-5D-Y, as determined by the psychometric properties, was variable. It could 
discriminate between children with an acute illness and children in the MS school. In addition, good 
convergent validity was demonstrated in the AI children and the largest treatment effect was observed in 
these children. However, it does not perform as well in children with no health condition or chronic 
conditions and should be used with caution in these groups. HRQoL did not appear to be linked to a life 
event. It is recommended that both proxy and self-report measures be taken into account when assessing 
a child’s HRQoL but these should not be used interchangeably. It appears to be feasible and useful to 
include the EQ-5D-Y in routine assessments. It was concluded that the EQ-5D-Y self-report can be used 
with confidence as an outcome measure for acutely-ill children. 
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1 Chapter 1: Introduction and Scope of Thesis 
1.1 Introduction 
 
Quality of life (QoL) is a concept which reflects many aspects related to the lived human experience 
and subjective sense of well-being. Most QoL definitions refer to how well an individual’s needs within 
a particular context are met and how satisfied or dissatisfied the individual is in various life areas. 
These life areas are variously known as domains or dimensions (2)(3)(4).  
 
Health Related Quality of Life (HRQoL) is a multi-dimensional concept, which concentrates on the 
impact of disease or a health condition and its treatment on a person’s daily life.  HRQoL outcome 
measures are typically questionnaires on which an individual self-reports on their experience in the 
various dimensions. Common dimensions in HRQoL outcome measures are physical, psychological and 
social (5)(6)(7). The essence of HRQoL measures is that they are Patient-Reported Outcomes (PRO) 
(8)(9), focussing on how a health condition impacts an individual’s daily life, from their own 
perspective (10). 
 
There are fewer outcome measures available for assessing HRQoL in children compared to the wide 
range of measures available for adults (12)(11). However, since about 2005, a growing interest in 
HRQoL of children has led to the development of various new outcome measures for use in the 
paediatric population (12). One of these outcome measures developed specifically for children 
between the ages of eight and twelve years is the European Quality of Life (EuroQoL) Five Dimension – 
Youth Version (EQ-5D-Y).  
 
The EQ-5D-Y is a short and easily-administered questionnaire in which children self-report on the 
extent of their problems in five dimensions, namely “Mobility” (walking about), “Looking After Myself” 
(LAM) (self-care), “Doing Usual Activities” (UA) (for example going to school, hobbies, sports, playing, 
doing things with family and friends), “Having Pain or Discomfort” (P/D) and “Feeling Worried ,Sad or 
Unhappy” (WSU). Scores are given for each dimension, and another score on a graduated Visual 
Analogue Scale (VAS) is provided for overall health status (13). The EQ-5D-Y, is one of the few 
paediatric HRQoL measures which have taken the views of the children for whom it is intended into 
account, during the development process (13). This was achieved through cognitive interviews with 
the children to assess their understanding of the wording and whether they found it acceptable to use. 
 
The scores generated by HRQoL outcome measures may be used in epidemiological and clinical 
research studies, for the evaluation and planning of the medical management of an individual, for 
assessing the performance of health care systems, and for determining resource allocation (13)(1)(11). 
In order to utilise the EQ-5D-Y for these purposes, this measure must be reliable and valid when used 
in children with different health conditions. Following the initial development of EQ-5D-Y, Ravens-
Sieberer et al (2010) (1) went on to assess the feasibility, reliability and validity of the measure when 
used with typically developing (TD) children from the general population. It was then recommended 
that the measure should be applied in a longitudinal, clinical study. The current research study sets out 
to examine the performance of the measure by comparing the responses of healthy children and 
those with chronic and acute health conditions in response to this recommendation.  The primary 
research question was: How reliable, valid and responsive to change is the EQ-5D-Y when used with 
children who have a health condition? Secondary questions were: Do the EQ-5D-Y dimension scores 
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correlate to the VAS in children with chronic health conditions? Is the EQ-5D-Y a useful and feasible 
instrument to use routinely within a clinical setting? 
1.2 Aims and objectives 
1.2.1 Aim 
The aim of the study was therefore to investigate the psychometric properties of the EQ-5D-Y and, 
thereby, to establish whether the measure is reliable, valid, and responsive, as well as feasible to use 
in children with different health statuses (as grouped in different institutional settings).  
1.2.1.1 Specific objectives 
This study recruited a sample of children between eight and twelve years of age from four different 
institutional settings; [1] a Main Stream (MS) school, all of whom were typically developing (TD); [2] a 
Chronic Care Institution (CI) for children with a chronic health condition; [3] a Special School (SS) for 
children with a chronic physical disability; and [4] acutely-ill children from an Acute Institution (AI). 
The specific objectives of this study were:  
 To determine the test-retest reliability of the EQ-5D-Y (performed in pilot study, Appendix 14). 
 To compare the intra-rater reliability of EQ-5D-Y and Paediatric Quality of Life Inventory 
(PedsQL) when repeated over a period of time, thus establishing the stability of the measures 
in the groups hypothesised to have a stable HRQoL (i.e. children attending MS school with no 
serious health conditions and children attending a SS with stable, chronic, physical disabilities) 
 To compare inter-rater reliability of the EQ-5D-Y between self-report and proxy report by 
determining if their description and perception of HRQoL differ (i.e. between children with a 
health condition and their physiotherapists and between MS children and their parents).  
 To investigate construct validity by examining both discriminant and convergent validity. 
o The discriminant validity of the EQ-5D-Y was examined by comparing the HRQoL 
profiles of the different groups of children.  
o Convergent validity was examined by comparing dimensions of EQ-5D-Y to similar 
dimensions on: 
 The PedsQL, another paediatric measure of HRQoL,  
 The WeeFIM , measure of functional independence  
 The Faces Pain Scale (FPS), a paediatric measure of pain. 
 To compare the responsiveness to change of the EQ-5D-Y, PedsQL, WeeFIM and FPS over 
time. It was hypothesised that there would be a large improvement in HRQoL over time in the 
AI group of children and slight improvement in CI group. No change was expected in the MS or 
SS groups.  
 To establish whether there is concordance between reporting of problems in the five EQ-5D-Y 
dimensions and the Visual Analogue Scale (VAS). It was anticipated that the VAS, which is an 
indication of overall global HRQoL, should improve in tandem with improvement in the five 
EQ-5D-Y dimensions, over time, as an indication of improved health condition or function. 
 To establish whether changes in HRQoL were related to life events and/or changes in 
management of health condition.  The specific research questions related to this objective 
included whether family related incidents, introduction or cessation of specific treatment 
regimes, change in pain management or surgical intervention influenced HRQoL. It was 
anticipated that HRQoL would mirror changes in these variables to a certain extent.  
 To assess the clinical feasibility and usefulness of using the EQ-5D-Y by determining the time 
taken to complete the measure, whether there were any difficulties in collecting the data and 
whether the data gathered has been used by the clinical physiotherapists in decision making 
regarding prioritisation of problems and management of the child’s condition. 
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1.3 Rationale and significance of the study 
This research study was conducted to further the development of the EQ-5D-Y outcome measure, by 
examining whether the measure performed equally well in TD children; children with a chronic 
disability; with a chronic health condition without a physical disability and acutely-ill children.   
 
A few studies subsequent to the original Feasibility, Reliability and Validity study of the EQ-5D-Y (1), 
have used the measure to compared HRQoL in children with a chronic health condition and healthy TD  
children. These studies found that the children with a chronic health condition reported a higher 
overall HRQoL on the VAS than those of MS children, whereas their dimension scores indicated greater 
problems (14)(15)(16). This finding raised the question as to whether this might have been an example 
of the occurrence of RS.  If so, RS may have an effect on the psychometric properties of the HRQoL 
measure and could influence clinical management and decision making.  
 
The ability of the EQ-5D-Y to detect a response to change in HRQoL over a period of time, has not yet 
been fully investigated. This study will examine which group of children demonstrated responsiveness 
on the EQ-5D-Y.    
 
Even though the EuroQol website states that the EQ-5D-Y VAS, overall global HRQoL, can be used as a 
quantitative measure of health outcome as judged by individual respondents, there is little data 
concerning the psychometric properties of the EQ-5D-Y when applied to children with health 
conditions or disabilities.  
 
If the EQ-5D-Y is found to be useful by the physiotherapists administering the EQ-5D-Y, in targeting 
their management to better address the problems identified by the child, routine inclusion of the EQ-
5D-Y in assessments at each research facility could be implemented. In this case, under-graduate 
physiotherapy students should also be taught to use the measure as an outcome measure in 
paediatrics.  
1.4 Outline of the study 
In preparation for this dissertation, a comprehensive review of the literature was conducted. The 
primary themes explored included QoL and HRQoL, especially within the paediatric population, as well 
as the use and psychometric properties of some commonly-used paediatric HRQoL outcome 
measures. This is presented in Chapter 2. The methodology of the study, which followed a 
longitudinal, descriptive, analytical design, is presented in Chapter 3. The data were subjected to 
various statistical analyses depending on the particular research question being addressed and the 
results are reported in Chapter 4 followed by a discussion of the results for each research question in 
Chapter 5.  Finally, a conclusion section, including recommendations for practice and future research, 
completes the dissertation (Chapter 6). 
 
2 CHAPTER 2: LITERATURE REVEIW 
2.1  Introduction  
This chapter describes a detailed review of related literature for the various objective of the study. 
Data were sourced from the following online databases: PubMed, CINAHL, EBSCO and Google Scholar. 
Key words included: quality of life, health related quality of life, paediatric HRQoL measures, EQ-5D-Y, 
PedsQL, WeeFIM, psychometric properties, reliability, validity and responsiveness. Only full-text 
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journal articles and web articles published in the English language were considered. A time limit for 
articles was not set as research in the area of HRQoL increased in interest in the 1990’s. However 
emphasis was placed on paediatric HRQoL literature published between 2005 and 2015, as this was 
the period of prolific research on the subject. 
 
The review will define QoL and, particularly, HRQoL. A summary of the reasons for assessing HRQoL 
will be presented. This will be followed by a description of the different types of paediatric HRQoL 
measures, as well as a discussion concerning their use. The general psychometric properties pertaining 
to HRQoL measures will also be described. 
2.2 Quality of Life 
To understand the concept of HRQoL, it is necessary to first understand what is meant by QoL, how it 
is measured and factors influencing the reporting on the concept. The concept of QoL is widely used in 
the literature, but it is well documented that agreement on its definition is lacking (3)(17)(18)(19)(20). 
The most commonly-used definition is that of the World Health Organization (WHO) which defines 
QoL as “an individual’s perception of their position in life in the context of the culture and value 
systems in which they live and in relation to their goals, expectations, standards and concerns” (21) 
(page e299). Within this definition the term “individual’s perception” implies that it should be a self-
report, determined by the individual (whether adult or child), concerning their own experience of their 
“position in life” or particular set of circumstances in which they live. The use of “in the context of the 
culture” suggests that the person’s ethnic customs and traditions may have an influence on their 
perceptions and “value systems”. This further implies that their moral standards and beliefs may 
influence their perception of QoL. All of these personal traits will shape the individual’s “goals” or 
ambitions, and “expectations” or outlook on life. A person’s perception of QoL is also influenced by 
their “standards” or values and “concerns” or anxieties regarding the life situation in which they find 
themselves.  These many factors may influence an individual’s satisfaction, well-being or happiness 
with their situation in life and all need to be taken into account when assessing QoL.  
 
There are many other varied definitions describing QoL as it would not be possible for this complex, 
abstract concept which measures objective needs and subjective satisfaction in the many contexts in 
which it is used, to have a single definition (17)(22)(23). The multiple definitions of QoL depend on 
which vocation/profession is defining it, whether community, group or individual well-being is being 
examined and  which indicators of QoL are being are assessed(24)(2)(8). For example, the psychology 
profession would define QoL with emphasis on psychological and emotional well-being, while the 
economic or environmental vocations might place more emphasis on material well-being or work 
related satisfaction. The medical profession would place more emphasis on health conditions and how 
disease and its management affect well-being. 
 
There is no single theoretical model of QoL as it is multi-faceted, covering numerous life areas and 
whether an individual’s requirements and aspirations in these areas are met.  The different 
dimensions examined in QoL outcome measures vary in significance depending on what indicators or 
items of a life situation are being assessed. Measurable, objective dimensions  may include indicators 
of socio-economic status, educational and literacy level, physical and/or mental health and life 
expectancy and the extent to which an individual’s needs in these areas are met (2)(4).  Subjective 
dimensions include indicators of personal values and beliefs, philosophies, traditions, politics and 
family and social relationships and require self-report on how satisfied, happy or fulfilled the individual 
is in these areas. The objective and subjective domains are interlinked; for example, an individual’s 
socio-economic status may enhance or limit their satisfaction in social relationships (2)(3). QoL may 
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also be affected by the environment; for example, a disabling or enabling environment plays a role in 
the Qol of a person with a disability. However, their dissatisfaction or satisfaction could change as 
their expectations change or if they are given the resources to adapt to the environment to meet their 
needs (2)(4).  
 
There is some concern among researchers as to whether or not QoL can in fact be defined and 
assessed, because little is known about how individuals reach a qualitative judgement regarding 
satisfaction or well-being. Research has shown that cognitive and linguistic processes are used by 
individuals in making this qualitative judgement  (17). Individuals are generally required to respond to 
abstract concepts such as “to what extent is your problem?” or “how satisfied are you?” and, 
therefore, need to have a good understanding of the expressive language being used.  Figurative 
language is also sometimes used in QoL items, such as “I feel sad or blue” or “it is hard to walk more 
than one block”. Not all individuals may be familiar with these expressions or language use and  they 
may respond differently, which could affect the quantitative analysis of the qualitative data (17). 
 
As the use of Qol outcome measures increases, continued development of the theoretical models is 
needed, ensuring that they are cross-culturally valid. Different cultures may have different 
interpretations of the same word or even have different opinions of what constitutes satisfaction and 
well-being, which could affect the measures psychometric  properties (25)(26).  
2.3 Health Related Quality of Life 
In the area of health, the impact of disease or treatment of disease on QoL is relevant and a specific 
aspect of QoL, termed Health Related Quality of Life (HRQoL) has been identified.  HRQoL is a multi-
dimensional concept, which focusses on the physical, psychological and social impact of a health 
condition on a person’s daily life socially and it is ever-changing (5) (6) (7). The physical dimension may 
include items such as mobility, activities of daily living, energy levels and pain. The psychological 
dimension may include positive and negative feelings, self-esteem, memory, concentration and 
anxiety. Relationships with family, friends and within a community may constitute the social 
dimension (25). Other indicators of QoL, such as socio-economic status, the environment in which the 
individual functions and access to education may also influence perceived satisfaction of the 
individual’s HRQoL (3). HRQoL refers to an individual’s well-being in the above dimensions, despite 
certain limitations imposed on them by their health condition or disability. At this point, it is necessary 
to define “health” in order to understand what constitutes “health” and how it relates to QoL. 
 
The current WHO definition of health was first described in 1948 and has never been changed. It 
describes health as, “a state of complete physical, mental and social well-being and not merely the 
absence of disease or infirmity” (27) (page 1). With regard to HRQoL, this definition has certain 
limitations which were discussed by Huber et al (2011) in a paper following a conference of 
international health experts in the Netherlands (28).  The main limitation was in the absoluteness of 
the words “complete well-being”, which may not be applicable as no-one is completely healthy all of 
the time. With increasingly advanced screening for diseases, some sub-clinical health conditions may 
now be identified before symptoms negatively affect a person’s QoL. However, in these cases, the 
term “complete wellness” would also not apply. Disease patterns have changed since 1948 with 
improved healthcare. Populations are living longer, often with chronic health conditions which are 
well managed with improved pharmaceutical drugs and have minimal negative impact on QoL. 
However, according to the WHO definition, people living with a chronic disease or disability would be 
defined as ill. This definition of health does not take into account the ability of  an individual to adjust 
to life’s changing physical, emotional and social challenges and still live a fulfilling life (28)(4). 
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Huber et al (2011) proposed that the definition of “health” be changed to include, “the ability of an 
individual to adapt and self-manage in the face of social, physical and emotional challenges”(28) (page 
1). In terms of their perceived HRQoL, the ability of an individual with a health condition to change 
their own methods of managing daily life and/or their environment in order to become more 
independent is seen as more important than their complete recovery from the condition (28). 
Another limitation of the WHO definition of health is the phrase “A state of complete physical, mental 
and social well-being and not merely the absence of disease or infirmity” (27) (page 1). This implies 
that children born with a health condition or disability or develop the condition very early in life and 
therefore do not know any other way of life, would also be defined as ill, which is not how they 
perceive themselves. As most HRQoL assessments are based on the WHO definition of health, children 
born with a disability would have a different frame of reference to the concept of health (29), 
compared to TD school children, who have never experienced living with a disability or chronic health 
condition. This could affect the validity of the measures and could lead to under-estimation of their 
QoL (30). 
Health care professionals, researchers and policy makers are becoming more interested in the impact 
of disease or treatment of disease on perceived QoL of patients and their families. HRQoL measures 
provide health care professionals with a self-report, completed by the patient, concerning the 
patient’s perspectives on how disease or the treatment of disease positively or negatively impacts 
their life. As such, HRQoL assessments may be used in conjunction with objective outcome measures 
which only monitor clinical changes, to holistically assess a patient. Self-reporting on HRQ0L may also 
reveal subjectively experienced problems not apparent to an outside observer (31)(11). Assessing the 
patient’s subjective experience of how the health condition affects their perceived QoL can assist 
clinical decision making by health care professionals. This may also be useful when examining the 
effectiveness of clinical trials in research and can assist health economists in making resource 
allocation decisions. However, before using HRQoL outcome measures for these purposes, it is 
important to verify that they have robust psychometric properties of validity, reliability and 
responsiveness (33). 
2.3.1 HRQoL in children  
The measurement of HRQoL in children between eight and twelve years, is the focus of this thesis and 
will depend on each child’s experiences and perceptions and on how important the life dimension 
being assessed is to the individual child. Two children with the same health condition may report a 
different  HRQoL but the emphasis should always be on self-reporting from the individual’s 
perspective (32). Following on from the key components in the WHO definition of HRQoL, the 
dimensions assessed in the HRQoL self-reported outcome measures are typically physical, mental, 
social and environmental (2). However, the items in each dimension vary depending on which HRQoL 
questionnaire is used.   
 
The physical dimension includes functional items which are assessed as the ability to perform activities 
required for daily living (33). Function refers to the execution of a task, but does not imply that 
everyone performs the task in the same manner. Three separate studies investigating  HRQoL and 
function in youths and young adults with spina bifida found that limitations in physical functioning did 
not negatively affect self-perceived HRQoL or limit the range of life experiences lived by the 
participants (34) (35) (36). A study determining associations between function and well-being in 
ambulatory children with cerebral palsy found that functional measures were good at predicting 
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functional well-being in HRQoL, but poor at predicting overall HRQoL, as there were no direct 
associations between the two (37). Another study investigating perceived HRQoL in children found 
that children with a disability and limited functional ability, did not perceive their HRQoL to be any 
worse than healthy, TD children (16). Therefore, there is a need to further investigate the reliability 
and validity of HRQoL measures in children with a chronic disability or health condition and whether 
these children who would be expected to report significant problems on individual dimension levels, 
report a high overall HRQoL or not. If they do report a high overall HRQoL despite problems on 
individual dimensions, it could affect the measurement properties, as it is generally expected that the 
level of problems in the dimensions would be reflected in the evaluation of overall HRQoL (38)(39). 
 
In contrast, three studies examining the impact of pain on function and HRQoL, found significant 
relationships between results on a pain measure, a functional measure and HRQoL (40)(41)(42). It 
would seem that while functional limitations in children with a disability might not negatively affect 
their overall HRQoL, pain is more likely to affect function and overall HRQoL.  
2.4 Reasons for assessing HRQoL 
Self-reported HRQoL has become increasingly recognised as an important supplementary 
measurement in assisting health professionals in clinical practice (11)(43)(44), in empowering patients 
(45)(46)(47), in research and clinical trials (48)(49)(31) and in analysing cost effectiveness of health 
programs (50)(51)(52).   
2.4.1 Clinical practice and patient empowerment  
 HRQoL assessments can be useful in clinical practice to enable health professionals to improve both 
the ‘quality of care’ and ‘health care provider-patient’ communication, especially in the paediatric 
population (53)(11). 
Using appropriate age related HRQoL measures to obtain information on how the health condition 
affects the child’s life, from the child’s perspective and using this information when planning an 
intervention, improves the effectiveness and sustainability of the intervention. It ensures that the 
patient’s priorities are met which may be surprisingly different from that of the health care 
professional. This shared decision making has been shown to improve compliance in the treatment 
process (47). Studies by Wang et al 2011 (45) and Izard et al 2014 (54) demonstrated how health care 
providers could use HRQoL measures to empower their patients.  The authors emphasised that 
discussing how different health care options could influence their HRQoL and by allowing the patient 
to be involved in choosing the option best suited for their perceived needs could empower them to 
achieve satisfaction in their life.  
Routine use of subjective self-report measures on health could ensure that health care providers do 
not overlook any functional, psychological or social problems patients might be experiencing, but may 
be hesitant to disclose (43). Some patients might be unwilling to initiate discussion of these issues, but 
by completing a  HRQoL questionnaire the issues become apparent to the health care provider and 
communication with the patient improves (11). Using HRQoL measures to guide and encourage 
discussions  could also result in improving patients’ understanding their health condition as well as 
their sense of control in the management of  their condition (54).  
HRQoL may be measured in both the chronically- and acutely-ill patients. Even though the primary 
outcome for acutely-ill individuals is survival, followed later by restoration to their previous health 
state, self-reported measures may be administered to assess sudden and relatively short lived changes 
in HRQoL while in hospital. Acutely-ill individuals often experience initial deterioration in some or even 
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all the dimensions of HRQoL. This reduced HRQoL may be temporary and generally improve with 
treatment of the acute condition and pain management, or may persist after discharge from the acute 
care setting (55) (56). Frequent assessment of pain in the acutely-ill patient is necessary in order to 
effectively manage it. One method of assessing pain may be by self-reporting on a pain scale (57). The 
effect of an acute illness on the long term HRQoL could also be assessed (55)(58).  
 
Patient self-reporting may be used, in conjunction with objective clinical findings, to monitor the 
efficacy of interventions  with regard to an improved or worsened health condition (7)(11)(44). Wilson 
and Cleary (1995) (59) developed a conceptual model of HRQoL linking HRQoL measures with clinical 
measures, such as biological and physiological function. They emphasised the importance in clinicians 
linking clinical findings to reported QoL, in order to plan effective treatment strategies.     
2.4.2 Research and clinical trails 
Researchers are interested not only in the clinical outcomes of new interventions, but also in how the 
intervention affects the patient’s HRQoL. Direct reporting by the patient on their subjective 
experiences of the impact a health condition has on their everyday life adds to the holistic information 
researchers need when evaluating new technologies (31)(7)(46). A new drug may prolong the life of a 
patient, but is also important to investigate whether it has improved the patient’s HRQoL because 
prolonged and improved HRQoL may be a more desirable outcome (48). When evaluating new 
technologies, objective measures may indicate improvement in body structures, but may not 
necessarily indicate improvements in daily functioning or perceived HRQoL. These concepts could be 
evaluated directly with HRQoL measures (7). 
2.4.3 Evaluating cost effectiveness and use of Quality Adjusted Life Years (QALYs) 
Both the cost and benefit of health care interventions need to be evaluated when economists decide 
on resource allocation (60)(52) and HRQoL assessments could be used to guide this analysis. It has 
been recognized that basing resource allocation on objective clinical outcomes alone may be 
misleading (50) and that quality of life and length of life are both important when determining cost 
value of any program.  The QALY, ‘Quality Adjusted Life Years’ was developed as a unit indicating the 
effectiveness of a health care program in terms of length and quality of life (50)(61). The QALY is  a 
single index obtained by combining the length of time spent in a particular health state and the HRQoL 
weighting or utility score given to that health state (3). Some HRQoL measures include standardised 
quantitative scales or quality of life index scores which were developed using different methods of 
attaching preferences or utility scores to different health states.  Measures which produce a single 
index score (utility preference score) on a 0 to 1 or +1 to -1 scale (which is needed to calculate ‘Quality 
Adjusted Life Years’ – QALY) are the most useful, where 1=full health and 0=death. Negative scores 
mean a health state worse than death. The use of QALYs allows for the comparison  across many 
health states (60) (51)(62) of cost effectiveness of interventions, in terms of length of life and HRQoL. 
2.4.4 Health utility measurements 
The different methods used to produce a health utility preference score (index score) or HRQoL 
weighting are described by Whitehead and Ali (2010) (51). There are direct and indirect methods, the 
latter being more appropriate as it is based on pre-scored, generic, preference-based measures. Of the 
direct methods the Visual Analogue Scale (VAS) is the simplest. A single vertical scale, the top and 
bottom of which indicates the ‘best health” and ‘worst health’, respectively, is used by the individual 
to mark where on the scale a particular health state would be.  
The Time Trade-Off (TTO) method asks individuals to choose between living for 10 years in an 
impaired health state and living for fewer years in full health. They are then asked to determine how 
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much time they would be prepared to lose to avoid living in a diminished health state. At this point the 
HRQoL can be weighted e.g. if the cut-off point is 6 years, then the weighting is 0.6 (6 divided by 10). 
 The Standard Gamble (SG) method asks the individual to choose between the certainty of remaining 
in a particular health state or taking a gamble of either being in full health or a chance of dying. The 
probability of death is altered until the individual is indifferent between certainty and the gamble (51). 
The data generated from some HRQoL measures, such as the EQ-5D-Y are ordinal and for research 
purposes it is useful to use value indexes to develop a summary measure against which to compare 
with other measures which do sum dimension scores (63). 
The adult EuroQol 5 Dimensions (EQ-5D ), the Short Form-6 Dimensions (SF-6D),  and the Health 
Utilities Index Mark 2 and 3(HUI2 and HUI3) are examples of generic HRQoL measures providing a 
single index score (64)(61). The EQ-5D used the TTO valuation method and the SF-6D and the HUI used 
the SG method (51).  
Until recently, the HUI 2 was one of the few HRQoL measures that produced preference weightings for 
the different dimensions, with which to summarise a child’s HRQoL, on a QALY scale (61). One USA 
health valuation study used SG to produce a summary Paediatric Asthma Health Outcome Measure 
score on a QALY scale (65), and another more recent study by Craig et al (2015) (66) used adult 
preferences for child health states on the EQ-5D-Y, to produce a summary score on a QALY scale (66).  
The QALY values produced by Craig et al were based on the values of 4155 adult respondents who 
participated in an exercise choosing between losses in HRQoL and/or life span, in children with a 
health condition. Even though the values developed by Craig et al were used in this study to allow for 
the calculation of a composite score, the Index Score, it should be noted that they have not yet been 
formally adopted by the EuroQoL Group. In addition, as the scores are said to be QALY values and not 
weights to be used in QALY calculations, it would be difficult to use these in economic evaluation in 
which a weight should be multiplied by the time in which the condition is spent. 
A question arises as to whose valuations should be utilised, child or parent proxy. Adults are ultimately 
responsible for the child’s health and have to make the resource allocation decisions in paediatric 
health care so their valuations would be valid. The cognitive ability of the child to complete the 
valuation task might be a challenge and therefore the  task would probably then fall back on the 
parent proxy, which in essence would be adult valuation (67).  
There are many reliable and validated HRQoL instruments varying in health and disease aspects, age 
ranges and population groups, and in length and time needed to complete. In research, an important 
consideration when choosing an appropriate HRQoL measure is the study design and population being 
assessed, as different measures may significantly affect the statistical analysis of HRQoL (68). 
2.5 Generic or specific HRQoL measures 
HRQoL assessments may be generic or disease specific. Generic measures tend to assess basic function 
required for physical, emotional and social well-being (69)(20).  They usually cover a range of 
dimensions, including function, functional incapacity and emotional distress that apply to most health 
conditions (70). Generic HRQoL measures enable comparison across different health conditions and 
with healthy populations, by providing a health profile of different aspects of QoL, in one outcome 
measure. This is achieved by a scoring system, which may generate a score for each dimension or even 
a total score, commonly known as an index.  They are normally used to assess general health status 
and are able to depict changes in overall health status after treatment, meaning they are responsive to 
change over time (20)(71)(72)(20).  
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Another benefit of generic, preference- based measures, of HRQoL is that they can be used as a utility 
measure, which is used to analyse the cost effectiveness of an intervention related to the number of 
Quality Adjusted Life Years (QALY) gained. A QALY is generated by combining a description of the 
health state with survival. Patients’ preferences for an intervention and its outcome are determined 
by measuring QoL as a single number somewhere between 0.0 (being death) and 1.0 (being full 
health). This can be achieved by one of two methods. The first being when a patient is asked a number 
of questions about their health and function and then classifying them into a particular category based 
on their responses. Each category has a QoL number between 0.0 and 1.0 assigned to it, which was 
determined by previous group’s ratings for that health state. The other approach is to ask patients to 
give a single rating to all aspects of their QoL. This can be achieved by using the Standard Gamble 
method, which requires patients to choose between remaining in their present health state or to take 
a gamble between dying immediately or being in full health for the remainder of their lives. The 
probabilities between immediate death and full health are varied until the patient chooses a particular 
QoL state. A simpler method of this is used in the Time Trade Off method, which requires patients 
decide on how many years in their present health state they would be willing to trade for a shorter life 
span in full health (70) (72). 
 
A limitation of generic measures is that they do not provide information needed to detect changes in 
specific disease related symptoms (24).  
 
Therefore in contrast to generic measures, the dimensions in disease specific measures of HRQoL are 
specific to one particular health condition and more sensitive or responsive  to changes in symptoms  
for that particular condition, but are unable to demonstrate comparisons between different diseases 
or comparison with the healthy population (11) (24)(73) (71). Disease specific measures are also not 
suitable if the patient has more than one health condition (32). 
 
Generic measures were preferable for this study as they enabled comparisons across different health 
conditions and have been shown to capture responsiveness to treatment over time.  
2.6 Paediatric HRQoL (p-HRQoL) measures 
The age of the respondent also informs the choice of outcome measure and there are several 
measures specific to children of different ages. Child health interventions need to be assessed, the 
same as adult health interventions and it is useful to know more about the child’s HRQoL and the 
impact of disease from their own perspective. This has been found to differ from the adult’s 
perspective of the child’s HRQoL in some cases (74)(75)(76)(76). As the essence of HRQoL measures is 
to assess the impact of a health state on the individual’s QoL from their own perspective, measures 
appropriate for the child’s developmental age are essential. Research has shown that paediatric 
HRQoL measures have rendered results, especially in the psychological dimension, that health service 
providers might not otherwise have been aware of (77)(11)(76). There has been a general under 
identification of psychological problems experienced by children. The need to include how this affects 
children’s daily life has been emphasized in a study in children with diabetes mellitus type 1(78). 
Different frameworks than those used for adults need to be considered when assessing children’s 
HRQoL. It is important to consider the context in which the child functions, as well as developmental 
changes that take place as the child matures (77)(79)(24). Children function within many different 
settings, such as within the family, at school, with friends and within the community and each of these 
environments will have an impact on the child’s HRQoL. The child is best able to report on the impact 
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of the health state within a school context and with friends, as this is often not directly observed by a 
parent (77). 
2.6.1 Essential elements of p-HRQoL measures 
Paediatric HRQoL measures need to take the cognitive development of a child into account 
(74)(79)(29). Children’s understanding of health and their perceptions of how the health condition 
impacts their lives will change as they mature, as will their priorities  on what is important to their 
HRQoL (80). 
Language comprehension and reading level of the targeted age group is another consideration (77). It 
has been found that children as young as five years can reliably and validly self-report on their HRQoL 
with age appropriate measures (81)(77)(82)(83).  Studies conducted on eight year old children have 
found that they are reliably able to respond to a Likert Scale (77)(82)(84); have a reliable recall period 
of up to four weeks (77);  and, as they have a longer attention span than younger children, are able to 
complete longer, more complex measures (77). Eiser & Morse (2001) (32) and Rajmil et al (2004) (20) 
reviewed the content of some generic HRQol measures for children. They found that items in the 
physical dimension of the various instruments were age related, including [a] physical activities 
requiring maximal effort, such as sport; [b] participation in everyday activities, such as walking; and, 
[c] physical symptoms, such pain and tiredness.  Mental or psychological dimensions included [a] 
negative feelings such as feeling worried, sad, difficulty with sleeping or being teased; [b] positive 
feelings such as happiness, ease of making friends and being able to do the same things as other 
children; and, [c] cognitive abilities where assessed mostly by asking about difficulty with paying 
attention in the classroom and coping with schoolwork. The items in the social dimension of the 
various instruments were very varied, but most included [a] the ability to make friends; [b] school 
functioning; and, [c] family involvement (32)(20).  
2.6.2 Value of p-HRQoL measures 
The child’s experiences within these contexts will have a bearing on their psychological and social 
development as they mature into adulthood. Likewise, as the child with a chronic health condition 
develops into adolescence and then adulthood, generic longitudinal monitoring of HRQoL may provide 
researchers with a better understanding of the changes, the influences, and adaptations that occur 
over time to form the child’s concept of a good or deteriorating HRQoL. This might be more useful 
than objective changes in specific indicators of the health condition (23)(11)(79). Health care providers 
and clinicians would also benefit from tracking the changes in HRQoL in children with chronic 
conditions in order to focus and adapt their management appropriately as the maturing child’s 
priorities change (11) (85). Physical, cognitive and emotional growth will also be taking place in 
children with a chronic health condition, which could affect their perceptions of the impact of their 
health condition on their HRQoL and measures need to take this into consideration (86). 
 
2.6.3 The EQ-5D-Y 
The EQ-5D-Y measure has specifically been developed by the EuroQol Group, keeping in mind all the 
considerations mentioned above (82) (20). Wille et al (2010) (13) described the development of the 
EQ-5D-Y by an international task team from seven different countries. The adult version, EQ-5D, was 
modified in language and comprehensibility to be appropriately in line with an eight to twelve year old 
child’s cognitive level (81)(20). This modified version was translated into Swedish, Spanish, Italian and 
German. The EQ-5D and the EQ-5D-Y were then randomly assigned to just under 3000 children and 
adolescents from German, Spain and South African children. The children completed either the adult 
or youth version and it was found that the EQ-5D-Y was generally easier to complete, with fewer 
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missing values. This was followed by cognitive interviews with the children to determine their 
understanding of the measure. Following further minor revisions, the English language version was 
adopted as the source version. 
2.6.4 Challenges in p-HRQoL 
Self-reporting by children has however raised a number of issues regarding the reliability and validity 
of the child’s reporting (12) and, there is a need to investigate this further, particularly in children with 
a health condition, as most research has been conducted on typically developing children. Some of 
these challenges are:  
2.6.4.1 Proxy reporting measures 
In some cases, when the child is unable to report a reliable and dependable account of their own 
perception of HRQoL, a proxy report may be needed. This could arise if the child is too young to 
understand the concept of HRQoL, is cognitively impaired or too ill to reliably self-report 
(87)(88)(89)(90). Any individual who knows the child fairly well may provide a proxy report. This could 
be a parent, caregiver, school teacher or health care provider(91). However it has been found that 
there is often poor agreement between the proxy report and the child’s self-report, in cases where it 
has been possible to compare the two (16)(92)(15)(77). It would seem that parents consider disease-
related symptoms and physical ability or lack thereof as factors negatively affecting their child’s 
HRQoL, whereas the child generally places less importance on this. Proxies may not always be aware 
of the extent of the emotional impact a health condition has on a child and they tend to under-report 
on this dimension (81)(26)(93). Parent proxy reporting may also be influenced by their own hopes for 
their child, their own perceptions of QoL and their own psychological health. This may cause a 
discrepancy between child and parent’s perceived impact of the disease on the child’s HRQoL and 
lends weight to the importance of  HRQoL being reported by the child directly, whenever possible 
(16)(15)(94)(95). 
As mentioned earlier, there is debate as to who should report on HRQoL for evaluating health benefits 
for economic evaluations and resource allocation; that is, the parent or the child, particularly in light 
of the self-report/proxy discrepancies (52)(15). However, the ability of a child with a disability to adapt 
to their condition and reconceptualise their concept of HRQoL, the phenomenon known as RS, may 
lead to under reporting of the effect of that health condition on HRQoL and, as a result, may lead to a 
smaller resource allocation(15). Therefore, there is argument against using the child’s self-report for 
economic analysis.  
2.6.4.1 Response shift (RS) / Disability paradox  
There is a concern, when measuring HRQoL in individuals with a chronic disability, that ambiguous or 
paradoxical results may be found. This phenomenon is known as RS or the disability paradox and 
needs to be taken into account when measuring HRQoL in these individuals as it could affect the 
psychometric properties of HRQoL outcome measures thus rendering confusing results. RS refers to 
the change in perceived HRQoL that takes place when people with a disability adapt to a reduced level 
of functioning.  Albrecht and Devlieger first described this in 1999 in an attempt to explain why many 
people with a long standing disability reported that they experienced good QoL, whereas people 
without a disability perceived this state as unsatisfactory (96). A study on successful aging, by Van 
Faber et al 2001, also discussed this phenomenon of disability paradox. The study found that elderly 
people viewed successful aging as an ongoing adaptation to all the changes and obstacles they 
encountered. Limitations in their physical and mental domains were viewed as less important to their 
sense of well-being and QoL, than being able to participate socially (97).  
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Huber et al (2011) (28) maintained that people with a health condition who were able to “adapt and 
self-manage” in order to maintain a balanced physiological state and still participate in work and social 
activities generally reported a good HRQoL. The same was true for people with a mental disorder who 
were able to “adapt and self-manage” their condition. 
This ability of people with a chronic health condition to adapt to their situation, known as RS (98) or 
hedonic adaptation (10), is achieved by either changing their internal standards and values or their 
conception of HRQol. When analysing response shift it is useful to refer to the Spranger and Schwartz 
response shift model of HRQoL (38). This model refers to a “catalyst” (alpha change), usually an 
observable physiological change in the health condition, that initiates the need for a “recalibration” 
(beta change) in the individual’s internal standards of measurement, resulting in “reconceptualization” 
(gamma change) or change in the meaning or importance of the construct being measured 
(38)(98)(99).  
RS could be related to a sudden or gradual change in a health condition, an improving or deteriorating 
health condition or even the severity of the condition. Therefore, response shift is described in this 
model as the interaction between the “catalyst” (change in health condition), the “antecedent” (which 
could include demographics such as age, gender, socioeconomic group, education, personality type or 
spiritual belief) and the “mechanisms a person relies on to adapt” to change (such as individual coping, 
social and community support structures, and ability to change expectations)(38). RS could affect the 
reliability and validity of an outcome measure because, despite indicating a lot of problems in one or 
more dimensions of HRQoL, the person might still rate their overall HRQoL as good (39). 
This has been noted in some HRQoL studies on children with chronic functional disabilities due to 
spina bifida, who, as mentioned previously,  reported high levels of satisfaction with overall HRQoL 
despite having functional challenges in individual domains (29)(35)(34). RS may also occur in a child 
with a health condition who does not report a change in their sense of well-being or overall life 
satisfaction, despite obvious observable changes in the condition (15). 
Schwartz (2010) (99) highlighted the impact of RS on the psychometric properties of HRQoL outcome 
measures which need to be able to accommodate changes in perceived Qol. Reliability, validity and 
responsiveness of HRQoL measures can be affected by the participants’ differing conceptions of QoL. 
For example, for high internal consistency (reliability) and cross measure correlation (convergent 
validity), it is assumed that the participants all have the same conception of what is being measured 
and similar experiences to refer to. This is, however, unlikely between individuals with a long standing 
health condition, individuals with a sudden acute health condition and individuals with no health 
condition (99). 
 
Likewise, for high inter-rater agreement (reliability), participants would need to experience similar 
participation levels. However, some individuals with limited physical abilities may have adjusted their 
internal references and rate their participation in social activities as high, whereas an individual 
without physical limitations would not rate this level of participation as high (99). As discussed earlier, 
it would seem that more emphasis is placed on functional ability in HRQoL assessments, resulting in a 
person with a disability scoring low in this particular area, but their self-perceived overall HRQoL may 
be scored higher leading to paradoxical findings if RS is not considered (39). 
 
Therefore, some ambiguity may arise when interpreting the responsiveness of a measure. A measure 
might not reflect a change in HRQoL, despite evident objective changes in the health condition, as a 
result of well-developed coping mechanisms and this could influence the interpretation of clinical 
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findings (99). Likewise, a person with a disability may have poor coping mechanisms and this may 
affect many dimensions, without objective changes being evident (99)(39).  
 
RS may also  contribute to reported  low correlations between self and proxy reports of HRQoL, as was 
evident in a study by Jelsma and Ramma (2010) (15). 
 
G. Norman (2003) (100) proposed that ‘RS’ was not the only theoretical model to explain the 
ambiguity that occurred when some people assessed their HRQoL over time, but that ‘The Implicit 
Theory of Change’ was another method. According to Norman, when patients were asked to rate their 
health at six months and again at two years and then to rate their health retrospectively (thentest) for 
the earlier time period, they consistently re-rated the earlier time lower than they did initially. RS 
theory views the retrospective measure of health as being the more valid measure because new 
insight or new standards were available at the second testing. This is in contrast to ‘The Implicit 
Theory of Change’, which asks people to rate their HRQoL today and then work backwards and rate 
how they felt six months ago. Implicit Theory implies that accurate recall is not possible and that the 
retrospective rating of the initial health state was reconstructed and contextual changes may since 
have occurred. Therefore according to Implicit Theory the prospective rating is more valid. As a result 
it is unclear which theory is more accurate and RS remains a conundrum.  
 
Further research into developing guidelines for detecting response shift and its effect on the 
psychometric properties of HRQoL outcome measures is being conducted by Schwartz et al (2013) 
(98). 
2.7 Psychometric properties of HRQoL outcome measures 
One approach used in developing self-reported HRQoL measures is the psychometric approach,  which 
ensures that the scores generated are reliable (with regard to internal consistency,  test-retest and 
intra-rater), valid (construct and criteria) and responsive to change (101)(102)(32). The diagram below 
(Figure 1) demonstrates the relationships between the different psychometric properties of a HRQol 
measure. 
QUALITY of a HR-PRO
Internal 
cons istency
Rel iability
(test-retest, 
intra-rater, 
inter-rater)
Measurement error
(test-retest,
intra-rater,
inter-rater)
Content 
va l idity
Face
Cri terion va lidity
Construct va lidity
Structural
Hypothesis-
testing
Cross -
cultural
Responsiveness
 
15 
 
Figure 1: Relationships between psychometric properties (25) 
As decisions on the management of a health condition or the effect of a treatment may be based on 
the scores obtained from the HRQoL measure, it is essential that the scores are precise and not biased 
(102). Therefore, before a HRQoL measure can be used clinically or for research, its reliability, validity 
and responsiveness has to be fully investigated. These investigations need to be of a high 
methodological quality and, as HRQoL measures essentially assess abstract constructs which are not 
directly measureable, the establishment of the reliability and validity of the constructs are vital.  
A checklist based on the numerical criteria such as the Consensus-based Standards for the selection of 
health Measurement Instruments (COSMIN) is useful when designing a research study on the 
psychometric properties of a HRQoL measure, such as the EQ-5D-Y. The COSMIN checklist was 
developed to evaluate the methodological quality of studies assessing the psychometric properties of 
HRQol outcome measures. Fifty seven international psychology, epidemiology, statistical and clinical 
experts participated in a four-round Delphi study, resulting in a consensus regarding measurement 
criteria. This checklist that ensued provides information on design requirements, which measurement 
properties should be included and how these properties should be evaluated, using appropriate 
statistical analysis  (102)(25). Therefore, COSMIN was used in the discussion of this research study. The 
full checklist is in Appendix 1.  
A COSMIN taxonomy of relationships of HRQoL measurement properties was developed, and this 
encompassed three main areas, namely reliability, validity and responsiveness. Even though 
interpretability is not a measurement property, it was included as a characteristic (25). Each of these 
will be discussed as they pertain to HRQoL measures. 
 
2.7.1 Reliability 
According to COSMIN taxonomy, reliability, being the consistency with which a HRQoL measure 
produces the same results and is free from random error, should be examined by assessing internal 
consistency, test-retest reliability, intra-rater reliability and inter-rater reliability (Figure 2). 
 
 
       
        
        
        
     
 
  
        
        
        
        
        Figure 2: Adapted from “COSMIN taxonomy of relationships of measurement properties” - Mokkink et al 2010 (25). 
2.7.1.1 Internal consistency  
The design requirement for internal consistency refers to whether the HRQoL measure contains 
indicators or items which accurately describe the dimension being assessed.  The statistical methods 
used should assess the extent to which the measure is consistent within itself. An internal consistency 
statistic should be assessed for each separate dimension. Relationships between the individual 
dimensions and overall HRQoL may also be examined for internal consistency. Cronbach’s alpha 
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coefficient, a reliability index, can be used to calculate internal consistency reliability. Cronbach's 
Alpha gives a score of between 0 and 1, with 0.7 or above generally accepted as a sign of acceptable 
reliability (102)(103)(104)(105)(25).  
In the development of the KIDSCREEN HRQoL questionnaire, the internal consistency was high. 
Cronbach’s alpha for the dimensions of the 52-item measure ranged from 0.77 to 0.89 (106). 
Cronbach’s alpha for The Child Health Questionnaire with  50 items (CHQ-PF50) ranged from 0.39 to 
0.96 for the subscales, while the 28 item measure (CHQ-PF28) demonstrated satisfactory internal 
consistency ranging from 0.56 to 0.92 for the summary scales but internal consistency for individual 
subscales was low (107). 
As most HRQoL measures are multi-trait measures, the internal consistency of the various 
dimensions/subscales is expected to be low because different indicators are being assessed (for 
example, anxiety should not necessarily be related to mobility) (21)(22)(20). In this case, low 
consistency would indicate a reliable measure. In particular, the EQ-5D-Y dimensions do not share the 
same underlying latent construct and, therefore, would have a low internal consistency. 
2.7.1.2 Measurement error 
Measurement error may affect the reliability of an outcome measure. Measurement error is the 
difference between the actual value and the value obtained through measurement. Some degree of 
measurement error is inevitable and is caused by either the accuracy limit of the measuring 
instrument (the EQ-5D-Y outcome measure), the variable nature of the characteristic being measured 
(HRQoL) or by errors reported by the respondents (the sample of children recruited and proxies). 
Whether or not the error is random (factors randomly affecting the measure or sample) or systemic 
error (introducing bias), it may not affect the overall result or the effect may be limited. Random error, 
such as an error resulting from an individual’s mood, is not consistent and will vary the data but not 
affect the average overall performance of any group. Systemic error, a consistent error that affects all 
participants, will either raise or lower the results, causing bias. It is possible to apply statistical 
procedures to adjust for measurement error or to use multiple measures of the same construct 
(108)(103)(109). 
All these aspects of measurement error will be assessed in the research study. 
2.7.1.3 Test-retest reliability 
External consistency is assessed by test-retest methods which examine the stability of the measure 
over time. Test-retest reliability refers to the ability of a measure to produce the same results when 
conducted at different times. The design requirements are that testing is performed under the same 
conditions each time and on the same group (102). The statistical analysis for ordinal data, as in the 
EQ-5D-Y dimensions, to assess percentage of agreement between test and retest responses for each 
dimension, should make use of Cohen's kappa coefficient. Kappa values, interpreted according to 
Landis and Koch guidelines (110) may be either  poor, slight, fair, moderate or good. The intraclass 
correlation coefficient (ICC) can be calculated to determine agreement between test and retest VAS 
scores. An ICC of >0.7 is considered reliable and a p value of <0.05 is statistically significant.  
The time between the tests should be no longer than two weeks, as  children’s recall becomes 
unreliable after this period (102)(103). In this research study, test-retest reliability was assessed on 
consecutive days and the reason for doing so will be discussed later. 
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2.7.1.4 Intra-and inter- rater reliability  
The test-retest scores give an indication of intra-rater reliability (being the consistency a child 
demonstrates in scores at different time intervals) as long as the child’s health is stable and the test 
conditions are the same (25)(111). This will be evaluated in the study. 
Inter-rater reliability may be assessed for the extent of concordance between child self-report and 
parent proxy report, as described in some research articles (91)(92) (112). The difference in 
perspective between the self-report and proxy report is known as the inter-rater gap (112). Other 
research articles refer to the comparison of reports from different proxies, on behalf of the patient as 
inter-rater reliability (72)(113). This may be comparing proxy reports from both parents or parent and 
clinician proxy (113). The design requirement for this test is that the administrations are independent. 
Issues which may affect this reliability have been discussed as a discrepancy between the two groups’ 
different perceptions of HRQoL. Parents seem to relate overall HRQoL more to problems reported in 
individual items, whereas children do not link the two aspects. In addition, parents place more 
emphasis on functional disability, while children focus on what they can achieve (16)(83)(114)(15)(92). 
There also seems to be better agreement between observable characteristics of health, than 
subjective perceptions of overall health (83). This can be calculated using ICC or Kappa coefficients 
(92)(115)(24). Proxy and self-report measures will be compared in the study. 
The reliability of a measure is affected by a ceiling effect, which occurs when the scores of an 
independent variable are all grouped together at the highest level. This might be observed in HRQoL 
measures with limited response categories, which would prevent all variations being captured 
(90)(116)(1). In addition, if aspects relevant to a particular indicator of HRQoL, for a particular 
population, were excluded from a measure, it may not be able to discriminate between groups as a 
ceiling effect would occur, with all groups responding similarly (117). In the event of a ceiling effect in 
the three possible levels of response in measures such as the EQ-5D-Y (that is,  all the responses fall 
into one level of “no problems”), it may not be possible to confirm reliability using kappa coefficients 
as the intra-rater reliability will automatically be reduced to only one level of response (111). 
2.7.2 Validity (content, criterion and construct) 
Validity is the extent to which a measure tests the characteristics it sets out to measure. This can be 
assessed by examining content, criterion-related properties of the measure and construct validity. 
Error! Reference source not found. Figure 3: Assembled from “A psychometric toolbox for testing validity and reliability” – 
DeVon et al 2007(103) and “COSMIN taxonomy of relationships of measurement properties” - Mokkink et al 2010 (25). 
2.7.2.1 Content validity  
The general requirements needed to examine content validity are whether the various items in the 
measure cover all aspects or all symptoms of a particular health issue (103)(76). In order to ensure 
this, a full search of the literature would need to be conducted, followed by population sampling and 
the acquisition of expert opinions. The Patient-Reported Outcomes Measurement Information System 
(PROMIS) is developing item banks to ensure that all relevant items (for example, all subjective 
indicators of physical, mental and social well-being) for a particular construct are available when 
developing core sets for HRQoL measures (118)(1).  To assess content validity of HRQoL measures, 
each item in the measure is rated by an expert in the field. These ratings also validate the 
appropriateness and completeness of the items as indicators of HRQoL (102)(103)(45). Focus groups of 
a larger sample of the population with or without a particular health issue may also be used to rate 
the items.  
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Face validity is a subjective evaluation of the measure in which the measure looks as though it 
measures the constructs it is supposed to. It is the weakest method of assessing validity. 
2.7.2.1 Criterion validity 
Criterion validity refers to the relationship between the characteristics of an outcome measure and 
the criteria it is measuring. It is usually assessed by comparing the outcomes of the HRQoL measure 
with the outcomes of a separate measure. This may make use of a number of methods: 
Concurrent validity: 
Concurrent validity refers to the relationship between the response to an item on one outcome 
measure and the corresponding criteria of an item on another measure when tested at the same time 
(103)(86)(67)(67)(119). Criterion validity is often used in the development of a new measure to assess 
the relationship between items of a well-established measure, often called the ‘gold standard’ or 
‘most accurate validated measure’, against items of the new measure. The measures are tested at the 
same time and a consistent relationship between the two item scores deduces concurrent validity 
(24). 
Predictive validity: 
This refers to degree to which initial test scores on an outcome measure predict performance on test 
scores when tests are taken again in the future (103). 
Convergent validity: 
Convergent validity refers to the degree to which two measures that are theoretically similar are in 
fact, related, but they need not be tested concurrently and one measure does not need to be the ‘gold 
standard'. Therefore convergent validity tests whether constructs of HRQoL that are expected to be 
similar are, in fact, related and can be examined by correlating items from one HRQoL measure with 
similar items on another validated HRQoL measure (1). The inter-item correlation coefficients, 
Spearman’s rank for dimensions and Pearson’s correlation coefficients for overall HRQoL would be 
high between measures that have convergent validity (103)(25). The convergent validity between 
similar items on various outcome measures will be assessed in the study. 
Discriminant validity: 
Discriminant validity tests that constructs which should be different are, in fact, different and do not 
have any relationship. For example, literature indicates that children with a disability tend to 
demonstrate passive behaviour, so scores on a measure assessing functional disability should not 
relate to scores on a measure assessing personality traits (40).  The inter-item correlation coefficients 
would be low between measures that have discriminant validity (102)(103)(40). Discriminant validity 
may also be assessed by hypothesising how differently a group with acute illnesses and a group with 
chronic health conditions might respond to the same HRQoL measure. Testing a measure’s ability to 
discriminate between  two known  groups with different health conditions may, therefore, rely on 
hypotheses based on expert knowledge or previous literature pertaining to the expected differences 
between groups (86)(40).  This method will be used to determine discriminant validity of the measures 
used in the study. 
Convergent and discriminant validity are similar but complementary concepts. 
A potential problem may exist when comparing different HRQoL measures. HRQoL measures are 
multi-dimensional and multi-item, which are scored on an ordinal scale. For comparison purposes, 
total scores of dimensions, typically generated by summing item scores (which are ordinal), are used. 
Mathematically, ordinal data should not be summed but, rather, weightings should be attached to the 
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individual item scores in order to rank them. Investigating the relationship between the rank ordering 
of the dimensions is preferential in order to limit measurement errors and misrepresentation of 
results. Bias may also occur due to categorisation error if the HRQoL measure has only two to four 
dimensions with ordinal scores. This bias would be negligible if the sample size is large enough to 
detect a change in HRQoL indicators (109)(120). As the EQ-5D-Y data is ordinal, each dimension was 
described individually and the summed total was not used. 
2.7.2.1 Construct validity  
Construct validity, first defined by Cronbach and Meehl in 1995, determines whether the items in a 
HRQoL measure correlate with all theoretical concepts of the aspect of health being investigated. 
  
Structural validity:  
Construct validity may be assessed by looking at structural validity, which refers to whether the 
structure of the items in the dimensions are in fact indicators of the construct being measured 
(86)(25). Confirmatory factor analysis, also known as the multi-trait multi-method approach, analyses 
relationships among a large number of items in the HRQoL measure to derive a different smaller 
number of items and discover the most important factors. Items that do not relate to the important 
aspect of HRQoL being assessed should be removed. All items in a particular dimension should assess 
the same construct (102)(103)(104)(102)(121). 
Hypothesis testing: 
In ‘hypothesis testing’, a hypothesis based on a theoretical framework would indicate the direction in 
which the scores are expected; that is, the scores indicate consistency with the hypothesis and confirm 
or reject it  (122).   
 
Construct validity can also be measured using the ‘known group method’ in which two groups known 
to be different should produce significantly different scores for the construct being measured 
(88)(52)(81)(123). 
  
A measure with both convergent and discriminant validity, described under criterion validity, would 
have excellent construct validity.  
 
Cross cultural validity refers to whether the measure has been assessed across different cultures in 
different countries (124)(1).  
2.7.3 Responsiveness (and ceiling/floor effect) 
Responsiveness refers to the ability of a HRQoL measure to accurately detect a change in health 
status, however small. The design requirement is that the change in health status, which may be as a 
result of clinical changes, should be assessed over a described period of time. The deterioration or 
improvement in the health condition may also be due to the effect of treatment. Usually a hypothesis 
regarding the expected change in HRQoL scores are made prior to data collection (123)(125)(125) 
(126)(25).  
There are two types of responsiveness, internal and external. Internal responsiveness is when a HRQoL 
measure is administered before and after an intervention which is known to produce change. Internal 
responsiveness may be assessed using the distributional approach, which evaluates the statistical 
significance of the change in the pre- and post-intervention scores (126). However, a statistically 
significant change may not be of clinical significance and vice versa, which limits the ability of an 
instrument to measure internal responsiveness (125).   
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It is important to determine the clinical relevance of a change in self-reported HRQoL, and what causes 
this the change. One method of determining this is to use the ‘Minimally Clinical Important Difference 
Approach (MCID approach). This uses the patient’s own evaluation of the smallest meaningful change 
in their health status which would result in a  change in HRQoL score (48)(18). This is also known as the 
‘Anchor-Based Approach’, as it is anchored to the patient’s own perception of change in HRQoL 
(107)(127). Another method used to assess the clinical significance of a change in HRQoL score is the 
Effect Size (ES) approach, which relies on the use of statistical analysis and standard deviation (Std. 
Dev.) (48). ES is the ratio between change in mean scores and the Std. Dev. of baseline scores and is 
described as small (0.20), medium (0.50) or large (0.80) in the HRQoL literature (128) (81)(88)(117) 
(129)(49).  
There is no ‘gold standard method’ for calculating MCID, but ES seems to be the most common in 
HRQoL research (12).  
External responsiveness is when the changes depicted in one HRQoL measure are related to the 
changes depicted by another valid outcome measure; for example, when scores for mobility on a 
HRQoL measure are related to scores on a measure of functional ability. This is also known as the 
anchor-based approach (125)(130)(126)(131). 
As is the case with reliability, the responsiveness of the measure could be affected by a ceiling or floor 
effect, which occurs when a HRQoL variable is not able to show a change as the scores are at the 
highest (ceiling) or lowest (floor) possible level. If the participants initially score the highest or lowest 
possible level, the measure would not be able to detect change in their HRQoL as there is no room for 
improvement or decline (1)(132)(7)(119). For the measure to be of use to a health care provider, it 
needs to be able to detect change due to the effect of treatment. 
 
In this study, effect size was used to examine responsiveness of the various outcome measures, and 
ceiling effects were discussed. 
2.7.4 Interpretability 
The Cosmin requirement for interpretability was whether scores and changes in score were presented 
for each individual group being assessed, which was done in this study (25). 
2.8 Review of some generic HRQoL Paediatric Outcome measures  
2.8.1 Introduction 
This section presents an alphabetical summary of some of the more commonly-used, generic 
measures for assessing HRQoL in children between 8 and 12 years (Table 1). In addition, this section 
provides details concerning the development of these measures, as well as their psychometric 
properties (Table 2). 
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Table 1: Commonly used generic, paediatric HRQoL measures 
Measure  Country of 
origin 
Age 
range 
(years) 
Dimensions Number 
of items 
Proxy 
version 
Time to 
complete 
(minutes) 
1. Child Health 
and Illness 
Profile – Child 
Edition (133) 
CHIP-CE USA 6-11 1. Satisfaction (with self and 
health) 
2. Comfort (emotional, 
physical and limitations) 
3. Resilience 
4. Risk avoidance 
5. Achievement (social roles) 
 
45-self 
76-parent 
yes 20 
2. Child Health 
Questionnaire 
(134) 
CHQ USA 10-18 
(self) 
5-18 
(parent) 
1. Physical function 
2. Pain 
3. role/social-physical 
4. General health 
5. Perception 
5. Role/social emotional 
behaviour 
6. Mental health 
7. General behaviour 
8. Self-esteem 
9. Parental emotional impact 
10. Parental time impact 
11. Family impact 
87 (self) 
98,50  
or 28 
(parent) 
yes 30 
3. DISABKIDS 
Chronic 
Generic  
Measure (86) 
DCGM Europe 4-16 1. Mental 
2. Social 
3. Physical 
6, 12 or 
37 
yes  
4. EuroQol Five 
Dimension – 
Youth Version 
(13) 
EQ-5D-Y Multi 
national 
8-12 1. Mobility (Walking about) 
2. LAM (looking After Myself) 
3. Doing my UA (Usual 
Activities) 
4. P/D (Pain or Discomfort) 
5. WSU (Worried, Sad or 
Unhappy) 
6. VAS (Visual Analogue Scale) 
5 yes 5 
5. Generic 
Children’s 
Quality of Life 
Measure (135) 
GCQ UK 6-16 Single scale 25 no  
6. Health 
Utilities Index 
(61) 
HUI 
Mark  III 
Canada 2-18 1. Vision 
2. Hearing 
3. Speech 
4. Ambulation 
5. Dexterity 
6. Emotion 
7. Cognition 
8. Pain 
45 yes 5-10 
7. How Are You 
(136) 
HAY Holland 7-13 1. Physical function 
2. Cognitive function 
3. Social function 
4. Physical complaints 
5. Happiness 
80 yes 30 
8. KIDSCREEN 
(106) 
 Europe  8-18 1. Physical well-being 
2. Psychological well-being 
3. Moods and emotions 
4. Self-perception 
5. Autonomy 
6. Parent relation and home 
life 
7. Social support and peers 
8. School environment 
9. Social acceptance (bullying) 
10. Financial resources 
52 yes  
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9. KINDL 
R 
(137)
 
 Germany 8-16 1. Physical well-being 
2. Emotional well-being 
3. Self-esteem 
4. Family 
5. Friends 
6. School 
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yes 10 
10. Paediatric 
Quality of Life 
Inventory 4.0 
Generic  Core 
Scales (123) 
PedsQL 
4.0 
USA 5-18 1. Physical functioning 
2. Emotional functioning 
3. Social functioning 
4. School functioning 
23 yes 5-10 
11. Patient 
Reported 
Outcome 
Measurement 
Information 
System  
Paediatric 
Global Health 
Measure (138) 
PROMIS 
PGH-7 
USA 5-17 General health 
Quality of life Physical health 
Mental health Feel sad 
Fun with friends Parents listen 
to ideas 
7 yes 1-2 
12. Quality of 
My Life 
Questionnaire 
(139) 
QoML Canada 8-12 Two Visual Analogue Scales 
and a categorical item 
assessing change in QoL  
3 yes <5 
13. TNO-AZL 
Child-Quality-of 
–Life (140) 
 
 
TACQOL 
Holland 8-11 1. Physical complaints 
2. Motor functioning 
3. Autonomous function 
4. Social function 
5. Cognitive function 
6. Positive emotions 
7. Negative emotions 
56 yes 5-10 
 
Of the 13 p-HRQoL measures summarised, only five are specifically targeted at an age range of 
between eight and twelve years, while the others cover child and adolescent problems with the same 
measure. The EQ-5D-Y is one of the measures that is specifically developed for children within the 
eight to twelve year developmental range. The number of items in the different measures range from 
seven to 98. A questionnaire containing 98 measures would take a child far more than five minutes to 
complete. However, a child typically takes five minutes to complete the five dimension EQ-5D-Y.    
Table 2: Development and psychometric properties of some paediatric HRQoL measures.  
1. Child Health and Illness Profile – Child Edition (CHIP-CE)(133)(76)(133) 
Purpose:  
 
To assess the health of 6 to 11-year-old children in epidemiological studies, and to provide a basis for 
measuring the impact of changes made to health services. 
Method of development: 
 
Based on the literature, this measure was developed and reviewed by a panel of experts, followed by 
testing on focus groups of teenagers.  
Scoring: 
 
Initially, items are summed. Then, a sub-score for each of the five dimensions is obtained, followed by 
a total score. 
Reliability:  
 
The internal consistency reliability of all items was found to have an acceptable α coefficient of 0.7 or 
higher. The ICC for test-retest reliability of total scores was above 0.6 levels.  
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Validity:  
 
Construct validity in the four groups of children known to have different health statuses was assessed 
by determining whether the mean scores for sub-dimensions were different according to illness, age 
or gender. These scores were, in fact, different. 
Ability to detect change:  
 
No responsiveness studies found. 
 
 
2. Child Health Questionnaire  (141)(107)(75)(142)(134) 
Purpose: 
 
To measure health-related quality of life (HRQOL) in healthy children and adolescents (aged 5–18 
years) and those with chronic or acute health conditions. 
Method of development: 
 
The CHQ development was based on the structure and methodology used by the Short Form 36 Health 
Survey (SF-36). Traditional item scaling analysis was used (6). 
Scoring: 
 
A CD on the CHQ Scoring and Interpretation Manual is required, but the individual items on each of 
the 14 dimensions can be summed to provide an overall health profile, or divided into two summary 
scores for physical and psychosocial functioning. Sub-scores and overall score can be transformed to a 
0–100 scale, where 0 indicates worst possible health and 100, best health 
Reliability: 
 
Cronbach’s α indicated adequate internal consistency for the two summary scales, ranging from 0.69 -
0.92. Test–retest mean scores were not significantly different, demonstrating test-retest reliability.  
Validity: 
 
Good construct validity was demonstrated by lower scores for children with no health condition and 
higher scores for those with chronic illnesses. 
Convergent validity with the HUI was acceptable with correlations between 0.21–0.49, for similar 
dimensions.  Good convergent validity was also found with the PedsQL 
Discriminant validity was moderate to strong between children with and without a chronic health 
condition. 
Ability to detect change: 
 
The CHQ demonstrated good sensitivity to clinical change in children whose health condition 
improved, moderate for those who worsened and small those whose health did not change.  
 
 
3. DISABKIDS Chronic Generic Measure(107)(86)  
Purpose: 
 
To assess HRQol in chronically-ill children between 4 and 16 years 
Method of development:  
 
In order to identify themes, focus groups were held with children, adolescents, parents and health 
professionals. This was followed by item selection and pilot testing on different age groups. 
Scoring: 
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Scoring of the main dimensions is on an ordinal scale ranging from 1 to 5. Raw scores are summed and 
transformed into a 0-100 scale, with 0 indicating worst health and 100, best health, respectively. 
Reliability:  
 
Cronbach’s α of 0.70–0.87 indicated good internal consistency on the six subscales across various 
health conditions. An intraclass correlation coefficient of 0.71–0.83 indicated satisfactory test–retest 
reliability.  
Validity: 
 
Satisfactory internal consistency was found for each of the 6 subscales. 
Moderate convergent validity was demonstrated with validated Children’s General Health 
Perceptions-Child Report and Paediatric Quality of Life Inventory. 
Discriminant validity: 
Significantly lower HRQOL was found in children with severe chronic diseases and those from low 
socio-economic backgrounds, demonstrating differences where expected.  
Ability to detect change: 
 
No information 
 
 
4. EuroQol Five Dimension – Youth Version (EQ-5D-Y)(13)(1) 
Purpose: 
 
To enable children to self-report on their health. 
Method of development: 
 
A multi-national task team of experienced HRQoL researchers, all with a paediatric background, 
reviewed the suitability of the adult EQ-5D dimensions for use in children. This was followed by a 
revision of the wording and design of the adult version to produce a version appropriate for children. 
The EQ-5D-Y was then piloted. The English piloted version was translated into German, Spanish, Italian 
and Swedish following the forward, backward, forward process. The measure was then tested on 
mostly healthy children, followed by cognitive interviews with respondents to determine their 
understanding of the measure. After discussions and adaptations, the English EQ-5D-Y was accepted 
as the source version. Thereafter the EQ-5D and EQ-5D-Y versions were tested for comparison of 
results.  
Scoring: 
 
Each item has three levels of responses, 1 being ‘no problem’, 2 ‘some problems’ and 3 ‘’lots of 
problems’. The VAS is a vertical graduated scale from 0 (worst possible health) to 100 (best health), 
giving an overall rating of both physical and psychological health.  
Reliability: 
 
Fair to moderate test-retest reliability was found, with most children reporting similar levels of 
problems on the dimensions and satisfactory ICC (0.82) with respect to VAS. High ceiling effects in the 
Mobility, Self-care and Doing Usual Activity dimensions limited the ability to fully assess reliability.  
Validity: 
 
Convergent validity was evident between EQ-5D-Y VAS and overall global health on KIDSCREEN, the 
General Health Item and Life Satisfaction Ladder, with correlation coefficients from 0.33-.0.65. 
Associations between EQ-5D-Y Mobility and KIDSCREEN physical well-being and PedsQL Physical 
Functioning scale were, however, low. 
Children with chronic conditions reported more problems on the dimensions than healthy children, 
but only children with severe problems were identified.  
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Ability to detect change: 
 
No information available. 
 
 
5. Generic Children’s Quality of Life Measure (GCQ)(135) 
Purpose: 
 
To examine differences in HRQoL between chronically-ill children and healthy children 
Method of development: 
 
Focus groups were held with children to determine what affected their HRQoL. The measure was 
drawn up and pilot-tested on healthy children. 
Scoring: 
 
On a Likert type scale, scores are first given for the child character in the story that the real child feels 
they are most like (self-perceived score) and then scores are given for the child character they would 
most like to be. The discrepancy between the two scores is calculated to determine child’s QoL.  
Reliability: 
 
Self-perceived and QoL scores showed acceptable reliability with Cronbach’s α of 0.74 and 0.78, 
respectively. 
Validity: 
 
Discriminant validity was not indicted by different scores across the different age ranges.  
Ability to detect change: 
 
No information. 
 
 
6. Health Utilities Index (HUI lll) (61)(143)(91) 
Purpose: 
 
HUI was designed to provide detailed descriptions of widespread health states and to provide a HRQL 
summary score for children with childhood cancer.  
Method of development:  
 
This measure, guided by theoretical and experimental evidence, evolved from the HUI and is used as a 
‘gold standard’ for other HRQoL measures. 
Scoring: 
 
Scoring was based on ratings for health states on eight dimensions of health, using a 0-100 VAS and 
then assessed for an overall score of health states using Standard Gamble method. 
Reliability:  
 
Assessed over the last 30 years in many clinical studies world-wide, found at http:// 
www.healthutilities.com  
Validity: 
  
Construct validity was assessed on patients with type 2 diabetes and the measure was found to 
differentiate between patients with different pain levels and different emotional qualities. 
Concurrent validity was tested with CHQ scores for similar dimensions and measured by Spearman’s 
rank correlation coefficients as the data was not normally distribution.  
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Discriminant validity was demonstrated by the measure’s ability to discriminate between the presence 
or absence of chronic conditions. 
Ability to detect change: 
  
Responsiveness was assessed in patients undergoing total hip arthroplasty and the measure was able 
to detect Minimally Clinical Important Difference (MICD). 
 
 
7. How Are You (HAY)(20)(144) 
Purpose:  
 
To examine the difference between actual achievement and expectant achievement in children’s 
functioning. 
Method of development: 
 
Development was based on self-discrepancy theory i.e. measuring the difference between how life 
really is, compared to how one expects it to be. 
Scoring: 
 
Children first rate frequency of an activity, then ability to perform it, then the importance of the task 
Reliability: 
 
For Cronbach’s α, internal consistency of dimensions was reported as 0.77 – 0.93.  
Validity 
 
Construct and convergent were assessed. 
Ability to detect change: 
 
No information 
 
 
8. KIDSCREEN(145)(124) 
Purpose: 
 
 A cross cultural measure of children’s HRQoL across Europe. 
Method of development:  
 
Developed as a shortened version of the original 52 item, to ensure its use clinically or as a screening 
tool for developmental problems. 
Scoring: 
  
Items are scored for frequency of feelings or intensity, for each of the five dimensions, on a 5-point 
scale. 
Reliability: 
 
Internal consistency of dimensions using Cronbach’s α, ranged from 0.77 to 0.99 for different 
dimensions. 
Test-retest reliability demonstrated ICC values of 0.56 to 0.77. 
Validity:  
 
Small to medium correlations (0.4) were shown between similar dimensions on PedsQL and Kindl. 
Discriminant validity was demonstrated by low correlations between dimensions expected to be 
different on KIDSCREEN and PedsQL and Kindl. 
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Ability to detect change: 
 
No information. 
 
9. KINDLR (137)(146) 
Purpose: 
 
To measure HRQoL in healthy and ill children, aged 4 to 16 years. 
Method of development: 
 
Developed from a conceptual model of the four main concepts of HRQoL, namely physical function, 
everyday activities, psychological well-being and social relationships. KINDL was tested on healthy 
children in two pilot studies.  
Scoring: 
 
Scoring of each item is on a 5 point ordinal scale. Item scores are reversed before being summed to 
produce subscales, which can be combined to produce a total score, or transformed to values 
between 0 and 100. Computer scoring software needed to interpret scores. 
Reliability: 
 
Satisfactory internal consistency for subscales and good reliability for total scores were reported, with 
Cronbach’s α >0.7. Test-retest reliability correlation of scores were r=0.8. 
Validity: 
 
Convergent validity with similar dimensions on the CHQ, Short Form 36 Health Survey and Life 
Satisfaction Questionnaire (adapted for children) was reported, with ICC 0.7. Convergent validity 
between the child and parent KINDL-R was also found.  
Discriminant validity:  
Low correlations between the KINDL-R and opposing dimensions of the SDQ were found.  
Ability to detect change: 
 
A change in environmental living conditions demonstrated a change in scores. 
 
10. Paediatric Quality of Life Inventory 4.0 Generic  Core Scales (PedsQL)  (123)(88) 
Purpose: 
 
To measure HRQoL in children and adolescents from 2 to 18 years 
Method of development: 
 
Data from paediatric cancer patients was collected with the aim of designing a generic HRQOL 
instrument to be used for all paediatric populations. This was followed by field testing on healthy 
children and their parents and then testing on children with juvenile rheumatic diseases. 
Scoring: 
 
Items on each of the four dimensions were rated on a 5 point ordinal scale. Items can be reversed 
scored and linearly transformed onto a 0 -100 scale.  
Reliability: 
 
The measure was tested and found to exceed the internal consistency reliability α coefficient of 0.7 for 
child self-report and parent proxy report scales. The individual child’s total score approached or 
exceeded the reliability criterion of 0.9 across all ages. 
Validity: 
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Construct validity was determined using the known group method, comparing scores between 
children with juvenile rheumatic diseases and healthy children. The healthy children scored 
significantly higher.  
Ability to detect change: 
 
Medium to large effect sizes between interventions in children with juvenile rheumatic diseases were 
recorded. 
 
11. Patient Reported Outcome Measurement Information System – Paediatric Global Health (PGH-7) 
measure (147) 
Purpose: 
 
To develop a paediatric global health measure for clinical, research and quality improvement 
purposes. 
Method of development: 
  
An item pool was developed from a computerised item bank of Patient –Reported Outcome Measures 
(PRO) to form the paediatric version of PROMIS, PGH-7, followed by interviews with children and 
parents to determine their understanding of global health and experiences of ill health. Thereafter 
field testing of the measure was conducted.  
Scoring:  
 
Individual items are scored between 1 and 5 and an overall score can be obtained. 
Reliability:  
 
Internal consistency reliability α was 0.88 for the child/youth sample and test-retest reliability 
coefficient was 0.73, indicting good stability.  
Validity: 
 
Not assessed yet 
Ability to detect change: 
 
Not assessed yet 
 
12. Quality of My Life Questionnaire (QOML)(139)(107) 
Purpose: 
  
To assess Quality of Life and Health-Related Quality of Life as two separate concepts in children. 
Method of development: 
 
The measure was developed from a paediatric rheumatology sample, basing the use of the VAS on 
previously validated HRQoL assessments in cancer patients. Pilot testing was performed on healthy 
children and children with various forms of rheumatology. 
Scoring: 
 
Children score their QoL on a  0-100 VAS by responding to ‘Overall my life is…’ and HRQoL by 
responding to ‘Considering my health, my life is…’ and answering ‘Since the last time I was here, my 
life is…’ on a five point ordinal scale ranging from much worse to much better. 
Reliability: 
 
No information available. 
Validity: 
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Convergent validity was performed by comparing scores on the QoL VAS and HRQoL VAS with scores 
on Childhood Health Assessment Questionnaire. Convergent validity was determined as good, as the 
expected relationships between scores were noted. 
Ability to detect change: 
 
Responsiveness was determined by asking the child to rate two hypothetical questions on the QoL and 
HRQoL VAS. The questions pertained to ‘How would a small improvement in health affect the scoring 
on the VAS?’ and ‘How would a small deterioration in health affect the VAS’? Numerical values were 
given for MCID and the measure assessed was able to depict changes in QoL and HRQoL 
 
13. TNO-AZL Child-Quality-of –Life (TACQOL)(140)(148) 
Purpose: 
 
To meet the needs for reliably and validly assessing HRQoL in children. 
Method of development: 
 
Development followed focus group discussions with paediatricians, parents and developmental 
psychologists. The measure was tested on healthy children and children with a chronic condition, as 
well as their parents. 
Scoring: 
 
The frequency of occurrence of a problem in each item is assessed by rating on a 4 -0 scale, with 4 
being ‘never’ and 0 ‘feeling bad’. Item scores for each dimension are added. 
Reliability: 
 
When comparing groups for internal consistency reliability, Cronbach’s α of 0.65-0.84, indicated 
acceptable reliability, but this was not the case in individual scores and caution was advised as the 
measure did not appear stable for all the children. 
Test-retest ICC 0.3-0.91 
Validity: 
 
The construct validity was considered good as Pearson’s correlation coefficient between dimension 
scores were low. 
Concurrent validity was assessed by comparing scores on similar dimension on the KINDL and 
correlation coefficients were low, indicating limited concurrent validity, which was felt to be due to 
the difference in time frame being assessed in the questionnaire. Chronic illness had a negative effect 
on the measure’s scores, indicating the measure’s ability to discriminate between healthy and 
chronically ill children. 
Ability to detect change: 
 
Clinical studies are being conducted. 
 
The EQ-5D-Y is unique in that it the population it was aimed at was included in cognitive interviews 
during the development of the outcome measure. The youth version has been adapted from the adult 
version, which results in consistency in the dimension assessed across the life-span. 
 
Most of the above measures have been investigated for reliability and validity, but responsiveness to 
change when a change occurred was only examined in the Child Health Questionnaire, Health Utilities 
Index (HUI lll), KINDL, Paediatric Quality of Life Inventory 4.0 Generic  Core Scales (PedsQL) and  
Quality of My Life Questionnaire. 
30 
 
2.9 Limitations in previous assessment of psychometric properties of EQ5D-Y 
To date, the psychometric properties (reliability, validity and responsiveness) of the EQ-5D-Y remain 
relatively unknown among acutely-ill children and children with a chronic health condition. Therefore, 
there was a need to test the performance of the EQ-5D-Y on participants with either an acute or 
chronic health condition and to compare this to healthy TD school children. In this latter population, a 
marked ceiling effect was observed in the original feasibility, reliability and validity study (1).   
 
A longitudinal study was needed to assess the measure’s ability to detect change in the participants 
over time, and to determine which factors are associated with the change. Comparing the information 
gained from the EQ-5D-Y with another validated outcome measure of the child’s physical, 
psychological and social health, the PedsQL, an objective measure of function, the WeeFIM, and a 
paediatric P/D scale, the Faces Pain Scale, could further validate the use of this measure in routine 
health assessments of children. In addition, determining whether or not children with differing levels 
of illness and disability demonstrate RS could direct the use of the EQ-5D-Y.  
 
2.10 Summary of literature review 
HRQoL assessments focus on how disease impacts a person’s daily life physically, psychologically and 
socially. Self-reported HRQoL has been recognised as an important measurement in research and 
clinical trials in order to improve clinical practice and patient management, as well as for economic 
evaluations aimed at improving health care services.  
Self-reporting from children on their HRQoL, using measures that take the child’s developmental age 
into account, such as the EQ-5D-Y and PedsQL, may identify unexpected health problems, especially 
psychological problems, which might otherwise be overlooked. Sometimes, the child’s perspective of 
their own HRQoL has been found to differ from their care-givers’ perspective. Children also function in 
different contexts from adults (for example, in play, at school, and with friends) and, therefore, there 
is a need to develop child-appropriate HRQoL measures with good psychometric properties. 
Few generic HRQoL measures for children have been validated in a clinical population and even fewer 
have examined the ability of the measure to detect change over time i.e. responsiveness. Therefore, 
this study aimed to validate the EQ-5D-Y in clinical samples and to determine the responsiveness of 
the measure over time. 
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3 CHAPTER 3: METHODOLOGY 
3.1 Introduction 
An observational, analytical cohort study with repeated measures was used to investigate the 
psychometric properties of the EQ-5D-Y. The research questions called for repeated assessments of 
HRQoL over six months using the main outcome measure, the EQ-5D-Y and comparing it’s 
performance to another HRQoL measure, the PedsQL; a measure of functional independence, the 
WeeFIM and a paediatric pain measure, FPS. Measures were taken at baseline and repeated three 
months later or shortly before discharge for the acutely ill children and again three month later i.e. 
seven months post baseline. The study design was an observational cohort study in that the same 
participants were followed over the research period. The analytical component of the study design 
refers to the testing of the psychometric  properties of the EQ-5D-Y in the children with different 
health statuses, including  whether the measure would depict different changes in the HRQoL in the 
groups expected to show a change, over time (138)(139). 
It was hypothesised that the children from the Chronic Institution (CI) group would show a slow, but 
steady improvement in HRQoL with improved management of their chronic health condition, as 
evidenced from changes in their EQ-5D-Y dimension scores and VAS scores. This change was expected 
to be minimal for the Special School (SS) group, whose chronic disabilities were more stable. Those in 
the Acute Institution (AI) were expected to demonstrate a larger, swifter improvement with treatment 
and once their medication took effect. The Main Stream (MS) school children were expected to 
maintain a more or less static HRQoL in terms of the VAS and the various dimensions on the EQ-5D-Y, 
as they were typically developing (TD) with no serious health problems. 
3.2 Research Settings 
3.2.1 Geography and Demographics 
The current study was conducted at four different facilities for children, within the same middle to low 
socio-economic area in the Western Cape (socio-economic information in Table 3 below). Cape Town, 
the largest city in the Western Cape, has a population of 3,740,0225, according to the latest 
population consensus carried out in 2011 (149). The four facilities were located in two Cape Town 
suburbs, which are closely linked geographically. In the suburb of Athlone, the population size is 
45 048. People whose home language is English or Afrikaans account for the majority of this 
population, while 8.5% are first language isiXhosa speakers. The population of the suburb of 
Bonteheuwel is 52 956, of which 4.1% are home language isi-Xhosa speaking. 
Table 3: Socio-economic information of the two suburbs in which the facilities are located 
 Athlone Bonteheuwel 
Total population    45 048   52 956 
Households    11 739   11 037 
Average household size         3.84         4.8 
Percentage of population 20 years and older having completed 
Grade 12 educational level or higher. 
59          23 
Percentage of population who are employed. 88          73 
Percentage of population with a monthly income of R3 200 or 
less. 
31          52 
Percentage of population living in a formal dwelling. 95          87 
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Monthly household income: Number  % Number  % 
No income 
R 1 - R 1 600 
R 1 601 - R 3 200 
R 3 201 - R 6 400 
R 6 401 - R 12 800 
R 12 801 - R 25 600 
R 25 601 - R 51 200 
R 51 201 - R 102 400 
R 102 401 or more 
Unspecified 
TOTAL 
1 254    10.7 
1 239    10.6 
1 185    10.1 
1 392    11.9 
1 890    16.1 
2 337    19.9 
1 638    14.0 
    606      5.2 
    195      1.7   
        0      0.0 
11 736  100.0 
1 275     11.6 
2 217     20.1 
2 220     20.1 
2 427     22.0 
1 899     17.2 
   759       6.9 
   189       1.7 
     21       0.2 
     24       0.2 
       0       0.0 
11 031  100.0 
2011 Census – Cape Town Suburb Profile (December 2012). Compiled by Strategic Development Information and GIS 
Department, City of Cape Town, using 2011 Census data supplied by Statistics South Africa. 
3.2.2 Description of facilities from which the children for the study were drawn 
In South Africa, the Department of Education is responsible for centres for early childhood learning, 
public schools, private schools and special needs schools. The state provides the schools with a subsidy 
depending on the level of poverty of the neighbourhood in which the school is situated. Therefore the 
eight public primary schools in Athlone and the 14 in Bonteheuwel receive more money per child, than 
schools in more affluent suburbs. One of the primary schools for TD children in the Bonteheuwel area 
was chosen as a research facility.   
Special Need Schools cater for children with various health conditions, providing them with classes of 
smaller numbers, feeding schemes and health care to ensure optimal learning occurs in these facilities. 
Some Special Schools follow the normal school curriculum and are also government-funded. They do 
their own fundraising to supplement their running costs because the children’s parents only pay what 
they can afford. 
The Athlone area includes Special Schools for the blind; for children with cerebral palsy and other 
physical, as well as learning problems; a Special School for children with mostly congenital disabilities, 
and a school attached to a home for children with chronic illnesses. Children from the latter two 
schools were included in this research study. 
An Acute Care Hospital in close proximity to Athlone, which admits children from a wide geographical 
area and from mid to low income bracket families, was also chosen as a research facility. 
The four research facilities were all clinical sites where physiotherapy students from the University of 
Cape Town carry out clinical training. From a practical point of view these facilities were chosen as the 
researcher was familiar with the sites from supervising students and the facilities were known to be 
amenable to interaction from the university.  
3.2.2.1 A Main Stream (MS) primary school for typically developing (TD) children 
A  Main Stream (MS) public primary school in Bonteheuwel, catering for about 350 TD children, 
ranging from an age of five to approximately 13 years, was one of the research settings. All the 
children live in the surrounding area and none presented with disabilities or serious health conditions. 
A few relatively minor health issues such as asthma, eczema and mild learning difficulties were 
reported. These children’s health status was not expected to change over the study period. For a 
complete list of the minor health conditions acquired by these learners, see Table 14 and Appendix 2.  
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3.2.2.2 A Special School (SS) for children with physical disabilities 
A Special School (SS) for about 200 learners with special needs is located in Athlone. Children from the 
age of five to 16 years attend this school which caters for children with primarily physical disabilities 
(such as spina bifida, various muscle diseases, spinal cord lesions and cerebral palsy). Many of these 
children are wheelchair bound or walk with assistive devices, and require management of their 
condition throughout their lives (See Table 14 and Appendix 2 for full range of conditions). A nursing 
service is provided at the school, as well as rehabilitation therapies. The children’s disabilities were 
expected to remain stable over the study period. At the time of this study, approximately 50/200 
(25%) of the learners were between the ages of eight and 12 years. Most of them lived on the 
premises during school terms and followed a main stream school curriculum. 
3.2.2.3 A facility for children with chronic health conditions (CI) 
A long-stay, chronic care institution (CI), also in Athlone, which cares for about 145 children aged from 
infancy to 18 years, was also recruited for this study. The children present with a wide range of 
conditions including diabetes mellitus, neoplasm and neurological disorders and heart, renal and 
respiratory impairments. They are admitted to the facility if their families are no longer able to 
manage their chronic health condition at home. Fewer of these children rely on mobility aids 
compared to the children at the SS, but they require nursing management of their chronic health 
condition. Most of the health conditions are acquired. They face more emotional challenges in 
adjusting to their new health status, than the children born with a disability. (See Table 14 and 
Appendix 2 for full range of conditions.) Children are typically admitted for six months or longer, 45% 
for up to a year.  Being a convalescent home, the majority of the children live on the premises while 
either recovering from a severe illness or suffer a chronic health condition that needs supervised 
medical care and rehabilitation. At the time of this study, approximately 50/145 (~34%) of the children 
were between eight and 12 years of age and cognitively able to attend school on the premises. 
3.2.2.4 An acute care children’s hospital (AI) 
A referral hospital, situated near Athlone, offers a comprehensive range of specialist paediatric 
services to acutely ill children, from low to middle income areas, but covering a large geographical 
catchment area. At the time of this study, there were about 350 in-patients who suffered a large range 
of conditions in either medical or surgical wards, in intensive care, trauma or oncology wards. Most of 
the children at this facility were typically developing (TD) before being admitted to hospital for 
management of an acute condition and most were in pain. See Table 14 and Appendix 2 for a 
complete list of health conditions.  Although the majority of the patients were younger than eight 
years of age, children up to the age of 16 were admitted to this acute institution (AI) for short term 
care of an acute health condition. The average length of stay was about one week. 
At the start of this research study, no standard instrument was being used by the physiotherapists at 
any of the institutions to assess or monitor changes in children’s HRQoL, and this aspect of child health 
was not being taken into account. 
3.3 Study participants 
The sampling frame included all children between eight and twelve years of age with a health 
condition at the three institutions catering for the needs of these children. Children from eight to 
twelve years in grades three to seven1   at a MS school for TD children, were also included as a 
                                                          
 
1
 Originally the sample was to be drawn from children in Grades three to six, but this was amended as a result of 
the pilot study. See Section 3.2.2 
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comparator. One child of thirteen years was included in the sample as he had been assessed by a 
school psychologist as being of a cognitively developmental level of eleven years.  The sample was one 
of convenience in that there was no random selection of either the facility or the individual 
participants.   
The MS school records indicated that there were 201 children between the ages of eight and 12 years. 
All of these children were considered eligible for recruitment and were given an informed consent 
form to take home for parents to sign and were asked to sign an informed assent form themselves. 
Only the 105 children who returned legible, signed consent and assent forms were included in the 
study.   
 
The records at the SS and the CI indicated 45 and 47 children, respectively, between the ages of eight 
and 12 years with a health condition attended each facility and they were all given an informed 
consent form to be signed by a parent, when they returned home for the weekend or the parent 
visited. Only 35 children at the SS and 32 children from the CI returned signed consent and assent 
forms and were included in the study. 
 
At the AI, all children admitted during the six week data collection period allocated to the institution, 
fulfilling the inclusion criteria, were recruited two days post admission. They were included in the 
study if both consent and assent forms were signed.  
 
All the physiotherapists treating children with a health condition at the various facilities, and all 
parents of MS children were invited to complete the EQ-5D-Y proxy measure. 
3.3.1 Sample size calculation 
The sample size was calculated based on the number of children with an acute or chronic health 
condition who were anticipated to indicate a change in overall HRQoL with repeated testing, 
compared to children with no health condition. There was no available literature on which to base 
how many points would make a meaningful difference in HRQoL when using the EQ-5D-Y on these 
children. Therefore the calculation was based whether a minimum of 30 children per group would be 
sufficient to demonstrate a change of 5 points on the EQ-5D-Y VAS, with a Standard Deviation (Std. 
Dev.) of 18, from baseline to repeated measure. The VAS scores and Std. Dev. were taken from a study 
using the measure in other South African children attending another MS school and the same SS for 
children with disabilities (16), as used in this study. While a larger difference in VAS, may be of more 
clinical relevance, it was decided to calculate the sample size needed to measure a small difference, so 
that even slight changes would be included. 
 
Table 4: 1-Way ANOVA: Power Calculation  
    Type I Error Rate (Alpha):      0.05 
    Number of Groups:              4 
    Group Sample Size (N):         30 
    RMSSE:                        0.929 
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Table 5: Power calculation based on root-mean-square error (RMSSE), as calculated above. 
 
Value 
Number of Groups 4.000 
Group Sample Size (N) 30.000 
RMSSE 0.929 
Non centrality Parameter (Delta) 77.678 
Type I Error Rate (Alpha) 0.050 
Effect Df 3.000 
Error Df 116.000 
Critical Value of F 2.683 
Power 1.000 
 
Therefore a minimum of 30 children per group are required to ensure the sample size is sufficiently 
powered to detect changes in HRQoL VAS scores as specified. 
3.3.2  Inclusion and exclusion criteria 
The children had to be able to respond independently to the EQ-5D-Y questionnaire, the other HRQoL 
self-report measure and the pain measure. There is evidence in the literature that children as young as 
five years can reliably and validly report on their health and this increases from seven years, so long as 
the measure has been specifically developed for the age of the children (82)(80). Most studies have 
found good reliability and validity in self-reporting on health by children of eight years and older 
(1)(127)(117)(125)(140). It has been recommended that children need to have attained a 
developmental age of eight or older in order to respond appropriately to the numerical Visual 
Analogue Scale (VAS) (1) (141). Children in South Africa may start formal schooling at age six and it is 
compulsory to start in the year in which they turn seven. Therefore, by grade three, most children will 
be eight years or older. It is assumed that these children, having successfully passed two years of 
schooling, should be of a developmental age of at least eight years because they came from a low to 
middle socio-economic background and were not exposed to extreme poverty or malnutrition, which 
may affect cognitive development (142). The upper age limit of the measure was 12 years and as most 
12 year old children were in grade seven, (as was evident following the pilot study which only included 
children up to grade six), grade seven children were also included in the main study. 
 
Children who were in the terminal stages of illness or were critically ill, with unstable and/or 
abnormally high or low vital statistics were excluded as it was likely that they and their parents might 
find the task too distressing.  
 
Any child who was unable or unwilling to respond was excluded.  
3.3.3 Sample for pilot testing 
A sub-sample of convenience of 38 children who met the above criteria participated in the pilot study 
and test-retest reliability testing of the EQ-5D-Y (Appendix 14). 
3.4 Instrumentation 
Information was gathered using two standardized measures of HRQoL developed for children between 
eight and twelve years, an observational measure of functional independence, a paediatric pain 
measure and two self-designed questionnaires. 
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3.4.1 Self-designed questionnaires 
3.4.1.1 Contextual information sheet 
Information related to the demographics, general health status and management of the health 
condition was entered into a contextual information sheet for each child. This sheet was designed by 
the researcher in order to capture the demographic information (institution, date of birth, age, 
gender, educational level and diagnosis) and specific information which could affect HRQol in the 
participants (Table 6). The full contextual information sheet can be seen in Appendix 3. 
 
Table 6: Contextual information sheet 
ITEM REASON 
Reason for admission To identify the reason for needing special health care or 
schooling and its impact on HRQoL. 
Medication In order to assess its action e.g. relieves pain or makes 
participant nauseous or drowsy and therefore impact on 
HRQoL.  
Health status: Acute, chronic or 
typically developing 
To enable differentiation between the groups and to 
identify a participant with a chronic health condition, who 
might have a superimposed acute illness 
Assistive device and type In order to identify whether a child with mobility problems 
is on bed rest (immobile and high impact on HRQoL) or in a 
wheelchair or walking with crutches ( more mobile and less 
impact on HRQoL) 
Urinary catheter or not, self-
catheterised or not 
Self-managed catheterisation would have less of an impact 
on HRQol, than an indwelling catheter 
Seen a doctor (other than for routine 
check-up) and/or cut down on activity 
level in last two weeks  
If so, this would indicated a deterioration in health 
condition, adversely affecting perceived HRQoL 
Medical management  To assess the level of intervention and whether it may be 
expected to influence any aspect of HRQoL, presently 
and/or over time 
Surgical management  Any recent surgical intervention would be expected to 
negatively influence all present aspects of HRQol, but might 
improve HRQoL over a longer period 
Physiotherapy management  Might contribute to improved function overtime.  
Occurrence of a life event in the last 
three months e.g. death in the family, 
divorce, moving home, new baby.  
To monitor whether  the occurrence of a life event affects 
HRQoL in any way 
Included in life event, is whether child 
is a border at school during the term 
and only goes home during vacation 
time. 
If child is acutely ill and hospitalised, do 
family visit regularly 
To assess whether being separated from family during the 
term affects HRQoL. 
 
 
To assess whether the lack of family visits affects HRQoL 
Time child took to complete the self-
report measures 
To determine feasibility of using the measures routinely 
 
The information to populate this questionnaire was obtained from medical files, nursing staff, 
therapists, teachers and direct questioning of children.  
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3.4.1.2 Usefulness and feasibility questionnaire 
 The clinical physiotherapists who administered the EQ-5D-Y to the participants or who completed the 
proxy version filled in a questionnaire designed by the researcher, asking them to comment on the 
feasibility and utility of the EQ-5D-Y as a standard outcome measure in the future (Table 7). Even 
though most of them only completed the proxy version, it was felt that they could comment on its 
potential usefulness. The full questionnaire can be seen in Appendix 4. The number of positive 
responses to the questions was recorded.  
 
Table 7: Usefulness and feasibility questionnaire (X refers to the number of responses) 
Number of self-reports administered? x 
Number of proxy report completed? x 
Ease of administration? Very easy; 
moderately easy  
or difficult 
Reason if not very easy? Time constraints; child did not 
understand;  
age group not understanding 
Which dimensions did children find difficult to understand? 
VAS? 
Mobility;  
LAM;  
UA; P/D/ discomfort; 
WSU 
Was a relationship noticed between child's response and clinical 
signs in any dimension? 
Mobility;  
LAM;  
UA;  P/D; WSU 
 
Did outcome measure assist with planning management of child? Yes or 
No 
Which dimension was most useful when planning management of 
child? 
Mobility;  
LAM;  
UA;  P/D; WSU 
Did the measure provide additional information on child's health 
status? 
Yes or  
No 
Which was the most useful dimension in providing additional 
information 
Mobility;  
LAM;  
UA;  P/D; WSU 
Will you continue to use measure routinely? Yes or 
No 
 
In order to determine content validity, the self-designed questionnaires were examined by a panel 
consisting of three paediatric physical therapists, with knowledge in research and HRQoL. The 
feasibility of gathering the content was examined during the pilot study (Appendix 14) 
3.4.2 Standardised outcome measures used  
The primary outcome measure of HRQoL was the EQ-5D-Y. The reason for using this measure and its 
psychometric properties will be discussed.  Justification for the selection of the other outcome 
measures, PedsQL, WeeFIM and Faces Pain Scale are also included, below. 
3.4.3 Translations 
Prior to using the two self-reported HRQoL outcome measures, EQ-5D-Y and PedsQL, translated 
versions were required. 
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As the most common languages, apart from English, spoken in the Western Cape are Afrikaans and 
isiXhosa, validated Afrikaans and isiXhosa translations of the EQ-5D-Y were sourced from the EuroQol 
Foundation, all of which had been through the rigorous translation process required by the EuroQol 
Foundation.  
There were, however, no Afrikaans and isiXhosa versions of the PedsQL4.0 Generic Core Scale. The 
translation process was undertaken following the forward, backward, forward method, prior to the 
start of the study. For this process, two translators bilingual in Afrikaans and English and two 
translators bilingual in isiXhosa and English were sourced.  
The English PedsQL version was translated forward into the two languages. Following the backward 
translation (back into English), discussions between the researcher and the translators were 
conducted in order to produce the best reconciled version.  The reconciled Afrikaans version made use 
of the most appropriate wording from each translator’s version, to preserve the original English 
meaning as closely as possible. 
The reconciled isiXhosa version, agreed upon after similar discussions, combined the more 
contextually accurate phrases and phrases that were more commonly used by isiXhosa speaking 
people, from each translator’s version. 
A report was then sent to Dr Varni at the Mapi Research Group and, following their recommendations, 
further slight changes were made to the wording of both the Afrikaans and isiXhosa versions. These 
changes mostly concerned finding a more appropriate word for “depressed” which was used in both 
the Afrikaans and isiXhosa languages and was felt to be too strong for “I feel sad”. This was changed to 
a more appropriate translation of the word “sad “in each language. “No energy” or “lack of energy” in 
the isiXhosa version was also felt to be too strong for “I have low energy” and this was changed to “I 
feel tired”.  
Cognitive interviews, using the newly translated measures were then conducted on five Afrikaans 
speaking children, between eight to twelve years of age, who all easily understood the form and could 
complete it independently. 
However, when tested on the isiXhosa speaking children, it was discovered that even though they 
spoke their home language fluently, most of them could not read isiXhosa as they attended English or 
Afrikaans speaking schools and had learnt to read in one of these languages. Five children who 
attended an isiXhosa school and who could read isiXhosa were sought and the form was tested on 
them. They also easily understood the form and could complete it without difficulty.  
The forms were proof-read and finalised, and a final report was submitted to Mapi Research Group. 
The translated PedsQL forms were considered appropriate for the research participants. 
 The full report on the PedsQL translation process can be found in Appendix 5. 
3.4.4 The EuroQoL Five Dimension – Youth Version (EQ-5D-Y) 
The EQ-5D-Y was the primary outcome measure of HRQoL (Appendix 6), as the research study was 
conducted out of a need, identified by the EuroQoL Group, following the reliability and validity study 
of the measure by Ravens-Sieberer et al (2010) (1). The authors suggested that the performance of the 
EQ-5D-Y be examined further on a clinical sample of children, as the original study used in the main, 
normal TD children. One of the principle aims of this research study was to assess the psychometric 
properties of the EQ-5D-Y (reliability, validity and responsiveness) in children with different health 
states. 
The EQ-5D-Y assessed HRQoL by requiring children to subjectively, self-reporting on five dimensions, 
namely: 
• Mobility (walking about) 
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• Looking After Myself (LAM) (self-care, washing and dressing)) 
• Doing Usual Activities (UA) (going to school, hobbies, sports, playing, doing things with family 
               or friends)      
• Having Pain or Discomfort (P/D) 
• Feeling Worried, Sad or Unhappy (WSU) (anxiety or depression) 
 
Each dimension, which consists of only one item, has three possible levels of response: 
1 “no problems” 
2 “some problems”  
3 “a lot of problems”  
 
It should be noted that the five dimensions do not share the same underlying construct (they are 
multi-dimensional) and the intervals between the three problems levels are not necessarily equal, so 
the dimensions were assessed individually. Until recently, there was no single index score for the EQ-
5D-Y which summarised the level of problems reported on each dimension. Recently Craig et al (2015) 
(66) developed a summary EQ-5D-Y on a QALY scale which was used to determine a composite score, 
the Index Score. 
Craig et al (66) used adults to weight losses and gains in children’s HRQoL to produce a QALY weighting 
to allow for comparison across different measures using a composite score, which takes into account 
the importance of different health states. For example, 1 year with ‘a lot’ of problems walking about, 
washing or dressing, and doing UA (i.e., physical problems) is worth the same as 1 year with ‘some to a 
lot’ of P/D, from the adults’ perspective. 
The EQ-5D-Y has five dimensions (each with three levels) and measures 10 possible losses in HRQoL 
(e.g., ‘no’ to “some” problems walking about). 
The weighting produced by Craig et al (66) describe the values of losses in child HRQoL, assuming that 
each lasted 1 year. For each dimension, the value of ‘no to some’ problems is less than ‘some to many’ 
problems. As the two largest losses are ‘some to a lot’ of P/D (4.0 QALYs, 95% CI, 3.8–4.4) and ‘a bit to 
very WSU (2.0 QALYs, 95% CI, 1.9–2.3), index scores of up to 10 are possible, using Craig’s QALY 
weightings, which are actually a decrement in QALY’s. This assumes that some states are worse than 
death. 
In addition to the dimensions, there is a Visual Analogue Scale (VAS) on which  subjective, self-rated 
overall health status is rated on a graduated VAS scale, with 0 indicating worst health state imaginable 
and 100 indicating best health imaginable (1). The measure takes five minutes to complete and refers 
to the child’s health on the day of completing the questionnaire.  
 
The previously Afrikaans translated versions for both self- and proxy reports were used for all 
Afrikaans speaking participants.  No isiXhosa speaking participants used the translated version, as the 
majority of these participants were unable to read isiXhosa, but were all able to read English. 
 
The EQ-5D-Y is a copyrighted instrument. Therefore, prior written consent to use the measure was 
obtained from the EuroQol Executive Office. The study was registered at the EuroQol website and 
permission was granted to use the paper version of the EQ-5D-Y (Appendix 7). 
3.4.4.1 Validity and reliability studies 
As mentioned in the literature review, the original reliability and validity of the EQ-5D-Y was 
conducted on a multi-national group of mostly healthy, (TD) children, including South African children 
(1). Some subsequent studies have compared the performance of the EQ-5D-Y between TD children 
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and children with a health condition. In 2009, a study on German children with cystic fibrosis found 
the measure to be valid in depicting differences in HRQoL as this chronic disease state progressed, 
even though it was not compared with any other group (123). A South African study in 2010 compared 
the EQ-5D-Y self-report and parent proxy report in children with a disability at a SS and children at an 
Open School for TD children. Even though there were differences between the parent respondents 
and the children’s self-report, the EQ-5D-Y was deemed to demonstrate inter-rater reliability in both 
groups. Validity between VAS and dimensions was evident with strong relationships between the two 
at the Open School sample, but not in the SS sample (16). Discriminative validity was examined in a 
Swedish study in 2011 to determining whether the EQ-5D-Y could discriminate between children with 
a prior known health condition, such as asthma, rhinitis, diabetes and coeliac disease and severe 
illness and/or handicap (which was not specified), and children with no reported health condition. The 
measure was found to have discriminate validity, however only 16% of the sample group had a health 
condition (144). An Italian study in 2011 found the measure to be reliable and valid when tested on 
healthy children and children with Acute Lymphoblastic Leukaemia (107). Again, the percentage of 
children with the acute health condition was very low (only 6% of the sample).  
 
None of these studies has assessed the performance of the measure across chronically-ill children with 
or without a physical disability, acutely-ill children and TD children. There have also been no 
longitudinal studies to examine the measure’s responsiveness to changes in HRQoL in these groups of 
children overtime. 
3.4.4.2 EQ-5D-Y Proxy version 
The EuroQol Group, the body responsible for the development of the HRQoL measures, has also 
developed a proxy version, which requires the adult caregiver, or anyone else who knows the child 
well such as the teacher or therapist,  to complete the form in the same way they think the child 
would complete the form (16) (17). Even though proxy measures are most commonly used when the 
person is unable to complete the form themselves, as in cases when the child is too young to 
understand the concepts of HRQoL being investigated or the respondent is either physically or 
mentally incapacitated in some way (87), they may be useful to determine whether the proxy 
respondent is in agreement with the child as to what extent the health condition affects their QoL (16) 
(73). 
3.4.5 The Paediatric Quality of Life Inventory (PedsQL4.0) 
The 23 item PedsQL Generic Core Scales, another generic paediatric HRQoL measure (Appendix 8), 
specifically developed and validated  for children between the ages of eight and twelve years (123), 
was used to compare results with the EQ-5D-Y.  
 
The PedsQL Generic Core Scales consists of self-reporting on 23 items, in four dimensions: 
 About My Health and Activities (Physical Functioning) – eight items 
 About My Feelings (Emotional Functioning) – five items  
 How I Get Along With Others (Social Functioning) – five items  
 About School (School Functioning) – five items  
 
The scoring ranges from 0-4 with: 
0 being “never a problem”, 
1 “almost never a problem” 
2 “sometimes a problem” 
3 “often a problem” and 
41 
 
4 “almost always a problem” 
 
The scores may be added together to produce a dimension sub-score and also a total score of all 
dimensions. Therefore the higher the score, the greater the problem in that dimension and the lower 
the HRQoL (150). 
3.4.5.1 Reliability and validity study  
The PedsQL was found to be reliable and valid for use as a paediatric health outcome, following a 
study in 2003 on children from the general population between different age ranges, including those 
between eight and twelve years. It was tested on a large sample of children, 86.3% of whom were 
healthy and 5.4% with a reported chronic health condition, such as asthma, ADHD (Attention Deficit 
Hyperactive Disorder) and diabetes  (123).  
 
The PedsQL is longer than the EQ-5D-Y and it takes about 15 minutes to complete. All items refer to 
how much of a problem was experienced in each item in the ‘past month’, as opposed to “today” in 
the EQ-5D-Y. 
 
Similar to the EQ-5D-Y translated versions all Afrikaans speaking participants used the translated 
version and no isiXhosa speaking participants used the translated version 
 
A User Agreement form was completed and returned to the Mapi Research Trust, thus allowing the 
researcher the use of the PedsQL4.0 (Appendix 10). 
Rationale for using the measure: 
The PedsQL was chosen as it is has similar dimensions to the EQ-5D-Y. It is longer than the EQ-5D-Y as 
each dimension is made up of a number of items, creating a sub-score per dimension for comparison 
with the similar dimension on the EQ-5D-Y. A total score is also generated by summing the sub-scores 
giving an overall HRQoL score, which could be compared to the EQ-5D-Y VAS. . It has been used 
reliably in conjunction with the EQ-5D-Y in other studies to assess HRQoL in children  
(151)(89)(1)(123). 
3.4.6 The Paediatric Functional Independence Measure (WeeFIM) 
The WeeFIM measure (Appendix 11) is an observational instrument, developed to assess daily 
functioning skills in children and was derived from the adult FIM (105)(140)(141)(120). It measures 
functional ability and independence in a variety of tasks and the level of assistance a child may need to 
achieve the task.   
 
Functional performance is measured in three dimensions, namely self-care, mobility and cognition. It 
is not a self-report measure, but requires direct observation or interview or a combination of both by a 
professional who understands the rating system. Translation was, therefore, not required as the 
researcher studied the accompanying user manual and administered the forms. The instrument 
comprised of 18 items, each rated on an ordinal scale from 1-7, ranging from complete dependence 
(rated as “1”) through modified dependence from a person or device to complete independence 
(rated as “7”). The higher the dimension sub-score, the more independently the person is able to 
perform functions in that dimension. A maximum total score of 126 would indicate complete 
independence in all dimensions (105) (152).  The scoring levels were: 
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No helper 
 7 = Complete Independence  
 6 = Modified  
Helper – Modified Dependence 
 5= Supervision  
 4= Minimal assistance  
 3= Moderate assistance 
Helper – Complete Dependence 
 2 = Maximal assistance 
 1 = Total assistance  
 
In order to use the WeeFim, the researcher obtained an International Research License Agreement 
from Uniform Data System for Medical Rehabilitation (UDSMR) ( 
COMMUNICATION 
14.Comprehension  Mode: A – Auditory V - Visual C - Both Yes 
No 
15.Expression  Mode: V – Vocal N - Non-vocal B - Both Yes 
No 
SOCIAL COGNITION 
16.Social 
interaction 
  Yes 
No 
17.Problem solving   Yes 
No 
18.Memory   Yes 
No 
Cognition total 
FIM total 
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Appendix 12). 
3.4.6.1 Reliability and validity studies 
The measure had been found reliable and valid in detecting change in functional independence in 
children under eight years and in children with developmental disorders over eight years  and has 
been used reliably in a variety of children up to sixteen years (143)(140)(105). 
 
 Rationale for using the measure: 
The WeeFIM was chosen as a measure of functional ability and independence because it allows for a 
functional assessment of bedridden or wheelchair bound children, as well as children who are able to 
climb stairs independently. Therefore, this measure could be used for acutely-ill children in a hospital 
bed, children confined to a wheelchair and ambulant children (130). It was used to determine 
functional ability in the children with a health condition or disability, in order to explore the 
relationship between the EQ-5D-Y Mobility dimension and their actual functional independence.   
3.4.7 The Faces Pain Scale-Revised (FPS-R) 
The FPS-R (Appendix 13) is a self-report measure of pain intensity developed for children. It was 
developed using a series of facial expressions depicting pain intensity. The scoring ranges from 0-10 
and can be used to self-rate pain intensity in children over eight years of age (153). 
 
A horizontal line of six faces, showing progressively worsening pain expressions, are used to rate pain.   
 The first face shows “no pain” = 0  
 The next four faces show increasing pain, rated 2, 4, 6, 8 respectively; and 
 The last face shows “very much pain” = 10  
The child marks the face indicating his/her pain level. A rating of 10 would indicate severe pain. 
 
The administrator of the measure needs to be mindful that their the explanation to the children 
should not to use words such as “happy” or “sad” because the child needs to measure how much pain 
they feel, not how the faces look (153). 
As the instrument relies on pictures, only the instructions needed to be translated into Afrikaans and 
isiXhosa. No specific translation procedure was required by the developers of the instrument. 
3.4.7.1 Reliability and validity study 
The measure has been found to be reliable and valid in measuring pain levels in a clinical sample of 
children from five years and upwards (153). 
  
No specific user agreement was required as the instrument could be photocopied for non-commercial 
clinical, educational or research purposes, directly from the International Association for the Study of 
pain (IASP) online at www.iasp-P/D.org/FPS-R.  
Rationale for using the measure:  
The FPS was easy to understand as it used pictures and allowed for a detailed rating of pain, which 
could then be compared to the pain dimension in the EQ-5D-Y measure. 
3.5 Summary of Pilot study    
Prior to the main research study a pilot study was undertaken to assess the reliability of the EQ-5D-Y in 
a smaller group of children from the same institutions as would be used in the main study. The pilot 
study is described in detail in Appendix 14.  
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The specific objectives of the pilot study were to: 
1. Establish test-retest reliability of the EQ-5D-Y in children with a chronic or acute health 
condition and MS children by re-administering the measure the day after the initial 
assessment. 
2. Determine the feasibility of administering the EQ-5-D-Y by assessing the time taken by the 
children to complete the form.  
3. Determine the usefulness of obtaining contextual information from the medical files, using the 
self-designed contextual information sheet by assessing some of the demographic and medical 
information of participants. 
In summary, the EQ-5D-Y was tested on 38 children and retested the next day. Nine children (23.7%) 
were drawn from the MS school, five (13.2%) from the SS, nine (23.7%) from the CI and 15 (39%) were 
from the acute hospital. The time taken for each child to complete the form was recorded. The 
contextual information sheet was used to obtain the extra information regarding the health status of 
each child.  
Following analysis of the collected data, it was found that using the test-retest scores, kappa values for 
each dimension mostly fell within the moderately agreeable range (>0.50), except for UA dimension 
which was poorly agreed (<0.20).  The ICC for VAS was 0.765 (95% Confidence intervals (CIs) =0.594-
0.870), indicating good reliability. The children completed the measure in a mean time of six minutes, 
ensuring feasibility as it did not require much time to complete. It was possible to obtain useful 
information on each participant’s demographics, medical condition and other factors which could 
influence HRQoL, using the self-designed contextual information form. This information was obtained 
from the medical file, nursing staff, therapists and from the children themselves.  
As a result of the pilot study, the inclusion criteria needed to be amended to include typically 
developing children in grade seven who fulfilled the other criteria, as there were too few MS children 
in the 12 year age group. It was also found necessary to allow for more time in which to obtain 
consent from parents with children at the SS, as they were not in regular contact with their parents. 
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3.6 Procedure followed for main study 
This section will describe the steps taken, after completion of the pilot study, in carrying out the main 
study. 
3.6.1 Ethical approval  
Ethical approval was obtained from the Human Research Ethics Committee of the University of Cape 
Town (HREC REF 354/2013) (Appendix 15). Permission was then sought from the various institutions at 
which the study took place (Appendix 16). 
3.6.2 Research personnel and their role in the study 
All clinical physiotherapists at the institutions were invited to participate in the study component 
related to the use of the EQ-5D-Y. Those who expressed interest were informed of the purpose of the 
study, their role in the study and were trained in the use of the EQ-5D-Y by the researcher. Their role 
included identifying children from their institution who fulfilled the inclusion criteria, giving the 
information packs to parents, explaining the purpose of the study and obtaining informed consent 
from the parents if they agreed to allow their child to take part in the study.  The therapists were 
required to provide some of the information on each child’s contextual information sheet. They were 
also initially required to administer the EQ-5D-Y to each child, but this was amended to whenever their 
time restraints allowed for this, as they felt that they would not always have the time to perform this 
task. 
Using the additional contextual information sheet (Appendix 3), the clinical therapists at the 
institutions were required to report whether there had been any change in health status or 
management of the child since admission and subsequent administrations of the EQ-5D-Y. This 
information was in the medical files of each child, to which the therapists had ready access. Nursing 
staff, parents and the child themselves were questioned with regard to any life event that might have 
occurred in the last six months at home or in the family of the child, such as divorce or a death, 
moving home or a new baby, which could impact on the child’s psychological well-being and the 
therapist recorded this on the information sheet. In the case of the MS children, the researcher 
examined the school records, questioned the class teachers and children themselves for this 
information. 
 
Ultimately, the research personnel consisted of the principle researcher and clinical physiotherapists 
from the SS (three), from the CI (two) and AI (four), who all signed consent to their part in the study 
(Appendix 17).   
3.6.1  Recruitment and requirements from participants 
All 201 children identified as fulfilling the inclusion criteria from the MS school records were given 
informed consent forms (Appendix 18) in their homework books for parents to sign. After three verbal 
reminders, during a two week period, only 105 children returned legible, signed consent forms. The 
purpose of the study was then explained to these children, as well as their role in the study, which was 
to complete two HRQoL outcome measures (EQ-5D-Y and PedsQL), a pain outcome measure (FPS) and 
to be observed and questioned about functional independence (recorded by researcher on the 
WeeFIM). They were required to sign an assent form if they were willing to participate. Their right to 
withdraw from the study at any time was also explained to them.  Subsequently, all 105 MS school 
children were included in the study.   
 
The therapists examined the records at the SS and the CI and identified 45 and 47 children, 
respectively, fulfilling the inclusion criteria. They were all diagnosed with a chronic physical disability 
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(SS) or chronic health condition (CI). Identified children were given an informed consent form to be 
signed by a parent when they returned home for the weekend/holidays or when the parent visited the 
institution. Extra time was allocated for this process, prior to starting data collection as most of the 
children were not in regular contact with their parents. One month was assigned to obtaining signed 
consent forms, with weekly reminders from the researcher. Only 35 children at the SS and 32 children 
from the CI returned signed consent and assent forms and were included in the study. Their role was 
explained to them, as in the case of the MS children. They were also afforded the right to withdraw at 
any time. 
 
At the AI, all children admitted during the six week data collection period allocated to the institution, 
and fulfilling the inclusion criteria, were recruited two days post admission by the therapist taking part 
in the study. Most children did have a parent with them in hospital and they were asked to sign an 
informed consent form after the therapists or researcher explained the process to both parent and 
child. A total of 52 children with signed consent and assent forms were included in the study.  
 
A total of seven parents did refuse consent without stating a specific reason; two from the MS school, 
one form the SS, two from the CI and two from the Acute Care Hospital. A large number of consent 
forms (78) were not returned at the MS school. 
Table 8 gives an outline of the research personal’s duties and what measurements were taken at the 
different time intervals. 
 
Table 8: Outline of procedure 
INSTITUTION Consent 
from: 
Obtained once by: Data collection 
timing 
Instruments Administered at the institution on the 
same day by: 
MS  Institution 
Parent 
Child assent 
Researcher 
Researcher 
Researcher 
Baseline,  
three  and 
six months  
Contextual info Teacher 
Child 
   EQ-5D-Y 
PedsQL 
FPS 
WeeFIM (if 
necessary) 
 
EQ-5D-Y Proxy 
All measures administered by researcher 
 
 
 
 
Completed once, at three months by a 
parent, on the same day as self-report 
SS Institution 
Parent 
Child assent 
Researcher 
School therapist 
Researcher  
 
Baseline,  
three  months and 
six months  
Contextual info School therapist 
Child 
     EQ-5D-Y Clinical physiotherapist (when possible, 
otherwise by researcher) 
 
     PedsQL 
FPS 
WeeFIM 
 
EQ-5D-Y 
Proxy 
Researcher 
Researcher 
Researcher 
 
Completed by clinical physiotherapist, on 
same day as self-report 
CI Institution 
Parent 
Child assent 
Researcher 
School therapist 
Researcher  
 
Baseline,  
three  months and 
six months  
Contextual info Clinical physiotherapist 
Child 
     EQ-5D-Y Clinical physiotherapist (when possible, 
otherwise researcher) 
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PedsQL 
FPS  
WeeFIM 
 
EQ-5D-Y 
Proxy 
Researcher 
Researcher 
Researcher 
 
Completed by clinical physiotherapist on 
same day as self-report 
AI Institution 
Parent 
Child assent 
Researcher 
Ward therapist or 
researcher 
Researcher 
  
 
Baseline 
and 
just prior to 
discharge  
OR 
at two weeks and 
one month  
later if still 
hospitalised 
Contextual info 
 
 
 
EQ-5D-Y 
 
 
 
 
PedsQL 
FPS  
WeeFIM 
 
EQ-5D-Y 
Proxy 
Ward  therapist 
Child 
 
 
Ward therapist (when possible, otherwise 
researcher) 
 
 
 
Researcher  
Researcher 
Researcher 
 
Completed by ward physiotherapist, on 
same day as self-report 
 
3.6.2 Baseline measures 
Following recruitment and once all necessary informed consent was obtained, baseline measures were 
taken. At the institutions the therapists were asked to complete the EQ-5D-Y proxy before 
administering the EQ-5D-Y to the child to complete, but on the same day as the child completed the 
self-report. They were asked to complete the proxy as they felt the child would complete it (Proxy 
version 2). The therapists were not always available to administer the self-report to the children, it 
which case it was done by the researcher.  At the MS school there were no therapists and the 
researcher administered the EQ-5D-Y to the children, but did not study the EQ-5D-Y self-reports of the 
children (in order to limit bias as much as possible). The researcher only ensured that there were no 
missing values, which was seldom. The parents of MS children were asked to complete EQ-5D-Y proxy 
measure (Proxy version 2).  
 
On the same day as the EQ-5D-Y was administered by either the therapist or the researcher, the 
researcher independently administered the other self-reported HRQoL measures, the PedsQL and FPS 
to each child and completed the observational/ interview WeeFIM instrument. Small groups of eight 
children at a time were taken out of class, to a quiet room, to complete the outcome measures. As 
each small group was from the same class and at the same educational standard, the explanations of 
the use of the different measures were set appropriately for their level of understanding.  
 
In the acutely-ill children this was performed at the bedside, usually without a parent present as the 
parents were often not available.  
 
The use of each measure was first explained to the group and they were then monitored to ensure 
that all items on the two self-reported HRQoL measures were completed. Missing values occurred 
slightly more often on the longer PedsQL outcome measure. The possibility of inadvertently 
introducing bias will be discussed later. Following this, each child completed the self-reported FPS. The 
researcher then observed and questioned each child individually with regard to their functional ability 
and scored each item on the WeeFIM sheet.  Children were then interviewed individually again to gain 
information needed on the contextual information sheet. After the children were returned to their 
class, the teacher was also interviewed for any additional contextual information of which they might 
be aware. 
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The same protocol was applied at all institutions at which the research took place, with some 
omissions at the MS school, which will be explained. The outcome measures were always 
administered in this order, with a short break in between measures, and under the same conditions in 
repeated assessments. 
 
For the purposes of the study, it was assumed that the children at the MS school were TD children, 
with no functional problems. They would, therefore, show a high ceiling effect in baseline WeeFIM 
test scores and hence no change over time. The WeeFIM was, therefore, administered only to the MS 
children who reported a problem with “Mobility” on the EQ-5D-Y, in order to assess whether or not 
they actually did have a functional problem. This was done to assess the specificity of the test in 
accurately identifying individuals who do not have a problem with function. If after assessment any 
MS child was found to have a health related functional problem, they were to be referred to an 
appropriate health care provider for further assessment. 
3.6.3 Repeated measures 
Repeated measures were taken three months post baseline and again three months after that. 
Contextual information was also updated. Each child was therefore assessed three times over a seven 
month period, under the same circumstances as described for baseline. Some slight variations were 
needed at the AI. 
 
At the AI, the child’s stay was short, usually no longer than seven days. Baseline measures were taken 
two days post admission, thus allowing the children time to settle in, and repeated just prior to 
discharge, which was approximately five days post baseline.  A third assessment was taken at two 
weeks or one month later, if the child was still hospitalised.  Only the longer stay, hospitalised children 
were therefore assessments three times. 
3.6.4 Proxy measures 
The clinical therapists at each of the three institutions were asked to complete an EQ-5D-Y proxy for 
each child. This was done at baseline and also repeated at three monthly intervals. The parents with 
children at the MS school were asked to complete EQ-5D-Y proxy forms in the same way, but only did 
this at the three month post baseline assessment, as it was anticipated that there would not be much 
change in the proxy version over a seven month period in these children. The parents were instructed 
not to consult with their child when completing the proxy measure.  
3.6.5 Usefulness and feasibility questionnaire 
At the end of the data collection period, all therapists participating in the study, whether using the EQ-
5D-Y measure or only filling in proxy measures, were asked to complete a questionnaire drawn up by 
the researcher, in order to assess feasibility and usefulness of including the measure in routine patient 
assessments (Appendix 4). This was done anonymously. 
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3.7 Data management, safety and monitoring 
All participants completed paper versions of the instruments.  The data were not anonymous as it was 
a longitudinal study and the responses of each child needed to be tracked. The completed paper 
versions were stored in a file in a locked cupboard in each institution’s physiotherapy department. 
Identifying features were removed once data collection was completed and the data had been 
entered into an Excel spreadsheet for electronic analysis. This data was stored on a laptop which was 
password protected and will be kept for a maximum of four years. Secure backups were stored on a 
separate hard drive, in a password protected file 
3.7.1  Data analysis 
Statistical analysis was performed using Statistica 12 and IBM SPSS Statistics version 22. Both 
descriptive and inferential statistics were used. The way in which the data was analysed to address 
each research objective is described in Table 9. 
The QALY weightings suggested by Craig et al, 2015, (66) were used in this study to produce a single 
composite score, the Index Score. The weighting produced by Craig et al (66) describe the values of 
losses in child HRQoL, assuming that each lasted 1 year.  It is noted that the weightings are actually a 
decrement in QALY’s and the Index Score should be calculated using 1-(the weighting). This was not 
done in this study, so the higher Index Score do indicate worse HRQoL. Where the Index Score is more 
than 1, it is assumed that the health state is worse than death. This EQ-5D-Y Index Score was used to 
compare against different measures which do sum dimension scores.  
Table 9: Data analysis 
Research Objective  Description Statistical Tests 
Describing the sample Frequency tables were used to 
indicate how many participants 
were: 
 of a particular gender, 
 age,  
 educational level, 
 drawn from each 
institution  
  diagnosed with a 
specific health 
condition and  
 whether the health 
condition was chronic 
or acute.  
 A One Way 
ANOVA was used 
to determine 
whether there 
were significant 
differences in 
mean values. 
 
 If the p value was 
=/<0.05, then 
post-hoc Tukey 
tests were 
performed to 
determine where 
the significant 
differences lay. 
The participants’ length of stay 
at each institution, at baseline 
assessment, was also indicated. 
 Minimum, 
maximum and 
Std. Dev. of length 
of stay. 
Describing baseline assessments of 
each outcome, as listed below. 
 
Baseline scores for each 
outcome measure were tested 
for distribution. 
 
 
If not normally 
distributed, as in the case 
of EQ-5D-Y Index Score 
and VAS, then non-
parametric analysis was 
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used. 
1. EQ-5D-Y dimensions 
 
The level of problem reported 
in each dimension, across 
institutions. 
Pearson Chi-square, P 
value. 
2. EQ-5D-Y Index Score 
 
The difference in mean rank 
and medians of Index Scores, 
across institutions. 
Median score, mean rank. 
 
3. EQ-5D-Y VAS Comparing VAS across 
institutions. 
Median score, mean rank, 
Kruskal-Wallis H test. 
4. EQ-5D-Y Proxy dimension scores Level of problems reported in 
each dimension across 
institutions. 
Percentage of proxy vs. 
self-reporting problems 
on the different level. 
5. EQ-5D-Y  Proxy Index Scores 
 
 
                 
Comparing mean ranking of 
proxy index score across 
institution. 
Median score, mean rank, 
Kruskal-Wallis H test 
6. Baseline PedsQL dimensions 
scores and total score 
 
Level of problems reported in 
each dimension across 
institutions. 
Percentage of children 
from each institution with 
similar level of problems. 
7. Baseline WeeFIM dimensions 
scores and total score 
Level of problems reported in 
each dimension across 
institutions. 
Percentage of children 
from each institution with 
similar level of problems. 
8. Baseline FPS Level of pain reported across 
institutions. 
Kruskal-Wallis ANOVA by 
ranks. 
To determine the performance of the 
EQ-5D-Y on children with different 
health statuses, by assessing the 
psychometric properties of the 
measure when used on these different 
groups of children: 
  
Reliability was assessed by: 
 Test-retest reliability of EQ-
5D-Y was assessed in the pilot 
study (Appendix 14:). 
 
 
Individual items of the EQ-
5D-Y dimensions and the 
VAS were tested to 
establish consistency 
between test and retest 
scores, at each institution. 
This was calculated using 
calculating Cohen’s kappa 
coefficient for agreement 
between the two sets of 
dimension scores. ICC was 
used for correlations 
between test and retest 
VAS scores. 
 Intra-rater reliability of EQ-
5D-Y was assessed in the main 
study to determine stability of 
the measure, in the groups 
which were not expected to 
show a change in HRQoL (MS 
and SS). 
  
 Stability of EQ-5D-Y 
dimension scores over 
time. 
 
The stability of dimension 
scores over time (from baseline 
to three months and to seven 
months) was examined at the 
institutions where the child’s 
Cohen’s kappa coefficient 
for agreement between 
the dimension scores at 
different times was 
calculated for the 
repeated measures. 
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health status was not expected 
to change (MS and SS). 
Correlations between scores 
were also given for children 
who were expected to show a 
change (CI and AI).  
 
 
 Stability of EQ-5D-Y Index 
Scores over time. 
 
Consistency of index scores 
between baseline and second 
assessment. 
 
This was calculated using 
calculating Cohen’s kappa 
coefficient for agreement 
between the two scores. 
 
 Stability of EQ-5D-Y VAS 
Scores over time. 
 
Consistency of VAS scores 
between baseline and second 
assessment. 
 
This was calculated using 
Spearman’s correlation 
coefficient (Rho) and (p) 
and Friedman ANOVA. 
 
o Intra-rater reliability of 
PedsQL total.  
PedsQL total scores were 
examined for consistency at the 
same time intervals as the EQ-
5D-Y. 
This was calculated using 
Spearman’s correlation 
coefficient (Rho) and (p). 
o Inter-rater reliability of EQ-
5D-Y was examined using 
proxy and self –reports. 
  
o Comparing proxy and self-
report dimension scores. 
Level of agreement between 
dimension scores. 
This was calculated using 
calculating Cohen’s kappa 
coefficient. 
o Comparing proxy and self-
report VAS scores. 
Correlations between proxy and 
self-report VAS scores. 
This was calculated using 
Spearman’s correlation 
coefficient (Rho) and (p), 
across institutions. And 
ICC for all groups. 
Validity was assessed by: 
 Construct validity of EQ-5D-Y 
was determined by examining 
both discriminant and 
convergent validity. 
  
 Discriminant validity of 
the EQ-5D-Y, was 
examined by comparing 
the profiles of the HRQoL 
of children with different 
health statuses, using 
dimension scores. 
It was hypothesised that the 
measure would be able to 
discriminate between MS 
school children (with no health 
problems and therefore a high 
HRQoL), chronically disabled or 
ill children (with some problems 
on the different dimensions, 
caused by their health 
condition) and acutely ill 
children (with a lot of problems 
on all dimensions and therefore 
low HRQoL). 
Kruskal-Wallis ANOVA by 
ranks, median scores and 
mean rankings were used 
to compare dimensions 
across groups.  
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 Discriminant validity 
based on VAS across 
institution. 
  
 
 Comparing VAS 
against the three 
levels of problems 
on the 
dimensions, across 
institutions 
Comparing VAS score against 
the ranking of the different 
levels of dimensions. 
Mean ranking, Kruskal-
Wallis H 
 
 Discriminant validity of 
PedsQL was also 
examined, to compare 
against discriminant 
validity of EQ-5D-Y. 
Dimension sub-scores and total 
scores were compared across 
the different groups of children. 
 
 
Box- Whisker graphs to 
demonstrate median 
scores, followed by 
Kruskal-Wallis H test to 
determine where 
differences lay. 
 Discriminant validity of 
the WeeFIM was 
examined, to compare 
against EQ-5D-Y. 
Dimension sub-scores and total 
scores were compared across 
the different groups of children. 
 
Box- Whisker graphs to 
demonstrate median 
scores, followed by 
Kruskal-Wallis H test to 
determine where 
differences lay. 
 Convergent validity was 
examined by comparing 
dimensions of EQ-5D-Y to 
similar dimensions on: 
  
 The PedsQL and 
 The WeeFIM and 
 The Faces Pain Scale 
Correlations between baseline 
dimension scores were used. 
Similar dimensions on each 
measure should produce similar 
results, in each institution. 
Correlations between EQ-5D-Y 
and PedsQL dimensions and FPS 
are expected to be positive. 
Negative correlations are 
expected between EQ-5D-Y and 
WeeFIM dimensions. 
 
 
Kruskal-Wallis H value or 
Mann-Whitney U z value, 
were used depending on 
the number of levels 
assessed, as well as p 
values. 
 
 Convergent validity was further 
examined by comparing total 
scores. 
Correlations between EQ-5D-Y 
Index Score and VAS are 
expected to be negatively 
correlated, as are Index Scores 
and WeeFIM. EQ-5D-Y Index 
Scores are expected to 
correlate positively with PedsQL 
total and FPS. 
Spearman Rho is 
significant for correlations 
at p<.05  
 
Responsiveness of the different 
outcome measures over time was 
examined. 
Repeat measures taken at three 
months post baseline were 
used to investigate the 
treatment effect, during this 
time period. 
Effect size (r) was based 
on Wilcoxon signed rank 
test (Z) and was calculated 
by (r=Z/Sq.Rt.N)2 
Responsiveness of:  
 EQ-5D-Y dimension 
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scores 
 VAS 
 Index score 
 FPS 
 PedsQL total 
 WeeFIM total  
Were all determined and compared 
over time, across institutions. 
To establish whether changes in HRQoL are related to life events: 
Changes or incidents in home life, 
surgery or change in management of 
condition was examined. 
Assessing whether there was a 
significant change in VAS score 
or change in WSU dimension 
score, after a life event. 
A t-test comparing mean 
“yes” with mean “no” 
answers to a life event 
was used. 
To determine the clinical feasibility 
and usefulness of using the EQ-5D-Y. 
The time taken to complete the 
measure compared to the 
recommended time. 
Mean, minimum, 
maximum and SD of time 
taken. 
 Assessing the answers to 
usefulness questionnaire 
completed by the participating 
therapists.  
Frequency of positive 
responses was analysed. 
 
3.8 Ethical considerations 
Ethical principles of autonomy, confidentiality, beneficence/non-maleficence and justice applied in the 
study were based on the Helsinki Declaration(154) and outlined below. Autonomy refers to the 
respect given to study participants to make their own decisions by ensuring that they have been given 
all the necessary information with which to make the decision. It includes confidentiality and 
maintaining the participant’s privacy. Beneficence/non-maleficence refers to actions performed to the 
benefit of the participants and to prevent and remove any harm that may occur. Justice refers to equal 
distribution of burdens and benefits to all members of a group.  
3.8.1 Autonomy  
Prior to commencement of the study, consent was obtained from the various institutions at which the 
study was to take place (Appendix 16).  To ensure autonomy, all participants in the study were asked 
to sign informed consent forms after the purpose of the study and their role was fully explained to 
them, in their home language if needed (a isiXhosa translator was available and the researcher could 
give the Afrikaans explanation). They were also made aware that they could refuse consent to taking 
part at any time in the study without negative consequences. 
 
The role of the clinical physiotherapists interested in participating in the study was explained to them, 
after which they were asked to complete forms consenting to their participation in the study 
(Appendix 17).  
 
Parents were required to consent to their child’s participation in the study by signing an informed 
consent form in their home language, English, Afrikaans or isiXhosa, prior to collecting any data 
(English version Appendix 18).  
The purpose of the study, the forms and information being used were described in the information 
pack each parent received. The participating therapists or the researcher also verbally explained the 
process to the parents at the initial contact or whenever the parent visited the child at each facility. An 
interpreter was used when necessary. When it was not possible to see the parents face-to-face, as in 
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the case of the MS children, information packs and informed consent forms were sent home with the 
children for their parents to sign. Permission to access contextual information from the nurse, teacher 
and school files was included in informed consent forms. 
The children of the seven parents who refused consent were withdrawn from the study, without any 
consequences. 
3.8.2 Confidentiality 
Participants’ information was kept confidential and secure in a locked cupboard and identifying names 
were removed once data capture was completed. The computer files were password protected and 
kept on secure computers. No participants were identified in the write up of the research.  
3.8.3 Beneficence/non-maleficence   
The study did not influence or affect any treatment the child was receiving and no extra costs were 
involved on the part of the participants; therefore, there was no need for monetary reimbursements. 
The study could potentially benefit children with a health condition if the information gained in HRQoL 
dimensions was used to assist the clinical physiotherapists in planning their management of each 
child.  Regular assessment of HRQoL might, in fact, improve the quality of treatment.  
 
As mentioned earlier, if any unidentified health related problem had been determined in a child at the 
mainstream school from the responses to the HRQol measures, this child would have been referred to 
the appropriate health provider by the researcher. This scenario, however, did not arise.  
 
The study was minimal risk as there were no known risks to the participants and therefore no 
insurance was required for research-related injuries.  In the unlikely event that a child became 
distressed during the assessment, the interview was to be terminated immediately and the treating 
therapist would counsel the child. This did not occur.  Acutely ill children with abnormally high or low 
and unstable vital statistics were not asked to participate as it is likely that they and their parents 
would have found it too stressful. 
If, by the end of this study, the EQ-5D-Y is found to be useful, a recommendation will be put forward 
to incorporate this measure into the undergraduate physiotherapy programme as a routine outcome 
measure to be used in paediatric practice. 
3.8.4 Justice  
Every child who was eligible for the study was recruited from the participating institutions.  
 
It is hoped that findings from this study will help to stimulate research into HRQoL in children in South 
Africa. Therefore, justice would have been served as this is an important area of research in 
paediatrics, which is often overlooked. The paucity of local research articles attests to this.  
 
As the EQ-5D-Y and other paediatric HRQoL measures take the child’s perspective into account, it may 
be used as more than an outcome measure. In particular, it can be used to develop a value set for use 
in children, which is presently lacking.  
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4 CHAPTER 4: RESULTS 
4.1 Sample 
A total of 347 children from all the institutions fell within the identified age range and had successfully 
completed a minimum of two years of schooling. Figure 4 gives an overview of the number of 
participants at each three monthly stage of assessment and data analysis. Two hundred and one 
children from the MS school were recruited, while there were a total of 45 and 47 children with a 
health condition that were recruited at the SS and CI, respectively.  Fifty four children were recruited 
from the AI where they fulfilled the inclusion criteria during the six week data collection period 
allocated to that institution. The parents of seven participants refused consent, while 99 children (78 
of whom were at the MS school) failed to return signed consent forms. Another 16 returned forms 
that were illegible and those participants were excluded, as were the 10 children who were absent 
during the first assessment period. 
A total of 224 children were, therefore, assessed at baseline. Of the 52 children from the AI, 12 were 
discharged before they were re-assessed at three days post admission and, of the remaining 40, 28 
children were discharged before the third assessment, six days later.  
At the second assessment stage, a total of 204 children were assessed and, of these, a further 39 were 
lost to follow-up at the third assessment period, resulting in a total of 167 children being assessed at 
the third stage. The 52 children at the AI were not assessed at three monthly intervals. The median for 
their length of stay was ten days, with a minimum of one day and a maximum of 131 days. Most 
children were assessed initially two days post admission and just prior to discharge which was 
approximately three to four days later. Only 12 children remained in hospital long enough to be 
assessed a third time. 
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Figure 4: Flow diagram indicating the number of participants at each stage of the study 
  
 
ELIGIBLE BUT NOT RECRUITED (n=123) (35.4%)  
 Refused consent: n=7 (2.0%) 
MS (n=2), Special (n=1), Chronic (n=2), Acute 
(n=2) 
 Failed to return signed informed consent form 
from parents n=99 (28.5%) 
MS (n=78), SS (n=8), CI (n=13), AI (n=0) 
 Illegible consent form returned n=16 (4.6%) 
MS (n=16), SS (n=0), CI (n=0), Acute (n=0) 
 Absent during week of baseline assessments 
n=10 (2.9%)                                
MS (n=9), Special (n=1), Chronic (n=0), Acute 
(n=0) 
 
 
 
LOST TO FOLLOW-UP AT 3 MONTHS n=26 (11.6%)  
 Absent during week of assessment n=3 (1.3%) 
MS (n=2), CI (n=1)  
 Discharged/left institution n=18 (8.0%) 
MS (n=5), AI (n=13) 
 Removed due to deteriorating health 
condition n=5 (2.2%) 
SS (n=1), AI (n=4) 
 
LOST TO FOLLOW UP AT 6 MONTHS. Total n=34 
(17.2%) 
 Absent during week of assessment n=8 (4.0%) 
MS (n=4), SS (n=1) Chronic (n=3) 
 Discharged/left institution n=26 (13.1%) 
MS (n=1), CI (n=2), AI (n=23) 
Total assessed at 3 months and 
data analysed. Total n=198 
MS   n=98 (49.5%) 
SS     n=34 (17.1%) (With 1 
deteriorating removed) 
CI     n=31 (15.7%) 
AI     n=35 (17.7%) (With 4 
deteriorating removed) 
 
Total assessed at 6 months and data 
analysed. Total n=167 
MS n=95 (56.9%)                             
SS   n=34 (20.4%)                
CI   n=26 (15.6%)   
AI   n=12 (7.2%) 
 
Participants eligible for 
recruitment (fulfilled inclusion 
criteria). Total n=347 
MS   n=201 (57.9%) 
SS     n= 45 (13.0%) 
CI      n= 47 (13.5%) 
AI      n= 54 (15.6%) 
 
Total assessed at baseline and data 
analysed. Total n=224 
MS n=105 (46.9%)                          
SS   n= 35 (15.5%) 
CI    n= 32 (10.3%) 
AI    n= 52 (23.2%) 
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4.1.1  Demographic details of the respondents 
There were 119 males and 105 females (Table 10).  Apart from the CI, there were more males in each 
of the institutions. Gender distribution was not significantly associated with institution (Chi-sq=1.43; 
p=.698) 
 
Table 10: Gender distribution in each institution  
Institution Gender Totals  
(N) 
 
Male Female 
MS  
 
54 51 105 
  
 
51.4% 48.6%  
SS  
 
21 14 35 
  
 
60.0% 40.0%  
CI 
 
15 17 32 
   
 
46.9% 53.1%  
AI  
 
29 23 52 
  
 
55.8% 44.2%  
Totals 
 
119 105 224 
N=224 
Chi-sq=1.43, p=.698 
 
The mean age of the children at the various institutions was 10.5 years (Std.Dev. = 1.45), with a 
minimum age of 7.0 years and a maximum of 13.8 years. A one-way ANOVA indicated that there was 
no significant difference in the mean ages of the children between the four institutions (p=0.379), 
although those in the CI were generally younger (Figure 5). The children from each institution were 
therefore similar in terms of age and gender.  
Mean ages across Institutions
Vertical bars denote 0.95 confidence intervals
Main Stream
Special School
Chronic Institution
Acute Institution
Institution
9.4
9.6
9.8
10.0
10.2
10.4
10.6
10.8
11.0
11.2
A
ge
 -
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N=224 
 F=(3, 220) = 1.03, p=0.379 
Figure 5: Mean age per institution  
The distribution of children in each grade is given in Table 11. A one-way ANOVA (Figure 6) indicated 
that the mean educational grade of the children differed significantly between the institutions 
(p=0.001), with more MS children in higher grades. There were generally fewer children with health 
conditions in the higher grades and the children at the CI were mostly in the lower grades.  
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Table 11:  Distribution (%) of educational grade at each institution  
N=224 
Mean educational levels across the different institutions
Vertical bars denote 0.95 confidence intervals
Main Stream
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Chronic Instit
Acute Instit
Institution
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N=224 
F(3, 220)=5.581, p=.001 
Figure 6: Mean educational level across institutions  
 
A post-hoc Tukey test (Table 12) indicated that the MS children were in higher grades than the SS or CI 
children. This difference was significant. In addition, the educational level of the children at CI was less 
than the AI and this difference was also significant. 
 
Table 12: Post-hoc Tukey test determining where the difference in educational level lay 
Institution 
 
Mean MS 
 
SS 
 
CI 
 
AI 
 
MS (n=105) 4.8  0.040 0.002 0.803 
SS (n=35) 4.1 0.040  0.820 0.342 
CI (n=32) 3.8 0.002 0.820  0.050 
AI (n=52) 4.6 0.803 0.342 0.050  
Bold and italic indicate a significant difference (p<.05)  
4.1.2 Health status of participants 
Seventy eight participants reported a chronic condition which was either a condition with a functional 
limitation or a chronic health condition. The majority (67) of these participants were at either the SS or 
the CI (Table 13). Amongst the 105 children at the MS, 8 participants reported a minor health problem 
such as asthma and other allergic responses, and three of the participants at the acute care facility had 
chronic as well as acute health problems. All 52 participants at the acute care facility were being 
treated for their acute health problems. 
Institution Grade 2 Grade 3 Grade 4 Grade 5 Grade 6 Grade 7 Totals 
MS  0 16 36 22 18 13 105 
SS 1 10 12 8 4 0 35 
CI 2 15 7 3 4 1 32 
AI 0 17 10 9 10 6 52 
All Groups 3 58 65 42 36 20 224 
Percentage 1.3 25.9 29.0 18.8 16.1 8.9 100 
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Table 13: Chronic or acute health status of participants at each institution  
Institution 
 
Health status  
 chronic 
 
Health status 
acute 
Health status  
none 
 
Totals 
(N) 
MS 8 (7.6%) 0 97 (92.4%) 105 
SS 35 (100%) 0 0 35 
CI 32 (100%) 0 0 32 
AI *3 (5.8%) 49 (94.2%) 0 52 
All Groups 78 (34.8%) 49 (21.9%) 97 (43.3%) 224 
N=224 
* These three children were treated for an acute health problem, unrelated to their chronic condition. 
Table 14 lists the health conditions reported. As was expected, the majority of the children at the MS 
school did not have a health condition, although eight of the total 105 reported minor ailments and 
three were diagnosed with mild learning difficulties. Cerebral palsy was the most common health 
condition seen overall with a total of 18 participants, 12 of whom were at the SS. There were ten 
children with spina bifida, again with the majority (9) being at the SS. The majority of the SS children 
were diagnosed with a disability which limits their functional independence.  Ten children were 
diagnosed with Human Immunodeficiency Virus (HIV), the majority (8) of whom were from the CI. 
Diabetes and muscle diseases were the next most common health conditions and they were mostly 
from the CI. These children were admitted for management of their chronic health condition but did 
not experience many limitations in their functional independence. The most common conditions seen 
at the AI were neoplasms (6), appendicitis (7) and joint injuries (7) and all of the AI children were 
confined to bed. Three AI children were diagnosed with an acute condition superimposed on an 
existing chronic condition. 
Table 14: Number and type of general health conditions of participants at each facility  
General Health Conditions  MS SS CI AI Totals %  
      
  
None 94 0 0 0 94 42.0  
Cerebral Palsy 0 12 4 2 18 8.0  
Spina Bifida 0 9 0 1 10 4.5  
Human Immunodeficiency Virus (HIV) 0 0 8 2 10 4.5  
Diabetes 0 0 8 0 8 3.6  
Muscle diseases 0 7 0 1 8 3.6  
Spinal Cord Injuries 0 5 1 1 7 3.1  
Neoplasms 0 0 1 6 7 3.1  
Appendicitis 0 0 0 7 7 3.1  
Joint injuries 0 0 0 7 7 3.1  
Asthma and allergic responses 5 0 0 1 6 2.7  
Cardiac defects, newly diagnosed 0 0 0 5 5 2.2  
Burns 0 0 0 5 5 2.2  
Infections 0 1 0 3 5 2.2  
Traumatic fractures 0 0 0 3 3 1.3  
Learning difficulty 3 0 0 0 3 1.3  
Failure to thrive 0 0 3 0 3 1.3  
Skeletal abnormalities, fractures/amputations 0 1 0 2 3 1.3  
Syndromes 0 0 3 0 3 1.3  
Traumatic Brain Injuries 0 0 2 0 2 0.9  
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Hepatitis 0 0 1 1 2 0.9  
Other 3 0 1 5 8 3.6  
All Groups 105 35 32 52 224 99.8  
N=224 
In summary the MS children were from the general population group with no disability. The children 
with a chronic disability and resulting limited mobility were from the SS, and the CI group were mostly 
diagnosed with a chronic health condition, but relatively functionally independent. The children from 
the AI were mostly previously TD, but were now limited to bed due to a short lived, acute condition. 
For the full list of health conditions see Appendix 2. 
4.1.3 Length of stay 
The majority of MS and SS children had attended the respective school since the first grade of 
schooling, with a stay of approximately four years. The CI children were only admitted to the facility 
(and attended school there) once the family could no longer manage their chronic health condition at 
home or it had deteriorated and required special care. They therefore had spent less time at the 
institution at baseline assessment, approximately two years. The AI children were only admitted at the 
institution for a short period while their acute problem was managed, which was approximately seven 
days (Table 15). 
Table 15: Length of stay of participants at each institution at baseline  
Institution Mean length stay at baseline 
in months 
Minimum Maximum Std.Dev. 
MS (n= 105) 50.9 0.1 84.1 20.4 
SS (n=35) 46.8 9.6 96.0 19.2 
CI (n=32) 27.8 0.5 97.0 25.4 
AI (n=52) 0.4 0.0 4.4 0.8 
N=224 
4.2 Test-retest reliability of EQ-5D-Y dimension scores 
This was performed in the pilot study (Appendix 14), on a small sample of convenience of children 
from each of the four institutions being used for the main study.  A sample of convenience was used in 
that the children most likely to return a signed consent form were recruited. Cohen's kappa coefficient 
of agreement was used to determine agreement between the test and retest dimension scores (Table 
16). According to Landis and Koch’s interpretation of kappa (110), Mobility, LAM (Looking After 
Myself) and WSU (Worried, Sad or Unhappy) dimensions all fell within the moderately agreed range, 
while P/D (Pain/Discomfort) was fairly well agreed. Only UA (Usual Activities) dimension fell with the 
slightly agreed category.  
Table 16: Agreement between first and second EQ-5D-Y dimension scores for pilot study. 
 
Kappa p 
Mobility 0.546 p<.001  
LAM* 0.653 p<.001 
UA* 0.199 p<.127 
P/D* 0.365 p<.08 
WSU* 0.551 p<.001 
N=38 
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*LAM (Looking After Myself) 
   UA (Usual Activities) 
   P/D (Pain/Discomfort) 
   WSU (Worried, Sad or Unhappy) 
4.3 Test-retest reliability of VAS scores 
This was also performed in the pilot study (Appendix 14) using the intraclass correlation coefficient, 
ICC and found to be 0.765 (95% Confidence intervals (CIs) =0.594-0.870), which is interpreted as 
strong agreement between the two scores according to Rankin and Stokes (1998) (155). As can be 
seen in Figure 7, apart from two outliers, the first and second VAS scores of the children were similar. 
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Figure 7: Test-retest EQ-5D-Y VAS scores for pilot study 
4.4 Baseline assessment of outcome measures across all institutions 
For the main study the baseline EQ-5D-Y, PedsQL, WeeFIM and FPS assessment results were described 
in frequency tables to determine the performance of the various measures when used on children 
with different health statuses (grouped by the different institutions). This was followed by statistical 
analyses to assess some psychometric properties of the EQ-5D-Y, using analyses of the other measures 
for comparison. 
There were no missing responses on the EQ-5D-Y or PedsQL, as the researcher asked the child 
whether the missing response was due to the child not wanting to provide a score for that item or if 
the child had forgotten to provide a score for the item. All children with missing responses did so 
inadvertently and were willing to provide the missing score, without coercion. There were only two 
missing responses on the FPS out of a total of 224 responses, which would not affect the 
interpretation of results. 
Each of the five EQ-5D-Y dimensions (Mobility, LAM, UA, P/D and WSU) was described per institution, 
using histograms and as the data were ordinal, non-parametric statistics was used.  The VAS scores 
were not normally distributed (K-S d=.29, p<0.01), therefore non-parametric statistics were used to 
determine whether there were significant differences in overall HRQoL (VAS) between the children 
with different health states (as indicated by institution). 
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The EQ-5D-Y dimensions and their scores were described individually as they do not share the same 
underlying latent construct (they are multi-dimensional) and the intervals between each problem level 
within a dimension are not equal.  
 
However, a composite score was developed (Index Score), using the QALY values suggested by Craig et 
al, 2015, (66). This recently published study is the first child health valuation study to use adult 
preferences on child health outcomes, to produce a composite score, derived from EQ-5D-Y dimension 
scores, based on a QALY scale. It should be noted that the results obtained by Craig et al have not yet 
been formally implemented by the EuroQoL Group. 
4.4.1 Baseline EQ-5D-Y Dimension scores: 
In total, 54.3% (57) of the MS children reported no problems on any dimension, compared to 11.8% 
(14) of the children with a health condition.  
The level of problems reported in each dimension was associated with the institution, as indicated by 
the Pearson Chi-square statistic and p value (p<0.001 in all cases). 
Just over 50% of the children at the AI reported “a lot of problems” (level 3) with Mobility, followed by 
37% of the children at the SS. Only 13% of children at the CI reported “a lot of problems” with Mobility 
and as expected the MS children reported the least problems in this dimension, 85% with no Mobility 
problems (level 1) (Figure 8). The level of problems (i.e. no problems, some problems or lots of 
problems) reported was significantly different across institutions (Chi-Sq= 82.8, p<.001). 
N=224  
Chi-Sq= 82.8, p<0.001 
Figure 8: Percentage of Mobility dimension at each institution  
At the AI 29% of children reported “some problems” (level 2) and 31% reported “a lot of problems” 
(level 3) in the Looking After Myself dimension (LAM). Similarly, 34% of children at the SS reported 
“some problems” with LAM, but only 14% reported “a lot of problems”. Sixty-six percent of the 
children at the CI and 87% at the MS school reported “no problems” with LAM (Figure 9).  
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N=224 
Chi-Sq= 53.0, p<0.001 
Figure 9: Percentage of Self-Care dimension (LAM) at each institution  
Fifty percent of the children at the AI reported having” lots of problems” (level 3) with doing their 
Usual Activities (UA), whereas the majority of the children at the other three institutions reported” no 
problem” in this dimension (Figure 10). 
 
N=224 
Chi-Sq= 103.2, p<0.001 
Figure 10: Percentage of UA dimension at each institution  
As expected 75% of the MS children reported “no” Pain /Discomfort (P/D) (level 1), whereas 31% of 
the children at the AI reported “a lot of” P/D (level 3). The majority of the children at the SS and at the 
CI reported “no” P/D (Figure 11).  
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N=224 
Chi-Sq= 33.9, p<0.001 
Figure 11: Percentage of P/D dimension at each institution  
 
Eighty four percent of the MS children were “not” Worried, Sad or Unhappy (WSU), as opposed to 
60%, 56% and 44% of the children at the SS, CI and AI respectively report “not” being WSU. About a 
third of the children at the SS, CI and AI all reported being “a bit” WSU and 21% of the AI children 
reported being “very” WSU (Figure 12). 
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Chi-Sq= 32.3, p<0.001 
Figure 12: Percentage of WSU dimension at each institution 
In summary, the children from the MS school had the least problems in all dimensions and on most 
levels of the EQ-5D-Y, the exception being the WSU dimension, in which 4.8% indicated problems on 
level 3 (lots of problems), compared to only 3.1% of children at the CI. The AI children reported the 
most problems on level 3 for all dimensions.  
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4.4.2 Index scores across institutions 
The index scores were not normally distributed and non-parametric tests were used. In Table 17 it can 
be seen that the median Index Score of the MS children was 0.15, indicating minimal problems on any 
dimension.  The AI children had the highest Index Score (2.8), followed by the SS (1.4) and the CC 
(0.75).  Note that the higher scores indicate worse HRQoL. 
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N= 224 
Figure 13: Median Index Score per institution 
 
There was a significant difference in the mean rank of Index Scores across institutions (H=72.86, 
p<0.001) and Table 17 indicated that the MS children scored significantly differently from the other 
three groups, as did the AI children. There was however no difference between the SS and CI Index 
Scores. 
 
Table 17: Comparing Index Scores across institutions 
Institution Mean 
Rank 
Median 
Score 
MS 
 
 
SS 
 
 
CI 
 
AI 
 
MS  
(n= 105) 
78.62 0.15  p<0.001 0.045 p<0.001 
SS  
(n=35) 
129.20 1.4 p<0.001  1.000 0.030 
CI  
(n=32) 
113.61 0.75 .045 1.000  p<0.001 
AI  
(n=52) 
168.98 2.8 <.001 0.030 p<0.001  
 
Kruskal-Wallis test: H (3, N= 224) =72.86 p<0.001 
4.4.3 Baseline EQ-5D-Y VAS scores 
As can be seen in Figure 14, the scores of the VAS in all Institutions apart from the AI were not 
normally distributed (KS<0.01 throughout). Consequently, non-parametric statistics were used. There 
was no correlation between age and VAS (rho=-0.04, p=0.515) 
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Figure 14: VAS scores categorised by Institution 
A higher VAS indicates better HRQoL. The median VAS was 100 for the MS (range 5-100), SS (range 50-
100) and CI (range 10-100), indicating a strong ceiling effect.  The median VAS of the AI was 50 (range 
0-100) (Figure 15) 
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Figure 15: Median VAS per Institution 
The Kruskal Wallace test indicated that there was a significant difference in the mean rank of VAS 
between the institutions (p<0.001). The mean ranking of the SS VAS was the highest, indicating better 
HRQoL, followed by CI and then MS. The AI children had the lowest ranked VAS, indicting worst HRQoL 
and it was significantly different from the other three groups. 
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Table 18: Comparison of ranking of VAS across institutions 
Institution N 
 
Mean 
Rank 
 
Median  
(range) 
 MS 
 
SS 
 
CI 
 
AI 
 
 MS 
 
105 125.9 100 
(5-100) 
 1.00 1.00 p<0.001  
SS 
 
35 138.9 100 
(50-100) 
1.00  1.00 p<0.001  
CI 
 
32 132.3 100 
(10-100) 
1.00 1.00  p<0.001  
AI 
 
52 55.6 50  
(0-100) 
p<0.001   p<0.001  p<0.001   
 
Kruskal Wallis (H (3, N= 224) =62.81 p<0.001) 
4.4.4 Proxy scores per EQ-5D-Y dimension 
Proxy forms were sent to all parents with children at the MS school and to all therapists managing 
children at the various institutions. Table 19 indicates that only 66 out of 98 parents with children at 
the MS school completed proxy forms. All the therapists managing children at the SS (34) and the CI 
(31) completed a proxy report. Only 11 proxy measures were completed by the therapists at the AI, as 
not all the children were receiving therapy. 
Table 19: Proxy EQ-5D-Y dimension scores per institution  
  MS  
(n=66) 
SS  
(n=34) 
CI  
(n=31) 
AI  
(n=11) 
Total 
(n=142) 
   count % count % count % count % count % 
Proxy Mobility 1 66 100 8 22.9 22 73.3 3 27.3 99 69.7 
  2 0 0 11 31.4 5 16.7 3 27.3 30 21.1 
  3 0 0 16 45.7 3 10 5 45.5 24 16.9 
Proxy Self-care 1 64 97 14 40 22 73.3 2 18.2 102 71.8 
  2 2 3 9 25.7 7 23.3 5 45.5 23 16.2 
  3 0 0 12 34.3 1 3.3 4 36.4 17 12.0 
Proxy UA 1 62 93.9 11 31.4 24 80 1 9.1 98 69.0 
  2 3 4.5 12 34.3 5 16.7 3 27.3 23 16.2 
  3 1 1.5 12 34.3 1 3.3 7 63.6 21 14.8 
Proxy P/D 1 49 74.2 31 88.6 28 93.3 4 36.4 112 78.9 
  2 15 22.7 4 11.4 2 6.7 6 54.5 27 19.0 
  3 2 3 0 0 0 0 1 9.1 3 2.1 
Proxy WSU 1 54 81.8 35 100 28 93.3 6 54.5 123 86.6 
  2 10 15.2 0 0 2 6.7 3 27.3 15 10.6 
  3 2 3 0 0 0 0 2 18.2 4 2.8 
1=no problems, 2=some problems, 3=lots of problems 
N=142 
4.4.4.1 Comparing proxy and self-report dimension scores 
Cohen's kappa coefficient of agreement was used to determine whether the dimension scores differed 
between children with a health condition and their therapists and MS children and their parents (Table 
20). There was moderate to good agreement for the Mobility domain at all institutions and Fair to 
Moderate in the UA domain for groups except SS. Each institution had two to three domains which 
demonstrated fair to good agreement. 
69 
 
Table 20: Kappa values comparing Proxy EQ-5D-Y dimensions scores and child self- report dimensions scores 
Institution Kappa value 
for Mobility 
Kappa value for 
LAM 
Kappa value 
for UA 
Kappa value 
P/D 
Kappa value for 
WSU 
MS  
(n=66) 
*.000 -0.048 
Slight 
0.363 
Fair 
0.222 
Fair 
0.074 
Slight 
SS  
(n=34) 
0.551 
Moderate 
0.198 
Slight 
0.082 
Slight 
-0.161 
Slight 
*.000 
CI  
(n=31) 
0.835 
Good 
0.508 
Moderate 
0.420 
Moderate 
0.082 
Slight 
0.007 
slight 
AI  
(n=11) 
0.725 
Substantial 
0.061 
Slight 
0.405 
Moderate 
0.457 
Moderate 
0.353 
Fair 
N=142 
*No kappa was computed because there was no variance in the proxy reporting for mobility at MS and 
WSU at SS. All proxies reported ‘no problems’ for mobility at MS and ‘no problems’ for WSU at SS. 
Of the children with a health condition, the proxies reported fewer problems in all dimensions than 
the children from the CI. The proxies at the SS reported more problems in the Mobility, LAM and UA 
dimensions than the SS children did, but fewer problems with P/D and no WSU problems. The proxies 
at the AI reported more problems in all dimensions, except for WSU, than the AI children themselves 
reported (Table 21). 
Table 21: Percentage of children and proxies reporting some or severe problems in each domain 
 MS (n=66) SS (n=34) CI (n=31) AI (n=11) 
Dimension  % 
Self 
% 
Proxy 
%  
Self 
% 
Proxy 
% 
Self 
% 
Proxy 
%  
Self 
% 
Proxy 
Mobility  
15.2 0 71.4 77.1 
41.
9 
25.8 63.6 72.7 
LAM 
13.3 3 48.6 60 
34.
3 
19.3 63.6 81.8 
UA 
21.9 6.1 37.1 68.6 
35.
5 
22.6 72.7 90.9 
P/D  
24.8 25.8 31.4 14.3 
45.
2 
6.7 45.4 63.6 
WSU  
16.2 18.2 40 0 
38.
7 
9.7 63.6 45.5 
Shaded cells denote more problems reported 
4.4.4.2 Index proxy scores across institutions 
Similar to the self-report, there was a significant difference in the mean ranking of the proxy Index 
Scores between institutions (Kruskal-Wallis H =39.466 p <0.001) (Figure 16). 
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Figure 16: Comparing proxy Index Scores across institutions. 
The significant differences in ranking of proxy Index Scores are depicted in Table 22. There were no 
differences in ranking between the MS and CI and between the SS and AI. 
Table 22: Mean rank of proxy Index Scores across institutions 
Institution N Mean rank MS SS CI AI 
MS 
 
66 59.17  p<.001 1.000 p<.001 
SS  
 
34 95.53 P<.001  0.001 0.890 
CI  
 
31 57.05 1.000 0.001  p<.001 
AI  
 
11 116.23 p<.001 0.890 p<.001  
 
Kruskal-Wallis test: H (3, N= 142) =39.466 p<0.001 
 
There was no significant difference in ranking of proxy VAS scores between MS and SS and between 
CI and AI (Table 23) 
Table 23: Comparison of ranking of proxy VAS across institutions 
 N 
 
Mean 
Rank 
 
Median  
(range) 
 MS 
 
SS  
 
CI 
 
AI 
 
MS 
 
65 85.18 100 
(0-100) 
 1 0.001 p<0.001 
SS 
 
35 82.4 100 
(80-100) 
1  0.011 p<.0001 
CI 
 
31 50.77 95 
(70-98) 
0.001 0.011  0.071 
AI 
 
11 14.41 70 
(6-95) 
p<0.001 p<0.001 0.071  
 
Kruskal-Wallis test: H (3, N= 142) =43.664 p<0.001 
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4.4.4.3 Comparing Proxy and self-report VAS scores 
The ICC for the child and proxy reports of the VAS of all respondents was .58 (n=142), which is 
considered moderate. However, at an institutional level, the proxy and child self-report VAS was only 
correlated significantly (p=0.015) at the MS School (r=0.30, a weak relationship) (Table 24). In contrast 
the correlation between child and proxy VAS, was moderate (r=0.50), but was not significant, possibly 
due to small sample size (n=11).  
Table 24: P value and Spearman’s Rho for Proxy: Child self-report for VAS  
 r p 
MS 0.297 0.016 
SS 0.080 0.653 
CI 0.201 0.288 
AI  0.503 0.115 
N=142 
The scatterplot in Figure 17 demonstrates the weak positive correlation between self- and proxy-
reported VAS, across institutions.   
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Figure 17: Self-report VAS versus proxy VAS, per institution 
4.4.5 Discriminant validity of EQ-5D-Y at baseline 
It was possible to examine the discriminant validity of the EQ-5D-Y by comparing the profiles of HRQoL 
of the different groups of children and determining whether the measure could discriminate between 
the groups. 
4.4.5.1 Examining discriminant validity by comparing the ranking of the different levels on 
each dimension across institutions  
Mobility Dimension  
Using the Kruskal-Wallis ANOVA by ranks for Mobility, across the institutions, it was evident that there 
was a significant difference between the different groups (H=71.058 p<0.001) (Table 25). Multiple 
comparisons of Mobility rankings across institutions indicate that the significant differences were 
between the MS and SS and between the MS and the AI. The CI was only significantly different from 
the AI. There was no significant difference evident between the CI and MS and between the CI and the 
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SS, on the mobility dimension, indicating poor discriminant validity of this dimension when used on 
these children (Table 26).   
Table 25: Kruskal-Wallis ANOVA by Ranks for Mobility, per institution 
Mobility  N 
 
Sum of 
Ranks 
 
Mean 
Rank 
 
MS 
 
105 8512.5 81.07 
SS 
 
35 5174.0 147.83 
CI 
 
32 3579.0 111.84 
AI 
 
52 7934.5 152.59 
 
Kruskal-Wallis test: H (3, N= 224) =71.058 p<.001 
 
Table 26: Multiple comparisons of mean ranking of Mobility problems, per institution 
Mobility MS SS CI AI 
MS  p<0.001 0.112 p<0.001 
SS p<0.001  0.139 1.000 
CI 0.112 0.139  0.031 
AI p<0.001 1.000 0.031  
 
LAM Dimension 
There was a significant difference in rankings for LAM, across the institutions (H=45.349 p<0.001) 
(Table 27). Multiple comparisons of mean rankings indicated that the significant differences were 
between the MS and SS and between MS and AI. There was again no significant difference evident 
between the CI and MS or between the CI and SS, on the LAM dimension, indicating poor discriminant 
validity when used on these children (Table 28).   
Table 27: Kruskal-Wallis ANOVA by Ranks for LAM problems, per institution 
LAM N Sum of  
Ranks 
Mean  
Rank 
MS 105 9439.5 89.90 
SS 35 4566.0 130.46 
CI 32 3525.0 110.16 
AI 52 7669.5 147.49 
 
Kruskal-Wallis test: H (3, N= 224) =45.349 p<0.001 
 
Table 28: Multiple comparisons of mean ranking of LAM problems, per institution 
LAM MS SS CI AI 
MS  0.008 0.730 p<0.001 
SS 
 
0.008  1.000 1.000 
CI 
 
0.730 1.000  0.062 
AI 
 
p<0.001 1.000 0.062  
 
UA Dimension  
There was a significant difference in mean ranking of UA problems across institutions (H=85.311 
p<.001) (Table 29). Multiple comparisons of mean rankings indicated that the significant differences 
were between the AI and the other three groups, which were not significantly different from each 
other (Table 30). 
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Table 29: Kruskal-Wallis ANOVA by Ranks for UA, per institution 
UA N 
 
Sum of 
Ranks 
 
Mean 
Rank 
 
MS 
 
105 9219.0 87.80 
SS 
 
35 3624.0 103.54 
CI 
 
32 3231.0 100.97 
AI 
 
52 9126.0 175.50 
 
Kruskal-Wallis test: H (3, N= 224) =85.311 p<0.001 
 
Table 30: Multiple comparisons of mean ranking of UA, per institution 
UA MS SS 
 
CI 
 
AI 
 
MS 
  
1.000 1.000 p<0.001 
SS 
 
1.000 
 
1.000 p<0.001 
CI 
 
1.000 1.000 
 
p<0.001 
AI 
 
p<0.001 p<0.001 p<0.001 
 
 
P/D Dimension 
There was a significant difference in mean ranking of P/D problems across institutions (H=21.030 
p<0.001) (Table 31). The only significant difference was between MS and AI. There was poor 
discriminant validity between the other groups (Table 32).  
Table 31: Kruskal-Wallis ANOVA by Ranks for P/D, per institution  
P/D N 
 
Sum of 
Ranks 
 
Mean 
Rank 
 
MS 
 
105 10372.5 98.786 
SS 
 
35 3717.5 106.214 
CI 
 
32 3800.0 118.750 
AI 
 
52 7310.0 140.577 
 
Kruskal-Wallis test: H (3, N= 224) =21.030 p<0.001 
 
Table 32: Multiple comparisons of mean ranking of P/D, per institution 
P/D MS 
 
SS 
 
CI 
 
AI 
 
MS 
  
1.000 0.763 0.001 
SS 
 
1.000 
 
1.000 0.092 
CI 
 
0.763 1.000 
 
0.803 
AI 
 
0.001 0.092 0.803 
 
 
WSU Dimension  
There was a significant difference in mean ranking of WSU problems across institutions (H=25.895 
p<0.001).The only significant difference was again between MS and AI. There was poor discriminant 
validity between the other groups for WSU (Table 33 and Table 34). 
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Table 33: Kruskal-Wallis ANOVA by Ranks for WSU dimension, per institution 
WSU N 
 
Sum of 
Ranks 
 
Mean 
Rank 
 
MS 
 
105 9946.5 94.729 
SS 
 
35 4213.5 120.386 
CI 
 
32 3810.0 119.063 
AI 
 
52 7230.0 139.038 
 
Kruskal-Wallis test: H (3, N= 224) =25.895 p<0.001 
 
Table 34: Multiple comparisons of mean ranking of WSU, per institution 
WSU MS 
 
SS 
 
CI AI 
 
MS 
  
0.255 0.378 p<0.001 
SS 
 
0.255 
 
1.000 1.000 
CI 
 
0.378 1.000 
 
1.000 
AI 
 
p<0.001 1.000 1.000 
 
 
The difference between the Index Scores across institutions was presented in 4.4.2 and indicated a 
significant difference in ranking between MS and the other three groups and between AI and the 
other three groups. There was however no difference between the SS and CI Index Scores. 
4.4.5.2 Examining discriminant validity by comparing VAS across Institutions 
The EQ-5D-Y VAS only indicated a significant difference in the mean rank of VAS scores between the AI 
and the other three institutions (p<0.001 for all three) and therefore showed poor discriminant 
validity across the other three groups (Table 18). 
4.4.5.3 Summary of discriminant validity of EQ-5D-Y 
Discriminant validity was evident between the AI and the MS school, only, on all dimensions. There 
was particularly poor discriminant validity between the SS children and the CI children.  
In the Mobility dimension, the EQ-5D-Y could discriminate between MS and SS and between the MS 
and the AI, as well as between AI and CI, all of whom did have different levels of mobility. However no 
difference in Mobility depicted between CI and MS and between CI and SS, despite differences in 
mobility between these groups. 
In the LAM dimension, differences were depicted between MS and SS between MS and AI. There was 
no difference depicted between the AI and SS and between AI and CI. The discriminant validity was 
particularly poor for the CI on this dimension, with no significant difference between it and any other 
group. 
On the UA dimension there was a significant difference between the AI and the other three groups, 
which were not significantly different from each other.  
On the P/D and WSU dimensions the only significant difference was again between MS and AI. There 
was poor discriminant validity between the other groups for WSU. 
The Index Score indicated a significant difference in ranking between all institutions apart from 
between the SS and CI. 
The EQ-5D-Y VAS could only discriminate between the AI children with significantly lower VAS (poorer 
HRQoL) and the other three groups.  
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4.4.6 Comparison of VAS against the three levels of the dimensions, across institutions.  
The VAS score was compared against the ranking of different levels of the dimensions, across 
institutions using Kruskal Wallis H statistic and p value and was found to be significant on all 
dimensions at the AI (Table 18). A significant difference was also evident for WSU dimension, at the SS, 
but was not detected with multiple comparisons of mean ranking (Table 34). 
  
When comparing VAS across the mean ranking of the three levels on each dimension, it was evident 
that this was significant at the AI only (Table 35).   
Table 35: Comparison of VAS against the three levels of the dimensions, across institutions. 
 
 MS SS CI AI 
Mobility H=2.135, NS H=1.530, NS H=1.870, NS H=11.227, p=0.004 
LAM H=.00, NS H=2.538, NS H=.813, NS H=8.958, p=0.011 
UA H=1.56, NS H=.429, NS H=2.36, NS H=5.22, p<0.001 
P/D H=4.440, NS H=1.166, NS H=1.722, NS H=23.334, p<0.001 
WSU H=4.295, NS H=6.412, p=0.041 H=2.110, NS H16.977, p<0.001 
 
NS, Not Significant 
N=224 
4.5 Baseline PedsQL measure across all institutions 
Children who “never had a problem” in each item of the four PedsQL dimensions (Activity, Feelings, 
Socialising and Schooling) were described per institution in a frequency table (Table 36). The 
difference in ranking for PedsQL dimension subtotals of the different health conditions was analysed 
using Kruskal-Wallis (as the data was ordinal) to determine where the difference between institutions 
lay. This was then illustrated graphically with Box-Whisker graphs. 
The full baseline PedsQL can be seen in (Appendix 21).  
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Table 36: Baseline PedsQL of children who “never had a problem” in the various items in each dimension 
  
MS 
(n=105) 
SS 
(n=35) 
CI 
(n=32) 
AI 
 (n=52) 
  
count % count % count % count % 
ACTIVITY: Hard to walk more than one 
block 
Never a problem 85 81.0 11 31.4 17 53.1 18 34.6 
Hard to run Never a problem 62 59.0 6 17.1 17 53.1 13 25.0 
Hard to do sport or exercise Never a problem 72 68.6 9 25.7 12 37.5 12 23.1 
Hard to lift something heavy Never a problem 38 36.2 7 20.0 6 18.8 11 21.2 
Hard to bath or shower by myself Never a problem 94 89.5 22 62.9 24 75.0 28 53.8 
Hard to do chores around house Never a problem 74 70.5 15 42.9 14 43.8 19 36.5 
I hurt Never a problem 35 33.3 15 42.9 6 18.8 19 36.5 
Have low energy Never a problem 46 43.8 14 40.0 12 37.5 17 32.7 
FEELINGS: Feel afraid or scared Never a problem 44 41.9 18 51.4 7 21.9 22 42.3 
Feel sad Never a problem 43 41.0 14 40.0 9 28.1 25 48.1 
Feel angry Never a problem 27 25.7 10 28.6 3 9.4 35 67.3 
Have trouble sleeping Never a problem 42 40.0 21 60.0 12 37.5 30 57.7 
Worry what will happen to me Never a problem 32 30.5 15 42.9 7 21.9 15 28.8 
SOCIALISING: Have trouble getting along 
with other kids 
Never a problem 44 41.9 27 77.1 13 40.6 28 53.8 
Other kids do not want to be my friends Never a problem 53 50.5 16 45.7 16 50.0 30 57.7 
Other kids tease me Never a problem 39 37.1 10 28.6 8 25.0 26 50.0 
Cannot do things other kids my age can 
do 
Never a problem 71 67.6 12 34.3 19 59.4 20 38.5 
Hard to keep up when I play with other 
kids 
Never a problem 55 52.4 10 28.6 18 56.3 18 34.6 
SCHOOLING: Hard to pay attention in 
class 
Never a problem 74 70.5 28 80.0 16 50.0 31 59.6 
I forget things Never a problem 36 34.3 12 34.3 11 34.4 18 34.6 
Have trouble keeping up with schoolwork Never a problem 71 67.6 23 65.7 15 46.9 24 46.2 
Miss school because not feeling well Never a problem 52 49.5 10 28.6 8 25.0 4 7.7 
Miss school to go to Dr or hospital Never a problem 46 43.8 11 31.4 4 12.5 0 0.0 
N=224 
Largest % highlighted in bold 
 
In the Activity and Schooling dimension, the MS children reported having the least problems. 
However, in the Feelings and Socialising dimensions, children in the other institutions reported less 
problems in most of the items e.g. 77% of children at the SS children reported no problems with “Have 
trouble getting along with other kids”, compared to 42% of MS children.  
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4.5.1 PedsQL dimension scores across all institutions 
4.5.1.1 Discriminant validity 
The ability of the PedsQL to depict significant differences between the different groups of children was 
examined for discriminant validity. Kruskal-Wallis analysis was used to determine whether there was a 
difference in ranking for dimension subtotals of the different health conditions at each institution and 
graphically illustrated with Box-Whisker graphs. 
4.5.1.2 PedsQL dimension subtotals, across all groups 
There was a significant difference in ranking for PedsQL Activity, Feelings and Schooling dimensions 
across all the institutions, but not for the Socialising dimension (Table 37), indicating fair discriminant 
validity. 
Table 37: Kruskal-Wallis H and p values for each PedsQL dimensions subtotal, across all groups  
Institution PedsQL 
dimension sub scores 
N Kruskal-Wallis  
H value 
p value 
All groups Activity 224 35.31 p<0.001 
All groups Feelings 224 14.38 0.002 
All groups Socialising 224 6.23 0.1 
All groups Schooling 224 20.86 p<0.001 
N=224 
4.5.1.3 PedsQL subtotal score for Activity dimension, per institution 
Figure 18 illustrates the medians for Activity score across institutions. The MS Activity scores were 
ranked significantly lower (fewer problems) than those of the SS and AI (Table 38). 
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Figure 18: PedsQL median for Activity subtotal per institution  
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Table 38: PedsQL Activity mean ranking across institutions 
 Mean rank N MS SS CI AI 
MS 86.4 105  p<0.001 0.081 p<0.001 
SS 139.1 35 p<0.001  1.000 1.000 
CI 118.7 32 0.081 1.000  0.528 
AI 143.5 52 p<0.001 1.000 0.528  
 
Kruskal-Wallis test: H (3, N= 224) =35.305 p <0.001 
4.5.1.4 PedsQL subtotal score for Feelings dimension, per institution 
Figure 19 illustrates the medians for Feelings score across institutions.   
Table 39 indicated that there was a significant difference in ranking for PedsQL Feelings subgroup, at 
the different institutions (p=0.002). The Feelings scores of the children in the CI were ranked 
significantly higher (more problems) than the SS and the AI and between the AI and CI.  
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Figure 19: PedsQL median for Feelings across institution  
Table 39: PedsQL Feelings mean ranking   
 Mean rank N MS SS CI AI 
MS 119.8 105  0.389 0.762 0.071 
SS 97.4 35 0.389  0.038 1.000 
CI 139.7 32 0.762 0.038  0.006 
AI 92.1 52 0.071 1.000 0.006  
Kruskal-Wallis test: H (3, N= 224) =14.378 p =0.002 
4.5.1.5 PedsQL subtotal score for Socialising dimension, per institution 
Figure 20 illustrates the medians for Socialising score across institutions. There was no significant 
difference in the ranking for PedsQL socialising dimension across the institutions (p=0.1).  
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PedsQL subtotal for socialising grouped by institution
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Figure 20: PedsQL median for socialising across the institutions  
4.5.1.6 PedsQL subtotal score for Schooling dimension, per institution 
Figure 21 illustrates the medians for Socialising score across institutions.   
Table 40 indicated that there was a significant difference in ranking for PedsQL schooling subgroup, at 
the different institutions (p<0.001). The Schooling score of the children in the AI was ranked 
significantly higher (more problems) than the MS and SS children. 
PedsQL subtotal for schooling grouped by institution
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 Figure 21: PedsQL Schooling median at each institution  
Table 40: PedsQL mean ranking for schooling 
 Mean ranking N MS SS CI AI 
MS 97.0 105  1 0.172 p<0.001 
SS 100.6 35 1  0.684 0.014 
CI 125.6 32 0.172 0.684  1 
AI 143.7 52 p<0.001 0.014 1  
 
Kruskal-Wallis test: H (3, N= 224) =20.860 p <.001 
4.5.2 PedsQL dimensions sub scores across institutions 
Figure 22, a radar graph, illustrates the weighted scores for the four dimensions assessed in the 
PedQL. A lower score indicted fewer problems in that dimension. The MS children had the fewest 
problems with Activities, Socialising and Schooling, whereas the AI children had the most problems 
with Activity and Schooling. The SS children had the most problems with Socialising and the CI children 
experienced the most problems in the Feelings dimension. 
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N=224 
Figure 22: PedsQL subtotal for activity, feelings, socialising and schooling at each institution  
4.5.3 PedsQL total scores across institutions 
 
The PedsQL total scores were not normally distributed Figure 23. 
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Figure 23: Histogram indicating distribution of PedsQL total scores 
A higher PedsQL score (obtained from a sum of the dimension scores) indicates worst HRQoL. The AI 
demonstrated the highest score and therefore worst HRQoL (median37, range 9-73), followed by the 
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SS (median 35, range 4-65) and CI (median 30, range 7-64). The MS children scored the lowest (median 
27, range 0-66), indicting the best HRQoL. 
The Kruskal Wallace test (Table 41) indicated that there was a significant difference in the mean rank 
of PedsQL total score between the institutions (p=.001) and that the ranking of the MS children was 
significantly lower than the AI children. There were no other significant differences in ranking, 
indicating poor discriminant validity when used on children with chronic conditions or disabilities. 
Table 41: Comparison of ranking of the PedsQL total across institutions 
 
Mean 
Rank 
 
N 
 
 MS 
 
 
SS 
 
 
CI 
 
 
AI 
 
 
MS 
 
94.4 105 
 
0.072 0.123 0.003 
SS 
 
126.2 35 0.072 
 
1.000 1.000 
CI 
 
124.7 32 0.123 1.000 
 
1.000 
AI 
 
132.3 52 0.003 1.000 1.000 
 
 
Kruskal-Wallis test: H (3, N= 224) =15.740 p =.001 
4.5.4 Summary of performance of PedsQL across the different health conditions, indicating 
discriminant validity  
Three of the PedsQL dimensions, Activity, Feelings and Schooling indicated a significant difference in 
ranking across the institutions. This did not apply to the Socialising dimension. 
The PedsQL total score ranking was significantly different (lower indicating better HRQoL) for the MS 
children compared to the ranking for the AI children. It was not possible to differentiate between the 
MS, SS, and CI children using the PedsQL total score ranking.   
4.6 Baseline WeeFIM measure across all institutions 
The WeeFIM, a measure of functional independence, consisting of three dimensions (self-care, 
mobility and cognition), is described for “complete independence” per institution in Table 42. This was 
followed by Kruskal Wallis ANOVA to determine the impact of different health conditions on 
functional independence of children at each institution.  
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Table 42: Baseline WeeFIM for “complete independence” of all items in each dimension  
 
MS 
(n=16) 
SS 
(n=35) 
CI 
(n=32) 
AI 
(n=52) 
Count  % Count % Count  % Count  % 
Self-care: Eat 16 100.0 34 97.1 31 96.9 33 63.5 
Groom 12 75.0 30 85.7 27 84.4 34 65.4 
Bath 15 93.8 28 80.0 28 87.5 16 30.8 
Dressing upper body 16 100.0 28 80.0 28 87.5 24 46.2 
Dressing lower body 16 100.0 21 60.0 27 84.4 17 32.7 
Toileting 16 100.0 23 65.7 28 87.5 36 69.2 
Bladder management 16 100.0 19 54.3 29 90.6 23 44.2 
Bowel management 16 100.0 21 60.0 29 90.6 23 44.2 
Mobility: Transfer - chair/wheelchair 16 100.0 12 34.3 26 81.3 23 44.2 
Transfer – 
 Toilet 
16 100.0 11 31.4 27 84.4 22 42.3 
Transfer –  
Bath tub 
16 100.0 11 31.4 27 84.4 20 38.5 
Walk / wheel 
Chair 
16 100.0 11 31.4 26 81.3 20 38.5 
Stairs 15 93.8 9 25.7 21 65.6 3 5.8 
Cognition: Comprehension 4 25.0 19 54.3 16 50.0 40 76.9 
Expression 11 68.8 23 65.7 23 71.9 40 76.9 
Social interaction 15 93.8 26 74.3 21 65.6 42 80.8 
Problem solving 10 62.5 15 42.9 18 56.3 43 82.7 
Memory 6 37.5 13 37.1 15 46.9 43 82.7 
N=135 
For full baseline WeeFIM assessment, see Appendix 22 
The WeeFIM, as a measure of functional independence, would have demonstrated a ceiling effect in 
most of the MS children (all being functionally independent). Since these children would have scored 
maximally, they were not assessed using this measure. There were, however, 16 MS children who 
indicated on the EQ-5D-Y measure that they had a problem with Mobility and were subsequently 
assessed with the WeeFIM instrument to determine whether they did in fact have a functional 
problem. As can be seen from Table 42 above, they did not have a problem with Mobility on 
assessment with WeeFIM.  Therefore, a total of 135 children were assessed with a WeeFIM measure 
at baseline; that is, 16 MS children and 119 children from SS, CI and AI were analysed. 
4.6.1 WeeFIM dimension scores across institutions 
4.6.1.1  WeeFIM Self-care across institutions 
The median scores for Self-care across institutions are illustrated in Figure 24. There was a significant 
difference in the WeeFIM Self-care score rankings across the institutions (p<.001). A  Kruskal Wallis 
ANOVA (Table 43) indicated that the AI children had significantly lower ranked Self-care scores, 
indicating lower independence, than the children at the SS and the CI, which were also significantly 
different in ranking, from each other.  
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WeeFIM Self-care median scores across Institutions
excluding Main Stream
 Median 
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N=119 Note: The higher the score, the greater the independence. 
Figure 24: WeeFIM median Self-care score per institution, excluding MS 
Table 43: Differences in WeeFIM Self-care ranking across Institutions 
 Mean Rank N SS CI AI 
SS 64.4 35  0.045 0.008 
CI 84.9 32 0.045  0.000 
AI 41.7 52 0.008 0.000  
N=119 
Kruskal-Wallis test: H (2, N= 119) =32.95 p<.001. 
4.6.1.2 WeeFIM Mobility across institutions 
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Figure 25: WeeFIM median Mobility scores per institution, excluding MS  
The median scores for Mobility across institutions are illustrated in Figure 25. There was a significant 
difference in Mobility ranking across the institutions p<.001). A  Kruskal Wallis ANOVA (Table 44) 
revealed that the AI children had significantly lower ranked Mobility scores, indicating lower 
independence, than the SS and CI children, whose rankings were also significantly different from each 
other.  
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Table 44: WeeFIM Mobility ranking across institutions 
 Mean rank N SS CI AI 
SS 62.6 35  0.007 0.011 
CI 88.3 32 0.007  p<.001 
AI 40.8 52 0.011 p<.001  
 
Kruskal-Wallis test: H (2, N= 119) =38.8 p<.001 
 
4.6.1.3 WeeFIM Cognition across institutions 
 
WeeFIM median for Cognition across institutions, excluding Main Stream
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N=119 
Figure 26: WeeFIM Cognition median score per institution  
The median scores for Cognition across institutions are illustrated in Figure 26. There was a significant 
difference in ranking of cognition scores across the institutions (p<.001). ). A Kruskal Wallis ANOVA 
(Table 45) indicates that the ranking of Cognition subtotal of the AI children was significantly higher 
(fewer problems) than the ranking of cognition of the SS and CI children. The ranking of Cognition 
scores was not significantly different between the CI and SS children.   
Table 45: Differences in mean ranking of WeeFIM cognition score between the institutions 
 Mean Rank N SS CI AI 
      
SS 45.9 35  0.965 0.001 
CI 54.2 32 0.965  0.045 
AI 73.1 52 0.001 0.045  
N=119 
Kruskal-Wallis test: H (2, N= 119) =16.60 p<.001 
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4.6.1.4 WeeFIM dimension totals across institutions 
As expected, the AI participants had the most problems (lowest percentage score) with Mobility (51%) 
and Self-care (74%), but the fewest problems overall with Cognition (94%). The participants at the SS 
experienced more problems with Self-care (89%), Mobility (74%) and Cognition (83%) compared to the 
participants at the CI. Out of all Cl children, 95%, 93% and 87% experienced problems in each of the 
three dimensions, respectively (Table 46). 
Table 46:  Weighted percentage scores for WeeFIM self-care, mobility and cognition  
 
 
 
 
4.6.2 WeeFIM total score per institution 
 
Figure 27 demonstrates the non-normal distribution of WeeFIM total scores across institutions.  
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Figure 27: Distribution of WeeFIM total scores across institutions, excluding MS 
 
 Self-care 
subtotal % 
Mobility 
subtotal % 
Cognition 
subtotal % 
SS (n=35) 89 74 83 
CI (n=32) 95 93 87 
AI (n=52) 74 51 94 
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Figure 28: WeeFIM median score per institution, excluding MS, at baseline  
The median scores for WeeFIM total across institutions are illustrated in Figure 28. There was a 
significant difference in the WeeFIM total scores ranking across three institutions (p<.001), excluding 
MS. A  Kruskal Wallis ANOVA (Table 47) revealed that the children from the CI had significantly higher 
ranked WeeFIM total scores (median 120, range 65-126), indicating greater functional independence 
than the participants at the SS (median 110, range 68-126) and the AI (median 93.5, range 47-126). 
However, according to the WeeFIM total scores, the AI and SS children experienced a similar degree of 
functional limitation.  
Table 47: Differences in WeeFIM total score ranking between the institutions, excluding MS  
 Mean 
Rank 
 
N 
 
 SS 
 
CI 
 
AI 
 
SS 
 
60.0 35   0.005 0.090 
CI 
 
86.6 32  0.005  p>0.001 
AI 
 
43.6 52  0.09 P<0.001  
N=119 
Kruskal-Wallis test: H (2, N= 119) =30.84 p<.001  
 
4.6.3 Summary of performance of WeeFIM across the different health conditions at the different 
institutions, indicating discriminant validity.  
The inclusion criterion for using the WeeFIM was a problem with mobility, as assessed on the EQ-5D-Y 
Mobility dimension. Sixteen of the MS children indicated a Mobility problem. These children were 
then assessed for functional independence using the WeeFIM and were found to not have a problem 
on the Mobility dimension. However, the WeeFIM Mobility dimension did not depict a significant 
difference between the MS children with no mobility problems and children from the CI, some of 
whom did have mobility problems. 
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The Self-care dimension on the WeeFIM indicated a significant difference between the AI children and 
the other two groups only. 
The Cognition dimension showed a significant difference between the acutely ill children and the SS 
children, but not between these and the other groups. 
The WeeFIM total score depicted a significant difference in functional independence between the 
children at the CI and the SS and AI. However, it was unable to depict a difference in functional 
independence between the AI and SS, indicating poor discriminate validity in these groups.   
4.7 Baseline Faces Pain Scale measure across all institutions 
Using six pictures to indicate increasing pain intensity from 0-10, the FPS was measured at each 
institution (Table 48). A total of 222 children completed the FPS at baseline. There were missing scores 
from two MS children. The Kruskal-Wallis ANOVA was used to determine the difference in pain ranking 
across institutions (Table 49).  
Table 48: Baseline Faces Pain Scale  
N=222; 2 missing 
Table 49: Kruskal-Wallis ANOVA by Ranks; Faces Pain Scale across institutions  
 Mean 
Rank 
Median 
(range) 
Std.Dev. MS SS CI AI 
MS 
(n=103) 
107.70 2 
(0-10) 
2.76  0.817 
 
1 
 
0.097 
 
SS 
(n=35) 
88.97 0 
(0-10) 
3.07 0.817 
 
 
 0.871 0.008 
CI 
(n=32) 
111.86 2 
(0-10 
2.41 1 
 
0.871  0.753 
AI 
(n=52) 
133.97 2 
(0-10) 
3.47 0.097 0.008 
 
0.753  
N=222 
Kruskal-Wallis test: H (N= 222) =12.67 p =.005 
There was a significant difference in pain ranking across the institutions. Table 49 shows that the mean 
ranking for pain was the highest at the AI, indicating that these children experienced the most pain, 
followed by the children at the CI, then the MS children.  The SS children’s ranking for pain was the 
lowest. The only significant difference in pain ranking was between the AI children (most pain) and the 
SS children (least pain). 
Faces Pain Scale Score 
MS 
(n=103) 
SS 
(n=35) 
 CI 
(n=32) 
AI 
(n= 52) 
Total 
(n=222) 
  count % count % count % count % count % 
0 51 49.5 24 68.6 14 43.8 16 30.8 105 47.3 
2 29 28.2 6 17.1 11 34.4 16 30.8 62 27.9 
4 12 11.7 1 2.9 3 9.4 8 15.4 24 10.8 
6 2 1.9 0 0.0 3 9.4 1 1.9 6 2.7 
8 3 2.9 1 2.9 0 0.0 4 7.7 8 3.6 
10 6 5.8 3 8.6 1 3.1 7 13.5 17 7.7 
All Groups 103  35  32  52  222 100.0 
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4.8 Convergent validity 
Convergent validity of the EQ-5D-Y was examined by correlating the dimension scores for children 
with different health states with their scores on similar dimensions of the PedsQL, WeeFIM and the 
FPS. Significant correlations between VAS and PedsQL and WeeFIM total scores, assessed at the same 
time, were also examined for concurrent validity.  
Of the two self-reporting HRQoL measures, the EQ-5D-Y has five dimensions and the PedsQL has four. 
Some dimensions are similar between the two measures. Pain is included as single items in the PedsQL 
Activity dimension, so the “I hurt” item was compared to EQ-5D-Y P/D dimension. EQ-5D-Y LAM was 
compared with Self-care subtotal on the WeeFIM.  As all the PedsQL dimensions contain some aspect 
of UA, the PedsQL total was used to compare with EQ-5D-Y UA dimension. The EQ-5D-Y P/D dimension 
was compared to the FPS. A summary of the dimensions that were compared is given in Table 50. 
Table 50: Comparing similar dimensions of EQ-5D-Y, PedsQL, WeeFIM and Faces Pain Scale 
 
EQ-5D-Y dimensions PedsQL dimensions WeeFIM Faces Pain Scale 
Mobility Health and Activity subtotal Mobility subtotal  
LAM   Self-care subtotal  
UA PedsQL total   
P/D “I hurt” item  FPS 
WSU “Feelings” subtotal   
 
The mean ranking of the relevant subtotal scores of the PedsQL and WeeFIM dimensions were 
compared across the different levels of similar EQ-5D-Y dimensions as described in Table 50. 
The scores were not normally distributed and as the EQ-5D-Y dimensions have three levels of 
problems, the Kruskal-Wallis H test was conducted to determine if the ranking of the PedsQL or 
WeeFIM scores were different for the three levels of the EQ-5D-Y. When there were five or fewer 
scores for a particular problem level (1, 2 or 3) on the independent EQ-5D-Y variable, this level was 
excluded and the Mann-Whitney U Test was used to compare the remaining two levels. 
 
Convergent validity was demonstrated when the Kruskall Wallis ANOVAs indicated that the scores 
between the two measures were significantly different across all the levels (p<.05 in every case). 
4.8.1 Convergent validity of the EQ-5D-Y Mobility and PedsQL Health and Activities dimensions 
across institutions 
In the MS children, there were no scores on level three of EQ-5D-Y Mobility dimension so this level 
was excluded. The Mann-Whitney U Test was used to compare the remaining two levels in these 
children (Table 51).  
 
Table 51: Comparing EQ-5D-Y Mobility and PedsQL Activities dimensions  
Institution N Kruskal-Wallis H value p value Mann-Whitney U  
z value 
p value 
MS 105    -1.42 0.156 
SS 35 16.7 p<0.001   
CI 32 3.73 0.15   
AI 52 15.81 p<0.001   
N=224 
Based on the Mann-Whitney U test, there was no significant difference in ranking of PedsQL Activity 
scores across two levels of the EQ-5D-Y Mobility in the MS children (Table 51). The Kruskal-Wallis test 
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showed that, in the children at the CI, there was no significant difference in ranking of the PedsQL 
Activity score across the different levels of the EQ-5D-Y Mobility dimension.  However, there was a 
significant difference in ranking of PedsQL Activity score across the three EQ-5D-Y levels for the SS and 
AI children, with p values of <0.001 in both cases, thus indicating good convergent  validity between 
the measures for these health conditions. 
The institutions at which there was a significant difference in ranking (SS and AI) are shown in the Box-
Whisker graph, in Appendix 23. 
4.8.2 Convergent validity of the EQ-5D-Y UA and PedsQL total  
All of the PedsQL dimensions contain items of Usual Activities, so the PedsQL total was compared 
against EQ-5D-Y AU dimension.   
 
Table 52: Comparing EQ-5D-Y UA dimension with PedsQL total across institutions 
Institution N Kruskal-Wallis  
H value 
p value Mann-Whitney U  
z value 
p value 
MS 105   -2.682 0.007 
SS 35   -0.847 0.397 
CI 32   -3.043 0.002 
AI 52 10.335 0.006   
 
In the case in the MS children, SS and CI, level 3 (a lot of problems) on the EQ-5D-Y UA dimension was 
excluded as there was only one score for this level and the Mann-Whitney U Test was used to 
compare two levels. 
The Mann-Whitney U in Table 52 indicated a significant difference in ranking of PedsQL total across 
two levels of the EQ-5D-Y UA dimension, for MS and CI children. The Kruskal-Wallis test showed there 
was a significant difference in ranking of PedsQL total across the different levels of the EQ-5D-Y UA 
dimension at the AI.  
The institutions at which there was a significant difference in ranking (MS, CI and AI) are shown in the 
Box-Whisker graph, in Appendix 23. 
4.8.3 Convergent validity of the EQ-5D-Y P/D dimension with PedsQL “I hurt” item across 
institutions 
As there were only 2 cases of level 3 P/D at SS and CI and only 4 cases at the MS, this level was 
excluded and these were analysed using Mann-Whitney U test.  
Table 53: Comparing EQ-5D-Y P/D dimension with PedsQL “I hurt” item  
Institution N Kruskal-Wallis  
H value 
p value Mann-Whitney U 
z value 
p value 
MS 103   0.753 0.452 
SS 35   1.678 0.093 
CI 32   1.566 0.117 
AI 52 26.78 p<0.001   
N=222 
The Mann-Whitney U test indicated no significant difference in ranking of PedsQL “I hurt” across two 
levels of EQ-5D-Y P/D dimension the MS children, the SS and CI 
The Kruskal-Wallis test indicated a significant difference in ranking of PedsQl “I hurt” across the three 
levels of EQ-5D-Y P/D dimension at the AI only (Table 53).  
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This is shown in Box-Whisker graph in Appendix 23. 
4.8.4 Convergent validity of the EQ-5D-Y WSU dimension with PedsQL Feelings dimension, at 
each institution  
In the MS children, SS and CI, level 3 on the EQ-5D- Y WSU was excluded as there were less than five 
reporting this level. The Mann-Whitney U Test was used to compare two levels. 
Table 54: Comparing EQ-5D-Y WSU dimension and PedsQL Feelings dimension across institutions 
Institution N Kruskal-Wallis 
 H value 
p value Mann-Whitney U  
z value 
p value 
MS 105   -2.318 0.020 
SS 35   -1.210 0.226 
CI 32   0.872 0.383 
AI 52 12.14 0.007   
N=224  
The Mann-Whitney U test in (Table 54) indicated a significant difference in ranking of PedsQL Feelings 
score across two levels of the EQ-5D-Y WSU dimension for MS children, but no difference in ranking at 
the SS and CI. 
 
The Kruskal-Wallis test, however, indicted a significant difference in ranking of PedsQL feelings score 
across all three levels of EQ-5D-Y WSU at the AI.  
 
The institutions at which there was a significant difference in ranking (MS and AI) are shown in the 
Box-Whisker graphs, in Appendix 23.  
4.8.5 Convergent validity of the EQ-5D-Y Mobility and WeeFIM Mobility dimensions, at each 
institution. 
 
All 16 MS children scored maximally (indicating no problem with mobility and a ceiling effect) on the 
WeeFIM, so they were excluded from this analysis. 
 
Table 55: Comparing EQ-5D-Y Mobility and WeeFIM Mobility dimension, across institutions  
 
 
 
 
 
 
 
 
N=135  
 
The Kruskal-Wallis test in Table 55 indicated that there was a significant difference in ranking of the 
WeeFIM Mobility score across the three levels of the EQ-5D-Y Mobility dimension, for the SS, CI and 
AI. This indicated concurrent validity for the EQ-5D-Y Mobility dimension and WeeFIM mobility, for 
these three institutions. 
 
This is shown in the Box-Whisker graphs, for each institution, in Appendix 23. 
Institution N Kruskal-Wallis  
H value 
p value 
SS 35 22.12 p<0.001 
CI 32 9.19 0.01 
AI 52 21.75 p<0.001 
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4.8.6 Convergent validity of the EQ-5D-Y LAM and WeeFIM Self-care dimension, at each 
institution 
In the MS children there were no scores for level 3 (a lot of problems) on the EQ-5D-Y self-care 
dimension so the Mann-Whitney U Test was used to compare the other two levels. 
Table 56: Comparing EQ-5D-Y LAM and WeeFIM Self-care dimensions, across institutions  
 
Institution N Kruskal-Wallis  
H value 
p value 
SS 35 14.19 p<0.001 
CI 32 8.69 0.013 
AI 52 15.57 p<0.001 
N=135 
In MS children, the Mann-Whitney U indicated no significant difference in ranking of WeeFIM 
subtotals across two levels of the EQ-5D-Y for the Self-care dimension. In the children at the SS, CI and 
AI, the Kruskal-Wallis test showed a significant difference in ranking of WeeFIM Self-care subtotal 
across the different levels of the EQ-5D-Y LAM dimension (Table 56).  
This is shown in the Box-Whisker graphs, in Appendix 23. 
4.8.7 Convergent validity of the EQ-5D-Y P/D dimension with Faces Pain Scale, at each of the 
institutions 
 
Table 57: Comparing Faces Pain Scale with the independent variable, EQ-5D-Y P/D 
Institution N Kruskal-Wallis  
H value 
p value Mann-Whitney U  
z value 
p value 
MS 103   0.150 0.881 
SS 35   0.788 
 
0.431 
 
CI 32   -0.360 0.719 
AI 52 29.76 p<0.001   
N=222 
In the MS, SS and CI children, the Mann-Whitney U test was used as there were only two levels in 
Table 57 indicated no significant difference in ranking of Faces Pain Scale (FPS) across two levels of EQ-
5D-Y P/D dimension.  
The Kruskal-Wallis test indicated a significant difference in ranking of FPS across the three levels of EQ-
5D-Y P/D dimension at the AI only.  
This is shown in Box-Whisker graph in Appendix 23. 
4.8.8 Summary of Convergent validity between similar dimensions for all outcome measures, 
across institutions 
The institutions at which convergent validity was evident on similar dimensions of EQ-5D-Y and the 
other outcome measures are illustrated in bold in Table 58. 
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 Table 58: Convergent validity between similar dimensions 
 
EQ-5D-Y 
dimensions 
PedsQL dimensions  
and institutions 
WeeFIM dimensions  
and institutions 
Faces Pain Scale 
and institutions 
Mobility 
 
 
Health and Activity subtotal: 
 
Convergent validity evident 
at SS and AI 
Mobility subtotal: 
 
Convergent validity 
evident at SS, CI and AI 
  
LAM    Self-care subtotal: 
 
Convergent validity 
evident at SS, CI and AI 
  
UA PedsQL total: 
 
Convergent validity evident 
at MS, Chronic and AIs 
    
P/D  “I hurt” item: 
 
Convergent validity evident 
at AI only 
  FPS: 
 
Convergent validity 
evident at AI only  
WSU Feelings subtotal: 
 
Convergent validity evident 
at MS and AI  
    
 
It would seem that the PedsQL and EQ-5D-Y demonstrated convergent validity at the AI for all 
dimensions compared. The WeeFIM and EQ-5D-Y demonstrated convergent validity at SS, CI and AI for 
all dimensions compared. The FPS and EQ-5D-Y P/D dimension showed convergent validity at the AI 
only.   
4.8.9 Convergent validity between the sets of total scores 
Convergent validity was indicated by significant correlations between the EQ-5D-Y VAS, Index Score 
and total scores of PedsQL and WeeFIM (p<.05 in all cases) across institutions (Table 59). The highest 
correlation was between the PedsQL and WeeFIM (-.48), followed closely by The EQ-5D-Y and PedsQL 
(.47) and the lowest between the PedsQL and the VAS (-.28). 
Table 59: Correlations between the different instruments total scores, all groups 
 
EQ-5D-Y VAS 
 
EQ-5D-Y 
Index Score 
PedsQL 
total 
 
WeeFIM 
total 
 
EQ-5D-Y VAS 
 
 -0.34 -0.28 0.39 
EQ-5D-Y Index Score -0.34  0.46 -0.59 
PedQl total 
 
-028 0.46  -0.48 
WeeFIM total 
 
0.39 -0.59 -0.48  
N=224, apart from WeeFIM where N=135 
Spearman Rho is significant at p<.05  
Note: High scores on VAS and WeeFIM indicate high HRQoL and high scores on the PedsQL and Index 
indicate poor HRQoL. 
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Table 60: Summary of significant correlations between the different instruments per institution 
Institution Significant correlations were evident between Rho p 
MS EQ-5D-Y Index Score and PedsQL total 0.199 0.041 
SS All similar EQ-5D-Y and WeeFIM dimensions 
EQ-5D-Y Index Score and PedsQL total 
PedsQL and WeeFIM total 
 
0.441 
0.557 
 
0.009 
p<0.001 
CI All similar EQ-5D-Y and WeeFIM dimensions 
EQ-5D-Y VAS and PedsQL total  
EQ-5D-Y index Score and WeeFIM total 
PedsQL and WeeFIM total 
 
-0.523 
-0.398 
-0.558 
 
0.002 
0.024 
p<0.001 
AI All similar EQ-5D-Y and PedsQL dimensions 
All similar EQ-5D-Y and WeeFIM dimensions  
EQ-5D-Y P/D dimension and FPS 
EQ-5D-Y VAS and Index Score 
EQ-5D-y Index Score and PedsQL total 
EQ-5D-Y Index Score and WeeFIM total 
EQ-5D-Y VAS and PedsQL total 
EQ-5D-Y VAS and WeeFIM total 
PedsQL and WeeFIM total 
 
 
 
-0.767 
0.635 
-0.659 
-0.564 
0.525 
-0.529 
 
 
 
p<0.001 
p<0.001 
p<0.001 
p<0.001 
p<0.001 
p<0.001 
 
Table 61: Summary of discriminant ability of the outcome measures, between the different groups 
Outcome Measure  Institutions between which the outcome measures discriminated 
significantly. 
EQ-5D-Y Dimensions Between the AI and the MS school on all dimensions.  
EQ-5D-Y  
Index Score 
Between AI all other groups 
Between MS and all other groups 
Between SS and MS and between SS and AI 
Between CI and MS and between CI and AI 
EQ-5D-Y VAS Between the AI and the other groups 
PedsQL Between the AI and  the MS 
WeeFIM Between the CI and SS and between CI and the AI, but  not between AI and SS 
 
4.9 Repeated measures over the study period 
The outcome measures were repeated at three months and six months, post baseline assessment to 
assess stability of scores, in the children whose HRQoL was not expected to change (MS and SS).  
The responsiveness of the two HRQoL measures, the EQ-5D-Y and PedsQL, and the measure of 
functional independence the WeeFIM, to change over time was also assessed. As noted previously, it 
was anticipated that the MS children would not show a change in HRQoL over time. The SS children, 
with a stable chronic disability, might show no change or a slight improvement as a result of continued 
treatment. The children at the CI would show some improvement with better management and 
treatment of their chronic health condition. The AI children should show a significant improvement in 
HRQoL over time with treatment and pain medication for their acute condition.  
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Table 62: Length of time between assessment periods 
 
Between baseline and 2
nd
 
assessment period 
Between 2
nd
 and 3
rd
 assessment 
periods 
Between baseline and 3
rd
 
assessment period 
  N Days since 
baseline 
(Mean) 
Days since 
baseline 
Std.Dev. 
N Days from 
2
nd
 
assessment 
(Mean) 
Days from 
2
nd
 
assessment  
Std.Dev. 
N Days from  
baseline 
(Mean) 
Days 
from  
Baseline 
Std.Dev 
Main 
Stream 
98 93.4 5.52 93 87.1 3.29 95 180.7 6.14 
SS 34 86.9 7.58 34 114.2 6.63 34 201.0 4.67 
CI 31 88.7 5.17 26 99.3 2.99 26 186.8 3.49 
AI 35 3.3 1.49 12 6.8 5.59 12 11.0 5.61 
 
Table 62 showed that the mean length of time between baseline and the second assessment period 
was approximately 90 days (three months), while the time between the second and third assessment 
periods was approximately 100 days (just over three months) for the MS, SS and CI participants. There 
were approximately 190 days between baseline and third assessment (just under seven months).  At 
the AI, the time period between baseline and second assessment was about three days and almost 
one week between second and third assessment periods. Only a few acutely-ill children were still in 
hospital for a third assessment, which was approximately 11 days post baseline. 
 
 
Table 63: Number of participants with a deteriorating health condition  
 
  
Between baseline and 2nd assessment 
period 
Between 2nd and 3rd assessment periods 
  
Worsening 
health 
condition* 
Indicated 
by 
Causative factor Worsening 
health 
condition 
Indicated 
by 
Causative 
factor 
MS N=0 
  
N=0   
SS *N=1 Decreased 
activity 
Superimposed 
acute illness 
N=1 Decreased 
activity 
Superimposed  
Acute illness 
CI N=0   N=0   
AI *N=4 Decreased 
activity 
Raised 
temperature in 
4 participants 
Surgical 
intervention 
since baseline in 
3 participants 
N=1 Decreased 
activity 
Surgical 
intervention  
*Excluded from data analysis 
A number of participants  with a deteriorating health condition were identified, as indicated in Table 63 
 
Table 63, indicates that a total of seven participants with deteriorating health, were removed from the 
data base after baseline data analysis to fit in with the hypothesis described above.   
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4.10 The EQ-5D-Y scores over time, across institutions  
4.10.1 Stability of dimension scores over time, per institution 
The ability of the EQ-5D-Y dimension scores and VAS to produce consistent results between baseline 
and second assessment ( three month interval) and between baseline and third assessment (seven 
month interval) whose HRQoL was not expected to change significantly, was examined for stability in 
the MS and SS children. Moderate agreement between scores over time, was expected, allowing for 
some variability in HRQoL, which would normally occur.  
Agreement between these values was also examined for the Chronic and AIs (about six days apart), 
but was expected to be weak, as the HRQoL of these children did change over time. 
Cross tabulations and Cohen’s kappa coefficient were used to measure observed agreement between 
scores at the different time intervals. Kappa values indicating level of agreement between scores 
(Table 64) were interpreted using Landis and Koch labelling (110). 
Table 64: Kappa values for agreement in EQ-5D-Y dimensions at all time intervals 
 
  MS SS CI AI 
Kappa value for 
Mobility 
Between 
baseline 
and 2
nd
 
assessment 
0.061 
Slight 
 
(n=98) 
0.516 
Moderate 
 
(n=34) 
0.248 
Fair 
 
(n=31) 
0.105 
Slight 
 
(n=35) 
 Between 
2
nd
 and 3
rd
  
assessment 
          0.00 
No statistics 
were 
computed 
because 3
rd
 
assessment 
Mobility was a 
constant  
(n=95) 
0.593 
Moderate 
 
 
 
 
 
(n=34) 
0.568 
Moderate 
 
 
 
 
 
(n=26) 
0.429 
Moderate 
 
 
 
 
 
(n=12) 
 Between 
baseline 
and 3
rd
 
assessment  
0.00 
No statistics 
were 
computed 
because 3
rd
 
assessment 
Mobility was a 
constant 
(n=95) 
0.688 
Substantial 
 
 
 
 
 
(n=34) 
0.133 
Slight 
 
 
 
 
 
(n=26) 
0.250 
Fair 
 
 
 
 
 
(n=12) 
Kappa value for 
LAM 
Between 
baseline 
and 2
nd
 
assessment 
0.125 
 
Slight 
0.341 
Fair 
0.336 
Fair 
0.173 
Slight 
 Between 
2
nd
 and 3
rd
  
assessment  
-.019 
Slight 
0.470 
Moderate 
0.540 
Moderate 
0.351 
Fair 
 Between 
baseline 
and third 
assessment  
-.020 
Slight 
0.421 
Moderate 
0.224 
Fair 
-0.200 
Slight 
Kappa value for UA Between 
baseline 
and 2
nd
 
assessment 
0.172 
Slight 
0.118 
Slight 
0.389 
Fair 
 
0.202 
Slight 
 Between 
2
nd
 and 3
rd
  
assessment  
.057 
Slight 
0.114 
Slight 
0.381 
Fair 
0.030 
slight 
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 Between 
baseline 
and third 
assessment  
-.010 
Slight 
0.339 
Fair 
0.177 
Slight 
-0.032 
slight 
Kappa value P/D Between 
baseline 
and 2
nd
 
assessment 
0.152 
Slight 
-0.12 
Slight 
0.069 
Slight 
0.186 
Slight 
 Between 
2
nd
 and 3
rd
  
assessment  
.086 
Slight 
0.122 
Slight 
-0.014 
Slight 
0.238 
Fair 
 Between 
baseline 
and third 
assessment  
.145 
Slight 
0.148 
Slight 
0.273 
Fair 
0.167 
Slight 
Kappa value for 
WSU 
Between 
baseline 
and 2
nd
 
assessment 
.172 
Slight 
0.205 
Fair 
0.082 
Slight 
0.111 
Slight 
 Between 
2
nd
 and 3
rd
  
assessment  
.279 
Fair 
0.106 
Slight 
0.084 
Slight 
0.600 
Moderate 
 Between 
baseline 
and third 
assessment  
.235 
Fair 
0.050 
Slight 
-0.174 
Slight 
0.077 
Slight 
Index score ICC for 
absolute 
agreement  
Between 
baseline 
and 2nd 
assessment 
0.409 0.488                    
0.395 
0.155 
Interpreted according to Landis, Koch (110) 
 
The Kappa values for all the EQ-5D-Y dimensions for MS children indicated slight agreement, all <0.20, 
indicating a change despite no change in health status. This indicated poor stability (which was not as 
hypothesised) between baseline and three months. Over the longer seven month period, similar poor 
agreement between scores was evident. 
 
At the SS, the kappa values indicated there was fair to moderate agreement for Mobility, LAM and 
WSU (some intra-rater reliability and stability in these dimensions, as hypothesised), but slight 
agreement for UA and P/D which demonstrated poor stability and changes in these dimensions. It was 
hypothesised that these children would show better stability in all dimensions as the state of their 
chronic disability did not change. Over the longer seven month interval, there was fair to substantial 
agreement in all dimensions expect P/D, indicating improved reliability and stability, which might 
indicate that over the longer period, transient variability in HRQoL was not as evident. 
 
The kappa values for Mobility, LAM and UA at the CI all indicated fair agreement between baseline 
and second assessment, indicating limited reliability and, therefore, some changes in the dimensions, 
as expected. P/D and WSU only slightly agreed (poor reliability), indicating a change which was 
hypothesised. P/D and LAM were the only dimensions with fair agreement over the seven month 
interval. The agreement between all other dimensions was poor, as expected.  
 
At the AI, the kappa values for all dimensions indicated slight agreement between baseline and second 
assessment, indicating a change had taken place, as was expected. The only difference over the seven 
month interval was fair agreement evident in the mobility dimension. 
 
 
97 
 
 
4.10.1.1 Summary of stability of EQ-5D-Y Index Scores on repeated testing  
 
Table 65: Correlations between baseline and second assessment Index Scores across institutions 
 ICC 95% Confidence Interval P value 
   Lower Bound Upper Bound  
MS 0.409 0.124 0.603 0.005 
SS 0.488 -0.036 0.745 0.031 
CI 0.395 -0.169 0.697 0.069 
AI 0.155 -0.478 0.543 0.285 
 
The ICC indicated that the absolute agreement between the baseline and second assessment Index 
Sores was significant in the MS and SS, demonstrating no significant change (and stability of score over 
time). The ICC in the CI and AI was not significant indicating that there was a change (and scores were 
not stable) (Table 65).  
 
4.10.2 Correlations of EQ-5D-Y VAS scores at different time intervals 
 
Table 66: Spearman’s Rho and p value for correlations in VAS at different time intervals 
Institution Between 1st and 2nd 
assessment 
Between 2nd and 3rd 
assessment 
Between 1st and 3rd 
assessment                                                      
 N r P 
value 
N r P 
value 
N r P  
value 
MS  98 0.235 0.020 95 0.282 0.006 95 0.346 0.001 
SS  34 -0.118 0.507 34 0.110 0.542 34 0.516 0.002 
CI  31 -0.183 0.361 26 0.238 0.242 26 0.201 0.324 
AI  35 0.359 0.043 12 -0.174 0.681 12 -0.300 0.344 
 
Table 66 indicated that the VAS of the MS school was significantly correlated, but weakly so, over the 
seven months from baseline to 3rd assessment, as was expected.  The SS VAS indicated a strongly 
significant correlation over the longer period only; that is, from baseline to third assessment. The VAS 
for CI and AI was not correlated at all times, which were expected as their HRQoL did change over 
time. 
4.10.3 Stability of VAS over baseline, 2nd assessment and 3rd assessment 
The stability of the VAS over all three assessment periods was assessed for all institutions  
Table 67: Friedman ANOVA showing differences between VAS over time, at all institutions 
 Average 
Rank 
Mean Std.Dev. 
Baseline VAS 1.952 89.97 17.91 
2nd assessment VAS 1.957 91.99 14.49 
3rd assessment VAS 2.091 94.30 12.13 
 
ANOVA Chi Sqr. (N = 160, df = 2) = 9.581 p = 0.008 
 
Table 67 indicated that there was a significant difference in VAS scores over time (p=0.008). The 
differences were evident at the AI between baseline and 2nd assessment (p=0.003) and between 
baseline and 3rd assessment (p=0.011).  
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The institutions at which the VAS scores were stable, e.g. MS and SS, are shown below (Table 68 and 
Table 69). 
Table 68: Friedman ANOVA showing differences between VAS scores at MS over time. 
 Average 
Rank 
Mean Std.Dev. 
Baseline VAS 1.95 89.97 17.91 
2nd Assessment VAS 1.96 91.99 14.49 
3rd assessment VAS 2.09 94.30 12.13 
 
ANOVA Chi Sqr. (N = 93, df = 2) = 2.237 p = 0.327  
 
The VAS scores were stable over time, at the MS School (p=0.327) 
 
Table 69: Friedman ANOVA showing differences between VAS at SS over time 
 Average 
Rank 
Mean Std.Dev. 
Baseline VAS 1.92 95.30 10.96 
2nd assessment VAS 1.95 96.82 6.23 
3rd assessment VAS 2.12 98.79 3.31 
 
ANOVA Chi Sqr. (N = 33, df = 2) = 1.922 p =0 .383 
 
The VAS scores were stable over time, at the SS (p=0.383) 
4.11 The PedsQL scores over time, across institutions  
4.11.1 Stability of PedsQL scores at different time intervals 
The stability of the PedsQL total score over time was examined in order to determine which measure 
of HRQoL, EQ-5D-Y or PedsQL showed better stability.  
Correlations between PedsQL total scores were also examined for the CI and AI, but, again, it was 
expected to be weak because these children’s HRQoL did change over time. 
Scatterplot of  2nd assessment PedsQL total against baseline PedsQL total, catergorised by
institution
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Figure 29: Scatter plot showing correlations between 2nd assessment PedsQL total and baseline PedsQL total; categorised by 
institution  
Table 70: Spearman’s Rho and p value for correlations between PedsQL totals at different time intervals 
Institution Between 1st and 2nd assessment Between 2nd and 3rd assessment 
 N r P value N r P value 
MS 98 0.433 p<0.001 95 0.554 p<0.001 
SS 34 0.819 p<0.001 34 0.747 p<0.001 
CI 31 0.464 0.009 26 0.845 p<0.001 
 AI 35 0.998 p<0.001 12 0.968 p<0.001 
 
Table 70 showed that the baseline PedsQL total scores were significantly correlated at all time 
intervals and across all institutions, despite that the children’s HRQoL at the CI and AI changed over 
this time period. The strongest correlations were at the AI and SS and the weakest at the MS. 
4.12 Responsiveness of the different outcome measures 
The ability of the EQ-5D-Y, PedsQL and WeeFIM to depict a change in HRQoL over a three month 
period was examined to determine the responsiveness of each outcome measure. The EQ-5D-Y 
dimensions were reduced to a binary categorical variable (no problems / any problems).  
Responsiveness was described by examining the effect size (r) of Wilcoxon Signed-rank test (Z) and 
was calculated by (r=Z/Sq.Rt. N)2 where N is the total number of the samples; that is, the number of 
responses before and after, not the number of participants (Table 71). 
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Table 71: The Wilcoxon Signed rank test and effect size of each outcome measure per institution, between baseline and 2
nd
 
assessment dimension scores 
Institution   No. of non-ties  T value Z p-value Effect size =(Z/Sq.Rt. N) Size 
MS Mobility 19 47.5 1.912 0.056 0.31 Medium 
  LAM 16 48.0 1.034 0.301 0.18 Small 
  UA 23 84.0 1.642 0.101 0.24 Small 
  P/D 37 204.0 2.225 0.026 0.26 Small 
  WSU 28 147.0 1.275 0.202 0.17 Small 
SS Mobility  11 30.5 0.222 0.824 0.05 Small 
  LAM  12 11.0 2.197 0.028 0.45 Medium 
  UA 15 59.5 0.028 0.977 0.01 Small 
  P/D 17 72.0 0.213 0.831 0.04 Small 
  WSU 14 42.0 0.659 0.510 0.12 Small 
CI Mobility 12 12.0 2.118 0.034 0.43 Medium 
  LAM  9 15.0 0.889 0.374 0.21 Small 
  UA  8 8.0 1.4 0.161 0.50 Medium 
  P/D 14 32.5 1.256 0.209 0.24 Small 
  WSU  14 39.5 0.816 0.414 0.15 Small 
AI Mobility  21 45.5 2.433 0.015 0.38 Medium 
 LAM  19 45.0 2.012 0.044 0.33 Medium 
  UA  17 42.5 1.609 0.108 0.28 Small 
  P/D 18 48.0 1.633 0.102 0.27 Small 
  WSU  17 27.5 2.320 0.020 0.40 Medium 
Effect size interpretation - Small: 0.1, Medium: 0.3, Large: 0.5  
3
 
The EQ-5D-Y dimension scores depicted a small effect size between baseline and second assessment in 
most dimensions at the MS school, except for mobility which was medium, but not significant. The 
only significant effect was in the P/D dimension.  
There was a small effect size in most dimensions at the SS, as expected, as these children’s chronic 
disabilities did not change over time (the exception being LAM dimension, which was significant).  
At the CI, a small effect size was evident in most dimensions, except for Mobility which was medium 
and significant, as a result of improved function due to better management of the chronic condition. 
At the AI, P/D and UA effect size was small, while Mobility, LAM and WSU dimensions demonstrated a 
significant, medium effect size due to management of the acute condition.   
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 Table 72: The Wilcoxon Signed rank test and effect size based on each outcome measure’s total score  
Institution   No. of non-ties  T value Z p-value Effect size =(Z/Sq.Rt. N) Size 
MS VAS 48 442.0 1.497 0.134 0.15 Small 
 Index Score 60 889.50 0.19 0.85 0.02 Small 
  Faces Pain Scale 53 403.50 2.76 0.01 0.27 Small 
  PedsQL 94 1235.0 3.762 p<0.001 0.27 Small 
  WeeFim*             
SS VAS 16 59.0 .465 0.642 0.08 Small 
 Index Score 25 123.50 1.05 0.29 0.15 Small 
 Faces Pain Scale 15 39.00 1.19 0.23 0.22 Small 
  PedsQL 32 78.0 3.478 0.001 0.43 Medium 
  WeeFim 34 44.5 4.325 p<0.001 0.52 Large 
 CI VAS 13 19.5 1.817 0.069 0.36 Medium 
 Index Score 21 45.00 2.45 0.01 0.38 Medium 
 Faces Pain Scale 15 52.50 0.43 0.67 0.08 Small 
  PedsQL 20 74.0 1.157 0.247 0.18 Small 
  WeeFim 15 18.5 2.357 0.018 0.43 Medium 
AI  VAS 28 62.0 3.211 0.001 0.43 Medium 
 Index Score 31 84.50 3.20 p<0.001 0.41 Medium 
 Faces Pain Scale 24 60.50 2.56 0.01 0.37 Medium 
   PedsQL 20 74.0 1.157 0.247 0.18 Small 
   WeeFim 34 44.5 4.325 p<0.001 0.52 Large 
*Not tested 
The EQ-5D-Y VAS detected a medium difference in the AI and CI and were therefore the most 
responsive to change in these children over time.  
The Index Score was also was the most responsive to change in the AI and CI children, with a medium 
difference. 
The FPS detected a significant small change in pain at the MS school and a significant medium change 
in the AI group. 
The PedsQL only detected a medium size change in the SS children whose condition might have been 
expected to be more stable and not in the children whose condition was expected to change at the CI 
and AI. 
The WeeFIM detected a medium to large improvement in all groups tested, even though the SS 
children had fairly stable health conditions with minimal changes. The CI children were expected to 
change slightly. The AI was the only institution at which a large change was expected.  
4.13 Correlations between dimension scores and VAS 
The dimension profiles as summarised by the Index Score were compared with the self-perceived 
global perception of health, VAS. There was no correlation between the VAS and Index Score or the 
change in VAS and the change in Index Score over time in any group apart from the AI children. (Figure 
30 and Table 73).  
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Scatterplot of VAS and Index Scores across Institutions
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Figure 30: Scatterplot of VAS versus Index Score 
 
Table 73: Spearman Rank Order Correlations between VAS and Index Scores across institutions 
 
 N 
 
Spearman 
Rho 
 
P value 
 
MS 
 
105 -0.047 0.638 
SS 35 0.304 0.075 
CI 32 -0.202 0.268 
AI 52 -0.786 p<0.001 
 
Similarly, when comparing the change in VAS scores against the change in Index Scores between 
baseline and second assessment (Figure 31 and Table 74), it was evident that the only significant 
correlations were, again, in the AI group.  
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Scatterplot of the change in VAS against the change in Index Score over time
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Figure 31: Scatterplot of Change in VAS versus Change in Index Score 
 
Table 74: Spearman Rank Order Correlations between Change in VAS and Change in Index Scores across institutions 
 N Spearman 
Rho 
P value 
MS 97 0.168 0.100 
SS 34 0.193 0.275 
CI 31 -0.084 0.652 
AI 35 0.692 p<0.001 
 
Despite reporting a lot of problems in the various dimensions (observable changes - alpha changes), 
(Figure 8-Figure 12), the CI and SS children reported the better overall global HRQoL on the VAS 
(changes in internal standards of overall HRQoL - beta changes) compared to the MS children (Table 
18), with no significant correlation  between the scores.  
4.14 Life events and changes in HRQoL 
In order to establish whether changes in HRQoL are related to life events, such as any change or 
incident in home life, surgery or change in management of condition, a Chi-Square was used to 
determine whether a “yes” response to a life event had an effect on WSU dimension scores.  A Mann 
Whitney U test was used to determine whether a life event had an effect on VAS score. 
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Table 75: Number of participants who experienced an additional life event between baseline and 2nd assessment  
 
Life event between baseline and 2nd 
assessment 
MS 14 (14.3%), varying from a death in the 
family, moving house, divorce and a new 
baby 
SS 0 reported     
CI 1 (3.2%), bullying 
2, changes in management of 
condition 
    
AI 2 (5.7%), depressed due to no visits 
from family 
4 (11.4%), varying from surgery, to 
changes in P/D medication, changes in 
management of condition 
  
 
 A total of 23 (11.6%) out of 198 children reported a life event occurring between baseline and 2nd 
assessment (Table 75).  
 
Table 76: Effect of life event on EQ-5D-Y WSU dimension 
 Number of 
“no” 
Number of 
“yes” 
Chi-Square df P value 
2nd assessment EQ-5D-Y WSU 175  23 6 22 0.999 
 (88.4%) (11.6%)    
 
Table 76 showed a Chi-Square test comparing “yes” responses to a life event (23; 11.6%) and WSU 
dimension scores, at second assessment. A life event did not significantly affect the dimension score.  
 
Table 77: Effect of life event on VAS 
 Rank Sum 
no 
 
Rank 
Sum 
yes 
 
U 
 
Z 
 
P 
value 
 
Difference in VAS between baseline 
and 2nd assessment 
 
17207.0 1708.0 1455.0 1.760 0.078 
 
As seen in Table 77, the Mann Whitney U test indicated that a life event did not have an effect on VAS 
either.  
4.15 Feasibility and Usefulness of EQ-5D-Y outcome measure 
The clinical feasibility of using the EQ-5D-Y was determined by assessing the time taken to complete 
the measure compared to the recommended time of five minutes. As can be seen in Table 78, it took 
the children approximately five minutes to complete the form. 
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4.15.1 Time taken to complete EQ-5D-Y measure  
 
Table 78: Time taken in minutes to complete EQ-5D-Y 
 N Mean Minimum Maximum Std.Dev. 
Time taken in minutes to complete 
EQ-5D-Y form at baseline. 
224 5.1 3 10 1.428 
Time taken in minutes to complete 
EQ-5D-Y form at 2nd assessment. 
198 4.6 3 8 0.804 
Time taken in minutes to complete 
EQ-5D-Y form at 3rd assessment.  
167 4.6 3 5 0.539 
 
4.15.2 Therapists responses to usefulness questionnaire 
The usefulness of the measure was assessed by analysing the frequency of positive responses in the 
questionnaire completed by the participating therapists, and assessing whether the measure was 
utilised by the therapists to inform management decisions and whether they would continue to use it 
in the future. 
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A summary of the participating therapists’ responses is in documented in Table 79 
Table 79: Responses on usefulness of EQ-5D-Y  
  CI 
(n*=2) 
SS 
(n*=3) 
AI 
(n*=4) 
Agree 
Count 
(out of 9) 
Number of self-
reports administered  
9  9  
Number of proxy 
report completed  
30 35 7  
Ease of administration Very easy  0 2 4 6 (66.7%) 
Moderately  easy 2 1  3 (33.4%) 
Difficult      0 
Reason if not very easy   Time constraints 2 1  3 (33.4%) 
Child not 
understanding 
  2 2 (22.3%) 
Age group of child 
not understanding 
  8-9 
years 
 
Dimensions which children 
found difficult to understand 
Mobility   1 1 
LAM     
UA   2 2 
P/D    0 
WSU    0 
VAS    0 
A relationship was noticed 
between child's response and 
clinical signs in: 
Mobility  1 3 4 8 (88.9%) 
LAM 1 2 2 5 (55.6%) 
UA  1  1 (11.1%) 
P/D   1 2 3 (33.3%) 
WSU 1  1 2 (22.2%) 
VAS   1 1 (11.1%) 
Outcome measure assisted 
with planning management of 
child 
 2 3 4 9 (100%) 
Most useful dimension when 
planning management of 
child 
Mobility 2 1 1 4 (44.4%) 
LAM 2 1 1 4 (44.4%) 
UA 1 1 2 4 (44.4%) 
P/D 2 2 3 7 (77.8%) 
WSU 1 2 3 6 (66.7%) 
VAS 1  3 4 (44.4%) 
Measure provided additional 
information on child's health 
status 
  3 4 7 (77.8%) 
Most useful dimension in 
providing additional 
information 
 Mobility  1 1 2 (22.2%) 
LAM  1 1 2 (22.2%) 
UA  1  1 (11.1%) 
P/D  3 2 5 (55.6%) 
WSU  1 2 3 (33.3%) 
VAS   3 3 (33.3%) 
Will continue to use measure 
routinely 
  3 3 6 (66.7%) 
*n=number of clinical physiotherapists 
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As can be seen in Table 79, there were nine clinical physiotherapists who administered the EQ-5D-Y to 
18 children and completed a total of 72 proxy reports. Six of the therapists found the measure very 
easy to use. The reason for three respondents finding it only moderately easy to use was mostly due 
to time restraints. In addition two therapists found 8-9 year- old acutely-ill children had some 
difficulties understanding the UA dimension. A relationship between responses and clinical signs was 
mostly noticed in the Mobility dimension (eight reported positively on observing this relationship), 
followed by P/D and WSU. All therapists found the measure useful in planning the management of the 
child, especially the information on P/D and WSU. Six of the therapist agreed that they would continue 
to use the instrument to assist the planning of management and as an outcome measure of HRQoL. 
4.16 Summary of the psychometric properties of the EQ-5D-Y, PedsQL and 
WeeFIM as assessed on the different health profiles of the children.  
 
Table 80: Summary of the psychometric properties of the outcome measures 
Test retest Reliability: Pilot study (n=38) 
EQ-5D-Y Dimensions kappa              P value Agreement interpreted according to  
Landis and Koch’s guidelines 
Mobility 0.55 p<0.001  Moderate 
LAM 0.65 p<0.001  Substantial 
UA 0.12 p<0.127 Poor 
P/D 0.37 p<0.08 Fair 
WSU 0.55 p<0.001  Moderate 
 
Agreement between  
EQ-5D-Y VAS scores 
 ICC=0.765 Good agreement 
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Main Study MS 
(no serious 
health 
condition) 
SS 
(chronic 
physically 
disabling 
condition) 
CI 
(chronic health 
condition) 
AI 
(acute health 
condition) 
All 
Groups 
Stability of  
EQ-5D-Y 
dimensions over a 
three monthly 
interval (three to 
five days at AI). 
Agreement 
between EQ-
5D-Y 
dimension 
scores on 
repeated 
assessment 
(kappa 
coefficient). 
All dimensions 
(<0.20)slight  
Mobility 
(0.51) 
moderate 
LAM 
(0.34) fair 
UA 
(0.12) slight 
P/D 
(-0.12) slight 
WSU 
(0.21) fair 
Mobility 
(0.25) fair 
LAM 
(0.35) fair 
UA 
(0.39) fair 
P/D 
(0.39) fair 
WSU 
(0.08) slight 
All dimensions 
(<0.20) slight 
Poor at MS and 
slight to 
moderate at SS, 
where there was 
no change in 
health status of 
the participants 
and greater 
stability would 
have been 
expected. 
 Correlations 
between VAS 
scores on 
repeated 
assessment 
(Spearman Rho 
and P). 
Weak 
correlation 
significant 
(r=0.24) 
(p=0.020) 
Weak, NS Weak, NS Weak, NS Weak correlations 
expected at CI 
and AI only. 
 Correlations 
between Index 
Scores on 
repeated 
assessment 
(ICC). 
Fair correlation, 
significant 
(ICC= 0.408) 
(p=0.005) 
Fair correlation, 
significant 
(ICC= 0.488) 
(p=0.031) 
Fair correlation, 
NS 
(ICC= 0.395) 
(p=0.069) 
Poor 
correlation, NS 
(ICC= 0.155) 
(p=0.285) 
Stability of Index 
Score at MS and 
SS, no change.  
AI and CI were 
not stable, did 
change. 
Stability of  
EQ-5D-Y over a 
seven month 
interval ( seven 
days at AI) using: 
Agreement 
between EQ-
5D-Y 
dimension 
scores (kappa 
coefficient). 
 
Mobility 
(0.00) 
No statistics 
was computed 
because 3
rd
 
assessment 
Mobility was a 
constant 
LAM 
(-0.02) slight 
UA 
(-0.01) slight 
P/D 
(0.15) slight 
WSU 
(0.24) fair 
Mobility 
(0.69) 
substantial 
LAM 
(0.42) 
moderate 
UA 
(0.34) fair 
P/D 
(0.15) slight 
WSU 
(0.05) slight 
Mobility 
(0.13) slight 
LAM 
(0.22) fair 
UA 
(0.18) slight 
P/D 
(0.27) fair 
WSU 
(-0.17) slight 
Mobility 
(0.25) fair 
LAM 
(-0.20) slight 
UA 
(-0.03) slight 
P/D 
(0.17) slight 
WSU 
(0.08) slight 
Poor reliability 
and stability at 
MS school over 
seven months. 
Fair to substantial 
for physical 
activities, but not 
for P/D or WSU at 
SS where stability 
and reliability was 
expected in all 
dimensions.  
 
 Correlations 
between VAS 
(Spearman’s 
Rho and P). 
(r<0.35) 
(p<0.001) 
Weak 
correlation 
significant  
 
Weak, NS Strong, 
significant 
(p=0.002) 
Weak, NS Significant 
correlations were 
expected at MS 
and SS, but were 
only evident at 
MS and CI. 
Stability of 
PedsQL scores 
over a three 
monthly interval 
(three to five days 
at AI). 
Correlation 
between 
PedsQL total 
scores  
(Spearman’s 
Rho and P 
value) 
Moderate, 
significant  
(r = 0.43) 
(p<0.001) 
Strong, 
significant  
(r=0.82) 
(p<0.001) 
Moderate, 
significant 
(r=0.46) 
(p=0.009) 
Strong, 
significant 
(r>0.99) 
(p<0.001) 
Moderate to 
strong 
correlations were 
not expected at 
Chronic or AIs 
Construct validity 
of  
EQ-5D-Y by 
examining 
discriminate 
validity of:  
EQ-5D-Y 
dimensions  
 
Multiple 
comparisons of 
Mobility 
Significantly 
different from 
SS 
(p<0.001) and 
AI 
(p<0.001) 
Significantly 
different from 
MS 
(p<0.001)only 
Significantly 
different from 
AI 
(p=0.031) only 
Significantly 
different from 
MS (p<0.001) 
and CI 
(p=0.031) 
All EQ-5D-Y 
dimensions were 
only significantly 
different between 
the MS and AI 
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 rankings  
(Krushkal-
Wallis H and p 
value). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Discriminant 
validity of: 
Multiple 
comparison of 
LAM rankings. 
 
Significantly 
different from 
SS (p=0.008) 
and AI 
(p<0.001) 
Significantly 
different from 
MS (p=0.008) 
only. 
NS different 
from any other 
group. 
Significantly 
different from 
MS (p<0.001) 
only. 
 
Multiple 
comparison of 
UA rankings. 
 
Significantly 
different from 
AI 
(p<0.001) only. 
Significantly 
different from 
AI 
(p<0.001) only. 
Significantly 
different from 
AI 
(p<0.001) only. 
Significantly 
different from 
all other groups 
(p<0.001). 
 
Multiple 
comparisons of 
P/D rankings. 
 
Significantly 
different from 
AI (p<0.001) 
only. 
NS different 
from any other 
group. 
NS different 
from any other 
group. 
Significantly 
different from 
MS (p<0.001) 
only. 
 
Multiple 
comparison of 
WSU rankings. 
 
Significantly 
different from 
AI (p<0.001) 
only. 
NS different 
from any other 
group. 
NS different 
from any other 
group. 
Significantly 
different from 
MS (p<0.001) 
only. 
 
EQ-5D-Y Index 
Score 
(Krushkal-
Wallis H and p 
value). 
Significantly 
different from 
SS (p<0.001)  
CI (p=0.045) 
AI (p<0.001) 
Significantly 
different from 
MS (p<0.001) 
AI (p=0.030) 
Significantly 
different from 
MS (p=0.045) 
AI (p<0.001) 
 
Significantly 
different from 
MS (p<0.001) 
SS (p=0.030) 
CI (p<0.001) 
 
 
MS and AI scored 
significantly 
differently from 
the other three 
groups, there was 
no difference 
between the SS 
and CI. 
EQ-5D-Y VAS 
(Krushkal-
Wallis H and p 
value) 
NS difference 
from any other 
group. 
NS difference 
from any other 
group. 
NS difference 
from any other 
group. 
Significantly 
different from 
other three 
groups 
(p<0.001) 
The EQ-5D-Y VAS 
only 
discriminated 
between the 
acutely ill children 
and the other 
groups, but not 
between the 
other groups. 
PedsQL total 
(median – 
range) (mean 
ranking) 
 
MS 
 
 
 
 
 
27 (0-66) 
94.41 
 
 
 
 
 
NS difference 
from any other 
group. 
 
 
 
 
 
NS difference 
from any other 
group. 
 
 
 
 
 
Significantly 
different from 
MS (0.003) only 
The PedsQL only 
discriminated 
between the MS 
and AI. 
 
 
 
 
 SS NS difference 
from any other 
group. 
35 (4-68) 
126.19 
NS difference 
from any other 
group. 
NS difference 
from any other 
group. 
 
 
 
 
 CI NS difference 
from any other 
group 
NS difference 
from any other 
group. 
30(7-64) 
124.73 
NS difference 
from any other 
group. 
 
 AI Significantly 
different from 
AI (0.003) only 
NS difference 
from any other 
group. 
NS difference 
from any other 
group. 
39 (9-73) 
132.29 
 
Discriminant 
validity of: 
WeeFIM 
MS 
Not tested.    WeeFIM total 
score was able to 
discriminate 
between the 
children at the CI, 
SS and AI. 
However it was 
unable to depict a 
difference in 
functional 
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independence 
between the AI 
and SS, indicating 
poor discriminate 
validity in these 
groups.   
 SS  110(68-126) 
61.94 
Significantly 
different from 
CI 
(p=0.005) 
NS difference 
from any other 
group 
 
 
 
 
 
 
 
 
 
 
 
 
Convergent 
validity between 
EQ-5D-Y and 
PedsQL was 
evident at the AI 
only for all similar 
dimensions. 
 CI  Significantly 
different from 
SS 
(p=0.005) 
120(65-126) 
94.17 
Significantly 
different from 
AI 
(p>0.001) 
 AI  NS difference 
from any other 
group  
Significantly 
different from  
CI 
(p<0.001) 
93.5(47-126) 
45.24 
Construct validity 
continued - by 
examining 
convergent 
validity between 
similar dimensions 
of EQ-5D-Y and 
PedsQL. 
EQ-5D-Y 
Mobility with 
PedsQL 
Activity 
dimension 
(Kruskal-Wallis 
and p value if 
all three levels 
of problems) 
(Mann-
Whitney U if 
only two levels 
of problems). 
NS, poor 
convergent 
validity  
Significant 
difference in 
PedsQL Activity 
score across all 
levels of EQ-5D-
Y mobility 
score. 
Good 
convergent 
validity 
(p<0.001) 
NS, poor 
convergent 
validity 
Significant 
difference in 
ranking of 
PedsQL Activity 
score across all 
EQ-5D-Y 
Mobility 
levels (p<0.001) 
 EQ-5D-Y UA 
and PedsQL 
total 
Significant 
difference in 
ranking of 
PedsQL total 
across different 
levels of the EQ-
5D-Y Usual 
Activity 
dimension 
compared to CI 
(p=0.002) and 
AI (p=0.006) 
Good 
convergent 
validity. 
NS, poor 
convergent 
validity. 
Significant 
difference in 
ranking of 
PedsQL total 
across different 
levels of the EQ-
5D-Y Usual 
Activity 
dimension 
compared to 
MS (p=0.007) 
and AI 
(p=0.006) 
Good 
convergent 
validity. 
Significant 
difference in 
ranking of 
PedsQL total 
across different 
levels of the EQ-
5D-Y Usual 
Activity 
dimension 
compared to 
MS (p=0.007) 
and CI 
(p=0.002)  
Good 
convergent 
validity. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
EQ-5D-Y P/D 
dimension with 
PedsQL “I 
hurt” item  
NS, poor 
convergent 
validity. 
NS, poor 
convergent 
validity. 
NS, poor 
convergent 
validity. 
Significant 
difference in 
ranking of 
PedsQl “I hurt” 
across the three 
levels of EQ-5D-
Y P/D (p=0.001) 
Good 
convergent 
validity. 
 
 EQ-5D-Y WSU 
dimension with 
PedsQL 
Feelings 
dimension 
Significant 
difference in 
ranking of 
PedsQL Feelings 
score across 
two levels of 
NS, poor 
convergent 
validity. 
NS, poor 
convergent 
validity. 
Significant 
difference in 
ranking of 
PedsQL feelings 
score across all 
three levels of 
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the EQ-5D-Y 
WSU 
(p=0.020) 
Good 
convergent 
validity 
EQ-5D-Y WSU 
(p=0.007) Good 
convergent 
validity 
Convergent 
validity between 
similar dimensions 
of EQ-5D-Y and 
WeeFIM. 
 
 
 
 
 
 
 
 
 
EQ-5D-Y 
Mobility and 
WeeFIM 
Mobility 
dimensions. 
Not tested. 
All scored 
maximally. 
Significant 
difference in 
ranking of the 
WeeFIM 
Mobility across 
the three levels 
of the EQ-5D-Y 
Mobility 
(p<0.001) Good 
convergent 
validity. 
Significant 
difference in 
ranking of the 
WeeFIM 
Mobility across 
the three levels 
of the EQ-5D-Y 
Mobility  
(p=0.01) 
Good 
convergent 
validity. 
Significant 
difference in 
ranking of the 
WeeFIM 
Mobility across 
the three levels 
of the EQ-5D-Y 
Mobility 
(p<0.001) 
Good 
convergent 
validity. 
Convergent 
validity between 
EQ-5D-Y and 
WeeFIM 
dimensions was 
evident at the SS, 
CI and AI.  
 
 EQ-5D-Y LAM 
and WeeFIM 
Self-care 
dimension. 
Not tested. Significant 
difference in 
ranking 
(p<0.001)  
Good 
convergent 
validity. 
Significant 
difference in 
ranking 
(p=0.001) 
Good 
convergent 
validity. 
Significant 
difference in 
ranking 
(p<0.001) 
Good 
convergent 
validity. 
 
Convergent 
validity between  
EQ-5D-Y P/D 
dimension and 
Faces Pain Scale 
 NS, poor 
convergent 
validity. 
NS, poor 
convergent 
validity. 
NS, poor 
convergent 
validity. 
Significant 
difference in 
ranking of FPS 
across the three 
levels of EQ-5D-
Y P/D 
(p<0.001) 
Good 
convergent 
validity 
The EQ-5D-Y P/D 
dimension and 
Faces Pain Scale 
showed 
convergent 
validity at the AI 
only.  
 
Correlations 
between VAS and 
PedsQL total  
 
EQ-5D-Y VAS 
with PedsQL 
total 
(Spearman 
Rho)  
(p value) 
NS,  
poor correlation 
(0 .156) 
NS,  
poor correlation 
(0.241) 
 
Significant, 
moderate 
correlation 
(-0.523) 
(0.002) 
Significant, 
moderate 
correlation 
(-0.564) 
(p<0.001) 
The highest 
correlation was 
between the 
PedsQL and 
WeeFIM (-0.48) 
and the 
lowestbetween 
the PedsQL and 
the VAS (-0.28). 
Correlations 
between VAS and  
WeeFIM total 
scores  
EQ-5D-Y VAS 
with WeeFIM 
total 
(Spearman 
Rho)  
(p value) 
NS,  
poor correlation 
(0.188) 
NS, 
 poor 
correlation 
(-0.194) 
NS,  
poor correlation 
(0.064) 
Significant 
moderate 
correlations 
(0.525) 
(p<0.001) 
Correlations 
between PedsQL 
and  WeeFIM 
total scores 
PedsQL total 
with WeeFIM 
total 
(Spearman 
Rho)  
(p value) 
NS,  
fair correlation 
(0.353) 
Significant, 
moderate 
correlation 
(0.577) 
(p=<0.001) 
Significant 
moderate 
correlation 
(-0.558) 
(p<0.001) 
 
Significant, 
moderate 
correlation 
(-0.529) 
(p<0.001) 
 
Correlations 
between EQ-5D-Y 
VAS and Index 
Score 
EQ-5D-Y VAS 
and Index 
Score 
(Spearman 
Rho)  
(p value) 
NS,  
poor 
correlation 
(0.0548) 
NS,  
fair correlation 
(0.316) 
NS,  
poor 
correlation 
(0.078) 
Significant, 
strong 
correlations 
(-0.767) 
(p<0.001) 
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Correlations 
between EQ-5D-Y  
Index Score and 
PedsQL total 
EQ-5D-Y Index 
Score and 
PedsQL total 
(Spearman 
Rho)  
(p value) 
Significant, poor 
correlation 
(0.199) 
(p=0.041) 
Significant, fair 
correlation 
(0.441) 
(p=0.009) 
Significant, fair 
correlation 
(0.443) 
(p=0.011) 
Significant, 
moderate 
correlations 
(0.635) 
(p<0.001) 
 
Correlations 
between EQ-5D-Y  
Index Score and 
WeeFIM total 
EQ-5D-Y Index 
Score and 
WeeFIM total 
(Spearman 
Rho)  
(p value) 
NS,  
poor 
correlation 
(0.047) 
NS,  
poor 
correlation 
(-0.278) 
Significant, fair 
correlation 
(-0.398) 
(p=0.024) 
Significant, 
moderate 
correlations 
(-0.659) 
(p<0.001) 
 
Responsiveness 
to change, over 
time, as indicated 
by effect size 
(r=Z/Sq.Rt. N) 
(Z=Wilcoxon 
Signed rank) 
when using the: 
EQ-5D-Y 
dimensions 
 
Mobility 
(p-value) effect 
size 
 
(p=0.056)  
0.31 Medium 
effect size 
(p=0.824) 
0.05 Small 
effect size 
(p=0.034) 
0.34 Large 
effect size 
(p=0.015) 
0.38 Medium 
effect size 
Using the 
dimensions the 
most 
responsiveness 
was evident at 
the AI, with a 
medium effect 
size in all 
dimensions, 
except UA and 
P/D.  
 LAM (p=0.301) 
0.18 Small 
effect size 
(p=0.028) 
0.45 Medium 
effect size 
(p=0.347) 
0.21 Small 
effect size 
(p=0.044) 
0.33 Medium 
effect size 
 
 UA (p=0.101) 
0.24 Small 
effect size 
(p=0.977) 
0.01 Small 
effect size 
(p=0.161) 
0.50 Medium 
effect size 
(p=0.108) 
0.28 Small  
effect size 
 P/D (p=0.026) 
0.26 Small 
effect size 
(p=0.831) 
0.04 Small 
effect size 
 
(p=0.209) 
0.24 Small 
effect size 
(p=0.102) 
0.27 Small 
effect size 
 
 WSU (p=0.202) 
0.17 Small 
effect size 
(p=0.510) 
0.12 Small 
effect size 
(p=0.414) 
0.15 Small 
effect size 
(p=0.020) 
0.40 Medium 
effect size 
 
 EQ-5D-Y Index 
Score 
(p=0.85) 
0.02 Small 
effect size 
(p=0.29) 
0.15 Small 
effect size 
(p=0.01) 
0.38 Medium 
effect size 
(p<0.001) 
0.41 Medium 
effect size 
 
 EQ-5D-Y VAS 
 
(p=0.134) 
0.15 Small 
effect size 
 
(p=0.642) 
 0.08 Small 
effect size 
 
(p=0.069) 
0.36 Medium 
effect size 
(p=0.001) 
0.43 Medium 
effect size 
The EQ-5D-Y VAS 
detected a 
medium 
difference in the 
Acute and CIs and 
were therefore 
the most 
responsive to 
change over time, 
in these children.  
 PedsQL total (p<0.001) 
0.27 Small 
effect size 
(p=.001) 
0.43 Medium 
effect size 
(p=0.247) 
0.18 Small 
effect size 
(p=0.001) 
0.37 Medium 
effect size 
The PedsQL only 
detected a 
medium size 
change in the SS 
children whose 
condition might 
have been 
expected to be 
more stable. 
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WeeFIM total Not tested (p<0.001) 
0.52 Large 
effect size 
(p=0.018) 
0.43 Medium 
effect size 
(p<0.001) 
0.52 Large 
effect size 
The WeeFIM 
detected a 
medium to large 
improvement in 
all groups tested, 
even though the 
children at the SS 
had fairly stable 
health conditions 
with minimal 
changes; the 
children at the CI 
were expected to 
change slightly 
and the AI was 
the only 
institution at 
which a large 
change was 
expected.  
 
FPS p=0.01 
0.27 Small 
effect size 
 
p=0.23 
0.22 Small 
effect size 
p=0.67 
0.08 Small 
effect size 
p=0.01 
0.37 Medium 
effect size 
The FPS detected 
a significant small 
change in P/D at 
the MS school 
and a significant 
medium change 
in the AI group. 
Agreement 
between Proxy 
reports and 
child self-
report 
dimensions 
(kappa) 
Mobility, 
(0.000), unable 
to compute, 
due to no 
variance 
LAM 
(-0.05) slight 
agreement 
UA 
(.36) fair 
agreement 
P/D 
(.22) fair 
agreement 
(1 - 0.21) 
WSU 
(0.07) slight 
agreement 
Mobility (0.55) 
moderate 
agreement 
LAM 
(0.20) slight 
agreement 
UA 
(0.08) slight 
agreement 
P/D 
(0.16) slight 
agreement 
WSU (0.000), 
unable to 
compute, due 
to no variance 
 
Mobility, 
(0.84) 
Good 
agreement 
LAM 
(0.51) 
Moderate 
agreement 
UA 
Kappa  
(0.42) 
moderate 
agreement 
P/D, 
(0.08) slight 
agreement WSU 
(0.01) slight 
agreement 
Mobility (0.73) 
Substantial 
agreement 
LAM  
(0.06) slight 
agreement 
Usual Activity  
(0.41) 
moderate 
agreement 
P/D 
(0.46) 
Moderate 
agreement 
WSU, P/D,  
(0.35) fair 
agreement 
There was 
moderate to good 
agreement for the 
Mobility 
dimension at all 
institutions, but 
each institution 
only 
demonstrated 
agreement in two 
to three 
dimensions  
 Agreement 
between Proxy  
reports and 
child self-
report VAS 
(Spearman’s 
Rho and p 
value) 
Weak, but 
significant 
(r=0.297) 
(p=0.016) 
Weak, NS Weak, NS Moderate, NS Even though the 
proxy and self-
report VAS scores 
demonstrated 
acceptable ICC 
overall 0.58, at an 
institutional level, 
there was only a 
significant 
correlation in the 
MS children. 
NS = not significant 
4.17 Summary of performance of EQ-5D-Y when used on children with different 
health states 
In the sample of children ranging from TD at a MS school, chronically disabled, chronically ill, and 
acutely ill children, the EQ-5D-Y performed as follows: 
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4.17.1 Performance of the EQ-5D-Y dimensions 
On a dimension level the various groups of children were able to identify their level of problem. The 
percentage and level of problems reported in each dimension was associated with the institution. The 
MS children had the least problems on all dimensions, except for the WSU dimension. As expected the 
acutely ill children reported the most problems in level 3 (a lot of problems) for all dimensions.  
The stability of the dimension scores, over a period was poor at MS and SS where better stability was 
expected as their health status did not change over time. Over a seven-month period there was better 
stability of MS dimension scores, except for WSU dimension.  
 
Discriminant validity was evident between only the AI and the MS school on all dimensions. 
 
Convergent validity between all similar dimensions on EQ-5D-Y and PedsQL was evident at the AI only, 
while convergent validity between EQ-5D-Y and WeeFIM dimensions was evident at the SS, CI and AI. 
The EQ-5D-Y P/D dimension and Faces Pain Scale showed convergent validity at the AI only. 
  
The EQ-5D-Y dimensions were the most responsiveness to change at the AI, with a medium effect size 
in three dimensions, except for UA and P/D. 
4.17.2 Summary of EQ-5D-Y Index Score  
Using the composite Index Score for dimensions, stability of these scores was evident at MS and SS 
groups, as expected. 
The Index Score was able to discriminate between MS and AI and the other three groups, but not 
between SS and CI. 
 
The EQ-5D-Y Index Score was the most responsive in the AI group, but also significantly responsive in 
the CI group. 
4.17.3 Performance of the EQ-5D-Y VAS 
The stability of the VAS scores was variable at the institutions which were expected to show better 
agreement between scores over time (MS and SS).  Over the shorter three month period reliability in 
VAS scores was evident at the MS school as expected, but to a lesser extent over the seven month 
period. The VAS scores indicated some stability at the SS over the seven month period only and not 
over the shorter three month period. It is possible that these children based their overall HRQoL on 
different aspects of well-being at the different time intervals. 
When comparing the VAS score against the ranking of different levels of the dimensions, across 
institutions, it was found to be significant on all dimensions at the AI only. The VAS was able to 
discriminate only between the AI and the other three groups, but not between the other three groups. 
Despite having problems in the various dimensions (alpha changes), the children with a chronic health 
condition or disability, scored similar levels on the VAS (beta changes) for overall HRQoL compared to 
the MS children who had minimal or no problems on the dimensions. This is possible evidence that the 
children with a chronic condition or disability and they do not equate functional problems with a 
lowered overall HRQoL. Instead, they report having a high overall HRQoL on the VAS. As a result VAS 
scores should be used with caution as an outcome measure in children with chronic health conditions 
or disability. 
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There were significant correlations between EQ-5D-Y VAS and PedsQL total at CI and AI and between 
EQ-5D-Y VAS and WeeFIM total at AI only. The EQ-5D-Y VAS and Index Score were significantly 
correlated at AI only. 
The VAS demonstrated responsiveness in that the effect size was medium in the AI and CI groups, with 
significantly different scores in the AI, where the greatest improvement was expected.  
4.17.4 Relationship between EQ-5D-Y proxy and self-report  
There were mostly slight correlations (low kappa) between proxies and self-report, at the individual 
dimension levels, except for the Mobility dimension which was higher. The proxy reports of children 
with a health condition, generally reported more problems on the other functional dimensions (Self-
care and UA) and fewer problems on the less obviously observed dimensions (P/D, WSU). 
However the intra-class correlation between proxy and self-report VAS was acceptable, indicating 
better agreement of overall HRQoL. 
The proxy and self-report should therefore not be used interchangeably, on an individual dimension 
level due to discrepancies between proxy and self-report scores.  
4.17.5 Feasibility and usefulness of the EQ-5D-Y   
The EQ-5D-Y took only five minutes to complete. The majority of the therapists (six out of nine)  
reported that they found the EQ-5D-Y easy to administer, that it provided additional information on 
the child’s status that was not obtained in routine assessments and that they would continue to use it 
routinely. The therapists felt that the extra information gained from this measure could be used when 
planning a rehabilitation programme for the children. 
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5 CHAPTER 5: Discussion 
5.1 Introduction 
The main finding of the research was that the EQ-5D-Y performed better when used in children with 
an acute health condition than when used in other groups of children (that is, children with no health 
conditions and children with chronic health conditions or chronic disabilities). We therefore 
recommend that it should be used with caution in these groups. The EQ-5D-Y displayed test-retest 
reliability in all groups, but poor stability using the dimensions scores and VAS, at the institutions 
which were expected to show stability in scores over time; that is at the MS and SS. The Index Scores 
derived from a summary score of the dimensions on a QALY scale, however, did display intra-rater 
reliability and stability, at the MS and SS. The EQ-5D-Y could discriminate between acutely ill children 
and healthy typically developing children, and demonstrated convergent validity with the other 
outcome measures (PedsQL, WeeFIM and FPS), when used on acutely ill children. It displayed the 
most responsiveness in the acutely ill children, with a medium treatment effect size in three 
dimensions and in VAS. It generally performed less satisfactorily in the other groups of children. These 
specific findings are discussed in detail, below, as they pertain to each research objective. 
The sample will first be discussed in order to determine the generalizability of the findings. The 
different groups of children’s responses to the EQ-5D-Y and the performance of the measure 
compared to other outcome measures will form the basis of the discussion. Comparisons will be made 
with other similar samples found in the literature. The psychometric properties of the EQ-5D-Y and the 
other outcome measures, as they pertain to the different groups of children will be highlighted, and 
recommendations will be made as to which instrument might be preferable in different contexts.  As 
there was evidence of a mismatch between the functional dimensions of the EQ-5D-Y and the global 
perception of HRQoL (as measured by the VAS), possible reasons for this will be elaborated on. The 
study limitations are highlighted and the methodology discussed. Finally, the conclusions and 
recommendations for future practice and research are presented. 
5.2 Sample 
The sample of 347 children was specifically recruited to represent South African children across a 
diverse range of health conditions, ranging from severe acute conditions (54), through a variety of 
disabling conditions (91) to transient, relatively minor and/or no ailments (201). In comparison 
previous studies have mostly described the use of the EQ-5D-Y as an outcome measure among TD 
school children without a health condition. Examples using the EQ-5D-Y with large samples of children, 
include studies in Spain with 620 children (90), 521 South African children (156), 3421 Canadian school 
children (157), 260 Swedish children (158), and a United Kingdom study with 160 children (122). Some 
studies have assessed HRQoL using the EQ-5D-Y on children with one chronic condition only. These 
studies assessed 96 children with Cystic Fibrosis (132); 310 children with eczema (159); 126 children 
with diabetes mellitus (78); 196 children with musculoskeletal deformities (160) and 450 children with 
mental health problems (161). A few studies have compared HRQoL between TD children and children 
with one health condition. These studies compared TD children and children with long standing 
chronic disabilities (15); children with and without Celiac Disease (162); and heathy children and 
children diagnosed with Acute Lymphoblastic Leukaemia (116). A study in 2013 assessed the feasibility 
and validity of assessing HRQoL using the EQ-5D-Y in 71 children and adolescents with a variety of 
chronic health conditions and 407 TD children from the general public (163). This study compared the 
performance of the EQ-5D-Y across a range of health states including chronic and acute health 
conditions. 
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One of the strengths of this study was that our sample size was large enough to allow for the 
comparison of the performance of the EQ-5D-Y across children with very different experiences of 
health conditions. The early validation study of the EQ-5D-Y (1)(2010) was done with large groups 
(between 258 and 756) of TD children from five different countries, who had few health conditions 
and consequently might have had a small variance in their responses. This could have inflated the 
reliability and validity as there would have been large numbers reporting no problems on different 
dimensions. In contrast, the studies using the EQ-5D-Y in children with one specific health conditions 
generally had smaller sample sizes (between 96 and 310) and even smaller samples when comparing 
TD with one health condition ( between 25 and 103). In addition, only a few of these studies (122)(90) 
(116)(122)(163) explicitly examine the psychometric properties of  reliability and validity of the EQ-5D-
Y. Even though they comment on the need to examine responsiveness of the measure in longitudinal 
studies, no paper has as yet reported this.  
As has been reported in a similar paediatric population (164), several of the MS children in this study 
did not return the informed consent forms signed by parents and that might have resulted in a bias 
towards children from generally more organized families, possibly with a more stable socio-economic 
status.  This was not explored but should be kept in mind. The attrition rate was acceptable in the MS, 
CI and SS children. It would have been desirable to follow up the AI children after discharge, but as the 
institution was a central hospital serving a large geographical catchment area, this would have been 
logistically very difficult. 
The gender distribution was balanced, although there were more males with health conditions, a 
common finding particularly in children with disabilities (15)(116)(165). Studies have shown that in 
older children, females generally report worse HQRoL than males (166)(114)(157) (166). However, the 
difference in responses between the genders was not explored in this study as it was felt that the 
children were still of an age where variances were not anticipated.  
The age range for which the EQ-5D-Y is specifically recommended was represented in the study and 
the children from each institution were similar in terms of age. As could be expected, the children in 
the MS school were enrolled at the appropriate grade level for age whereas children in the CI were 
enrolled in lower grades for their ages. Although schooling is provided in the CI, the long-term nature 
of the health conditions might have had a negative impact on the academic achievement of these 
children. This might need to be taken into account if studies in the lower age group were to be 
undertaken. 
5.3 Responses to the EQ-5D-Y 
5.3.1 Typically developing children at a MS school 
The majority of published studies that include TD children report the most problems in the WSU 
dimension, followed by P/D , with the least problems in LAM, followed by Mobility and UA 
(1)(158)(90)(156). This pattern was not evident in our study. The children attending a MS school 
reported the most problems in the P/D dimension, followed by UA, with the least problems in LAM, 
Mobility, and followed by WSU.  It is difficult to interpret these findings in the absence of additional 
information regarding the reasons for their self-reported ratings. However, the low income area in 
which these children live, has limited recreational facilities and the area is often affected by 
violence/crime. Parents tend to restrict children from playing outside (UA) when gang violence 
escalates. The children seem to view this restriction as a problem with UA, but do not seem to 
perceive the dangers as affecting their psychological QoL (WSU). 
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Despite the relatively small number of MS children reporting anxiety or depression (16.2%), compared 
to approximately 40% in the children with a health condition, there is still cause for concern among 
what is supposed to be TD children. This may be an indication that these children are very aware of 
the conditions in which they live and that the situation prevents them from performing UA, which 
causes anxiety. 
It is unclear why so many MS children reported experiencing some problems with Mobility (15.3%) 
and P/D (24.8%). A possible explanation for this finding is in the interpretation of the phrase “walking 
about” in the EQ-5D-Y. Even though it is a health-related QoL measure, many of the children 
interpreted this to mean “the freedom to walk around” without environmental hindrances, and not 
whether they had physical limitations due to a health condition. This would apply to this group of 
children who might have difficulty walking about their community because of the crime.  
A study on anxiety in South African children by Muris e al (2008) (167)highlighted several contributing 
factors which still exist in post-apartheid South Africa. A difference in living conditions persists 
between the different population groups, with the majority of black and coloured populations living in 
poorer areas. All the children in our study came from these poorer communities and were exposed to 
crime, violence, gangs, weapons, drugs and rape, which as Muris discussed were possible causes of 
increased anxiety in children, which could have affected some aspects of their QoL.  
A study examining correlations between pain, function and HRQoL found poor correlations between a 
specific pain outcome measure and HRQoL measures (EQ-5D and SF-36), with increased 
responsiveness to a change in pain on the more specific pain measure (168). These authors felt that 
the different measures were measuring different constructs of pain. This might be the case in our 
study, as the MS children did not report high levels of pain when reporting on the FPS, which 
specifically assesses the level of pain. The P/D being reported on in the EQ-5D-Y may be related to 
relatively minor and transient pain in these children.  
There was a considerable ceiling effect in dimension scores in the MS children, with over half reporting 
no problems on any dimension, as was found in other studies (116) (122) (132) (90). This finding 
emphasizes that the EQ-5D-Y should be used with caution in children who have no health condition. 
The original reliability and validity study of the EQ-5D-Y (1) acknowledged the high ceiling effects in all 
dimensions for TD children and that the measure may be limited in detecting moderate impairments 
or discriminating between groups of healthy children.  
It is interesting to note that when comparing the performance of the adult and youth versions of the 
EQ-5D-Y on the same participants, the youth version (EQ-5D-Y) lowered the ceiling effect, by the use 
of slightly different wording (169) (156) and generally performed better in the general population. 
The VAS scores, an indication of overall HRQoL, were not the highest (indicating better HRQoL), for the 
MS children. These children scored their overall HRQoL lower than the SS and CI children, but not 
significantly so. This was a similar finding to Jelsma and Ramma (15) who found that able bodied 
children scored slightly lower on the VAS compare to children with disabilities at a SS. 
The Index Score, however, representing a summary dimension score on a QALY scale, indicated 
minimal problems on the various dimensions for MS children, which was significantly lower than the 
Index Score of the other groups.  
The recent valuation study by Craig et al (2015) (66) raises the question as to who should value the 
children’s health states, the parents or the child. It has been found that adults do not assign the same 
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value to a particular health state in adults, as they do to the same health state in children (170). An 
earlier Canadian study, conducted in 2014, was the first study to use the EQ-5D-Y to value health 
states in children, using  approximately 6 800 children's own ratings of health (171). Positive evidence 
showed that 10 to 11-year-old children can assess their own health status for valuation studies. These 
studies indicate an interest in valuating children’s health for research and economic purposes.    
5.3.2 Children with health conditions 
The SS children reported the most problems in the Mobility and LAM dimensions; the CI children in 
Mobility, and AI children in the UA and Mobility dimensions. The children with a chronic condition or 
disability (CI and SS) reported the least problems in the P/D dimension, which was to be expected as 
the children were still relatively young and may not yet be experiencing pain related to poor posture, 
severe contractures or condition related pain. The responses of the children with either a chronic or 
acute condition seemed to be consistent with their health conditions and therefore, the EQ-5D-Y 
dimensions performed adequately in these children. 
Similarly, a Swedish study (158) exploring self-reported dimension ratings across groups of children 
known to differ in health status, also reported an increased percentage of problems on all dimensions, 
in children with a disabling handicap. In particular, these children reported more problems on the 
Mobility and P/D dimensions compared to the healthy children. The increased reporting on the P/D 
dimension in these children was in contrast to our study.  
Despite their physical limitations, over half of the CI children reported having no problems with LAM, 
as they were generally all encouraged by caregivers and therapist at the institution to be as 
independent with self-care as possible and had devised methods of coping in this dimension. Many of 
the CI and SS children also reported no difficulty with doing their UA. It seems that, as long as they 
were able to socialise with their peers, they scored “no problems” in this dimension and did not 
perceive their physical limitations as an obstacle. This could indicate reconceptualization of their 
concept of UA and even though it may not be the same as the MS children’s concept for this 
dimension, the CI and SS children did not perceive themselves as having problems with UA. This 
dimension is affected in both MS group and chronic health condition group, by their environment. As 
mentioned earlier the MS children are limited in performing their UA by the unsafe environment in 
which they live, while the CI and SS groups live in a sheltered  institutional environment which is able 
to facilitate socialising and doing UA. The factors contributing to the scores in this dimension are 
worth exploring in future studies.  
A Dutch HRQoL study (172) also found that children with muscular dystrophy responded differently to 
healthy children when rating UA, as a result of different experiences and conceptions. 
In contrast to the high ceiling effect observed in the MS group, only 12% of the children with a health 
conditions reported no problems on any dimension but, as they were all specifically included in the 
study due to their having a health condition, this still seems quite a high number to report no impact 
on HRQoL.   
Ceiling effects have also been observed in other studies using the EQ-5D-Y on TD children 
(1)(116)(157), children with cystic fibrosis (132) or asthma (67), and children with musculoskeletal 
problems (160), with a high percentage of “no problems” on dimensions being reported.  This finding 
may be a reflection of the generic nature of the EQ-5D-Y, which may not be responsive to an adequate 
range of health states. Some of the authors mentioned above have suggested increasing the number 
of possible response choices on dimensions from three to five, as has been done with adult EQ-5D, to 
reduce the ceiling effect. 
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The ceiling effect with regard to the VAS was most obvious in MS, SS and CI and contributed to the 
skewness of the distribution of data in our study. A study by Canaway and Frew (2013)(122), found 
that the large percentage of respondents reporting “no problems” on all EQ-5D-Y dimensions or a 
median VAS of 100 as was the case in our study, presented a ceiling effect, resulting in a clustering of 
values at one end of the distribution curve.  
The median VAS was 100 in all but the AI, which would indicate that either the children do not 
understand the VAS or that functional limitations as result of a health condition do not influence 
HRQoL as much as one would imagine. As no correlation was found between age and VAS, and no 
pattern was evident with regard to the ages of the children scoring 100, the latter explanation is more 
likely. This is discussed below in section 5.8.  
The Swedish study (158) found that children with a health condition reported a lower VAS compared 
to healthy children, which is in contrast to this study.   
The AI group scored significantly lower Index Scores, than the other groups, indicating that these 
children experienced the most problems in the various dimensions, as was expected.  
When comparing the EQ-5D-Y dimension scores to the other outcome measure, the EQ-5D-Y 
dimensions and WeeFIM indicated that the MS children had the least problems, followed by the SS 
and CI and that the AI children had the most problems. However, this was not the case in the PedsQl 
dimension scores, except for the Activity dimension. Interestingly however, when comparing PedsQL 
and WeeFIM total scores, the same pattern emerges with the MS children experiencing the least 
problems, followed by CI and SS children and lastly AI children with the most problems, indicating that 
the different measures performed similarly overall.  
5.4 Evaluation of the psychometric properties of the EQ-5D-Y. 
The COSMIN checklist (25) which is a consensus based checklist developed to ensure methodological 
rigour in the reporting of the psychometric properties of outcome measures, was used in the study 
(Appendix 1).  General requirements for discussion when evaluating psychometric properties of an 
outcome measure include: 
Missing items: 
A weakness of the study was that there were no missing responses on the EQ-5D-Y or PedsQL to 
report on because, unfortunately, the researcher checked for these while the children were 
completing the self-reported outcome measures. This could have potentially affected the results 
concerning the usefulness of the EQ-5D-Y compared to the PedsQL, as it was not possible to compare 
the number of missing responses between the two outcome measures. However, the researcher did 
anecdotally report that children required more reminding to rate all items when using the longer 
PedsQL than for the EQ-5D-Y. Other studies, using either outcome measure, have also reported very 
few missing responses and this has no effect on the results (145)(1)(114)(113).   An Italian study (106) 
and an English study (156) found no missing responses on the EQ-5D-Y, rating it easy to understand 
and use in children between eight and twelve years. 
Sample size: 
The sample size was sufficiently powered to depict a change in HRQoL in those groups hypothesised to 
change over time (CI and AI). There was some attrition over time from the AI group as they were 
discharged before they could be reassessed, but the overall number of children with a health 
condition, remained sufficient. 
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Number of measurements taken: 
A strength of the study was the number of measurements taken. Most participants repeated the 
measure three times. The majority of the acutely ill children repeated the measure at least twice, 
which was considered sufficient to determine responsiveness in the studies mentioned below. Only 
five of the 13 generic HRQoL measures reviewed had repeated the measures over a period of time and 
were able to comment on responsiveness. These included the CHQ (118), HUI (62), KINDL (99), PedsQL 
(114) and QOML (118). No repeated measure studies assessing the responsiveness of the EQ-5D-Y on a 
clinical sample was found, which highlights the relevance of this study. 
Time interval: 
A possible weakness was the short interval between test-retest periods. Being only one day apart 
some of the children may have remembered their previous scores. However a longer period may have 
resulted in a change in the acute health condition of the children in hospital. Measurements repeated 
at three monthly intervals allowed for changes in the children with a chronic health condition, due to 
better management of their condition. However over the seven month period, developmental changes 
and altered priorities may have occurred in all the groups of children, changing their concept of 
HRQoL. 
Stability of respondents in interim periods: 
The stability of the children’s’ health in interim periods could be determined from the contextual 
information provided by the therapists and from medical files. The performance of the instruments 
was tested under the assumption that the MS and SS children’s health status would remain stable and 
that AI and CI children would show an improvement in HRQoL over time. It was possible to identify 
which children in each group did not fit the hypothesis based on worsening health status and they 
were removed from the analysis. 
Test conditions: 
Test conditions at all facilities were described and were exactly the same at each assessment period, 
for all outcome measures.   
The following psychometric properties of the EQ-5D-Y were evaluated and will be discussed as they 
pertain to the research study objectives: 
 
Internal consistency: 
As the EQ-5D-Y and the other HRQoL measures used were multi-dimensional, the internal consistency 
of the various dimensions was expected to be low and was not assessed in this study. The ICC of test-
retest VAS scores was determined and relationships between the dimensions and overall HRQoL (VAS) 
were examined and will be discussed.   
 
Reliability: 
The various forms of reliability were examined by assessing the measurement error. The measuring 
instrument error was assessed through test-retest of the children’s responses 24 hours apart. The 
variability or stability of the characteristic was assessed by repeated measures over a three and seven 
month period (intra-rater reliability). The error attributed to the individual taking the measurement 
was assessed by correlating the responses of proxies and children’s self-report (inter-rater reliability). 
It is recommended that further research investigate the inter-rater reliability between different 
proxies for the same child, as this aspect was not investigated in this study. 
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Content validity: 
The EQ-5D-Y has been developed from the adult EQ-5D into a paediatric HRQoL measure, and it is 
recognised that it does not contain child specific dimensions. However, all dimensions measure 
aspects of HRQoL, but this was not specifically assessed. 
 
Structural validity: 
The relationship between dimension scores and overall HRQoL was examined 
 
Hypothesis testing: 
The ways in which the EQ-5D-Y was expected to perform with the different groups of children was 
hypothesised, before data collection. 
 
Cross-cultural testing: 
The original English version of the EQ-5D-Y and the version translated into Afrikaans were used, but 
both versions were not tested on the same participant. The isiXhosa version was not used as the 
isiXhosa speaking children could not read the language, but could read the English version. The PedsQL 
had not previously been translated into Afrikaans or isiXhosa and this was performed, following the 
forwards and backward translation process, before data collection. However the isiXhosa version was 
also not used, for the reason given above. 
 
Criterion validity: 
The ability of the EQ-5D-y to discriminate between children with different health statuses was 
examined. Convergent validity between similar dimensions on the PedsQL, WeeFIM and FPS were 
investigated, for the different groups of children. 
 
Responsiveness: 
The responsiveness of the measure to depict a change in HRQoL over time, was examined. 
 
Interpretability: 
The mean age (Std. Dev. and range) of the sample population was analysed, as well as the gender 
distribution and educational level of the children. The disease characteristics for each group was given. 
The selection of participants and the study settings were described. The distribution of scores in the 
different groups of children was analysed.  
5.5 Reliability of the EQ-5D-Y 
The first specific objectives of the study related to the reliability of the instrument.  Reliability is a 
reflection of the relative amount of true or fixed value and random error. Sources of error include the 
measuring instrument, the variability of the characteristics and the individual taking the measure 
(108). Measuring instrument error was assessed through test-retest of the children’s responses 24 
hours apart. The variability or stability of the characteristic was assessed by repeated measures over a 
three and seven month period. The error attributed to the individual taking the measurement was 
assessed by correlating the responses of proxies and children. 
5.5.1 Measuring instrument error 
Generally the EQ-5D-Y dimensions demonstrated acceptable test-retest reliability in all the groups of 
children. As the dimension ratings are ordinal in nature, the Kappa statistic was used. This measures 
the consistency; that is whether or not the highest and lowest scoring children remain the highest and 
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lowest, respectively, on the second assessment. In other words, it measures consistency of the 
dimensions rather than absolute agreement across the groups. The EQ-5D-Y was found to be 
consistent in all dimensions except for the UA dimension. A possible reason for poor agreement in this 
dimension, in the present reliability study, is that several examples of usual activities are included in 
the questionnaire to explain the construct, for example “going to school, hobbies, sports, playing, 
doing things with family or friends” and the child might have been relating to a different, specific 
activity each time. 
The encouraging results are similar to an Italian study (116) which assessed test-retest reliability of the 
EQ-5D-Y on children from the general population and children with Acute Lymphoblastic Leukaemia. 
The authors reported fair agreement across the dimensions, including UA.  
Apart from the nature of the instrument, there may be other reasons that could contribute to the test-
retest result. The test-retest method was applied on consecutive days and the short time interval 
between measurements may have resulted in measurement bias. According to Devon et al 
(2007)(103), the recommended time interval between original test and retest should be long enough 
to ensure that participants don’t remember their initial scoring, but not too long for changes to have 
taken place. These authors recommend an interval of between two weeks to one month, but there is 
little consensus as to what time interval is suitable for children (83). Seven to ten days was the time 
interval used in the EQ-5D-Y Feasibility, Reliability and Validity multi-national study (1), two weeks 
apart in the development of the KIDSCREEN outcome measure (106) and DISABKIDS (86) and 
morning/afternoon in a study comparing the performance of the CHU and EQ-5D-Y (122). Test-retest 
on consecutive days was deemed appropriate in this study as the health status was likely to change in 
the AI children.   
The absolute agreement of test-retest VAS, calculated using Interclass Correlation Coefficient (ICC) 
was found to be 0.77, indicating good agreement. It would appear that the VAS gives reliable results, 
similar to the Italian study by Scalone et al which also reported a high  level of agreement (ICC  of 
0.82)(116).  This was a heartening result, as there are concerns as to whether children as young as 
eight have the numeracy skills to respond appropriately to this task. However, as mentioned above, 
the marked ceiling effect could have influenced this. 
It would appear that the EQ-5D-Y is a reliable measurement instrument in children with different 
health states. 
5.5.2 Variability of the characteristic (HRQoL) 
The stability of the self-reported HRQoL was measured over three and seven months in the MS and SS 
children as their health status was not anticipated to change much over this time. Transient variability, 
as is the nature of HRQoL over time (5)(6)(7), was considered and therefore it was expected that there 
would be moderate agreement between scores over time.  HRQoL was however less stable than 
expected and only slight agreement was reported in each dimension over three months at the MS 
school. The SS children demonstrated moderate agreement between mobility and LAM scores only, 
over three months. However, over the longer seven month period there was better stability between 
scores in all dimensions, except for the WSU dimension. There are several possible explanations for 
the weak agreement between scores. There have been a true alteration in HRQoL due to fluctuating 
levels of perceived independence in the various dimensions over time, which could be attributed to 
fatigue on a particular day. This explanation was reported on in a United Kingdom study (122) which 
found limited reliability in EQ-5D-Y and CHU test-retest results in younger TD children. The test was 
performed in the morning and then in the afternoon of the same day, when the children were 
fatigued. Even though the measures were administered in repeated assessments at roughly the same 
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time of day in our study, it is possible that the children, especially the SS children with limited mobility, 
would be easily fatigued if they had recently performed a physically activity which they found 
challenging. This could affect their responses on the EQ-5D-Y dimensions.  
 
Also, different levels of maturity might account for a decrease in stability. As children’s abilities, 
outlook and priorities may change as they develop, this could account for some inconsistencies in 
reporting  over a period of time (90). In the light of the increased stability at the SS over the longer 
seven month period however, however, it is unlikely that this played a role in their responses. 
 
This lack of stability might also be an indication that children are not able to differentiate between 
specific HRQoL and general QoL which may fluctuate more over time. This was not case in the United 
Kingdom study (122) which reported that  children understood the construct being measured and 
children as young as five years can reliably self-report if given age appropriate measures (81). The poor 
stability observed in MS and SS children in the current study may not be due to a misunderstanding of 
the constructs, but rather to confusion as to whether the problem encountered was due to a health 
condition or to other factors, such as being hungry or feeling unsafe on that day, emotional distress 
due to personal conflicts with others or being excluded from a particular social peer group. The 
argument that children are unable to distinguish between general QoL and specific HRQoL is 
weakened, however, by the lack of impact of major life events on HRQoL. In this study it was found 
that life events such as a death in the family, divorce, birth of a new sibling, moving house or a surgical 
intervention, did not have an effect on the VAS or the WSU dimension.  
 
The stability of the VAS, compared to the fluctuations in the dimension scores, may indicate that, for 
children, a functional limitation does not necessarily translate into a reduction in HRQoL, so that 
although the function of a child may alter with time, the VAS remains relatively stable or even 
improves over time. This is discussed below in Section 5.7. 
 
When the summary EQ-5D-Y dimension score (Index Score), derived from a QALY scale developed by 
Craig et al (2015) (66), is used the Index Score shows stability at the MS and SS, as expected.  This is in 
line with the stable VAS at these institutions. This could indicate that the fluctuations in individual 
dimensions are levelled out when a summary score is used. Although the values developed by Craig et 
al were used in this study to allow for the calculation of a composite score, these have not yet been 
adopted by the EuroQoL Foundation.  
5.5.3 Agreement between individuals taking the measure 
Correlations between children and their proxies report were used to explore the amount of error that 
might be due to the respondents. Similar to the self-report, there was a significant difference in the 
mean ranking of the proxy Index Scores between institutions, but whereas the self-reports Index 
Scores rankings were significantly different between all institutions except for SS and CI, there were no 
differences in ranking between the MS and CI, and the SS and AI in the proxy reports. It would seem 
that the children are better able to identify their problems on the dimensions than the proxies.  
For all groups, there was limited agreement between self-report and proxy at a dimension level, 
except for Mobility, being an easily observable dimension, for which there was moderate to good 
agreement. The highest levels of agreement between child and proxy were seen in the AI, with only 
LAM dimension having slight disagreement.  
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As the validity and reliability study of the Spanish EQ-5D-Y proxy version (90) found high agreement 
between proxy and self-report on the Mobility, LAM and UA dimensions and lower agreement for P/D 
and WSU dimensions, it was expected that the proxies might report similar or maybe more problems 
in the first three dimensions, which are observable dimensions and less in the other two which are 
more subjective. This is often true for the psychological component in children’s health (16). Children 
with a health condition clearly are more anxious than their proxies realise. There were very large 
discrepancies in the percentages of children versus proxies reporting problems in the WSU dimension 
(for example 40% of the children at the SS reported problems, whereas the proxy reported that no 
child had any problems). Of similar concern is that, in the CI, there was a large difference between the 
high percentage of children reporting problems and the relatively low number of children identified as 
having problems in all domains by the proxies. In contrast, the proxies of the AI children reported 
more problems in all dimensions apart from WSU. This highlights the need for clinicians, who were the 
proxies in children with health conditions, to use self-reported HRQol measures to become more 
aware of how a health condition affects the child’s experience of HRQoL.  
For all groups combined there was moderate agreement between self-report and proxy VAS scores, 
but this was not the case at institutional level, where the two respondent’s VAS scores were only 
significantly correlated at the MS school.  The majority of respondents from the MS reported full 
health and there were a larger number of respondents at this institution, which may have inflated the 
correlation. This discrepancy between raters was similar to a number of other studies (93) (92) (15) 
(77). The correlation between proxy and child report was the highest at the AI and this might have 
been significant if the sample size had not been so small.  
These discrepancies in raters’ description and perception of HRQoL may be due to a limited 
understanding by the proxy on how the child functions in different contexts, such as at school, home 
and when socialising with peers. Proxies and children may also have different perceptions of HRQoL as 
seen in a study by Kaartina et al (93). When they compared parent proxy and self-report HRQoL from 
379 Malaysian adolescents, these authors found that the proxies reported lower HRQoL than the 
children. While the proxy may not be aware of the extent of the emotional impact the health 
condition has on their child, they do have a broader perspective and comparison base on which to 
base their report. As it is the adult proxy who makes decisions on the child’s health care and utilisation 
of services, their perspective needs to be considered. It is therefore generally recommended that both 
proxy and self-report measures be taken into account when assessing a child’s HRQoL whether for 
planning a management programme in which the child’s perspective is most important or for 
determining the cost effectiveness of a programme and resource allocation, where the proxy report 
may be of more benefit (93)(26).  
In this study it would appear that a proxy report might be useful in an acute setting, especially if the 
child is too ill to self-report, but less reliable in settings where children have chronic illness or disability 
as the proxies seem to under-estimate the emotional distress of the condition on these children. It is 
clear, however, that the proxy and self-report should not be used interchangeably. 
5.6 Validity of the EQ-5D-Y 
The next study objective related to the construct validity of the EQ-5D-Y, which was examined by 
assessing both discriminant and convergent validity. 
5.6.1 Discriminant validity based on dimensions 
The discriminant validity of the EQ-5D-Y dimensions was examined by comparing the HRQoL profiles of 
the different groups. As hypothesised, the MS children reported significantly fewer problems in each 
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dimension than the children in the AI. In addition, they reported fewer problems in the functioning 
domains of Mobility and LAM than the SS children, many of whom had functional limitations due to 
their health conditions. It was interesting that, apart from the AI children, there was no difference 
between the rankings of UA, P/D or Discomfort or WSU between the other groups. This would indicate 
that, despite being in special institutions, the children appear to correctly reference their UA against 
themselves and their class mates rather than against children in general. In addition, the existence of a 
chronic health condition or disability did not significantly impact on their emotional state, which may 
be an indication that RS took place. This however, was not analysed in sufficient detail to ascertain 
that RS indeed took place. As discussed previously, it is unclear why so many MS children reported P/D 
and although the mean ranking of the SS and CI was higher, there was no significant difference 
between these groups. 
 
These results are similar to an Italian study(116) which compared TD children to acutely ill children, 
and which found that TD children reported significantly fewer problems in all dimensions of the EQ-
5D-Y compared to the acutely ill children. Therefore discriminant validity between these two groups 
was evident. The Swedish study (158) using children in groups known to differ in health status, also 
found discriminant validity between children with severe illness and/or handicap and children with 
chronic rhinitis and/or asthma. A Spanish and Catalonian study (173) also found the EQ-5D-Y able to 
satisfactorily discriminate between known groups of TD children with and without a chronic or mental 
health condition.  
It would appear that the EQ-5D-Y dimensions exhibited discriminant, known group validity. 
5.6.1 Discriminant validity of the VAS 
Similar to the dimensions, the VAS of the AI children was significantly lower than all other groups but 
there was little difference in VAS between the other groups. Jelsma et al. (15) reported that children 
with disabilities in Cape Town actually reported higher overall HRQoL than their able-bodied peers so 
the lack of difference between the MS and SS children was not surprising. However, the lack of 
difference between the children in the CI and the other children was unexpected, as it was anticipated 
that children with health conditions would have a poorer overall perception of their health state.  The 
Swedish study (158) found that children with two or more clinical characteristics reported significantly 
lower on the VAS. In contrast to a Canadian study (2010)(157) which found disparities between 
dimension scores and VAS, depending on the children’s socio-demographics, the children in this study 
were all from the same socio-economic background and this was unlikely to have been a factor.  
The VAS was able to clearly discriminate between the AI and MS children. 
While the EQ-5D-Y VAS could discriminate between the acutely ill children and the other three groups, 
the PedsQL total score was only able to discriminate between the MS children and the AI children. The 
WeeFIM total score was able to discriminate between the children at the CI and SS and AI. However, it 
was unable to depict a difference in functional independence between the AI and SS. It would seem 
that the WeeFIM is not sensitive enough to depict a functional difference between children using a 
mobility device and children confined to a hospital bed.  
5.6.2 Convergent validity 
The study objective of assessing convergent validity was investigated by determining whether there 
were correlations between the scores on similar dimensions of previously validated p-HRQoL outcome 
measures across the three levels of the EQ-5D-Y dimensions.  
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Convergent validity was found between the different levels of all similar dimensions of the EQ-5D-Y 
and the PedsQL, for the AI group only. However, convergence between the functional (observable) 
items on EQ-5D-Y and the WeeFim was evident across all groups tested (SS, CI and AI). The dimensions 
of P/D and WSU did not show the expected relationship with the PedsQL items in the SS or CI children, 
but only in the AI children. As the PedsQL references the construct to “the last month” and the EQ-5D-
Y to that day, it might not be surprising that the dimensions do not concur. It was previously noted 
that there were more MS children reporting P/D than would be expected and the lack of concurrence 
between the PedsQL “I hurt” item and the P/D dimension might be due to the relatively minor and 
transient nature of the pain or discomfort experienced by these children.  
Similar to this study, Ravens-Sieberer et al (2010) (1) reported convergent validity  between EQ-5D-Y 
WSU and PedsQL Feelings dimension in TD children. It is not clear why this relationship was not 
evident in children with a chronic health condition.   
The Italian study (116) investigating concurrent validity between EQ-5D-Y and PedsQL found good 
levels of convergence for Self-care in TD and acutely ill children. However, it is not clear which 
dimensions or items were compared, as there is no specific self-care dimension in the PedsQL 
measure, only “I have problems with showering or bathing myself”, which is only one item of self-care.  
As with the dimensions, the VAS performed best at the AI and was correlated with both the WeeFim 
and the PedsQL totals in this group. It was noted that the WeeFIM Social cognition subscale focuses on 
language and cognitive skills, while the PedsQL Socialising dimension focuses on the child’s emotional 
and social abilities, which are different constructs and therefore associations between the two would 
be expected to be poor. The EQ-5D-Y does not assess either of these constructs, so they were not 
included in the analysis.  
The total PedsQL and WeeFim scores did show convergent validity across all groups, which is 
consistent with some of the literature. A Turkish study (174) of 32 children with cerebral palsy found 
significant relationships between all the WeeFIM subscales and PedsQL dimensions. A Canadian study 
(175) of 224 children with physical disabilities ranging from cerebral palsy to spina bifida and 
developmental delay found fair to moderate correlations between WeeFIM Self-care and Mobility 
subscales and PedsQL Health and Activities dimension. However, this was in contrast to another 
Canadian study (176) of 124 children with physical disabilities and a USA study (177) of 562 children 
with ambulatory cerebral palsy. This finding highlights the usefulness of using more than one outcome 
measure to accurately determine a child’s HRQoL from their own perspective and an objective 
measure of their actual functional independence. 
No other studies were found comparing the EQ-5D-Y with WeeFIM. The WeeFIM demonstrated high 
ceiling effects in the various dimensions in the CI children and should be used with caution in these 
children.  
The convergent validity of the EQ-5D-Y with the other outcome measures, therefore, appears to be 
acceptable in the AI children, but variable in other groups of children. 
5.7 Responsiveness to change in HRQoL over time 
The responsiveness to change, when a change in HRQoL does occur, is an extension of validity and was 
examined in the three outcome measures, EQ-5D-Y, PedsQL and WeeFIM. Responsiveness was 
quantified as the effect size (178) in order to give an indication of the minimally clinically important 
observed change in these children (179)(126). In order to interpret the meaning of the change in 
scores, the types of change which occurred was examined by linking it to underlying clinical change 
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(178)(125) according to the hypothesis. A mixed, rather confusing picture emerged with regard to the 
dimensions with MS and CI children reporting a medium effect for Mobility, children at the SS 
reporting a medium effect for LAM and the AI children reporting medium effects for Mobility, LAM 
and WSU. Although it was not surprising that there was no change in UA in the AI children who were 
still in hospital at the time of the second assessment, the lack of responsiveness of the P/D dimension 
was unexpected, especially since the FPS did demonstrate a medium effect. However, when the 
summary Index Scores were used, a clearer picture emerged with a medium effect size evident in the 
two groups, the CC and AI groups, who were expected to show improvement. There is an obvious 
need to do further studies using this composite score derived from summarising the EQ-5D-Y scores 
on a QALY scale, as is emphasised by Craig et al (66).   
A similar pattern of responsiveness was detected in the VAS scores in that the CC and AI were the only 
two groups to demonstrate a medium change. The AI children improved as their acute condition and 
pain was managed. The CI children improved after being admitted to a facility for better management 
of their chronic health condition. 
The WeeFIM detected a large improvement in SS and AI groups and medium in CI. Even though the 
children at the SS had fairly stable health conditions with minimal physical changes occurring within 
the study period, most of their changes occurred in the cognition dimension. A USA study (180) did 
find the WeeFIM responsive in detecting a change over a one year period, in 205 children identified 
with chronic disabilities such as spina bifida and cerebral palsy (similar conditions to the SS children) 
and developmental delays, using effect size. The difference between this study and the present one is 
the time period and, even though the SS children were not expected to change within the three month 
period, they might change over a longer period as their chronic disability deteriorates.  
The WeeFIM performed the best in the CI children, who were expected to change slightly, and the AI 
where a large change was expected.  
The PedsQl did not respond as expected in any of the groups, only detecting a change in the children 
at the SS. A possible reason for the lack of responsiveness in the AI could be that the PedsQL questions 
how much of a problem the child had in the various dimensions during the last month and it may not 
be suitable for repeated assessments on acutely ill children, who are assessed more often than once a 
month. It did not seem to detect a change in the CI children and may not be sensitive enough to 
changes occurring in this group. This was in contrast to a PedsQL study (181) which found the generic 
measure to be responsive to change in 231 children with chronic rheumatoid arthritis, assessed 60 
days apart. Another two year study, using the PedsQL to assess HRQoL in children who regularly 
participated in sport compared to those who did not, found an increase in overall HRQoL in the 
children regularly participating. As this  was expected, it indicated that the PedsQL was able to show 
change when it was expected, but interestingly no change was observed on the physical dimension or 
emotional dimension (even though this was expected to change) (182).  
The MS group were not expected to show change, so it would seem that the PedsQL only performed 
as expected in this group. 
The FPS performed as expected in detecting a small change in pain levels in the MS, SS and CI. A 
medium change over time was seen in the AI group as their pain medication took effect. 
5.8 Response shift 
It might be expected that scores on the different dimensions and overall HRQoL (VAS score) would  be 
associated (39). However, in this study the VAS scores were only significantly correlated with all 
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dimension scores in the children at the AI. Based on the descriptive analyses, the reported changes on 
the five dimensions of the EQ-5D-Y do not seem to be strongly related to the VAS scores in the CI and 
SS children. It is not possible to conclude whether this is an example of Response Shift or not, as the 
children’s responses were not tested retrospectively with a “then-now” test to determine whether 
they would rate their health at baseline differently. 
It has been recognized in other studies that individuals with a chronic disability adapt to their situation 
by either changing their internal standard and values or their conception of HRQoL, a phenomenon 
known as RS (38)(99)(183)(96)(184)(16). The children with a chronic health condition or disability were 
able to correctly identify their problems on a dimensional level, but scored similar levels on the VAS 
for overall HRQoL as the MS children with minimal or no problems on the dimensions.  
A previous South African study (15) found that children with long standing, chronic conditions 
reported a higher general HRQoL on the VAS than those of TD children, whereas their dimension 
scores indicated greater problems. This was similar to other studies that found that children with a 
chronic disability did not equate limited functional independence with a lowered HRQoL (26)(36)(15). 
It would seem, in children with a chronic disabling condition who are otherwise healthy, the VAS and 
the dimension scores might be measuring different constructs and that functional limitations might 
not always equate to poor HRQoL on the VAS.  
This disparity between dimension scores and VAS could have an impact on the psychometric 
properties of a HRQoL outcome measure, which may influence the interpretation of clinical research 
findings (99) and, therefore, the EQ-5D-Y should be used with caution in children with a chronic 
condition or permanent disability.  
The VAS could be seen by these children as a measure of their satisfaction level with their 
participation within their community, despite their physical limitations. Albrecht and Devlieger (1999) 
(96) described the QoL of people with a disability as a balance between body, mind and spirit within 
their community context. They suggested the factors that negatively influenced the QoL of people 
with a disability are a lack of social and community ties, poor access to resources and a disabling 
environment. None of these negative influences were present in the sample of children with a chronic 
disability or health condition, which could account for their high satisfaction levels, as seen by high 
VAS scores. The children were all at schools which catered for their disability, were well resourced, 
with an adaptive environment and situated within the community from which the children came.  
 
A similar finding was evident in a study of HRQoL, in  40 children from Dutch neuromuscular referral 
centres, living with muscular dystrophy (172) and 30 children with physical disabilities attending a 
special school in the North West Province, South Africa (165). The severity of their condition and 
physical limitations did not negatively affect their HRQoL, while being able to socialise with their peers 
positively influenced their HRQoL. 
It is also unlikely that the children with a long-standing chronic health condition, some of whom were 
born with the health condition, would have the same concept of HRQoL as children with no health 
condition or those with a sudden acute health condition, as discussed by Swartz in a paper on the 
application of RS theory (99). It is possible that MS children, who have had no experience of a health 
condition resulting in a disability or needing hospitalisation, would have a very different concept of 
HRQoL compared to children with a chronic or acute health condition. 
This could affect the psychometric properties of HRQoL measures (99)(39). For high discriminant 
validity, it is assumed that the participants all have the same conception of what is being measured 
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and similar experiences to refer to (103), which is not the case in the children in this study. RS may 
also influence the sensitivity of HRQoL measures to depict differences between different health 
conditions and interpretation of clinical research findings (39), which could ultimately introduce bias 
(185).  
Despite observable, objective limitations (alpha change) in the children with chronic disabilities, the 
phenomena of possible RS could result in underestimation of the effect of the health condition on 
their HRQoL. This has been discussed by Swartz (99) and could lead to the incorrect impression, if the 
HRQoL measure is used to calculate quality-adjusted-life-years (QALY). As the QALY is the basis of 
economic evaluations used for resource allocation (52), RS could result in fewer resources being 
allocated to these children. It is important for users of HRQoL outcome measures to be aware of 
possible RS when interpreting results for planning changes in management of the condition or for 
economic evaluations, as it seems to have occurred in the children with chronic conditions in this 
study. 
5.9 Feasibility and Usefulness of EQ-5D-Y outcome measure 
Feasibility was assessed by the length of time taken to complete the measure and not by the number 
of missing responses as other studies have done (1)(90)(116)(158), as the researcher was present to 
ensure that the children did not leave out any responses. The EQ-5D-Y, being a short questionnaire, 
took only five minutes to complete compared to 15 minutes to complete the PedsQL. Children became 
easily distracted when completing the longer PedsQL  and had to be reminded to complete the task at 
hand more often, compared to when completing the EQ-5D-Y.  This would indicate a preference for 
using the EQ-5D-Y in these children. The EQ-5D-Y would seem to consist of enough items to assess 
HRQoL, but  does not take long to complete, a desirable attribute of a paediatric HRQoL measure 
(144). As the EQ-5D-Y displayed an equivalent or greater responsiveness to change, there is strong 
argument to use the shorter instrument as a routine outcome measure. 
Although there have been several reports on the usefulness  of the EQ-5D-Y as an outcome measure 
(13)(1)(90)(15), this is the first study, to our knowledge, which examined the usefulness within a 
routine clinical context.   
The sample of physiotherapists who reported on the measure was quite small (nine) but these were 
the only clinicians involved with the children in the study.  In general, these clinicians reported that the 
EQ-5D-Y was acceptable, useful and easy to apply. The majority stated that they would continue to use 
it in future as it provided them with insight into the children’s subjective perception of their own 
health condition.  
Two therapists at the AI found some eight to nine-year-old children had difficulties understanding the 
“UA” dimension, but this was not the case elsewhere. It was found that the children generally 
understood the questions, rendering the measure feasible to use in this population.  
All the therapists noticed a relationship between responses and clinical signs, mostly in the Mobility 
and LAM dimensions. As was discussed earlier, the large discrepancy between self-report and proxy, 
particularly in the SS and CI, emphasises the need for therapists to become more aware of the 
subjective experiences of the children that they treat. This was recognised and all therapists found the 
measure provided them with additional information in the P/D and WSU dimensions and the extent to 
which these aspects affected the children’s HRQoL. They found this less obviously observable 
information most useful when planning the management of the child, as they gained better insight 
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into the areas most affecting the child’s HRQoL and could, therefore, pay more attention to these 
aspects. 
The EQ-5D-Y appears to be a useful measure to include in assessing children, for completeness of 
information and for aiding the planning of a management programme for the child. However, in 
contrast to the FPS, the dimension of P/D did not demonstrate responsiveness in the AI children and it 
is suggested that the EQ-5D-Y be supplemented by the FPS within the AI group.   
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6 CHAPTER 6: CONCLUSION 
Research into HRQoL, resource allocation and decisions regarding the management of a health 
condition may be based on the scores obtained using a HRQoL measure. For these purposes, it is 
important that the measure is reliable and valid when used on a particular population sample (25)(31). 
HRQoL measures should be stable in the absence of observable change, but responsive to change if 
changes do occur.  
We found that the EQ-5D-Y performed well when used on acutely-ill children. The VAS scores in this 
group of children were significantly correlated with all dimension scores in these children. This 
measure was found to be reliable and could clearly discriminate between children with an acute illness 
and children in the MS schools with no health condition. In addition, good convergent validity 
between the EQ-5D-Y and the other outcome measures, the PedsQL, WeeFIM and FPS was 
demonstrated in the AI children. It seems that children with an acute health condition are able to 
respond most appropriately to the EQ-5D-Y as they are able to recognise the impact of their health 
condition on their QoL, comparing their acute condition to their normal condition. They have a 
comparison of HRQoL on which to base their responses. Likewise, responsiveness to change in EQ-5D-
Y dimension scores, except for P/D and VAS, was most noticeable in the acutely-ill children. It would 
seem that a specific pain measure, FPS, is better able to depict changes in pain in these children and 
should be used in conjunction with the EQ-5D-Y in a hospital setting. 
The EQ-5D-Y dimensions did reflect the SS and CI problems appropriately, but this was not the case 
with the VAS.  Despite reporting problems in the various dimensions, these children scored a high 
overall HRQoL on the VAS. It would seem that these children do not equate lowered functional ability 
on dimensions with lowered overall HRQoL on VAS. 
The measure did not perform well in the MS children with unexpected results obtained for the P/D 
dimension. In addition, some children reported problems with Mobility, although this was not 
reflected on the functional independence outcome measure, the WeeFIM. This may reflect an 
interpretation and contextual issue. It would seem that a healthy child might not relate problems with 
“walking about” to a health state, but rather to environmental barriers. 
There was a disparity between dimension scores and VAS in the MS children. It is possible that 
children who have not experienced a health condition may not be able to differentiate between health 
related quality of life and general quality of life. High ceiling effects, as were evident in the MS 
children, also affected the psychometric properties of the measure. 
However, when comparing the Index Score (a composite summary score of dimensions, based on a 
QALY scale (66)) across institutions, the MS children’s score indicated almost no problems on any 
dimension, followed by the CI, SS and the AI with the most problems, as expected. There was a 
relationship between the responsiveness of the VAS and Index Score, with both being the most 
responsive to change in the AI and CI children, who were expected to show a change over time. This 
highlights the need for more studies to be done using the composite score summarising the health 
condition for comparison against other measures which produce a single summary score. Proxy and 
self-reports should not be used interchangeably. The proxy report is appropriate for use if the acutely 
ill child is unable to self-report, but is not recommended for use in the SS and CI children. 
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6.1.1 Recommendations for practice: 
When choosing a HRQoL outcome measures for practice, the population on which it will be used 
should be considered.  
 
The EQ-5D-Y can be used with confidence in acutely ill children as it fulfils all psychometric 
requirements in this group. It was quick and easy to use and provided the therapists with additional 
information of which they were not previously aware. The EQ-5D-Y dimensions performed adequately 
in the SS and CI groups, but not the VAS. 
 
The PedsQL could discriminate between the MS and AI groups, but was not responsive in depicting a 
change in HRQoL in the AI group. Therefore PedsQL is recommended for use in assessing HRQoL in MS 
children, but not in acutely ill children.  
 
The WeeFIM, which is an objective measure of function rather than HRQoL, performed well in 
identifying different levels of independence between the SS, CI and AI groups. It was most responsive 
to change in the AI group, but is also recommended for use in children with a chronic disability. Ceiling 
effects may be apparent of this measure is used on children with a chronic health condition and 
without a physical disability. In this case, the suitability of this measure for assessing function in these 
children may be limited.  
6.1.2 Recommendations for research: 
When choosing a HRQoL measure for research purposes, the effect of RS on the psychometric 
properties of the measure, when used on children with a chronic health condition, should be 
considered. Response shift as such, was not investigated in this study but it was found that these 
children appear not to equate lowered functional ability with lowered overall HRQoL. It is therefore 
recommended that further qualitative research is necessary to understand the constructs 
underpinning children with a chronic health condition’s VAS reported health. 
 
The need to develop paediatric-based weights for use on EQ-5D-Y health states is currently being 
considered. Further research should be conducted in valuation studies assessing preferred EQ-5D-Y 
health states in children, in order to develop a value set for use in children. As the EQ-5D-Y has been 
found to be reliable, valid and responsive in acutely-ill children and less so in chronically-ill children, 
there is a need to develop a EuroQoL composite score summarising the health condition for 
comparison against other measures which produce a single summary score. There has been progress 
in this direction with the 2015 valuation study of Craig et al (66). However, further studies using the 
summary score, based on the QALY scale, are needed before the results of Craig et al study can be 
adopted by the EuroQoL Group. 
6.1.3 Recommendations for use of the EQ-5D-Y outcome measure in economic valuations 
Children with a chronic health condition tend to under-report on the effect of limited functional ability 
on their HRQoL. This may lead to fewer resources being allocated to their health care. In this case, the 
use of proxy reports is advisable. The adult proxy is ultimately responsible for the child’s health care 
needs and has a broader outlook on which to base responses. 
 
The EQ-5D-Y was therefore found to be a useful instrument to measure HRQoL and its use is 
recommended in children with acute illness and, to a lesser extent, in those with chronic health 
conditions.  Routine use may result in more holistic care being delivered to these children as their 
perspective is taken into account in the planning of their own management. 
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APPENDICES 
Appendix 1: COSMIN checklist 
Properties that have been assessed in this study are marked with x 
A. Internal consistency x 
B. Reliability x 
C. Measurement error  x 
  
 
D. Content validity 
 
 (including face validity) o 
Construct validity 
 
     E. Structural validity x 
     F. Hypotheses testing x 
     G. Cross-cultural validity x 
H. Criterion validity x 
  
 
I. Responsiveness x 
  
 
J. Interpretability x 
A. Internal consistency    
Design requirements Yes No NA 
1. Was the percentage of missing items given?  
  
x 
2. Was there a description of how missing items were handled? x 
  
3. Was the sample size included in the analysis adequate?   x 
  
Statistical methods 
   
4. Was the Cronbach’s alpha calculated? x 
  
Reliability (including test-retest, intra- and inter-rater reliability) 
  Design requirements    
1. Was the percentage of missing items given?  
  
x 
2. Was there a description of how missing items were handled? x 
  
3. Was the sample size included in the analysis adequate?   x 
  
4. Were at least two measures available? x 
  
5. Were the administrations independent?  x 
  
6. Was the time interval stated? x 
  
7. Were the patients stable in the interim period for the construct being 
measured? 
x 
  
8. Was the time interval appropriate?  x 
  
9. Were the test conditions similar for both measurements? x 
  
Statistical methods 
   
10. Was the intraclass correlation coefficient (ICC) calculated, for 
continuous scores? 
x 
  
11. Was the kappa calculated for dichotomous scores? x 
  
B. Measurement error 
   
Design requirements and checks were the same as for reliability.    
Statistical methods 
   
1. Were limits of agreement assessed x 
  
D. Content validity (including face validity) 
   
Design requirements 
   
1. Was there an assessment of whether all items refer to relevant 
aspects of the construct being assessed? 
  x 
E. Structural validity 
   
Design requirements 
   
1. Does the scale consists of effective indicators? 
  
x 
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G. Cross-cultural validity 
   
Design requirements 
   
1. Were both the original language in which the HR- PRO instrument 
was developed and the language into which it was translated 
described? 
x 
  
2. Were the expertise of the persons translating the measure 
described? 
x   
3. Did the translators work independently from one another? x   
4. Were the items translate backwards and forwards? x 
  
5. Was there adequate description of how the differences between the 
original and translated were resolved? 
x   
6. Was the translation reviewed by a committee (i.e. original 
developer?) 
x   
7. Was the HR-PRO instrument pre-tested (cognitive interviews to check 
for interpretation, cultural relevance and ease of comprehension? 
x   
Statistical methods 
   
8. Was confirmatory factor analysis performed? 
 
x 
 
9. Was differential item function between language groups assessed? 
 
x  
H. Criterion validity 
   
Design requirements 
   
1. Can the criterion used be considered as a reasonable "gold standard" x   
G. Responsiveness 
   
Design requirements 
   
1. Was a longitudinal design of at least two measurements used? x 
 
 
2. Was the time interval stated? x 
  
3. If anything occurred in the interim period was it adequately 
described? 
x 
  
4. Was a portion of patients changed (improved or deteriorated)? x 
  
5. Were hypotheses about changes in score formulated a priori? x 
  
Statistical methods 
   
1. Were design and statistical methods adequate for the hypotheses to 
be tested? 
x   
Generalisability    
Was the sample for which the HR-PRO was evaluated adequately 
described in terms of: 
x   
1. Mean or median age with Std Dev and range? x   
2. Distribution of sex? x   
3. Important disease characteristics x   
4. Settings at which the study was conducted? x   
5. Language in which the instrument was evaluated? x   
7. Was the method used for selection of participants described? x   
8. Was the percentage of missing responses acceptable? x   
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Appendix 2 Specific health conditions 
Diagnosis Count 
Specific health conditions of MS participants 
 
Asthma 
 
3 
Asthma and Eczema 
 
1 
Attention Deficit Hyperactive Disorder 
 
1 
Developmental Coordination Disorder 
 
2 
Eyesight problems 
 
1 
High blood pressure 
 
1 
Sinusitis 
 
1 
Stomach ulcer 
 
1 
TOTAL 11 
Specific health conditions of participants at the SS 
 
Cerebral Palsy, cerebella ataxia 
 
1 
Cerebral Palsy, flaccid quadriplegic 
 
1 
Cerebral Palsy, right hemiplegic 
 
5 
Cerebral Palsy, spastic diplegic 
 
4 
Cerebral Palsy, spastic quad 
 
1 
Congenital Muscle Disease, centronuclear myopathy 
 
1 
Duchennes Muscular Dystrophy 
 
2 
Lymphatic venous malformation, Klippel-Trenaunay Syndrome 
 
1 
Osteogenesis Imperfecta 
 
1 
Paraplegia, acute ascending flaccid paralysis 
 
1 
Spastic paraparesis, congenital 1 
Spina Bifida, lumbar 
 
7 
Spina Bifida, sacral 
 
2 
Spinal Cord Injury C6-C7, incomplete 
 
1 
Spinal Cord Injury L2-L3, complete 
 
1 
Spinal Cord Injury T4-T6, complete 
 
1 
Spinal Muscular Atrophy- type 2 
 
4 
TOTAL 35 
Specific health conditions of participants at the chronic care facility 
 
Acute Lymphoblastic Leukaemia 
 
1 
Cerebral Palsy, spastic diplegia 
 
2 
Cerebral Palsy, spastic hemiplegia 
 
1 
Chronic lung disease, oxygen dependent 
 
1 
Diabetes mellitus, type 1 
 
8 
Epilepsy 
 
1 
Failure to Thrive 3 
Fanconi's Syndrome 
 
1 
Guillain–Barré Syndrome 
 
1 
Hepatitis 
 
1 
Human Immunodeficiency Virus (HIV) 
 
4 
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Human Immunodeficiency Virus (HIV) and Pulmonary Tuberculosis (PTB) 4 
Prada Willi Syndrome 
 
1 
Transverse Myelitis 
 
1 
Traumatic Brain Injury, ataxia 
 
1 
Tuberculous meningitis 
 
1 
TOTAL 32 
Specific health conditions of participants at the acute care facility 
 
Acute glomerulonephritis 1 
Acute Lymphoblastic Leukaemia 2 
Acute pancreatitis post fall 1 
Appendicitis, acute 6 
Appendix, perforated 1 
Arthritis, rheumatoid, right knee 1 
Arthritis, septic, ankle 1 
Arthritis, septic, knee 1 
Asthma 1 
Burkitts lymphoma 1 
Burn, flame 3 
Burn, hot water 2 
Cardiac arrest 1 
Cardiac, Mitral Valve Disease 1 
Cardiac, Tetralogy of Fallot 2 
Cardiac, Transposition of the Great Arteries, Ventricular Septal Defect, Patent Ductus Arteriosis 1 
Caustic soda injestion 1 
Complex seizure disorder 1 
Craniopharngioma 2 
Cyst, cervical spinal cord 1 
Dog bite, thigh 1 
Fractured neck of femur 1 
Fractured tibia with compartment syndrome 1 
Hepatitis 1 
Human Immunodeficiency Virus (HIV) 2 
Hypospadia 1 
Idiopathic abdominal P/D 1 
Motor Vehicle Accident, compound fracture left ankle with degloving of foot 1 
Motor Vehicle Accident, pelvic fracture, degloving of perineum 1 
Neurocystercicicosis 1 
Neuropathic bladder 1 
P/Dful left knee, post fall 1 
Parapneumonic effusion  1 
Pedestrian Vehicular Accident,ankle degloving 1 
Scoliosis, idiopathic 1 
Spina Bifida, sacral  1 
Tuberculosis of the hip 1 
Tumour, paraspinal T4-T8 1 
Tumour, post fossa 1 
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Tumour, supratentorial  1 
TOTAL 52 
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Appendix 3: Self designed contextual information sheet 
CONTEXTUAL INFORMATION REQUIRED FOR HRQoL RESEARCH 
Please complete section 7 BEFORE administering EQ-5D-Y to child. 
1. Date of 1st administration of EQ-5D-Y/survey 1:    year/month/day............................... 
2. Institution where survey was conducted, please circle appropriate one: 
Mainstream School - MS children               St. Joseph’s Home – CI 
Astra School – SS                                               RXH – AI                                      
3. Name of person conducting the survey: ................................................................................ 
 
4. Date of discharge:  year/month/day................................................................................... 
 
5. DEMOGRAPHICS 
Name of patient: ................................................................................................................................ 
Folder number (if available): ............................................................................................................... 
Date of birth:  year/month/date............................................................................................................ 
Age: ....................................................................................................................................................                                                        
Gender, please circle:                        male                         female 
Present level of education: ................................................................................................................: 
Date of admission to institution: year/month/day................................................................................ 
Full Diagnosis: Primary....................................................................................................................... 
                         Secondary................................................................................................................ 
5. HEALTH CHARACTERISTICS 
Reason for admission: 
.....................................................................................................................................................................
.....................................................................................................................................................................
.................................................................. 
Medication: 
.....................................................................................................................................................................
.....................................................................................................................................................................
.....................................................................................................................................................................
................................................................................................... 
Health status of child at 1st administration of EQ-5D-Y: 
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 Is child acutely ill    or    chronically ill? Please circle one 
 Does child use an assistive device and/or is confined to bed, please circle? 
Yes                                           No 
If yes, please circle one or more options? 
Confined to bed 
Motorised wheelchair                                         Self-propelled wheelchair 
Walking frame                                                    elbow crutches 
Axillary crutches                                                 Orthoses 
Catheterised: indwelling or self-catheterised 
Other, please specify: 
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6. EQ-5D-Y: NOTE: This section is only to be completed by therapist if the patient is   known to 
you. 
Please complete BEFORE administering the EQ-5D-Y to the patient. 
If patient is not known to you, continue with section 5.2 
 
 As the health professional how would you rate the child’s health status today with regard to the 
following, please tick one: 
Mobility? (walking about) 
Has no problems walking about  
Has some problems walking about  
Has a lot of problems walking about  
LAM? 
Has no problems washing or dressing self  
Has some problems washing or dressing self  
Has a lot of problems washing or dressing myself  
Doing UA? (for example, going to school, hobbies, sports,  
playing, doing things with family or friends) 
Has no problems doing UA  
Has some problems doing UA  
Has a lot of problems doing UA  
Having P/D? 
Has no P/D or discomfort  
Has some P/D or discomfort  
Has a lot of P/D or discomfort  
Feeling WSU? 
Is not WSU  
Is a bit WSU  
Is very WSU  
 
How would you rate the child’s health today, if 100 is the best 
health imaginable and 0 the worst health imaginable. 
Please mark with an X on the line to show how good or bad  
the child’s health is TODAY 
 
 
 
 
 
 
Best health  
10 
0 
20 
30 
40 
50 
60 
80 
70 
90 
100 
5 
15 
25 
35 
45 
55 
75 
65 
85 
95 
Worst health 
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7.  During the last two weeks has the child had to cut down on 
any of the things he/she usually does (for example at school 
or leisure) because of illness or injury? 
  Yes    No  
8. In the last two weeks has the child needed to see a doctor for any reason? (Excluding this 
admission, if hospitalised) 
 
 Yes    No  
 
9. Briefly describe general management of the health condition: 
MEDICAL MANAGEMENT  ................................................................................................................ 
.....................................................................................................................................................................
.....................................................................................................................................................................
.................................................................. 
SURGICAL MANAGEMENT..............................................................................................................  
.....................................................................................................................................................................
.....................................................................................................................................................................
.......................................................................................................................................... 
PALLIATIVE MANAGEMENT  ..........................................................................................................  
.....................................................................................................................................................................
.....................................................................................................................................................................
.................................................................. 
  
10. Does the child receive physiotherapy, please circle? 
Yes    No  
11. Has there been an occurrence of any life event related to the child or family in the 
preceding 6 months, such as a death in family, divorce, moving house, arrival of new baby, 
bullying at school etc.? 
Yes    No  
If yes, which of the above?  ............................................................................................................... 
......................................................................................................................................................... 
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12. Number of visits from family members since admission 
............................................................................................................................................................
............................................................................................................................................................ 
 
13. Does child go home for weekends, please circle? 
        Yes    No  
 
14. How long did it take the child to fill in the EQ-5D-Y form, in minutes? 
.....................................................................................................................................................................
................................................................................................................................................... 
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Health status at SECOND administration of EQ-5D-Y                    
Date: .............................. 
Changes in medication?: 
.....................................................................................................................................................................
.....................................................................................................................................................................
.......................................................................................................................................... 
15. Is child acutely ill    or    chronically ill? Please circle one 
16. Any change in assistive device since 1st survey, please circle? 
Yes                                                                        No 
17. (i) EQ-5D-Y: Only complete if child is known to you, before administering the form to child, 
otherwise continue with (ii). As the health professional how would you rate the child’s 
health status today with regard to the following, please tick one: 
 
Mobility? (walking about) 
Has no problems walking about  
Has some problems walking about  
Has a lot of problems walking about  
LAM? 
Has no problems washing or dressing self  
Has some problems washing or dressing self  
Has a lot of problems washing or dressing myself  
Doing UA? (for example, going to school, hobbies, sports, playing, doing 
things with family or friends) 
Has no problems doing UA  
Has some problems doing UA  
Has a lot of problems doing UA  
Having P/D? 
Has no P/D or discomfort  
Has some P/D or discomfort  
Has a lot of P/D or discomfort  
Feeling WSU? 
Is not WSU  
Is a bit WSU  
Is very WSU  
 
How would you rate the child’s health today, if 100 is the best 
health imaginable and 0 the worst health imaginable. Mark with 
an X.                    
Best health  
10 
0 
20 
30 
40 
50 
60 
80 
70 
90 
100 
5 
15 
25 
35 
45 
55 
75 
65 
85 
95 
Worst health 
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18. (ii) Since the 1st EQ-5D-Y has the child had to cut down on extra things he/she usually 
does 
 (for example at school or leisure) because of illness or injury? 
  Yes    No  
 
 Since the 1st EQ-5D-Y has the child needed to see a doctor for any reason? (Excluding 
this admission, if hospitalised) 
 
 Yes    No  
Briefly describe any changes in general management of the health condition: 
MEDICAL MANAGEMENT CHANGES: 
........................................................................................................................................................... 
.....................................................................................................................................................................
.....................................................................................................................................................................
..........SURGICAL MANAGEMENT CHANGES:  
............................................................................................................................................................  
.....................................................................................................................................................................
.....................................................................................................................................................................
.......... 
Does the child receive physiotherapy, please circle? 
Yes    No  
Has there been an occurrence of any life event related to the child or family since 1st EQ-5D-Y, such 
as a death in family, divorce, moving house, arrival of new baby, bullying at school etc.? 
Yes    No  
If yes, which of the above? ............................................................................................................... 
......................................................................................................................................................... 
 
Number of visits from family members since 1st EQ-5D-Y  
............................................................................................................................................................
............................................................................................................................................................ 
Does child go home for weekends, please circle? 
        Yes    No 
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How long did it take the child to fill in the 2nd EQ-5D-Y form, in minutes? 
.....................................................................................................................................................................
................................................................................................................................................... 
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Appendix 4: Feasibility and usefulness questionnaire  
Questionnaire on feasibility and utility of including the EQ-5D-Y form in routine assessments 
Thank you for taking the time to provide your input, by completing this questionnaire. 
Name of facility at which you are a physiotherapist   .............................................................................. 
Question 1:  How easy was it to implement the EQ-5D-Y measure in an assessment of a child? 
• Please circle one option or make a cross next to choice:     
Very easy      Moderately easy 
Difficult        Did not use on a child 
• If moderately easy or difficult, was this due to time: (please tick appropriate box/es) 
Time constraints  
Lack of resources  
Language barrier  
Lack of understanding on the child’s part  
IF YOU ADMINISTERED THE EQ-5D-Y TO A CHILD, PLEASE CONTINUE WITH ALL QUESTIONS 
IF YOU ONLY COMPLETED A PROXY MEASURE i.e. FILLED IN THE FORM IN THE CONTEXTUAL INFO AS 
YOU WOULD EXPECT THE CHILD TO, THEN PROCEED TO QUESTION 4 
Question 2:  If you administered form to a child did the child generally encounter problems with 
completing the form? 
• Please indicate response by circling:              YES                   or                        NO 
 
• If YES, which age group had difficulties? Please tick appropriate box 
  8 year olds              
  9 year olds  
10 year olds  
11 year olds  
12 year olds  
 
• If YES, in which domain/s did they have difficulties and/or with VAS? 
Mobility  
LAM  
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Doing UA  
P/D  
WSU  
VAS  
 
Question 3: Did you notice a relationship between child’s responses on the EQ-5D-Y form and clinical 
signs and symptoms? 
• Please indicate response by circling              YES                   or                        NO 
• If YES, in which dimension/dimensions in which you observed a close link to clinical signs and 
symptoms 
Mobility  
LAM  
UA  
P/D   
WSU  
VAS  
 
TO BE COMPLETED BY ALL 
Question 4: Whether you administered a form to a child or filled in a proxy, do you think using the 
outcome measure routinely during patient assessment might assist your planning of the management 
of the child? 
• Please indicate response by circling              YES                   or                        NO 
 Question 5: Do you feel that any information from a specific domain and/or VAS is the most useful? 
Please indicate response by circling              YES                   or                        NO 
• If YES, which domain/domains/VAS were most useful 
Mobility  
LAM  
UA  
P/D   
WSU  
VAS  
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Question 7:  Will the EQ-5D-Y provide you with additional information on the child’s health status? 
• Please indicate response by circling              YES       or        NO 
 
• If  YES, indicate which domain/s/VAS provided new information 
Mobility  
LAM  
UA  
P/D  
WSU  
VAS  
Question 8: Would you continue to include the EQ-5D-Y as part of your patient assessment in future? 
• Please indicate response by circling              YES                   or                        NO 
 
Thank you for participating in the study and for completing the questionnaire. 
You will be informed of the results 
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Appendix 5: Translation process 
Report on the linguistic validation process in translating PedsQL4.0, Generic-Core-Child and Generic-
Core-Parent Proxy, from English into Afrikaans and isiXhosa 
The PedsQL questionnaire was developed in United States English and consists of instructions, items 
being investigated and response choices. When translating it into another language, a linguistic 
validation process is necessary to ensure that the original concept is maintained, so that the meaning 
and content of the translated version is no different to the original version. The translated version 
however must be easily understood by the population it is being translated for. When translating text, 
the translator has to be familiar with both languages in order to first read the text and mentally 
paraphrase it into comprehensible chunks. The next step is to work out how the words and phrases 
relate to one another and then determine the accurate meaning from the context. Finally the 
translator has to figure out how to capture that contextual meaning in the other language. 
Before translating the PedsQL into Afrikaans and isiXhosa, two of the most common languages spoken 
in the Western Cape, apart from English, a Translation Agreement was entered into between the 
researcher, who was the user of the instrument and MAPI Research Trust, acting on behalf of Dr. 
James W. Varni, the copyright owner in the PedsQL (Error! Reference source not found.. Authorization 
was granted to the researcher to translate the English PedsQL into these two languages, for use in 
South Africa subject to the following conditions, all of which were acknowledged and adhered to: 
“1. Dr. James W. Varni owns all copyright in the PedsQL and in all PedsQL versions including but not 
limited to existing and future translations of the PedsQL.  
2. The researcher acknowledges Dr. James W. Varni’s copyright in the PedsQL and shall not contest 
such copyright or perform any act or omission adverse to such exclusive right. Further the researcher 
acknowledges that Dr. James W. Varni holds the unfettered right to use, reproduce and exploit the 
aforesaid translation(s), throughout the world, for its full term without any cost or conditions.  
3. The researcher agreed to the new translation undergoing a full linguistic validation process 
according to guidelines and recommendations that have been established in collaboration with Dr. 
James W. Varni as to the process to be followed in order to obtain a conceptually equivalent 
translation.”  
The following recommended methodological steps were followed: 
• Forward translation 
• Backward translation 
• Patient testing 
• Proofreading and finalization 
• Report 
 
The researcher agreed to translate both the child self-report and parent proxy-report PedsQL 4.0 
Generic Core Scales for 8-12 year olds. The reason for this was that the PedsQL 4.0 Generic Core Scales 
use parallel child self-report and parent proxy-report forms, therefore any translations needed to 
include both child and parent proxy forms for the same age-group.  
Procedure: 
The researcher sourced local professional language translators from a database of freelance language 
service providers, used by the Department of Cultural Affairs & Sport, Western Cape Government. 
Method: 
Phase 1: Forward translation process 
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For this process, two translators’ bilingual in Afrikaans and English and two isiXhosa and English 
bilingual translators, were each independently given the original US English version of the PedsQL 4.0 
Generic Core Child and PedsQL4.0 Generic Core Parent-Proxy, to translate into their respective native 
languages. They were required to independently produce a forward translation of the original items, 
instructions and response choices, of the above mentioned forms. The translators all listed their field 
of expertise in Health, Education or Medical and had more than 10 years’ experience in translating. 
After a discussion between both translators and the researcher, a single reconciled version of each 
language, namely an Afrikaans reconciled version and an isiXhosa reconciled version of the PedsQL 
Child-Report and PedsQL Parent-Proxy-Report was produced.  
Forward translation process of Afrikaans version: 
The researcher being familiar with the Afrikaans language could compare the two Afrikaans versions 
and found them to be similar in language use. Afrikaans does not have the continuous tense form so 
some accommodations had to be made for this grammatical issue. Some discrepancies were however 
noticed. Translator 1 had clear, specific instructions and response choice words were easier to 
understand and closer to the original meaning. However the wording of task items was complicated 
with pronouns often being left out. Translator 2 had simpler wording of task items, closer to the 
original meaning, but cumbersome wording of response choices.  
The following issues were discussed between the researcher and the two translators: 
On page one of both forms, it was agreed upon to use the shorter “kinderverslag” rather than “verslag 
van kinders”, as they mean the same thing but “kinderverslag” is closer in meaning to the English 
“child report”. 
The word “aanwysings” has two meanings either “directions” or “instructions”, so it was considered 
suitable. 
It was decided by all that “Lewenskwaliteit” “Quality of Life” should be kept instead of 
“Lewensgehalte”, as they mean the same thing, but “Lewenskwaliteit” is slightly closer to the original 
meaning. 
In the instructions block, it was decided to use the same word “byna”, meaning “almost” instead of 
introducing a new word  “amper” (also meaning “almost”) to be consistent. 
On the items page, the word “moeilik” was kept as a translation of “hard” as the direct Afrikaans 
translation of “hard” would imply ‘ firm’ or ‘not yielding to pressure’, which has a different contextual 
meaning. 
The word “rondom die huis” was inserted to keep to the orginal “around the house” 
Translator 2 used the word “sukkel met…” to describe “trouble with…”, whereas translator 1 kept to 
the word for “difficult” being “moeilik”. It was decided by all to use the word “sukkel met…” as a 
translation for “trouble with…” as it was closer to the original contextual meaning of the word. 
Following the discussions a combined reconciled version, Afrikaans Version 1 was agreed on, taking 
the best wording from each translation, while aiming for a version as close to the original one as 
possible. 
Forward translation process of isiXhosa version: 
The linguistic process of translating the forms into isiXhosa was challenging as the researcher did not 
have an adequate understanding of the language and had to rely solely on the abilities of the 
translators. The Xhosa language, or isiXhosa, is spoken predominantly in the Eastern Cape province of 
South Africa and for numerous historical, social, and political reasons, it is not often used in natural 
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language processing (NLP) research (Xhosa-English Machine Translation: Working with a Low-Resource 
Language. A report by Kristine K. Johnson kkjohnson@wesleyan.edu Summer 2011).ref As a result one 
of the major issues in translating the language is that it is that there are very few available language 
resources such as dictionaries or morphological analysers to determine the internal structure of the 
words.  There is no well-researched, carefully compiled collection of written parallel Xhosa and English 
text. One has to rely on the expertise of the translators. 
In English, there are several ways of expressing the present tense, but not so in isiXhosa. For example: 
I have a problem with…. / I am having a problem with…. / I do have a problem with ….  would all be 
translated using the same isiXhosa words. 
There is also no grammatical gender in isiXhosa. For example, u- represents both him and her, or you. 
There are no different pronouns for different sexes.  Also, ndi- which means I and u- which means you 
are not separate words which can stand on their own, as in English. They are always attached to the 
verb and they are an equivalent of the English pronoun. 
Many isiXhosa phrases have more than one meaning: the literal or obvious one and a figurative or 
symbolic one. Often the arrangement of words in isiXhosa cannot be translated literally or directly into 
English and remain meaningful as the example “difficulty in walking one block” – the literal translation 
resulted in “difficulty in walking on top of a block”. There is no equivalent for the distance 
measurement of one block in isiXhosa; therefore the wording had to be changed to “difficulty in 
walking a short distance between houses”. 
Additionally, isiXhosa is a morphologically rich language using a variety of affixes to modify or form a 
new word. Therefore when attempting to translate a word into isiXhosa or back from isiXhosa into 
English, different forms of the word may be used and still mean the same thing. This became evident 
after the researcher received what looked like two quite different forward translations of the same 
form. After discussion with the translators it became clear that both versions of the forward 
translation were contextually equivalent.  
A reconciled version 1 in isiXhosa was agreed upon after these discussions, using the most 
contextually accurate phrases and phrases that would be used more extensively by isiXhosa speaking 
people. 
Phase 2: Backward translation process 
The backward translation process involved translating the first reconciled version of the Afrikaans and 
isiXhosa translations back into English. A third translator, bilingual in both Afrikaans/isiXhosa and 
English was approached and asked to translate the forms back into English, without have access to the 
original English version. 
The backward translation of the Afrikaans version was then compared with the original English 
version to determine whether there were any miss-interpretations or misunderstandings in the 
forward translated version. In the backward translation some words were different from the original 
English word, but have the equivalent contextual meaning. These words are: 
Original English version                                                                        Afrikaans backward translated version 
 
“hard to…”                                                                                              “difficult to…” 
“chores” “tasks” 
“ache” “P/D” 
“low energy”      “little energy” 
“blue” “depressed” 
“trouble” “struggle” 
“kids” “children” 
“miss school” absent from school” 
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After discussions with the backwards translator, version 2 of the questionnaires was decided on 
 
The backward translation of the isiXhosa version was compared with the original English version for 
comparison of items, instructions and response choices. In the backward translation some phrases 
were different from the original English version, but were considered to be the best contextual fit.  
Original English version                                                                        isiXhosa backward translated version 
 
“hard to…”                                                                                              “difficult to…”
“difficulty in walking one block” difficulty in walking a short distance between houses” 
“ache” “P/D” 
“low energy”       “I lack energy” 
“sad or blue” “depressed” 
“trouble” “difficulty” 
“kids” “children” 
“It is hard to keep up when I play with other 
kids” 
“It is difficult to follow when I am playing with other 
children”      
“It is hard to pay attention in the classroom”         “I can't be attentive in the classroom”      
“I have trouble keeping up with my school 
work” 
“I have problems with doing my schoolwork” 
 
After discussions with the backward translator, version 2 of the isiXhosa questionnaires was decided 
on. 
Report: 
At this stage before the translated versions were tested on participants a report with comments was 
sent to Dr. James Varni, at Mapi Research  www.mapigroup.com | www.mapi-trust.org for author’s 
feedback.  
On review the following comments were made: 
1. “Depressed” in both the Afrikaans and isiXhosa languages was too strong. “I feel sad” for self-report 
or “Feels sad” for parent proxy-report would be better. “Blue” should not be translated since it is 
culturally specific to the US. 
2. “No energy” or “lack of energy” in the isiXhosa version was too strong. “I feel tired” for self-report 
or “Feels tired” for parent proxy-report should be used if “low energy” was not possible.  
The translator made the changes and cognitive interviewing took place on five Afrikaans and five 
isiXhosa speaking children between the age of eight and twelve years. 
 Cognitive interviews: 
All five Afrikaans speaking participants ranging from eight to twelve years easily understood the form 
and could complete it.  
However it was discovered that even though the isiXhosa children spoke their home language fluently, 
most of them could not read isiXhosa as they attended English or Afrikaans speaking schools and had 
learnt to read in one of these languages. It was possible to find five children who attended an isiXhosa 
school could read isiXhosa and the form was tested on them. They also easily understood the form 
and could complete it without difficulty. The forms were proof read and finalised. A final report was 
submitted to Dr Varni. 
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Conclusion: 
The translated PedsQL forms were considered appropriate for the research participants. 
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Appendix 6: EQ-5D-Y, South African English version 
 
 
NAME OF CHILD : 
 
 
DATE OF ADMINISTRATION OF FORM : 
 
 
 
 
 
 
 
 
 
 
Health Questionnaire 
 
 
English version for South Africa 
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EQ-5D-Y 
Describing your health TODAY 
 
Under each heading, please tick the ONE box that best describes your health TODAY 
Mobility (walking about) 
I have no problems walking about  
I have some problems walking about  
I have a lot of problems walking about  
 
Looking After Myself 
I have no problems washing or dressing myself  
I have some problems washing or dressing myself  
I have a lot of problems washing or dressing myself  
 
Doing Usual Activities (for example, going to school, hobbies, sports, playing, 
doing things with family or friends) 
I have no problems doing my usual activities  
I have some problems doing my usual activities   
I have a lot of problems doing my usual activities   
 
Having Pain or Discomfort 
I have pain or discomfort  
I have some pain or discomfort  
I have a lot of pain or discomfort  
 
Feeling Worried, Sad or Unhappy 
I am not worried, sad or unhappy   
I am a bit worried, sad or unhappy   
I am very worried, sad or unhappy   
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How good is your health TODAY 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 We would like to know how good or bad your health  
is TODAY. 
 This line is numbered from 0 to 100. 
 100 means the best health you can imagine. 
0 means the worst health you can imagine. 
 Please mark with an X on the line to show how good or bad  
your health is TODAY. 
 
 
 
 
 
 
The best health 
you can imagine 
10 
0 
20 
30 
40 
50 
60 
80 
70 
90 
100 
5 
15 
25 
35 
45 
55 
75 
65 
85 
95 
The worst health 
you can imagine 
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Appendix 7: Registration of research study with EuroQoL Group 
 
 
 
EQ-5D Registration Form 
Dear Des,  
Thank you for registering your study/trial/project or other at the EuroQol website.  You sent us the 
following information: 
Job title: Clinical Educator 
First name: Des 
Surname: Scott 
Organization: University of Cape Town 
Postal address: Faculty of Health Sciences, Department of Health and Rehabilitation Sciences, 
Physiotherapy Division, F45 Old Main Building, Groote Schuur Hospital, Observatory 
Postal/Zip code: 7935 
City: Cape Town 
Country: ZA 
Telephone: +27839498333 
E-mail: des.scott@uct.ac.za 
Work environment: Academia 
Title / Description of your study, trial, project or other: The association between Health Related 
Quality of Life, health condition and function in South African children. 
Objective: The overall aim of the study is investigate the HRQoL in children with a health 
condition and to determine associations between different health conditions, with regard to 
function and P/D. The ability of EQ-5D-Y measure to detect change in these children (between 8-12 
years) within different contexts over a 7 month period will be assessed. The feasibility of the data 
collection process, using the EQ-5D-Y will be monitored, as well as examining how useful the 
collected data are to the therapists. 
Design: Other 
Other design: A longitudinal, descriptive, analytical observational cohort study 
Clinical area: Physiotherapy 
Other clinical area: Paediatric HRQoL 
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Source of funding: The EuroQol Group Foundation 
Number of patients / respondents: 240 
Starting date (year only): 2013 
Finishing date (year only): 2015 
Which version of the EQ-5D would you like to use?  EQ-5D-Y Paper (Youth version: 7-12 years) 
Countries: South Africa 
Languages: English (South Africa), Xhosa (South Africa), Sesotho (South Africa), Zulu (South 
Africa), Afrikaans (South Africa) 
Which other generic health measures will you use? PedsQol, Faces Pain Scale, WeeFIM 
Which other disease / condition specific health measures will you use? None 
Are you prepared to have this information published in any EuroQol reports/surveys regarding 
usage of EQ-5D? Yes 
Are you prepared to have your details made available to colleagues who are involved in research in 
a similar area? Yes 
Terms of use: I agree with the Terms of use √ 
 
Copyright © 2013 EuroQol Group By internet agency Redkiwi | Design Sphere Design  
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Appendix 8: EQ-5D-Y Proxy version 2 
 
NAME OF PARENT : 
 
NAME OF CHILD : 
 
 
DATE WHEN COMPLETING FORM : 
 
 
 
 
 
 
 
 
 
 
 
Health Questionnaire 
 
 
English version for South Africa 
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EQ-5D-Y 
 
Describing your child’s health TODAY 
Under each heading, please tick the ONE box that best describes your child’s health TODAY 
 
Mobility (walking about) 
I have no problems walking about  
I have some problems walking about  
I have a lot of problems walking about  
 
Looking After Myself 
I have no problems washing or dressing myself  
I have some problems washing or dressing myself  
I have a lot of problems washing or dressing myself  
 
Doing Usual Activities (for example, going to school, hobbies, 
sports, playing, doing things with family or friends) 
I have no problems doing my usual activities  
I have some problems doing my usual activities   
I have a lot of problems doing my usual activities   
 
Having Pain or Discomfort 
I have no pain or discomfort  
I have some pain or discomfort  
I have a lot of pain or discomfort  
 
Feeling Worried, Sad or Unhappy 
I am not worried, sad or unhappy   
I am a bit worried, sad or unhappy   
I am very worried, sad or unhappy   
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How good is your child’s health 
TODAY 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
We would like to know how good or bad your child’s 
health  
is TODAY. 
This line is numbered from 0 to 100. 
100 means the best health you can imagine for your child. 
0 means the worst health you can imagine for your 
child. 
Please mark with an X on the line to show how good or bad  
your child’s health is TODAY. 
The best health 
you can imagine 
for your child 
10 
0 
20 
30 
40 
50 
60 
80 
70 
90 
100 
5 
15 
25 
35 
45 
55 
75 
65 
85 
95 
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Appendix 9: PedsQL4.0 English version 
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Appendix 10: PedsQL user agreement 
                                                                                                                                                                                          
 
USER-AGREEMENT 
 
 
Use of the PedsQL 4.0 Generic Core Scales, Modules and Translations 
 
 
Date : 31/07/2013 
 day month year 
 
PART 1. LICENSEE’S DETAILS 
LICENSEE Name: Please have the information type written   Des Scott ...................................................  
LICENSEE Title:   Mrs...................................................................................................................................  
Company :  University of Cape Town ............................................................................................................  
Address : Faculty of Health Sciences ....................................................................................................  
  PBag X3 .................................................................................................................................  
  Observatory, 7935 ................................................................................................................  
Country : South Africa ..........................................................................................................................  
Phone : +27214066401 / 6428..................................  Fax :+27214066323 ..........................................  
Email : des.scott@uct.ac.za .....................................  ...........................................................................  
VAT number (if applicable):  ....................................................  ...........................................................................  
2. CONTEXT OF PEDSQL USE  
1.  Individual clinical practice  X  (please go directly to section 4) 
 
- Expected duration of use:  Indefinite  or Number of years _________   
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2.  Mode of administration X  Paper  
      Electronic version 
 
If electronic administration, please precise the type of medium: 
     - PDA   - Web-based    
- CDr / DVD   - OtherX  (please precise):..IPAD................... 
  
3.  Research study X    
Title: The association between Health Related Quality of Life, health condition and function in South 
African children. 
Disease or disorder:_Multiple disorders, from acute illness e.g. pneumonia to chronic conditions such as 
spina bifida________________ 
 Type of research:  
 clinical trial - Phase II  / Phase III   
 epidemiologic/observational  
 X other: longitudinal, descriptive, analytical observational cohort study ..........................  
 PedsQL used as primary end point: yes X no  
 Number of expected patients (total): 240 
 Number of administrations of the questionnaire per patient: 3 
 Length of the follow-up (if any) for each patient:    7 
 Planned study date: start 01 2014 end 07     2014 
         
 
 
3. PROJECT FINANCING 
 Not funded academic research   
Not funded academic research: if your project is not explicitly funded,  
but funding comes from overall departmental funds or from the University or  
individual funds then fees are waived. 
 Funded academic research  X 
Funded academic research: academic projects receiving funding from 
commerce, government, EU or registered charity should anticipate 
paying the corresponding fees 
 
months 
month/year month/year 
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Note: Funded academic research sponsored by industry fits 
"commercial study" category 
 Large non-commercial organization Research and Evaluation   
(per-study license) 
Large non-commercial organization Research and Evaluation; e.g. states, nations, 
hospitals, healthcare systems (includes an important number of patients and/or centres) 
 
 Large non-commercial organization Unlimited Research and Evaluation and clinical use   
(annual license, unlimited use)   
Large non-commercial organization Research and Evaluation; e.g. states, nations, 
hospitals, healthcare systems (includes an important number of patients and/or centres) 
Please specify number of centres------------------------------------------ 
 Commercial study    
Commercial studies (industry, CRO, any for-profit companies) 
Please specify number of centres------------------------------------------ 
 
Granting / Sponsoring from (if any) (name of the governmental/foundation/company or other 
funding/sponsoring source): EuroQol Foundation .................................................................................................  
4. REQUESTED PEDSQL™ SCALES (please tick the appropriate box(es)) 
  
PedsQL Generic Core Scales           Please specify:  Standard  X   Acute     Both   
 
Adult 
 (over 26) 
Young Adult  
(18-25) 
Adolescent  
(13-18) 
Child 
(8-12) 
Young Child  
(5-7) 
Toddler  
(2-4) 
Self-report 
Parent 
proxy- 
report 
Self-
report 
Parent 
proxy- 
report 
Child self-
report 
Parent 
proxy- 
report 
Child self-
report 
Parent 
proxy- 
report 
Child self-
report 
Parent 
proxy- 
report 
Parent 
proxy- 
report 
      X      
 
 
5. TRANSLATIONS 
Please indicate in which language(s) and for which country(ies) the above requested PedsQL scale(s) is/are 
needed:  
Language: For use in the 
following country 
Language: For use in the 
following country 
Language: For use in the 
following country 
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e.g. English USA     
e.g. Spanish USA     
ENGLISH SOUTH AFRICA     
AFRIKAANS SOUTH AFRICA     
isiXHOSA SOUTH AFRICA     
The PedsQL translation(s) may not be available in the country required. Please check availability of 
translations with Mapi Research TRUST or consult the PedsQL  website at www.pedsql.org section 
“Translations”.  
If not available in the language(s) required, a Linguistic Validation must be undergone. 
USER AGREEMENT 
This agreement is between Mapi Research Trust and   Des Scott ............................................................................... ("user"). 
Mapi Research Trust shall deliver the original PedsQL and/or the translations requested by “User” subject to the 
following conditions: 
 The translations requested are available, and 
 The present contract is duly completed and signed by “User” 
The use of the PedsQL in the above mentioned context is subject to the following conditions: 
1.This user agreement is for the use of the PedsQL, i.e., the PedsQL  Pediatric Quality of Life Inventory 
report forms, registered copyrights in the PedsQL  (e.g., U.S. copyright registration No. TXu 856-101) and related 
treaty, convention and common law rights pertaining thereto, with all rights reserved to Dr. James W. Varni, 
licensor and author of the PedsQL . 
IN WITNESS WHEREOF, the parties hereto have caused this agreement to be executed by their duly authorised representatives 
as of the date first above written. 
AGREED 
User’s Signature:  
Title: Mrs __________________________________________  
Company/Organisation: University of Cape Town __________  
Date: 31/07/2013 ________________________________  
Company/Organisation Stamp (if applicable): 
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Appendix 11: WeeFIM measure 
FIM™ score sheet LTCS FIM score sheet Feb 08 FIM is a non-registered trademark of Uniform Data 
System for Medical Rehabilitation, a division of UB Foundation Activities, Inc. AROC (the Australasian 
Rehabilitation Outcomes Centre) holds the territorial licence for the FIM in Australia. 
  
FIM™ score sheet                                        
                                                                                                                                                                                                                                                                                    
Name: Date of birth:  
Date of assessment:  
Hospital/unit:  
Method of administration: Direct observation Interview with:  
* Injury: TBI Multiple 
amputations Burns (Note FIM 
is not required for SCI or 
blindness) Area  
Score  Explain reasons for giving this score *Due to 
injury? 
SELF CARE  
1.Eating    Yes  
No  
2.Grooming    Yes  
No  
3.Bathing    Yes  
No  
4.Dressing– Upper    Yes  
No  
5.Dressing– Lower    Yes  
No  
6.Toileting    Yes  
No  
7.Bladder    Yes  
No  
8.Bowel    Yes  
No  
Self care total  
MOBILITY  
9.Transfers: Bed/ 
Chair/Wheelchair  
 Mode: W– Walk C- Wheelchair B- Both  Yes  
No  
10.Transfers: Toilet   Yes  
No  
11.Transfers: Bath/Shower    Yes  
No  
12.Walk/ Wheelchair    Yes  
No  
13.Stairs   Yes 
No 
Mobility total 
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COMMUNICATION 
14.Comprehension  Mode: A – Auditory V - Visual C - Both Yes 
No 
15.Expression  Mode: V – Vocal N - Non-vocal B - Both Yes 
No 
SOCIAL COGNITION 
16.Social 
interaction 
  Yes 
No 
17.Problem solving   Yes 
No 
18.Memory   Yes 
No 
Cognition total 
FIM total 
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Appendix 12: WeeFIM research agreement  
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Appendix 13: Faces Pain Scale 
Faces Pain Scale – Revised (FPS-R) 
In the following instructions, say "hurt" or "pain," whichever seems right for a particular child. 
"These faces show how much something can hurt. This face [point to left-most face] shows no pain. 
The faces show more and more pain [point to each from left to right] up to this one [point to right-
most face] - it shows very much pain.  
Point to the face that shows how much you hurt [right now]." 
 
Score the chosen face 0, 2, 4, 6, 8, or 10, counting left to right, so '0' = 'no P/D' and '10' = 'very much 
P/D.' Do not use words like 'happy' and 'sad'. This scale is intended to measure how children feel inside, 
not how their face looks. 
 
Permission for Use. Copyright of the FPS-R is held by the International Association for the Study of P/D 
(IASP) ©2001. This material may be photocopied for non-commercial clinical, educational, 
and research use. For reproduction of the FPS-R in a journal, book, or web page, or for any commercial 
use of the scale, request permission from IASP online at www.iasp-P/D.org/FPS-R. 
Sources. Hicks CL, von Baeyer CL, Spafford P, van Korlaar I, Goodenough B. The Faces Pain Scale – 
Revised: Toward a common metric in pediatric P/D measurement. P/D 2001;93:173-183. Bieri D, 
Reeve R, Champion GD, Addicoat L, Ziegler J. The Faces Pain Scale for the self-assessment of the 
severity of P/D experienced by children: Development, initial validation and preliminary 
investigation for ratio scale properties. P/D 1990;41:139-150. 
(fold along dotted line) 
 
………………………………………………………………………………………………………………………………….. 
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Appendix 14: Pilot study 
Aim of Study: 
The overall aim of the pilot study was to investigate the reliability of the primary outcome measure, 
EQ-5D-Y, on a sample of children between 8-12 years, in the same contexts as the main study.  
Specific objectives: 
The specific objectives of the pilot study were to: 
 Establish test-retest reliability of the EQ-5D-Y in children with a health condition and MS 
children by re-administering the measure the day after the initial assessment. 
 Determine the feasibility of administering the EQ-5-D-Y by assessing the time taken by the 
children to complete the form.  
 Determine the usefulness of obtaining contextual information from the medical files by 
assessing some of the demographic and medical information of participants. 
 
Participants: 
A sample of convenience of 40 children fulfilling the inclusion criteria of the main study and with 
parents readily available to sign consent, were selected. Two children, one from the SS and one from 
the CI were absent on the retest day, leaving a total of 38 participants.  
Research settings:  
All four institutions at which the main study would take place i.e. the mainstream school for MS (MS) 
children, the SS, the CI and the acute care hospital were included in the pilot study. 
Methodology 
Research design: 
A descriptive, analytical study design was used. 
Permission and recruitment:  
Permission to perform the study was obtained from the Faculty of Health Sciences Human Research 
Ethics Committee (HREC REF: 354/2013) (Appendix 15). Following this, approval from all the 
institutions at which the study took place was obtained. Children eligible for recruitment into the pilot 
study were then identified by the clinical physiotherapist at the various facilities. 
A parent of each child was asked to sign an informed consent form and the children were asked to sign 
an assent form, after the purpose of the study had been explained to them. Clinical physiotherapists 
interested in assisting with data collection signed a consent form and obtained parental consent from 
the children at the institutions’, parents. This was performed by the researcher at the mainstream 
school. 
 
Participant’s inclusion criteria:  
Approximately ten children from each institution with stable vital signs were recruited and only 
children who were willing and returned a signed consent form from a parent were included. Children 
absent on the day of retest were excluded.  
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Instrumentation: 
The primary outcome measure of the main study, EQ-5D-Y, was used. 
Time taken to complete the questionnaire was recorded 
Demographic information obtained from medical files was recorded on a contextual information 
sheet, drawn up the researcher. 
 
Procedure 
The clinical physiotherapists were instructed on the use of the EQ-5D-Y and administered it to the 
identified children on day one. They recorded how long each child took to complete the form. 
Additional demographic information was also recorded on a contextual information sheet.  
The measure was repeated the following day at all facilities. 
Ethical considerations: 
The same ethical considerations for informed consent, beneficence/ non-malfeasance, confidentiality 
and privacy which were taken for the main study were also taken in the pilot study. 
Data analysis: 
Descriptive statistics were used to describe the demographics of the participants and how long they 
took to complete the form. Frequency tables indicated how many participants were drawn from each 
institution and how many were diagnosed with a specific health condition.  
 To determine the test-retest reliability of the EQ-5D-Y in the pilot study: 
 Test-retest reliability for the individual items of the EQ-5D-Y was tested by calculating Cohen’s 
kappa coefficient to establish consistency between test and retest scores for each item. 
 The correlation coefficient (ICC) for the total EQ-5D-Y score between test and retest was used 
to determine the strength of concordance between scores. 
 The same was done for the first and second VAS score.  
 
Results 
Demographic and medical conditions of the participants: 
There were 38 children who participated in the pilot study, 21 of whom were female and 38 were 
male. The institutions from which they were drawn are listed in Pilot study table 2 and their 
educational grade in Pilot study table 3 
 
Pilot study table: 1: Institutions from which the participants came (n=38) 
 Count Percent 
MS  9 23.7 
SS 5 13.2 
CI 9 23.7 
AI 15 39.5 
Total 38 100 
  
There were more children drawn from the AI and from Grade 5 than from the other grades. 
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Pilot study table: 2: Level of education (grade) of participants (n=38) 
Grade Count Percent 
2 2 5.3 
3 6 15.8 
4 5 13.2 
5 16 42.1 
6 6 15.8 
7 3 7.9 
Total 38 100 
 
The range of primary diagnoses of the participants are recorded in Pilot study table 4 
Pilot study table: 3: Primary diagnosis of participants (n=38)  
 
Count Percent 
Hodgkins lymphoma 1 2.6 
Diabetes Mellitus 3 7.9 
Transverse Myelitis 1 2.6 
Acute lymphoblastic leukemia 1 2.6 
HIV+ve 2 5.3 
Autoimmune hepatitis 1 2.6 
Spinal muscular atrophy 1 2.6 
Lymphatic venous malformation R foot 1 2.6 
Spinal cord injury, MVA 1 2.6 
Duchennes Muscular Dystrophy 2 5.3 
MS 9 23.7 
Burn 1 2.6 
Caustic ingestion 1 2.6 
Pneumonia meningitis 1 2.6 
Congenital heart defect 1 2.6 
Caustic ingestion at 18mnths 1 2.6 
Burkitts lymphoma 1 2.6 
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Appendectomy 1 2.6 
Rheumatic fever 1 2.6 
traumatic eye injury 1 2.6 
PVA 2 5.3 
Sclerosing cholangitis 1 2.6 
bowel obstruction 1 2.6 
Menstrual P/D, vomiting 1 2.6 
Spina bifida 1 2.6 
Missing 0 0.0 
 
First test and second re-test scores of EQ-5D-Y 
The scores for each item of the EQ-5D-Y in the first (test) and second (retest) assessments are shown 
in Pilot study table 5. 
Pilot study table: 4: First and second EQ-5D-Y dimension scores (n=38)  
Mobility Second 
assessment 
No 
proble
ms 
Some 
problems 
Lots of 
problem
s 
Row 
total 
Kappa App p 
First assessment              
No problems 
  
20 4 1 25 0.546 p<.001  
Some Problems 
 
1 4 0 5     
     Lots of problems 
 
1 2 4 7     
Totals  22 10 5 37     
LAM Second 
assessment 
            
First assessment               
No problems 
  
25 0 0 25 0.653 p<.001 
Some Problems 
  
3 6 0 9     
Lots of problems 
  
1 2 1 4     
Totals   29 8 1 38     
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UA Second 
assessment 
            
First assessment               
No problems 
  
19 3 3 25 0.199 p<.127 
Some Problems 
  
6 4 1 11     
Lots of problems 
  
0 2 0 2     
Totals   25 9 4 38     
P/D Second 
assessment 
            
First assessment             
  
No problems 
  
15 3      18   0.365 p<.0.08 
Some Problems 
  
6 9 15     
  
Lots of problems 
  
2 2 4     
  
Totals   23 14 37       
Worried Second 
assessment 
            
First assessment           0.551 p<.001 
No problems   18 2 0 20 
  
  
Some Problems   4 10 0 14 
  
  
Lots of problems   1 1 1 3 
  
  
Totals   23 13 1 37     
 
The intraclass correlation (ICC) for absolute agreement for single measures for summed dimension 
scores (total score/misery index) was 0.662 (95% Confidence intervals (CIs) =0.437-0.809) which 
indicates good agreement between the two scores 
The mean scores on the VAS were 75.8(SD=27.9) and 72.3 (SD=30) for the first and second 
assessments respectively.  
The intraclass correlation (ICC) for absolute agreement for single measures for VAS scores was 0.765 
(95% Confidence intervals (CIs) =0.594-0.870) which indicates strong agreement between the two VAS 
scores. As can be seen in figure 1, apart from two outliers, the first and second scores of the children 
were similar. 
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Scatter plot of the first and second VAS scores
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Pilot study figure: 1: Test-retest EQ-5D-Y VAS score 
Time taken to complete EQ-5D-Y form 
Pilot study table: 5: Time, in minutes, taken to complete EQ-5D-Y form (n=38) 
Mean Std.Dev Minimum Maximum n 
6.47 3.59 1 15 38 
 
The mean time taken to complete the measure was 6.5 minutes as can be seen in Pilot study table 6. 
Thirteen children took 5 minutes to complete the form as can be seen in Pilot study figure 3 with eight 
children taking 10 minutes and three children taking 15 minutes to complete the form. 
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Time taken to complete EQ-5D-Y form
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Pilot study figure: 2: Time taken to complete EQ-5D-Y, in minutes 
Discussion 
From the results of the pilot study it would seem that the study is feasible in that a sample of 
convenience easily elicited a sufficient number of participants within the eight to twelve year age 
group, from all four institutions, from whom it was possible to obtain demographic and medical 
information.  
Informed signed consent was obtained from thirty eight children, ranging from grade two to grade 
seven educational levels. The two children in grade two should have been excluded from the study as 
they were not quite eight years old. The upper level of the inclusion criteria needs to be amended to 
include twelve year old children who are in grade seven, as there were three children in this category.  
Sixteen of the children were at a grade five educational level. There were seventeen more male than 
female children. More children, a total of fifteen, from the AI were recruited into the study than from 
the other facilities and the fewest, only five children from the SS. This institution was the most difficult 
to obtain parental consent from as most of the children board at the school and contacting parents is 
difficult. There were twenty four different health conditions in the participants, varying from acute to 
chronic and also MS children. 
Percentage of agreement between the test and retest scores for each item of the EQ-5D-Y was 
determined using Cohen’s kappa coefficient. According to Landis and Koch’s guidelines (110), kappa of 
< 0.2 indicates poor agreement, 0.21-0.40 fair agreement, 0.41- 0.60 moderate agreement, 0.61- 0.80 
substantial agreement.  
The kappa for mobility 0.546, self-care 0.53 and worried 0.551, were all within the moderately 
agreeable range with a p value of < 0.001. The P/D item with a kappa of 0.365 was fairly agreeable 
with a p value of <0.08. However UA just fell into the poor agreement category, with a kappa of 0.199 
and p value of <0.127 
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For the first and second test VAS scores, Intraclass Correlation Coefficient( ICC) was found to be 0.765 
(95% Confidence intervals (CIs) =0.594-0.870) which indicated good agreement between the two 
assessment scores (155) 
Conclusion 
In summary the EQ-5D-Y is a reliable measure to use as the primary outcome measure in assessing 
HRQoL in the participants for the study. It is feasible as it only takes about six minutes to complete. It 
is possible to obtain useful contextual information on each participant from the medical file, which 
could be analysed further with information from the outcome measure. The inclusion criteria need to 
be amended to include children in grade seven, who fulfil the other criteria. More time needs to be 
allowed for obtaining consent from parents with children at the SS.  
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Appendix 15: Ethical Approval for the study 
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Appendix 16: Consent form from institutions 
 
 
 
UNIVERSITY OF CAPE TOWN 
Faculty of Health Sciences 
Department of Health and Rehabilitation Sciences 
Divisions of Communication Sciences and 
Disorders; Nursing and Midwifery; Occupational 
Therapy; Physiotherapy; Disability Studies 
F45 Old Main Building, Groote 
Schuur Hospital  
Observatory, Cape Town, W Cape, 
7925 
Tel: +27 (0) 21 406 6401/ 6428/ 
6628/ 6534 
Fax: +27 (0) 21 406 6323 
__________________________________________________________________________________ 
Authorisation from institution 
 
Investigator: Des Scott (B.Sc. Physiotherapy) 
University of Cape Town 
Department of Health and Rehabilitation Sciences 
Division of physiotherapy 
 
Supervisor: Professor Jennifer Jelsma 
University of Cape Town 
Department of Health and Rehabilitation Sciences 
Division of physiotherapy 
 
Title of study: The association between Health Related Quality of Life, health condition and function in 
South African children. 
 
I am a physiotherapist from the University of Cape Town, conducting a research project investigating 
quality of life in children with a health condition, for a master’s degree. I am requesting your 
permission to conduct part of this study at your institution. 
 
The aim of the study is to investigate whether and how children’s health conditions affect their daily 
life, physically, psychologically and socially. 
 
This will require children, between eight and twelve years, from your institution, completing two short 
Health Related Quality of Life forms, namely the EQ-5D-Y and PedsQL, as well as a P/D measure, Faces 
Pain Scale, all of which are self-reporting and will take approximately ten minutes each to complete.  
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Their functional ability will also be recorded. These forms will be administered by the physiotherapists 
in conjunction with their usual assessment method and by myself, after parental consent has been 
obtained. Assent will also be sought from each child. The physiotherapists have been approached and 
are willing to participate in the study. The procedure will be explained in detail to them, by the 
researcher. Repeat measures will need to be taken three times over a seven month period, from 
January 2014 to July 2014. 
 
There are no risks to the children participating in this study, nor will it affect any treatment the child 
may be receiving. The research could result in a better understanding of HRQoL in children within the 
institution. This information could be incorporated into guidelines regarding the use of the EQ-5D-Y as 
an instrument that can be used on a routine basis to improve the management of the child. 
 
All information obtained will be confidential and keep in a secure place and only used for the purposes 
of this study. The information will only be made available to the research personnel. 
 
Should you have any questions or concerns about the study you may contact the researcher or 
supervisor. 
 
RESEARCHER 
Des Scott at: 
University of Cape Town 
Department of Health and Rehabilitation Sciences 
Division of physiotherapy 
F45 Old Main Building 
Groote Schuur Hospital 
Observatory 
Tel: 021-4066401/6628 
Fax: 021 4066323 
Cell: 083 949 8333 
 
SUPERVISOR 
Professor J. Jelsma at: 
University of Cape Town 
Department of Health and Rehabilitation Sciences 
Division of physiotherapy 
F45 Old Main Building 
Groote Schuur Hospital 
Observatory 
Tel: 021-4066401/6628/6595 
Fax: 021 4066323 
 
Or 
 
Professor M. Blockman at: 
University of Cape Town 
Faculty of Health Sciences Human Research Ethics committee 
Tel: 021 406 6492 
Fax: 021 406 6411 
Room: E52.24 Old Main Building 
 
CONSENT FORM 
Declaration Yes No 
I give consent from the institution allowing the researchers to conduct the above 
mentioned study at.............................................. (Name of institution). 
  
 
Signed: ______________________________________         ______/________/________ 
Authorising signature      Date 
______________________________________          ______/________/________ 
Researcher       Date 
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Appendix 17: Consent form from therapists taking part in the study 
UNIVERSITY OF CAPE TOWN 
 
Faculty of Health Sciences 
 
Department of Health and Rehabilitation Sciences 
Divisions of Communication Sciences and 
Disorders; Nursing and Midwifery; Occupational 
Therapy; Physiotherapy; Disability Studies 
 
F45 Old Main Building, Groote 
Schuur Hospital 
Observatory, Cape Town, W Cape, 
7925 
Tel: +27 (0) 21 406 6401/ 6428/ 
6628/ 6534 
Fax: +27 (0) 21 406 6323 
                                                                                                                              
                                                                                                           Informed Consent Form 
INFORMED CONSENT FOR THERAPISTS TAKING PART IN THE STUDY 
 
INFORMATION SHEET  
Investigator: Des Scott – BSc Physiotherapy  
                        University of Cape Town 
                        Department of Health and Rehabilitation Sciences 
                        Division of physiotherapy 
 
Title of study: The association between Health Related Quality of Life, health condition and function 
in South African children. 
 
I am a physiotherapist from the University of Cape Town and am conducting a research project 
investigating quality of life in children with a health condition, for a Master’s Degree. I am interested in 
finding out in what way a child’s health condition affects his/her ability to move, look after him/her 
self, go about his/her UA, P/D or feels WSU. 
 
I am inviting you to participate in the study by administering the EQ-5D-Y, a health related quality of 
life (HRQoL) outcome measure to your patients, which will take approximately five minutes and to 
complete a contextual information sheet on the child. The study will continue for seven months. At 
the conclusion of the study I would like you to complete a questionnaire on whether the data 
gathered when using the EQ-5D-Y were useful and whether you intend to include the outcome 
measure as part of your routine assessment tools in the future. 
 
You are not obliged to participate, it is voluntary and the choice is yours alone. The study will not 
affect the management of patients, which will continue as usual.  
There are no risks or benefits to participating in this study, but you might find the use of the EQ-5D-Y 
useful in planning the management of your patients.  
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Should you have any questions or concerns about the study you may contact the researcher or the 
supervisor: 
RESEARCHER 
Des Scott at:  
University of Cape Town 
Department of Health and Rehabilitation Sciences 
Division of physiotherapy 
F45 Old Main Building 
Groote Schuur Hospital 
Observatory 
Tel: 021-4066401/6628 Cell: 083 949 8333 
Fax: 021 4066323 
SUPERVISOR 
Professor J. Jelsma at:  
University of Cape Town 
Department of Health and Rehabilitation Sciences 
Division of physiotherapy 
 F45 Old Main Building 
Groote Schuur Hospital 
Observatory 
Tel: 021-4066401/6628/6595 
Fax: 021 4066323 
 
Or  
Professor M. Blockman at:  
The University of Cape Town 
 Faculty of Health Sciences Human Research Ethics committee 
 Tel: 021 406 6492 
 Fax: 021 406 6411 
 Room: E52.24 Old Main Building 
CONSENT FORM 
Declaration Yes No 
I have read through the information sheet and understand it’s content   
I understand that my consent is required    
I understand that participation is voluntary and I can withhold my consent without 
any consequences 
  
I understand that I will not be personally identified should this research study be 
published 
  
I consent to participating in this research study of my own free will   
 
Signed: ______________________________________         ______/________/________ 
Participant 
______________________________________         ______/________/________                                                                                                                                                     
Researcher   
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Appendix 18: Parental/care giver informed consent 
 
UNIVERSITY OF CAPE TOWN 
 
Faculty of Health Sciences 
 
Department of Health and Rehabilitation Sciences 
Divisions of Communication Sciences and 
Disorders; Nursing and Midwifery; Occupational 
Therapy; Physiotherapy; Disability Studies 
 
F45 Old Main Building, Groote Schuur Hospital 
Observatory, Cape Town, W Cape, 7925 
Tel: +27 (0) 21 406 6401/ 6428/ 6628/ 6534 
Fax: +27 (0) 21 406 6323 
__________________________________________________________________________________ 
INFORMED CONSENT FROM PARENTS OR LEGAL GUARDIANS OF CHILDREN TAKING PART IN THE 
STUDY 
INFORMATION SHEET  
Investigator: Des Scott – BSc Physiotherapy  
                        University of Cape Town 
                        Department of Health and Rehabilitation Sciences 
                        Division of physiotherapy 
 
Title of study: The association between Health Related Quality of Life, health condition and function 
in South African children. 
 
I am a physiotherapist from the University of Cape Town and am conducting a research project 
investigating quality of life in children with a health condition, for a Master’s Degree. I am asking you 
to allow the physiotherapists and myself to conduct interviews with your child asking specific 
questions about his/her quality of life. 
I am interested in finding out in what way your child’s health condition affects his/her everyday life 
and to follow them up for seven months to see what changes occur in their health condition and what 
it is related to. In order to do this the physiotherapist will ask your child to fill in a short form asking 
about his/her ability to move, look after him/her self, go about his/her UA, P/D, feels WSU. This should 
take about ten minutes. The physiotherapist will also ask you and /or the nurses about anything else 
that may be happening in the child’s life, affecting his/her condition. I will then be asking your child to 
fill in two other short forms asking the same type of questions and about his/her P/D. I will also be 
looking at how your child moves about. This should take about half an hour. We will be following your 
child’s health condition for seven months and will be asking him/her to fill these short forms in again 
at three months and at seven months.   All children between 8 and 12 years at this facility and others 
are being invited to participate. 
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Please understand that you do not have to give consent allowing us to interview your child. It is 
voluntary and the choice is yours alone. If you choose not to consent, there will be no negative 
consequence to you or your child. If you decide to consent now, but at a later date decide that you no 
longer want your child to be part of the study, you may withdraw your consent and your child’s 
information will be removed from the study. However we would be grateful if you would assist us by 
allowing us to interview your child. 
By allowing your child to be part of the study, the treatment he/she is receiving will not be affected at 
all. This will continue as usual.  
All information you or your child gives us will be confidential and only the researcher and the child’s 
therapist will see the information and know the name of your child, which will be removed once your 
child has completed all the forms. The completed forms will be kept in a file in a locked cupboard in 
the physiotherapy department until the information has been recorded onto a secure computer in a 
password protected file. The information will only be used for the purposes of this study. When the 
study is written up your child’s name will not be used. 
There are no risks to participating in this study. There are also no financial benefits to participating. I 
will be comparing the information your child gives us, with other children who are ill, in the hope of 
improving the management of children with a health condition. 
Should you have any questions or concerns about the study you may contact the researcher or the 
supervisor: 
RESEARCHER 
Des Scott at:  
University of Cape Town 
Department of Health and Rehabilitation Sciences 
Division of physiotherapy 
F45 Old Main Building 
Groote Schuur Hospital 
Observatory 
Tel: 021-4066401/6628 
Fax: 021 4066323 
Cell: 083 949 8333 
 
SUPERVISOR 
Professor J. Jelsma at:  
University of Cape Town 
Department of Health and Rehabilitation Sciences 
Division of physiotherapy 
 F45 Old Main Building 
Groote Schuur Hospital 
Observatory 
Tel: 021-4066401/6628/6595 
Fax: 021 4066323 
 
Or if you have any questions about your rights or welfare as a parent of a participant please contact 
Professor M. Blockman at:  
The University of Cape Town 
 Faculty of Health Sciences Human Research Ethics committee 
 Tel: 021 406 6492 
 Fax: 021 406 6411 
 Room: E52.24 Old Main Building 
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CONSENT FORM 
Declaration Yes No 
I have read through the information sheet and understand it’s content   
I understand that my consent is required    
I understand that participation is voluntary and I can withhold my consent without 
any consequences to myself or my child 
  
I understand that refusal to give consent will not affect the current or future 
health care of my child. 
  
I understand that I nor my child will be personally identified should this research 
study be published 
  
I consent to my child participating in this research study of my own free will   
 
 
Signed: 
 
 
______________________________________         ______/________/________ 
Parent’s signature                      Date  
 
 
______________________________________ 
Child’s name 
 
 
______________________________________          ______/________/________ 
Researcher/Physiotherapist                      Date  
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Appendix 19: Child assent form 
                                                                                                                                              
 
UNIVERSITY OF CAPE TOWN 
Faculty of Health Sciences 
Department of Health and Rehabilitation Sciences 
 
Divisions of Communication Sciences and 
Disorders; Nursing and Midwifery; Occupational 
Therapy; Physiotherapy; Disability Studies 
 
F45 Old Main Building, Groote 
Schuur Hospital 
Observatory, Cape Town, W Cape, 
7925 
Tel: +27 (0) 21 406 6401/ 6428/ 
6628/ 6534 
Fax: +27 (0) 21 406 6323 
__________________________________________________________________________________ 
INFORMED ASSENT FROM CHILD TAKING PART IN THE STUDY 
INFORMATION SHEET  
Investigator: Des Scott – BSc Physiotherapy  
                        University of Cape Town 
                        Department of Health and Rehabilitation Sciences 
                        Division of physiotherapy 
 
Title of study: The association between Health Related Quality of Life, health condition and function 
in South African children 
I am a physiotherapist from the University of Cape Town and am trying to learn more about how you 
would describe your health and your satisfaction with your life. I would like you to think about being in 
my study. I am inviting other children between 8 and 12 years, at this place and at other places to join 
in, if they want to. 
If you decide you want to be in my study, you will be asked by the physiotherapist to fill in a short 
form asking you how easily you move about, look after yourself, go about your UA and whether you 
feel P/D or feel WSU. This should take about ten minutes to fill in. The physiotherapist will also ask 
your parents and/or the nurses if anything is changing in your life.   I will have another two forms for 
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you to fill in later the same day, asking similar questions and about how much P/D you might have. I 
will also be watching how you move about. This will take about half an hour. 
I am interested in following up whether your health changes over seven months, so you will be asked 
to fill in these three short forms again three months later and again three months after that. 
By choosing to be in the study I may learn from you how to improve the way we take care of you. 
Other people will not know if you are in the study.  I will put what we learn about you together with 
things we learn about other children, so no one can tell what things came from you.  When I tell other 
people about the research study, I will not use your name, so no one can tell who we are talking 
about. 
Your parents or guardian have to say it’s OK for you to be in the study. After they decide, you get to 
choose if you want to do it too. If you don’t want to be in the study, no one will be angry at you.  If you 
want to be in the study now and change your mind later, that’s OK. You can stop at any time.  
You can call me or my supervisor if you have any questions about the study: 
RESEARCHER 
Des Scott at:  
University of Cape Town 
Department of Health and Rehabilitation Sciences 
Division of physiotherapy 
F45 Old Main Building 
Groote Schuur Hospital 
Observatory 
Tel: 021-4066401/6628 
Fax: 021 4066323 
Cell: 083 949 8333 
 
SUPERVISOR 
Professor J. Jelsma at:  
University of Cape Town 
Department of Health and Rehabilitation Sciences 
Division of physiotherapy 
 F45 Old Main Building 
Groote Schuur Hospital 
Observatory 
Tel: 021-4066401/6628/6595 
Fax: 021 4066323 
 
Or if you have any questions about your rights or welfare as someone taking part in the study, you can 
contact Professor M. Blockman at: 
The University of Cape Town 
Faculty of Health Sciences Human Research Ethics committee 
Tel: 021 406 6492 
Fax: 021 406 6411 
Room: E52.24 Old Main Building 
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 Agreement 
Declaration Yes No 
I have read through the information sheet and understand it.   
 I know that I don’t have to take part in this study if I don’t want to.   
I know that my name will not be used when you tell people about the study   
I have decided I want to be in the study   
 
  
 ______________________________   ________________ 
Signature of Study Participant (child)                                               Date 
 
 
______________________________    
Name of child 
 
 
______________________________   ________________ 
 Researcher/Physiotherapist                Date 
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Appendix 20: Consent for proxy form by parents with children at the Main Stream school   
                                  UNIVERSITY OF CAPE TOWN 
 
Faculty of Health Sciences 
 
Department of Health and Rehabilitation Sciences 
Divisions of Communication Sciences and 
Disorders; Nursing and Midwifery; Occupational 
Therapy; Physiotherapy; Disability Studies 
 
F45 Old Main Building, Groote Schuur Hospital 
Observatory, Cape Town, W Cape, 7925 
Tel: +27 (0) 21 406 6401/ 6428/ 6628/ 6534 
Fax: +27 (0) 21 406 6323 
_________________________________________________________________________________ 
INFORMED CONSENT FROM PARENTS OR LEGAL GUARDIANS OF CHILDREN AT A SCHOOL ALREADY 
TAKING PART IN THE STUDY TO: 
 COMPLETE AN EQ-5D-Y PROXY FORM 
 
INFORMATION SHEET  
Investigator: Des Scott – BSc Physiotherapy  
                        University of Cape Town 
                        Department of Health and Rehabilitation Sciences 
                        Division of physiotherapy 
 
Title of study: The association between Health Related Quality of Life, health condition and function 
in South African children. 
 
I am the physiotherapist from the University of Cape Town conducting the research project 
investigating quality of life in children, for a Master’s Degree. You have already kindly given your 
consent, allowing me to conduct interviews with your child asking specific questions about his/her 
quality of life. I completed the first set of interviews in February this year. 
As I am preparing for the second set of interviews, I am also interested in finding out the relationship 
between your child’s reported Health Related Quality of Life and what you think of your child’s Health 
Related Quality of Life.  
In order to do this I am asking you to fill in a short form asking what you think about your child’s ability 
to move, look after him/her self, go about his/her UA, P/D, feels WSU. This should take about ten 
minutes. I would be grateful if you would assist me by completing the form and allowing me to use this 
information in my research study. 
The information on the form will be confidential and only I will see it. Your name and your child’s 
name will be removed once all the forms have been completed. The completed forms will be kept in a 
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file in a locked cupboard in the physiotherapy department until the information has been recorded 
onto a secure computer in a password protected file. The information will only be used for the 
purposes of this study. When the study is written up neither your name nor your child’s name will be 
used. 
Please understand that you do not have to consent to completing this form. It is voluntary and the 
choice is yours alone. If you choose not to consent, there will be no negative consequence to you or 
your child. If you decide to consent now, but at a later date decide that you no longer want your 
information to be part of the study, you may withdraw your consent and this information will be 
removed from the study.  
There are no risks to participating in this study. There are also no financial benefits to participating.  
Should you have any questions or concerns about the study you may contact the researcher or the 
supervisor: 
RESEARCHER 
Des Scott at:  
University of Cape Town 
Department of Health and Rehabilitation Sciences 
Division of physiotherapy 
F45 Old Main Building 
Groote Schuur Hospital 
Observatory 
Tel: 021-4066401/6628 
Fax: 021 4066323 
Cell: 083 949 8333 
 
SUPERVISOR 
Professor J. Jelsma at:  
University of Cape Town 
Department of Health and Rehabilitation Sciences 
Division of physiotherapy 
 F45 Old Main Building 
Groote Schuur Hospital 
Observatory 
Tel: 021-4066401/6628/6595 
Fax: 021 4066323 
 
Or if you have any questions about your rights or welfare as a parent of a participant please contact 
Professor M. Blockman at: 
The University of Cape Town 
 Faculty of Health Sciences Human Research Ethics committee 
 Tel: 021 406 6492 
 Fax: 021 406 6411 
 Room: E52.24 Old Main Building 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CONSENT FORM 
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Declaration Yes No 
I have read through the information sheet and understand it’s content   
I understand that my consent is required    
I understand that participation is voluntary and I can withhold my consent without 
any consequences to myself or my child 
  
I understand that I nor my child will be personally identified should this research 
study be published 
  
I consent to participating in this research study of my own free will   
 
Signed: 
______________________________________         ______/________/________ 
Parent’s signature       
______________________________________           
Child’s name 
______________________________________          ______/________/________ 
Researcher/Physiotherapist     
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Appendix 21: PedsQL results at baseline, complete 
 
  
MS 
n=105) 
 SS 
(n=35) 
 CI 
(n=32) 
 AI 
(n=52) 
 
  
count % count % count % count % 
ACTIVITY: Hard 
to walk more 
than one block 
Never a problem 85 81.0 11 31.4 17 53.1 18 34.6 
  Almost never a problem 2 1.9 0 0.0 1 3.1 2 3.8 
  Sometimes a problem 10 9.5 5 14.3 6 18.8 7 13.5 
  Often a problem 1 1.0 2 5.7 1 3.1 5 9.6 
  Almost always a problem 7 6.7 17 48.6 6 18.8 20 38.5 
Hard to run Never a problem 62 59.0 6 17.1 17 53.1 13 25.0 
  Almost never a problem 18 17.1 0 0.0 1 3.1 0 0.0 
  Sometimes a problem 20 19.0 7 20.0 6 18.8 11 21.2 
  Often a problem 2 1.9 1 2.9 0 0.0 4 7.7 
  Almost always a problem 3 2.9 21 60.0 7 21.9 24 46.2 
Hard to do 
sport or 
exercise 
Never a problem 72 68.6 9 25.7 12 37.5 12 23.1 
  Almost never a problem 11 10.5 0 0.0 1 3.1 1 1.9 
  Sometimes a problem 12 11.4 19 54.3 11 34.4 10 19.2 
  Often a problem 4 3.8 1 2.9 0 0.0 5 9.6 
  Almost always a problem 6 5.7 6 17.1 7 21.9 24 46.2 
Hard to lift 
something 
heavy 
Never a problem 38 36.2 7 20.0 6 18.8 11 21.2 
  Almost never a problem 13 12.4 1 2.9 2 6.3 2 3.8 
  Sometimes a problem 31 29.5 13 37.1 11 34.4 14 26.9 
  Often a problem 3 2.9 0 0.0 4 12.5 7 13.5 
  Almost always a problem 20 19.0 14 40.0 8 25.0 18 34.6 
Hard to bath or 
shower by 
myself 
Never a problem 94 89.5 22 62.9 24 75.0 28 53.8 
  Almost never a problem 2 1.9 0 0.0 0 0.0 0 0.0 
  Sometimes a problem 4 3.8 7 20.0 3 9.4 9 17.3 
  Often a problem 1 1.0 0 0.0 1 3.1 8 15.4 
  Almost always a problem 4 3.8 6 17.1 3 9.4 7 13.5 
Hard to do 
chores around 
house 
Never a problem 74 70.5 15 42.9 14 43.8 19 36.5 
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  Almost never a problem 4 3.8 0 0.0 4 12.5 3 5.8 
  Sometimes a problem 15 14.3 14 40.0 7 21.9 6 11.5 
  Often a problem 3 2.9 1 2.9 1 3.1 5 9.6 
  Almost always a problem 9 8.6 5 14.3 5 15.6 19 36.5 
I hurt Never a problem 35 33.3 15 42.9 6 18.8 19 36.5 
  Almost never a problem 13 12.4 0 0.0 2 6.3 6 11.5 
  Sometimes a problem 40 38.1 17 48.6 16 50.0 11 21.2 
  Often a problem 5 4.8 1 2.9 6 18.8 3 5.8 
  Almost always a problem 12 11.4 2 5.7 1 3.1 13 25.0 
Have low 
energy 
Never a problem 46 43.8 14 40.0 12 37.5 17 32.7 
  Almost never a problem 11 10.5 1 2.9 1 3.1 1 1.9 
  Sometimes a problem 34 32.4 10 28.6 12 37.5 13 25.0 
  Often a problem 2 1.9 3 8.6 2 6.3 10 19.2 
  Almost always a problem 12 11.4 7 20.0 4 12.5 11 21.2 
FEELINGS: Feel 
afraid or scared 
Never a problem 44 41.9 18 51.4 7 21.9 22 42.3 
  Almost never a problem 9 8.6 2 5.7 4 12.5 3 5.8 
  Sometimes a problem 30 28.6 8 22.9 13 40.6 19 36.5 
  Often a problem 3 2.9 2 5.7 0 0.0 4 7.7 
  Almost always a problem 19 18.1 5 14.3 7 21.9 4 7.7 
Feel sad Never a problem 43 41.0 14 40.0 9 28.1 25 48.1 
  Almost never a problem 13 12.4 5 14.3 2 6.3 2 3.8 
  Sometimes a problem 38 36.2 15 42.9 12 37.5 15 28.8 
  Often a problem 2 1.9 0 0.0 5 15.6 5 9.6 
  Almost always a problem 9 8.6 1 2.9 3 9.4 5 9.6 
Feel angry Never a problem 27 25.7 10 28.6 3 9.4 35 67.3 
  Almost never a problem 11 10.5 3 8.6 4 12.5 1 1.9 
  Sometimes a problem 36 34.3 15 42.9 12 37.5 10 19.2 
  Often a problem 8 7.6 2 5.7 7 21.9 3 5.8 
  Almost always a problem 23 21.9 5 14.3 5 15.6 3 5.8 
Have trouble 
sleeping 
Never a problem 42 40.0 21 60.0 12 37.5 30 57.7 
  Almost never a problem 8 7.6 1 2.9 0 0.0 1 1.9 
  Sometimes a problem 34 32.4 11 31.4 12 37.5 9 17.3 
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  Often a problem 3 2.9 1 2.9 2 6.3 8 15.4 
  Almost always a problem 18 17.1 1 2.9 5 15.6 3 5.8 
Worry what will 
happen to me 
Never a problem 32 30.5 15 42.9 7 21.9 15 28.8 
  Almost never a problem 8 7.6 1 2.9 2 6.3 2 3.8 
  Sometimes a problem 25 23.8 9 25.7 13 40.6 19 36.5 
  Often a problem 2 1.9 4 11.4 3 9.4 7 13.5 
  Almost always a problem 38 36.2 6 17.1 6 18.8 9 17.3 
SOCIALISING: 
Have trouble 
getting along 
with other kids 
Never a problem 44 41.9 27 77.1 13 40.6 28 53.8 
  Almost never a problem 10 9.5 1 2.9 2 6.3 0 0.0 
  Sometimes a problem 33 31.4 6 17.1 7 21.9 21 40.4 
  Often a problem 4 3.8 1 2.9 2 6.3 1 1.9 
  Almost always a problem 14 13.3 0 0.0 7 21.9 2 3.8 
Other kids do 
not want to be 
my friends 
Never a problem 53 50.5 16 45.7 16 50.0 30 57.7 
  Almost never a problem 14 13.3 2 5.7 3 9.4 1 1.9 
  Sometimes a problem 23 21.9 13 37.1 10 31.3 19 36.5 
  Often a problem 1 1.0 3 8.6 1 3.1 2 3.8 
  Almost always a problem 14 13.3 1 2.9 1 3.1 0 0.0 
Other kids 
tease me 
Never a problem 39 37.1 10 28.6 8 25.0 26 50.0 
  Almost never a problem 11 10.5 2 5.7 3 9.4 2 3.8 
  Sometimes a problem 28 26.7 12 34.3 8 25.0 18 34.6 
  Often a problem 5 4.8 0 0.0 5 15.6 4 7.7 
  Almost always a problem 22 21.0 11 31.4 7 21.9 2 3.8 
Cannot do 
things other 
kids my age can 
do 
Never a problem 71 67.6 12 34.3 19 59.4 20 38.5 
  Almost never a problem 10 9.5 0 0.0 0 0.0 2 3.8 
  Sometimes a problem 9 8.6 7 20.0 5 15.6 17 32.7 
  Often a problem 2 1.9 5 14.3 5 15.6 6 11.5 
  Almost always a problem 13 12.4 11 31.4 2 6.3 7 13.5 
Hard to keep 
up when I play 
with other kids 
Never a problem 55 52.4 10 28.6 18 56.3 18 34.6 
  Almost never a problem 14 13.3 3 8.6 1 3.1 1 1.9 
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  Sometimes a problem 26 24.8 8 22.9 8 25.0 19 36.5 
  Often a problem 2 1.9 6 17.1 1 3.1 8 15.4 
  Almost always a problem 8 7.6 8 22.9 3 9.4 6 11.5 
SCHOOLING: 
Hard to pay 
attention in 
class 
Never a problem 74 70.5 28 80.0 16 50.0 31 59.6 
  Almost never a problem 7 6.7 2 5.7 3 9.4 1 1.9 
  Sometimes a problem 14 13.3 5 14.3 7 21.9 17 32.7 
  Often a problem 2 1.9 0 0.0 2 6.3 3 5.8 
  Almost always a problem 8 7.6 0 0.0 3 9.4 0 0.0 
I forget things Never a problem 36 34.3 12 34.3 11 34.4 18 34.6 
  Almost never a problem 14 13.3 3 8.6 5 15.6 3 5.8 
  Sometimes a problem 35 33.3 17 48.6 9 28.1 28 53.8 
  Often a problem 4 3.8 1 2.9 3 9.4 3 5.8 
  Almost always a problem 16 15.2 2 5.7 3 9.4 0 0.0 
Have trouble 
keeping up 
with 
schoolwork 
Never a problem 71 67.6 23 65.7 15 46.9 24 46.2 
  Almost never a problem 9 8.6 3 8.6 1 3.1 2 3.8 
  Sometimes a problem 21 20.0 8 22.9 7 21.9 21 40.4 
  Often a problem 1 1.0 1 2.9 5 15.6 4 7.7 
  Almost always a problem 3 2.9 0 0.0 3 9.4 1 1.9 
Miss school 
because not 
feeling well 
Never a problem 52 49.5 10 28.6 8 25.0 4 7.7 
  Almost never a problem 9 8.6 0 0.0 7 21.9 0 0.0 
  Sometimes a problem 26 24.8 18 51.4 12 37.5 32 61.5 
  Often a problem 5 4.8 3 8.6 3 9.4 12 23.1 
  Almost always a problem 13 12.4 4 11.4 1 3.1 4 7.7 
Miss school to 
go to Dr or 
hospital 
Never a problem 46 43.8 11 31.4 4 12.5 0 0.0 
  Almost never a problem 12 11.4 6 17.1 3 9.4 0 0.0 
  Sometimes a problem 35 33.3 12 34.3 21 65.6 32 61.5 
  Often a problem 3 2.9 3 8.6 3 9.4 16 30.8 
  Almost always a problem 9 8.6 3 8.6 0 0.0 4 7.7 
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Appendix 22:  Baseline WeeFIM results, complete (n=135)  
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MS 
(n=16) 
SS 
(n=35) 
CI (n=32) AI 
(n=52) 
Count  % Count % Count  % Count  % 
SELF-CARE:  
W1 eat 
Total 
assistance  
0 0.0 0 0.0 0 0.0 12 23.1 
Mod 
assistance  
0 0.0 0 0.0 0 0.0 2 3.8 
Min 
assistance  
0 0.0 0 0.0 1 3.1 5 9.6 
Modified 
assistance  
0 0.0 1 2.9 0 0.0 0 0.0 
Complete 
independe
nce  
16 100.0 34 97.1 31 96.9 33 63.5 
W1 groom Total 
assistance  
0 0.0 0 0.0 0 0.0 11 21.2 
Max 
assistance  
0 0.0 2 5.7 0 0.0 1 1.9 
Mod 
assistance  
0 0.0 1 2.9 1 3.1 2 3.8 
Min 
assistance  
2 12.5 2 5.7 3 9.4 4 7.7 
Supervision  2 12.5 0 0.0 1 3.1 0 0.0 
Complete 
independe
nce  
12 75.0 30 85.7 27 84.4 34 65.4 
W1 bath Total 
assistance  
0 0.0 0 0.0 0 0.0 1 1.9 
Max 
assistance  
0 0.0 2 5.7 1 3.1 3 5.8 
Mod 
assistance  
0 0.0 2 5.7 2 6.3 8 15.4 
Min 
assistance  
1 6.3 3 8.6 1 3.1 23 44.2 
Supervision  0 0.0 0 0.0 0 0.0 1 1.9 
Complete 
independe
nce  
15 93.8 28 80.0 28 87.5 16 30.8 
W1 dress up Total 
assistance  
0 0.0 0 0.0 0 0.0 4 7.7 
Max 
assistance  
0 0.0 2 5.7 1 3.1 1 1.9 
Mod 
assistance  
0 0.0 3 8.6 1 3.1 5 9.6 
Min 
assistance  
0 0.0 2 5.7 2 6.3 16 30.8 
Supervision  0 0.0 0 0.0 0 0.0 2 3.8 
Complete 
independe
nce  
16 100.0 28 80.0 28 87.5 24 46.2 
W1 dress low Total 
assistance  
0 0.0 0 0.0 0 0.0 19 36.5 
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Max 
assistance  
0 0.0 3 8.6 1 3.1 1 1.9 
Mod 
assistance  
0 0.0 3 8.6 2 6.3 3 5.8 
Min 
assistance  
0 0.0 7 20.0 2 6.3 12 23.1 
Modified 
assistance  
0 0.0 1 2.9 0 0.0 0 0.0 
Complete 
independe
nce  
16 100.0 21 60.0 27 84.4 17 32.7 
W1 Toileting Total 
assistance  
0 0.0 0 0.0 0 0.0 2 3.8 
Max 
assistance  
0 0.0 3 8.6 1 3.1 2 3.8 
Mod 
assistance  
0 0.0 0 0.0 0 0.0 4 7.7 
Min 
assistance  
0 0.0 1 2.9 1 3.1 0 0.0 
Modified 
assistance  
0 0.0 8 22.9 2 6.3 8 15.4 
Complete 
independe
nce  
16 100.0 23 65.7 28 87.5 36 69.2 
W1 Bladder 
management 
Total 
assistance  
0 0.0 0 0.0 0 0.0 3 5.8 
Max 
assistance  
0 0.0 1 2.9 0 0.0 1 1.9 
Mod 
assistance  
0 0.0 1 2.9 0 0.0 2 3.8 
Min 
assistance  
0 0.0 1 2.9 0 0.0 2 3.8 
Supervision  0 0.0 4 11.4 0 0.0 0 0.0 
Modified 
assistance  
0 0.0 9 25.7 3 9.4 21 40.4 
Complete 
independe
nce  
16 100.0 19 54.3 29 90.6 23 44.2 
W1 Bowel 
management 
Total 
assistance  
0 0.0 0 0.0 0 0.0 3 5.8 
Max 
assistance  
0 0.0 1 2.9 0 0.0 3 5.8 
Mod 
assistance  
0 0.0 6 17.1 1 3.1 3 5.8 
Min 
assistance  
0 0.0 1 2.9 0 0.0 2 3.8 
Supervision  0 0.0 3 8.6 0 0.0 0 0.0 
Modified 
assistance  
0 0.0 3 8.6 2 6.3 18 34.6 
Complete 
independe
nce  
16 100.0 21 60.0 29 90.6 23 44.2 
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MOBILITY: 
W1 Transfer 
chair/wchair 
Total 
assistance  
0 0.0 0 0.0 0 0.0 18 34.6 
Max 
assistance  
0 0.0 3 8.6 0 0.0 2 3.8 
Mod 
assistance  
0 0.0 2 5.7 1 3.1 2 3.8 
Min 
assistance  
0 0.0 4 11.4 0 0.0 5 9.6 
Supervision  0 0.0 0 0.0 0 0.0 2 3.8 
Modified 
assistance  
0 0.0 14 40.0 5 15.6 0 0.0 
Complete 
independe
nce  
16 100.0 12 34.3 26 81.3 23 44.2 
W1Transfers 
toilet 
Total 
assistance  
0 0.0 0 0.0 0 0.0 25 48.1 
Max 
assistance  
0 0.0 4 11.4 0 0.0 1 1.9 
Mod 
assistance  
0 0.0 5 14.3 3 9.4 0 0.0 
Min 
assistance  
0 0.0 2 5.7 0 0.0 2 3.8 
Supervision  0 0.0 0 0.0 0 0.0 2 3.8 
Modified 
assistance  
0 0.0 13 37.1 2 6.3 0 0.0 
Complete 
independe
nce  
16 100.0 11 31.4 27 84.4 22 42.3 
W1 transfers 
tub 
Total 
assistance  
0 0.0 0 0.0 0 0.0 25 48.1 
Max 
assistance  
0 0.0 4 11.4 0 0.0 1 1.9 
Mod 
assistance  
0 0.0 7 20.0 3 9.4 1 1.9 
Min 
assistance  
0 0.0 2 5.7 1 3.1 3 5.8 
Supervision  0 0.0 0 0.0 0 0.0 2 3.8 
Modified 
assistance  
0 0.0 11 31.4 1 3.1 0 0.0 
Complete 
independe
nce  
16 100.0 11 31.4 27 84.4 20 38.5 
Walk/Wheel 
chair 
Total 
assistance  
0 0.0 1 2.9 0 0.0 24 46.2 
Max 
assistance  
0 0.0 0 0.0 0 0.0 1 1.9 
Mod 
assistance  
0 0.0 0 0.0 2 6.3 0 0.0 
Min 
assistance  
0 0.0 3 8.6 1 3.1 2 3.8 
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Supervision  0 0.0 0 0.0 0 0.0 4 7.7 
Modified 
assistance  
0 0.0 20 57.1 3 9.4 1 1.9 
Complete 
independe
nce  
16 100.0 11 31.4 26 81.3 20 38.5 
Stairs Total 
assistance  
0 0.0 15 42.9 3 9.4 37 71.2 
Max 
assistance  
0 0.0 0 0.0 1 3.1 0 0.0 
Mod 
assistance  
0 0.0 1 2.9 0 0.0 1 1.9 
Min 
assistance  
0 0.0 0 0.0 0 0.0 1 1.9 
Supervision  0 0.0 1 2.9 0 0.0 0 0.0 
Modified 
assistance  
1 6.3 9 25.7 7 21.9 10 19.2 
Complete 
independe
nce  
15 93.8 9 25.7 21 65.6 3 5.8 
COGNITION: 
W1 
Comprehension 
Mod 
assistance  
0 0.0 4 11.4 0 0.0 0 0.0 
Min 
assistance  
3 18.8 1 2.9 3 9.4 1 1.9 
Supervision  9 56.3 11 31.4 13 40.6 7 13.5 
Modified 
assistance  
0 0.0 0 0.0 0 0.0 4 7.7 
Complete 
independe
nce  
4 25.0 19 54.3 16 50.0 40 76.9 
W1 Expression Mod 
assistance  
0 0.0 2 5.7 0 0.0 0 0.0 
Min 
assistance  
2 12.5 1 2.9 3 9.4 2 3.8 
Supervision  3 18.8 9 25.7 6 18.8 6 11.5 
Modified 
assistance  
0 0.0 0 0.0 0 0.0 4 7.7 
Complete 
independe
nce  
11 68.8 23 65.7 23 71.9 40 76.9 
W1 Social 
interaction 
Mod 
assistance  
0 0.0 1 2.9 0 0.0 0 0.0 
Min 
assistance  
0 0.0 0 0.0 2 6.3 2 3.8 
Supervision  1 6.3 8 22.9 9 28.1 5 9.6 
Modified 
assistance  
0 0.0 0 0.0 0 0.0 3 5.8 
Complete 
independe
15 93.8 26 74.3 21 65.6 42 80.8 
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nce  
W1 Problem 
solving 
Mod 
assistance  
0 0.0 8 22.9 0 0.0 1 1.9 
Min 
assistance  
2 12.5 2 5.7 3 9.4 1 1.9 
Supervision  3 18.8 9 25.7 11 34.4 6 11.5 
Modified 
assistance  
1 6.3 1 2.9 0 0.0 1 1.9 
Complete 
independe
nce  
10 62.5 15 42.9 18 56.3 43 82.7 
W1 Memory Mod 
assistance  
0 0.0 8 22.9 0 0.0 1 1.9 
Min 
assistance  
1 6.3 2 5.7 3 9.4 1 1.9 
Supervision  7 43.8 9 25.7 12 37.5 6 11.5 
Modified 
assistance  
2 12.5 3 8.6 2 6.3 1 1.9 
Complete 
independe
nce  
6 37.5 13 37.1 15 46.9 43 82.7 
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Appendix 23:  Convergent Validity 
Box –Whisker graphs comparing EQ-5D-Y dimensions with similar dimensions on PedsQL and WeeFIM 
Comparing EQ-5D-Y Mobility and PedsQL Activity dimensions at SS 
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Appendix Figure 1: Comparing the EQ-5D-Y Mobility and PedsQL Activities dimensions, for SS  
There was a significant difference in the ranking of PedsQL scores across the three levels of EQ-5D-Y 
Mobility, at the SS (p<0.001).  
Comparing the EQ-5D-Y Mobility and of PedsQL Activities dimension, at AI  
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Appendix Figure 2: Comparing the Mobility EQ-5D-Y and Activities dimension of PedsQL, for AI  
There was a significant difference in ranking of PedsQL Activity score across the three EQ-5D-Y levels 
for the AI (p<0.001) 
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Comparing EQ-5D-Y UA dimension with PedsQL total, for MS children  
Institution=Main Stream
PedsQL total grouped by EQ-5D-Y Usual Activities dimensions
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Appendix Figure 3: Comparing the UA EQ-5D-Y dimension and PedsQL total for MS school 
Institution=Chronic Institution
PedsQL total grouped by  EQ-5D-Y Activ ities
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Appendix Figure 4: Comparing the UA EQ-5D-Y dimension and PedsQL total for CI 
There was a significant difference in ranking of PedsQL total score across two levels of the EQ-5D-Y UA 
dimension, for MS children (p=0.007) and CI (p=0.002).  
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Institution=Acute Institution
PedsQL total grouped by EQ-5D-Y Usual Activities
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Appendix Figure 5: Comparing UA EQ-5D-Y dimension and PedsQL total for AI 
There was a significant difference in ranking of PedsQL total score across three levels of the EQ-5D-Y 
UA dimension, for AI children (p=0.006).  
Comparing EQ-5D-Y P/D dimension with PedsQL “I hurt”, for AI 
Institution=Acute Institution
PedsQL "I hurt" grouped by EQ-5D-Y Pain Dimension
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Appendix Figure 6: Comparing EQ-5D-Y P/D dimension with PedsQL “I hurt”, for AI 
Comparing EQ-5D-Y WSU dimension with PedsQL Feelings dimension, for MS 
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Institution=Main Stream
PedsQL subtotal for Feelings grouped by EQ-5D-Y Worried, Sad or
Unhappy
 Median 
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Appendix Figure 7: Comparing EQ-5D-Y WSU dimension and PedsQL Feelings dimension, for MS  
There was a significant difference in ranking of PedsQL Feelings dimension score across two levels of 
the EQ-5D-Y WSU dimension for MS children (p=0.020).  
Comparing EQ-5D-Y WSU dimension with PedsQL Feelings dimension, for AI 
Institution=Acute Institution
PedsQL subtotal for Feelings grouped by EQ-5D-Y Worried, Sad or
Unhappy
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Appendix Figure 8:  Comparing EQ-5D-Y WSU dimension with PedsQL Feelings dimension, for AI  
There was a significant difference in ranking of PedsQL Feelings dimension score across the three 
levels of the EQ-5D-Y WSU dimension for acutely ill children (p=0.007)).  
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Comparing EQ-5D-Y Mobility and WeeFIM Mobility dimension for SS  
Institution=Special School
WeeFIM Mobility subtotal grouped by EQ-5D-Y Mobility
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Appendix Figure 9: Comparing the EQ-5D-Y Mobility and WeeFIM Mobility dimension for SS  
There was a significant difference in ranking of the WeeFIM mobility score across the three levels of 
the EQ-5D-Y mobility dimension, for the SS (p<0.001).  
Institution=Chronic Institution
WeeFIM Mobility subtotal grouped by EQ-5D-Y Mobility
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Appendix Figure 10: Comparing the EQ-5D-Y Mobility and WeeFIM Mobility dimension for CI  
There was a significant difference in ranking of the WeeFIM mobility score across the three levels of 
the EQ-5D-Y mobility dimension, at the CI (p=0.01). 
Institution=Acute Institution
WeeFIM Mobility subscore grouped by EQ-5D-Y Mobility
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Appendix Figure 11: Comparing the EQ-5D-Y Mobility and WeeFIM Mobility dimension for AI  
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There was a significant difference in ranking of the WeeFIM mobility score across the three levels of 
the EQ-5D-Y mobility dimension, at the AI (p<0.001). 
Comparing WeeFIM Self-care subtotal with EQ-5D-Y LAM dimension at SS  
Institution=Special School
WeeFIM Self-care subtotal grouped by EQ-5D-Y Looking After Myself
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Appendix Figure 12: Comparing WeeFIM Self-care subtotal with EQ-5D-Y LAM dimension at SS  
There was a significant difference in ranking of PedsQL Self-care subtotal across the different levels of 
the EQ-5D-Y LAM  dimension, in the children at the SS (p<0.001).  
Comparing WeeFIM Self-care subtotal with EQ-5D-Y LAM dimension at CI 
Institution=Chronic Institution
WeeFIM Self-care subtotal grouped by EQ-5D-Y Looking After Myself
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Appendix Figure 13: Comparing WeeFIM Self-care subtotal with EQ-5D-Y LAM dimension at CI  
There was a significant difference in ranking of PedsQL Self-care subtotal across the different levels of 
the EQ-5D-Y LAM dimension, in the children at the CI (p<0.013).  
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Comparing WeeFIM Self-care subtotal with EQ-5D-Y LAM dimension at AI 
Institution=Acute Institution
WeeFIM Self-care subtotal grouped by EQ-5D-Y Looking After Myself
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Appendix Figure 14: Comparing WeeFIM Self-care subtotal with EQ-5D-Y LAM dimension at AI  
There was a significant difference in ranking of PedsQL Self-care subtotal across the different levels of 
the EQ-5D-Y LAM  dimension, in the children at the AI (p<0.001).  
Comparing EQ-5D-Y P/D dimension and Faces Pain Scale score at AI 
Institution=Acute Institution
Faces Pain Scale score grouped by EQ-5D-Y pain dimension
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Appendix Figure 15: Comparing EQ-5D-Y P/D dimension and Faces Pain Scale score at AI  
There was a significant difference in ranking of FPS across the three levels of EQ-5D-Y P/D dimension 
at the AI (p<0.001).  
 
 
 
 
 
 
